original_value,curated_ontology,match_level,stage,top1_match,top1_score,top2_match,top2_score,top3_match,top3_score,top4_match,top4_score,top5_match,top5_score
nan,nan,1,1,nan,1.0,nan,1.0,nan,1.0,nan,1.0,nan,1.0
1-ERG,ERG Gene,1,2,ERG Gene,0.6789,Ewing Sarcoma<;>ERG Gene Rearrangement,0.4684,immortal epithelial cell line cell,0.4488,First Relapse,0.4485,Retinoblastoma,0.4274
2-ETV1,ETV1 Gene,1,2,ETV1 Gene,0.6251,ETV4 Gene,0.5729,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.5249,immortal epithelial cell line cell,0.4821,immortal embryo-derived fibroblast cell line cell,0.4759
20% DYSGERMINOMA AND 80% YOLK SAC TUMOR,Ovarian Dysgerminoma<;>Yolk Sac Tumor,1,2,Ovarian Dysgerminoma<;>Yolk Sac Tumor,0.8746,Yolk Sac Tumor,0.7987,Nongerminomatous Germ Cell Tumor<;>Yolk Sac Tumor,0.7546,Nonseminomatous<;>Yolk Sac Tumor,0.7484,Yolk Sac Tumor<;>Seminoma,0.7273
25-30% DUCTAL COMPONENT,Prostate Ductal Adenocarcinoma,99,2,Ductal,0.6075,Breast Ductal Carcinoma In Situ,0.5760,Ductal<;>Micropapillary Growth Pattern,0.5648,Proximal Bile Duct,0.5614,Breast Ductal Carcinoma,0.5519
3-ETV4,ETV4 Gene,1,2,ETV4 Gene,0.6574,ETV1 Gene,0.5452,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.5104,Anaplastic Ependymoma,0.4549,Embryonal Tumor with Multilayered Rosettes,0.4487
4-FLI1,FLI1 Gene,1,2,FLI1 Gene,0.7913,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.5458,immortal embryo-derived fibroblast cell line cell,0.4765,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.4458,"Supratentorial Ependymoma, ZFTA-RELA Fusion-Positive",0.4427
5-SPOP,SPOP Gene,1,2,SPOP Gene,0.5884,Myelodysplastic Syndrome with Isolated del(5q),0.4376,Myelodysplastic Syndrome with del(5q),0.4331,Serous,0.4203,Papillary Serous Cystadenocarcinoma,0.4132
6-FOXA1,FOXA1 Gene,1,2,FOXA1 Gene,0.6999,PAX3/FOXO1 Fusion Gene,0.6231,Thyroid Gland Follicular Carcinoma<;>Thyroid Gland Oncocytic Carcinoma,0.4422,Thyroid Gland Oncocytic Adenoma,0.4018,Follicular Variant Thyroid Gland Papillary Carcinoma,0.3935
7-IDH1,IDH1 Gene,1,2,IDH1 Gene,0.8017,"Astrocytoma, IDH-Mutant, Grade 2",0.5215,"Astrocytoma, IDH-Mutant, Grade 3",0.5024,Glioblastoma<;>IDH Family Wildtype,0.4948,Gliosarcoma<;>IDH Family Wildtype,0.4940
82463 NEUROENDOCRINE CARCINOMA NOS,Neuroendocrine Carcinoma,2,2,Adenocarcinoma with Neuroendocrine Differentiation,0.7027,Neuroendocrine Carcinoma,0.6599,Neuroendocrine Carcinoma<;>Poorly Differentiated,0.6372,Endometrial Neuroendocrine Carcinoma,0.6234,Cervical Neuroendocrine Tumor,0.6153
AB,Thymoma Type AB,4,2,Bilateral,0.5363,Basal,0.5219,Activated B-Cell Positive,0.5066,Thymoma Type AB,0.4841,Alveolar,0.4694
ABC,Activated B-Cell Positive,99,2,Basal,0.4837,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.4759,Arm,0.4702,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.4500,Castleman Disease,0.4498
ABDOMEN,Abdomen,1,2,Abdomen,1.0000,Abdominal Wall,0.8532,Extrahepatic,0.6136,Peritoneum,0.5974,Stomach,0.5795
ABDOMINAL WALL,Abdominal Wall,1,2,Abdominal Wall,1.0000,Abdomen,0.8532,Peritoneum,0.6958,Omentum,0.5422,Malignant Peritoneal Neoplasm,0.5321
ACANTHOLYTIC,Skin Acantholytic Squamous Cell Carcinoma,1,2,Skin Acantholytic Squamous Cell Carcinoma,0.5446,Histiocytosis,0.5205,Basal,0.5134,Leukapheresis,0.5002,Kataegis,0.4981
ACC,Adrenal Cortical Carcinoma,99,2,Acinar Cell Carcinoma,0.5359,Astrocytoma,0.5207,Pancreatic Acinar Cell Carcinoma,0.5130,Adenosquamous Carcinoma,0.4953,Adenocarcinoma with Neuroendocrine Differentiation,0.4951
ACINAR,Acinar Cell,1,2,Acinar Cell,0.8248,Acinar Cell Carcinoma,0.6832,Lobular,0.6727,Alveolar,0.6511,Ductal,0.6367
ACINAR ADENOCARCINOMA 85513,Lung Acinar Adenocarcinoma,3,2,Prostate Acinar Adenocarcinoma,0.6841,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.6800,Lung Acinar Adenocarcinoma,0.6632,Acinar Cell Carcinoma,0.6321,Pancreatic Mixed Acinar-Ductal Carcinoma,0.6188
ACINAR AND CRIBRIFORM,Prostate Acinar Adenocarcinoma<;>Cribriform,1,2,Prostate Acinar Adenocarcinoma<;>Cribriform,0.7128,Acinar Cell,0.6694,Cribriform,0.6446,Acinar Cell Carcinoma,0.6326,Acinar Cell Carcinoma<;>Papillary,0.6156
ACINAR AND DUCTAL,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,99,2,Ductal,0.7579,Acinar Cell,0.7300,Duct,0.6682,Pancreatic Mixed Acinar-Ductal Carcinoma,0.6496,Pancreatic Ductal Adenocarcinoma,0.6412
ACINAR CELL CARCINOMA,Acinar Cell Carcinoma,1,2,Acinar Cell Carcinoma,1.0000,Pancreatic Acinar Cell Carcinoma,0.9016,Acinar Cell Carcinoma<;>Papillary,0.8589,Lung Acinar Adenocarcinoma,0.8525,Prostate Acinar Adenocarcinoma,0.8408
ACINAR CELL CARCINOMA OF THE PANCREAS,Pancreatic Acinar Cell Carcinoma,1,2,Pancreatic Acinar Cell Carcinoma,0.9795,Acinar Cell Carcinoma,0.8975,Prostate Acinar Adenocarcinoma,0.8235,Pancreatic Adenocarcinoma,0.8185,Lung Acinar Adenocarcinoma,0.8099
"ACINAR CELL CARCINOMA, NOS",Acinar Cell Carcinoma,1,2,Acinar Cell Carcinoma,0.9939,Pancreatic Acinar Cell Carcinoma,0.8963,Acinar Cell Carcinoma<;>Papillary,0.8532,Lung Acinar Adenocarcinoma,0.8468,Prostate Acinar Adenocarcinoma,0.8356
ACINAR/ PAPILLARY,Acinar Cell Carcinoma<;>Papillary,2,2,Papillary,0.7731,Acinar Cell Carcinoma<;>Papillary,0.7603,Papillary Adenocarcinoma,0.7189,Papillary Carcinoma,0.6686,Non-Papillary Pattern,0.6633
ACINIC CELL CARCINOMA,Acinar Cell Carcinoma,1,2,Acinar Cell Carcinoma,0.8804,Pancreatic Acinar Cell Carcinoma,0.8014,Acinar Cell Carcinoma<;>Papillary,0.7449,Lung Acinar Adenocarcinoma,0.7353,Prostate Acinar Adenocarcinoma,0.7266
ACRAL,Acral Lentiginous Melanoma,3,2,Arm,0.5947,Distal,0.5225,Acral Lentiginous Melanoma,0.5128,Manubrium,0.4937,Bone,0.4883
ACRAL LENTIGINOUS,Acral Lentiginous Melanoma,2,2,Lentigo Maligna,0.7568,Acral Lentiginous Melanoma,0.7458,Lentigo Maligna Melanoma,0.6337,Keratoacanthoma,0.4989,Neurocutaneous Melanosis,0.4958
ACRAL MELANOMA,Acral Lentiginous Melanoma,1,2,Acral Lentiginous Melanoma,0.8809,Amelanotic Melanoma,0.7154,Cutaneous Melanoma,0.6875,Lentigo Maligna Melanoma,0.6645,Low-CSD Melanoma,0.6565
ACTIVATED B-CELL TYPE,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,3,2,Activated B-Cell Positive,0.8293,B-Lymphocyte,0.7253,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.6847,germinal center B cell,0.6603,Blastic Phase,0.5705
ACUTE BIPHENOTYPIC LEUKEMIA,Acute Biphenotypic Leukemia,1,2,Acute Biphenotypic Leukemia,1.0000,"Mixed Phenotype Acute Leukemia, B/Myeloid",0.8522,"Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified",0.8427,Acute Monoblastic and Monocytic Leukemia,0.8204,Acute Leukemia of Ambiguous Lineage,0.8176
ACUTE ERYTHROID LEUKAEMIA,Acute Erythroid Leukemia,1,2,Acute Erythroid Leukemia,0.9918,Pure Erythroid Leukemia,0.9007,Erythroleukemia,0.8101,Acute Myeloid Leukemia,0.7787,Acute Myeloid Leukemia Not Otherwise Specified,0.7325
ACUTE ERYTHROID LEUKEMIA,Acute Erythroid Leukemia,1,2,Acute Erythroid Leukemia,1.0000,Pure Erythroid Leukemia,0.9015,Erythroleukemia,0.8057,Acute Myeloid Leukemia,0.7858,Acute Myeloid Leukemia Not Otherwise Specified,0.7349
ACUTE LEUKAEMIAS OF AMBIGUOUS LINEAGE,Acute Leukemia of Ambiguous Lineage,1,2,Acute Leukemia of Ambiguous Lineage,0.9845,Acute Undifferentiated Leukemia,0.8229,Acute Myeloid Leukemia Not Otherwise Specified,0.8199,Acute Biphenotypic Leukemia,0.8165,Acute Myeloid Leukemia,0.8058
ACUTE LEUKEMIAS OF AMBIGUOUS LINEAGE,Acute Leukemia of Ambiguous Lineage,1,2,Acute Leukemia of Ambiguous Lineage,0.9837,Acute Undifferentiated Leukemia,0.8234,Acute Biphenotypic Leukemia,0.8177,Acute Myeloid Leukemia Not Otherwise Specified,0.8046,Acute Myeloid Leukemia,0.7924
ACUTE LYMPHOBLASTIC LEUKEMIA,Acute Lymphoblastic Leukemia,1,2,Acute Lymphoblastic Leukemia,1.0000,B Acute Lymphoblastic Leukemia,0.8791,Lymphoblastic Lymphoma,0.8184,T Acute Lymphoblastic Leukemia,0.7750,B Lymphoblastic Leukemia/Lymphoma,0.7707
"ACUTE LYMPHOBLASTIC LEUKEMIA ALL, B-CELL",B Acute Lymphoblastic Leukemia,1,2,B Acute Lymphoblastic Leukemia,0.9528,B Lymphoblastic Leukemia/Lymphoma,0.8340,Acute Lymphoblastic Leukemia,0.8039,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.7273,B Acute Lymphoblastic Leukemia with t(9<;>22)(q34.1<;>q11.2)<;> BCR-ABL1,0.7197
"ACUTE LYMPHOBLASTIC LEUKEMIA ALL, T-CELL",T Acute Lymphoblastic Leukemia,1,2,T Acute Lymphoblastic Leukemia,0.9360,Early T Acute Lymphoblastic Leukemia,0.8412,T Lymphoblastic Leukemia/Lymphoma,0.8410,Adult T-Cell Leukemia/Lymphoma,0.7825,T-Cell Non-Hodgkin Lymphoma,0.6912
ACUTE LYMPHOID LEUKEMIA,Acute Lymphoblastic Leukemia,1,2,Acute Lymphoblastic Leukemia,0.8122,B Acute Lymphoblastic Leukemia,0.7843,Lymphoblastic Lymphoma,0.7571,B Lymphoblastic Leukemia/Lymphoma,0.7184,Acute Leukemia of Ambiguous Lineage,0.6766
ACUTE MEGAKARYOBLASTIC LEUKAEMIA,Acute Megakaryoblastic Leukemia,1,2,Acute Megakaryoblastic Leukemia,0.9938,Acute Myelomonocytic Leukemia,0.8609,Acute Megakaryoblastic Leukemia<;>Down Syndrome,0.8098,Acute Monocytic Leukemia,0.7889,Acute Myeloid Leukemia,0.7794
ACUTE MEGAKARYOBLASTIC LEUKEMIA,Acute Megakaryoblastic Leukemia,1,2,Acute Megakaryoblastic Leukemia,1.0000,Acute Myelomonocytic Leukemia,0.8594,Acute Megakaryoblastic Leukemia<;>Down Syndrome,0.8206,Acute Monocytic Leukemia,0.7847,Acute Myeloid Leukemia,0.7764
ACUTE MONOBLASTIC AND MONOCYTIC LEUKAEMIA,Acute Monoblastic and Monocytic Leukemia,1,2,Acute Monoblastic and Monocytic Leukemia,0.9917,Acute Monocytic Leukemia,0.8796,Acute Myelomonocytic Leukemia,0.8291,Acute Biphenotypic Leukemia,0.8214,Acute Myeloid Leukemia,0.8173
ACUTE MONOBLASTIC/MONOCYTIC LEUKEMIA,Acute Monoblastic and Monocytic Leukemia,1,2,Acute Monoblastic and Monocytic Leukemia,0.9893,Acute Monocytic Leukemia,0.9032,Acute Myelomonocytic Leukemia,0.8397,Acute Biphenotypic Leukemia,0.8146,Acute Myeloid Leukemia,0.8139
ACUTE MYELOBLASTIC LEUKEMIA,Acute Myeloid Leukemia,1,2,Acute Myeloid Leukemia,0.9302,Acute Myeloid Leukemia Not Otherwise Specified,0.9192,Acute Myelomonocytic Leukemia,0.8687,Acute Myeloid Leukemia with Maturation,0.8368,Acute Monoblastic and Monocytic Leukemia,0.8355
"ACUTE MYELOBLASTIC LEUKEMIA, IN RELAPSE",Recurrent Acute Myeloid Leukemia,1,2,Recurrent Acute Myeloid Leukemia,0.8506,Acute Myeloid Leukemia with Maturation<;>Auer Rods Present,0.7286,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.6966,Acute Myeloid Leukemia with Maturation,0.6758,Acute Myeloid Leukemia without Maturation,0.6694
ACUTE MYELOGENOUS LEUKEMIA AML,Acute Myeloid Leukemia,1,2,Acute Myeloid Leukemia,0.9370,Acute Myeloid Leukemia Not Otherwise Specified,0.9131,Acute Myelomonocytic Leukemia,0.8525,Acute Myeloid Leukemia with Maturation,0.8363,Acute Monoblastic and Monocytic Leukemia,0.8084
"ACUTE MYELOGENOUS LEUKEMIA AML, M2 MYELOBLASTIC",Acute Myeloid Leukemia with Maturation,2,2,Acute Myelomonocytic Leukemia,0.7549,Acute Myeloid Leukemia with Maturation,0.7524,Acute Myeloid Leukemia with Minimal Differentiation,0.7388,Acute Myeloid Leukemia without Maturation,0.7358,Acute Monoblastic and Monocytic Leukemia,0.7317
"ACUTE MYELOGENOUS LEUKEMIA AML, M3 PROMYELOCYTIC",Acute Promyelocytic Leukemia with PML-RARA,2,2,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.7638,Acute Promyelocytic Leukemia with PML-RARA,0.7622,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.7204,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.7204,Acute Myelomonocytic Leukemia,0.6955
"ACUTE MYELOGENOUS LEUKEMIA AML, M4 MYELOMONOCYTIC",Acute Myelomonocytic Leukemia,1,2,Acute Myelomonocytic Leukemia,0.8433,Acute Monoblastic and Monocytic Leukemia,0.7298,Acute Myeloid Leukemia with Maturation,0.7243,Acute Myeloid Leukemia with Multilineage Dysplasia,0.7101,Acute Megakaryoblastic Leukemia,0.6974
"ACUTE MYELOGENOUS LEUKEMIA AML, M5 EOSINOPHILIC/MONOCYTIC",Acute Monoblastic and Monocytic Leukemia,1,2,Acute Monoblastic and Monocytic Leukemia,0.7942,Acute Myelomonocytic Leukemia,0.7785,Acute Myeloid Leukemia with Multilineage Dysplasia,0.7519,Acute Monocytic Leukemia,0.7471,Acute Myeloid Leukemia with Maturation,0.7340
"ACUTE MYELOGENOUS LEUKEMIA AML, M5 MONOCYTIC",Acute Monoblastic and Monocytic Leukemia,2,2,Acute Monocytic Leukemia,0.8465,Acute Monoblastic and Monocytic Leukemia,0.8395,Acute Myelomonocytic Leukemia,0.8310,Acute Myeloid Leukemia with Maturation,0.7593,Acute Myeloid Leukemia with Multilineage Dysplasia,0.7346
"ACUTE MYELOGENOUS LEUKEMIA AML, M6 ERYTHROLEUKEMIA",Acute Erythroid Leukemia,1,2,Acute Erythroid Leukemia,0.7092,Acute Myelomonocytic Leukemia,0.6999,Acute Myeloid Leukemia with Mutated CEBPA,0.6867,Acute Promyelocytic Leukemia with PML-RARA,0.6817,Acute Megakaryoblastic Leukemia,0.6799
"ACUTE MYELOGENOUS LEUKEMIA AML, M7 MEGAKARYOBLASTIC",Acute Megakaryoblastic Leukemia,1,2,Acute Megakaryoblastic Leukemia,0.8208,Acute Myelomonocytic Leukemia,0.7657,Acute Megakaryoblastic Leukemia<;>Down Syndrome,0.7089,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.6825,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.6660
ACUTE MYELOGENOUS LEUKEMIA M5A,Acute Monoblastic and Monocytic Leukemia,3,2,Acute Myelomonocytic Leukemia,0.8188,Acute Myeloid Leukemia,0.7966,Acute Monoblastic and Monocytic Leukemia,0.7784,Acute Myeloid Leukemia with Maturation,0.7734,Acute Myeloid Leukemia Not Otherwise Specified,0.7667
ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS,Acute Myeloid Leukemia,1,2,Acute Myeloid Leukemia,0.8023,Acute Myeloid Leukemia Not Otherwise Specified,0.8010,Acute Myeloid Leukemia Not Otherwise Specified<;>Therapy-Related Myeloid Neoplasm,0.7534,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.7513,Acute Monoblastic and Monocytic Leukemia,0.7489
ACUTE MYELOID LEUKAEMIA AML AND RELATED PRECURSOR NEOPLASMS,Acute Myeloid Leukemia,2,2,Acute Myeloid Leukemia Not Otherwise Specified,0.7890,Acute Myeloid Leukemia,0.7862,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.7789,Acute Monoblastic and Monocytic Leukemia,0.7705,Acute Promyelocytic Leukemia with PML-RARA,0.7528
"ACUTE MYELOID LEUKAEMIA, NOS",Acute Myeloid Leukemia,1,2,Acute Myeloid Leukemia,0.9828,Acute Myeloid Leukemia Not Otherwise Specified,0.9591,Acute Myeloid Leukemia with Maturation,0.8125,Acute Monoblastic and Monocytic Leukemia,0.8085,Acute Myelomonocytic Leukemia,0.7945
"ACUTE MYELOID LEUKAEMIA, NOS, THERAPY-RELATED MYELOID NEOPLASMS",Acute Myeloid Leukemia Not Otherwise Specified<;>Therapy-Related Myeloid Neoplasm,1,2,Acute Myeloid Leukemia Not Otherwise Specified<;>Therapy-Related Myeloid Neoplasm,0.9709,Therapy-Related Myeloid Neoplasm,0.8533,Acute Myeloid Leukemia,0.7882,Acute Myeloid Leukemia Not Otherwise Specified,0.7807,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.7413
ACUTE MYELOID LEUKEMIA,Acute Myeloid Leukemia,1,2,Acute Myeloid Leukemia,1.0000,Acute Myeloid Leukemia Not Otherwise Specified,0.9693,Acute Myeloid Leukemia with Maturation,0.8460,Acute Monoblastic and Monocytic Leukemia,0.8193,Acute Myelomonocytic Leukemia,0.8136
ACUTE MYELOID LEUKEMIA WITH MULTILINEAGE DYSPLASIA,Acute Myeloid Leukemia with Multilineage Dysplasia,1,2,Acute Myeloid Leukemia with Multilineage Dysplasia,1.0000,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,0.9152,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.8456,Acute Myeloid Leukemia with Minimal Differentiation,0.8213,Acute Myeloid Leukemia with Maturation,0.8156
"ACUTE MYELOID LEUKEMIA WITH MULTILINEAGE DYSPLASIA, NOT HAVING ACHIEVED REMISSION",Acute Myeloid Leukemia with Multilineage Dysplasia,1,2,Acute Myeloid Leukemia with Multilineage Dysplasia,0.7671,Acute Myeloid Leukemia without Maturation<;>Auer Rods Present,0.7240,Acute Myeloid Leukemia without Maturation,0.7141,Acute Myeloid Leukemia with Maturation<;>Auer Rods Present,0.7117,Acute Myeloid Leukemia with Minimal Differentiation,0.7101
ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA RELATED CHANGES,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,1,2,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,0.9959,Acute Myeloid Leukemia with Multilineage Dysplasia,0.9085,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.8421,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.8143,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,0.7778
ACUTE MYELOID LEUKEMIAS,Acute Myeloid Leukemia,1,2,Acute Myeloid Leukemia,0.9885,Acute Myeloid Leukemia Not Otherwise Specified,0.9549,Acute Myeloid Leukemia with Maturation,0.8284,Acute Monoblastic and Monocytic Leukemia,0.8108,Acute Myelomonocytic Leukemia,0.8064
ACUTE MYELOMONOCYTIC LEUKAEMIA,Acute Myelomonocytic Leukemia,1,2,Acute Myelomonocytic Leukemia,0.9916,Acute Megakaryoblastic Leukemia,0.8580,Acute Monocytic Leukemia,0.8517,Acute Monoblastic and Monocytic Leukemia,0.8388,Acute Myeloid Leukemia,0.8147
ACUTE MYELOMONOCYTIC LEUKEMIA,Acute Myelomonocytic Leukemia,1,2,Acute Myelomonocytic Leukemia,1.0000,Acute Megakaryoblastic Leukemia,0.8594,Acute Monocytic Leukemia,0.8452,Acute Monoblastic and Monocytic Leukemia,0.8353,Acute Myeloid Leukemia,0.8136
ACUTE PROMYELOCYTIC LEUKAEMIA WITH T(15;17)(Q22;Q12); PML-RARA,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,1,2,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.9472,Acute Promyelocytic Leukemia with PML-RARA,0.9162,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.7857,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.7550,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.7550
ACUTE PROMYELOCYTIC LEUKAEMIA WITH T15;17Q22;Q12;  PML-RARA,Acute Promyelocytic Leukemia with PML-RARA,2,2,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.9098,Acute Promyelocytic Leukemia with PML-RARA,0.8374,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.7542,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6745,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.6745
ACUTE PROMYELOCYTIC LEUKAEMIA WITH T15;17Q22;Q12; PML-RARA,Acute Promyelocytic Leukemia with PML-RARA,2,2,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.9098,Acute Promyelocytic Leukemia with PML-RARA,0.8374,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.7542,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6745,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.6745
ACUTE UNDIFFERENTIATED LEUKAEMIA,Acute Undifferentiated Leukemia,1,2,Acute Undifferentiated Leukemia,0.9890,Acute Leukemia of Ambiguous Lineage,0.8254,Acute Myeloid Leukemia,0.7880,Acute Biphenotypic Leukemia,0.7814,Acute Myeloid Leukemia Not Otherwise Specified,0.7760
ACUTE UNDIFFERENTIATED LEUKEMIA,Acute Undifferentiated Leukemia,1,2,Acute Undifferentiated Leukemia,1.0000,Acute Leukemia of Ambiguous Lineage,0.8222,Acute Myeloid Leukemia,0.7953,Acute Biphenotypic Leukemia,0.7870,Acute Myeloid Leukemia Not Otherwise Specified,0.7801
ACUTE_BIPHENOTYPIC_LEUKEMIA,Acute Biphenotypic Leukemia,1,2,Acute Biphenotypic Leukemia,0.9818,"Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified",0.8165,"Mixed Phenotype Acute Leukemia, B/Myeloid",0.8164,Acute Monoblastic and Monocytic Leukemia,0.8074,Acute Leukemia of Ambiguous Lineage,0.8073
ACUTE_LYMPHOBLASTIC_B_CELL_LEUKAEMIA,B Acute Lymphoblastic Leukemia,1,2,B Acute Lymphoblastic Leukemia,0.9538,Acute Lymphoblastic Leukemia,0.8859,B Lymphoblastic Leukemia/Lymphoma,0.8557,Lymphoblastic Lymphoma,0.7750,B-Cell Prolymphocytic Leukemia,0.7227
ACUTE_LYMPHOBLASTIC_LEUKAEMIA,Acute Lymphoblastic Leukemia,1,2,Acute Lymphoblastic Leukemia,0.9767,B Acute Lymphoblastic Leukemia,0.8706,Lymphoblastic Lymphoma,0.7974,Acute Leukemia of Ambiguous Lineage,0.7776,B Lymphoblastic Leukemia/Lymphoma,0.7725
ACUTE_LYMPHOBLASTIC_T_CELL_LEUKAEMIA,T Acute Lymphoblastic Leukemia,1,2,T Acute Lymphoblastic Leukemia,0.9504,Early T Acute Lymphoblastic Leukemia,0.8785,T Lymphoblastic Leukemia/Lymphoma,0.8583,Acute Lymphoblastic Leukemia,0.7936,Adult T-Cell Leukemia/Lymphoma,0.7637
ACUTE_MONOCYTIC_LEUKEMIA,Acute Monocytic Leukemia,1,2,Acute Monocytic Leukemia,0.9687,Acute Monoblastic and Monocytic Leukemia,0.8931,Acute Myelomonocytic Leukemia,0.8586,Acute Myeloid Leukemia,0.8399,Acute Myeloid Leukemia Not Otherwise Specified,0.8316
ACUTE_MYELOID_LEUKAEMIA,Acute Myeloid Leukemia,1,2,Acute Myeloid Leukemia,0.9769,Acute Myeloid Leukemia Not Otherwise Specified,0.9602,Acute Myeloid Leukemia with Maturation,0.8271,Acute Monoblastic and Monocytic Leukemia,0.8124,Acute Leukemia of Ambiguous Lineage,0.8096
ACYC,Adenoid Cystic Carcinoma,99,2,Atypical Chronic Myeloid Leukemia,0.4921,Astrocytoma,0.4910,Anaplastic Astrocytoma,0.4680,nan,0.4634,Angiocentric Glioma,0.4568
ADAMANTINOMA,Adamantinoma,1,2,Adamantinoma,1.0000,Adamantinomatous Craniopharyngioma,0.7838,Amelanotic Melanoma,0.6318,Alveolar Soft Part Sarcoma,0.6284,Angiocentric Glioma,0.5914
ADCA ACINAR WITH MUCIN PRODUCTION,Lung Colloid Adenocarcinoma,99,2,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.6531,Acinar Cell Carcinoma,0.6488,Pancreatic Mixed Acinar-Ductal Carcinoma,0.6464,Acinar Cell Carcinoma<;>Papillary,0.6250,Prostate Acinar Adenocarcinoma,0.6230
ADENOCARCINOMA,Adenocarcinoma,1,2,Adenocarcinoma,1.0000,Adenocarcinoma<;>Undifferentiated,0.8629,Adenocarcinoma<;>Invasive,0.8618,Adenocarcinoma<;>Well Differentiated,0.8557,Adenocarcinoma<;>Undifferentiated Carcinoma,0.8469
ADENOCARCINOMA AND MATURE CYSTIC TERATOMA,Adenocarcinoma<;>Dermoid Cyst,2,2,Mixed Cell Adenocarcinoma,0.7416,Adenocarcinoma<;>Dermoid Cyst,0.7219,Mixed Carcinoma,0.7151,Mucinous Cystadenocarcinoma,0.6971,Mucinous Adenocarcinoma,0.6946
ADENOCARCINOMA OF GALLBLADDER,Gallbladder Adenocarcinoma,1,2,Gallbladder Adenocarcinoma,0.9842,Gallbladder Carcinoma,0.9124,Gallbladder Squamous Cell Carcinoma,0.7952,Gallbladder Adenosquamous Carcinoma,0.7850,Gallbladder Large Cell Neuroendocrine Carcinoma,0.6820
ADENOCARCINOMA OF THE GASTROESOPHAGEAL JUNCTION,Gastroesophageal Junction Adenocarcinoma,1,2,Gastroesophageal Junction Adenocarcinoma,0.9796,Gastroesophageal Cancer,0.7403,Esophageal Adenocarcinoma,0.6849,Gastric Adenocarcinoma,0.6681,Esophageal Neuroendocrine Carcinoma<;>Adenocarcinoma,0.6651
ADENOCARCINOMA P/MD,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,3,2,Adenocarcinoma,0.7782,Poorly Differentiated Adenocarcinoma,0.7664,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.7449,Adenocarcinoma<;>Poorly Differentiated,0.7410,Mixed Cell Adenocarcinoma,0.7393
ADENOCARCINOMA PROSTATE WITH PROMINENT DUCTAL DIFFERENTIATION IDENTIFIED,Prostate Ductal Adenocarcinoma,1,2,Prostate Ductal Adenocarcinoma,0.8009,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.7819,Prostate Acinar Adenocarcinoma,0.7276,Prostate Adenocarcinoma,0.7035,Pancreatic Adenosquamous Carcinoma<;>Ductal,0.6501
ADENOCARCINOMA WITH FOCAL MUCINOUS FEATURES,Mucinous Adenocarcinoma,1,2,Mucinous Adenocarcinoma,0.8179,Mucinous Cystadenocarcinoma,0.7378,Mixed Cell Adenocarcinoma,0.7345,Invasive Lung Mucinous Adenocarcinoma,0.6873,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.6841
ADENOCARCINOMA WITH NE FEATURES,Adenocarcinoma with Neuroendocrine Differentiation,1,2,Adenocarcinoma with Neuroendocrine Differentiation,0.8456,Adenocarcinoma<;>Undifferentiated Carcinoma,0.7538,Adenocarcinoma<;>Well Differentiated,0.7496,Adenocarcinoma<;>Undifferentiated,0.7490,Adenocarcinoma,0.7453
"ADENOCARCINOMA, CLEAR CELL",Adenocarcinoma Clear Cell,1,2,Adenocarcinoma Clear Cell,0.9891,Clear Cell Adenocarcinoma,0.9860,Clear Cell Renal Cell Carcinoma,0.8450,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.8026,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.7759
"ADENOCARCINOMA, ENDOMETRIOID",Endometrioid Adenocarcinoma,1,2,Endometrioid Adenocarcinoma,0.9918,Endometrial Endometrioid Adenocarcinoma,0.9532,Endometrioid Tumor,0.9220,Ovarian Endometrioid Adenocarcinoma,0.9004,Cervical Endometrioid Adenocarcinoma,0.9003
"ADENOCARCINOMA, HIGH GRADE SEROUS",Serous Adenocarcinoma<;>High Grade,1,2,Serous Adenocarcinoma<;>High Grade,0.9765,Serous Adenocarcinoma,0.9359,Ovarian High Grade Serous Adenocarcinoma,0.9081,Serous Cystadenocarcinoma,0.8918,Cystadenocarcinoma<;>High Grade<;>Serous,0.8870
"ADENOCARCINOMA, LOW GRADE SEROUS",Ovarian Low Grade Serous Adenocarcinoma,2,2,Serous Adenocarcinoma,0.9329,Ovarian Low Grade Serous Adenocarcinoma,0.9073,Serous Adenocarcinoma<;>High Grade,0.8761,Ovarian Serous Adenocarcinoma,0.8702,Serous Cystadenocarcinoma,0.8481
"ADENOCARCINOMA, MIXED",Mixed Cell Adenocarcinoma,1,2,Mixed Cell Adenocarcinoma,0.9711,Mixed Carcinoma,0.9055,"Lung Adenocarcinoma, Mixed Subtype",0.8309,Adenocarcinoma<;>Undifferentiated Carcinoma,0.8086,Adenocarcinoma<;>Undifferentiated,0.8054
"ADENOCARCINOMA, MIXED SUBTYPES","Lung Adenocarcinoma, Mixed Subtype",3,2,Mixed Cell Adenocarcinoma,0.9469,Mixed Carcinoma,0.8627,"Lung Adenocarcinoma, Mixed Subtype",0.8419,Adenocarcinoma<;>Undifferentiated,0.8121,Adenocarcinoma<;>Undifferentiated Carcinoma,0.8055
"ADENOCARCINOMA, MUCINOUS",Mucinous Adenocarcinoma,1,2,Mucinous Adenocarcinoma,0.9900,Mucinous Cystadenocarcinoma,0.8662,Mucinous,0.8249,Gastric Mucinous Adenocarcinoma,0.8203,Mucinous gastric carcinoma,0.8073
"ADENOCARCINOMA, NOS",Adenocarcinoma,1,2,Adenocarcinoma,0.9894,Adenocarcinoma<;>Undifferentiated,0.8619,Adenocarcinoma<;>Well Differentiated,0.8545,Adenocarcinoma<;>Undifferentiated Carcinoma,0.8491,Adenocarcinoma<;>Invasive,0.8456
"ADENOCARCINOMA, NOS 81403",Adenocarcinoma,99,2,Endometrial Clear Cell Adenocarcinoma,0.5969,Mixed Cell Adenocarcinoma,0.5945,Clear Cell Adenocarcinoma,0.5909,Poorly Differentiated Adenocarcinoma,0.5866,Adenoid Cystic Carcinoma,0.5807
"ADENOCARCINOMA, SEROUS",Serous Adenocarcinoma,1,2,Serous Adenocarcinoma,0.9902,Ovarian Serous Adenocarcinoma,0.9183,Serous Adenocarcinoma<;>High Grade,0.9148,Serous Cystadenocarcinoma,0.9056,Ovarian High Grade Serous Adenocarcinoma,0.8576
"ADENOCARCINOMA, SIGNET RING CELL",Signet Ring Cell Carcinoma,1,2,Signet Ring Cell Carcinoma,0.9558,Signet Ring Adenocarcinoma Cell,0.9513,Pancreatic Signet Ring Cell Carcinoma,0.8767,Gastric Signet Ring Cell Adenocarcinoma,0.8720,Signet Ring Cell<;>Mucinous,0.8419
"ADENOCARCINOMA, TUBULAR",Tubular Adenocarcinoma,1,2,Tubular Adenocarcinoma,0.9908,Tubular Adenocarcinoma<;>Well Differentiated Adenocarcinoma Cell,0.8704,Gastric Tubular Adenocarcinoma,0.7901,Tubular Adenocarcinoma<;>Moderately Differentiated,0.7877,Breast Tubular Carcinoma,0.7706
ADENOCARCINOMA- MAMMARY GLAND,Breast Adenocarcinoma,1,2,Breast Adenocarcinoma,0.8899,Breast Carcinoma,0.7685,Breast Ductal Carcinoma,0.7062,Adenocarcinoma,0.6703,Invasive Breast Carcinoma,0.6491
ADENOCARCINOMA- MAMMARY GLAND; BREAST; METASTATIC SITE: PLEURAL EFFUSION;,Breast Adenocarcinoma<;>Pleural Effusion<;>Site of Metastasis,1,2,Breast Adenocarcinoma<;>Pleural Effusion<;>Site of Metastasis,0.8953,Breast Ductal Carcinoma<;>Pleural Effusion<;>Site of Metastasis,0.7895,Pleural Effusion<;>Site of Metastasis,0.6394,Breast Adenocarcinoma,0.5314,Malignant Pleural Neoplasm,0.5086
ADENOCARCINOMA- NOS,Adenocarcinoma,1,2,Adenocarcinoma,0.9889,Adenocarcinoma<;>Undifferentiated,0.8632,Adenocarcinoma<;>Invasive,0.8483,Adenocarcinoma<;>Well Differentiated,0.8472,Adenocarcinoma<;>Undifferentiated Carcinoma,0.8438
ADENOCARCINOMA- PROSTATE,Prostate Adenocarcinoma,1,2,Prostate Adenocarcinoma,0.9642,Prostate Carcinoma,0.9034,Prostate Ductal Adenocarcinoma,0.8291,Adenocarcinoma,0.7696,Prostate Acinar Adenocarcinoma,0.7673
ADENOCARCINOMA- PROSTATE; METASTATIC SITE: BONE;,Bone<;>Site of Metastasis<;>Prostate Adenocarcinoma,1,2,Bone<;>Site of Metastasis<;>Prostate Adenocarcinoma,0.8958,Prostate Adenocarcinoma,0.6697,Castration-Resistant Prostate Carcinoma<;>Metastatic Prostate Carcinoma,0.6429,Prostate Carcinoma,0.6207,Castration-Resistant Prostate Carcinoma<;>Prostate Adenocarcinoma,0.6142
ADENOCARCINOMA-MAMMARY GLAND,Breast Adenocarcinoma,1,2,Breast Adenocarcinoma,0.8899,Breast Carcinoma,0.7685,Breast Ductal Carcinoma,0.7062,Adenocarcinoma,0.6703,Invasive Breast Carcinoma,0.6491
ADENOCARCINOMA-MAMMARY GLAND; BREAST; EPITHELIAL; METASTATIC SITE: PLEURAL EFFUSION;,Breast Adenocarcinoma<;>Pleural Effusion<;>Site of Metastasis,1,2,Breast Adenocarcinoma<;>Pleural Effusion<;>Site of Metastasis,0.8789,Breast Ductal Carcinoma<;>Pleural Effusion<;>Site of Metastasis,0.7634,Pleural Effusion<;>Site of Metastasis,0.6386,Pleural Epithelioid Mesothelioma,0.5521,Pleural Biphasic Mesothelioma,0.5341
ADENOCARCINOMA-MD,Adenocarcinoma<;>Moderately Differentiated,99,2,Adenocarcinoma,0.7906,Poorly Differentiated Adenocarcinoma,0.7877,Moderately Differentiated Adenocarcinoma Cell,0.7820,Mixed Cell Adenocarcinoma,0.7817,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.7793
ADENOCARCINOMA-P/MD,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,4,2,Adenocarcinoma,0.7888,Poorly Differentiated Adenocarcinoma,0.7763,Adenocarcinoma<;>Poorly Differentiated,0.7557,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.7543,Mixed Cell Adenocarcinoma,0.7499
ADENOCARCINOMA-UD,Adenocarcinoma<;>Undifferentiated,2,2,Adenocarcinoma,0.8466,Adenocarcinoma<;>Undifferentiated,0.7931,Adenocarcinoma<;>Undifferentiated Carcinoma,0.7718,Adenocarcinoma<;>Well Differentiated,0.7450,Poorly Differentiated Adenocarcinoma,0.7399
ADENOCARCINOMA-VPD,Adenocarcinoma<;>Poorly Differentiated,99,2,Adenocarcinoma with Neuroendocrine Differentiation,0.6444,Poorly Differentiated Adenocarcinoma,0.6305,Mixed Cell Adenocarcinoma,0.6222,Prostate Ductal Adenocarcinoma,0.6194,Pancreatic Adenosquamous Carcinoma<;>Ductal,0.6118
ADENOCARCINOMA-WD,Adenocarcinoma<;>Well Differentiated,2,2,Adenocarcinoma,0.7255,Adenocarcinoma<;>Well Differentiated,0.7165,Poorly Differentiated Adenocarcinoma,0.6829,Adenocarcinoma with Neuroendocrine Differentiation,0.6764,Adenocarcinoma<;>Undifferentiated,0.6742
ADENOCARCINOME-PD,Adenocarcinoma<;>Poorly Differentiated,99,2,Metaplastic Carcinoma,0.6525,Adenocarcinoma with Neuroendocrine Differentiation,0.6518,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.6289,Mucinous,0.6249,Lung Atypical Carcinoid Tumor,0.6212
ADENOCARINOMA,Adenocarcinoma,99,2,Adenosarcoma,0.7845,Adenoid Cystic Carcinoma,0.7429,Breast Adenoid Cystic Carcinoma,0.6913,Cervical Adenoid Cystic Carcinoma,0.6469,Chondroblastoma,0.6392
ADENOID CYSTIC BREAST CANCER,Breast Adenoid Cystic Carcinoma,1,2,Breast Adenoid Cystic Carcinoma,0.9414,Adenoid Cystic Carcinoma,0.7638,Cervical Adenoid Cystic Carcinoma,0.7441,Breast Carcinoma with Chondroid Metaplasia,0.7238,Breast Mucinous Carcinoma,0.6886
ADENOID CYSTIC CARCINOMA,Adenoid Cystic Carcinoma,1,2,Adenoid Cystic Carcinoma,1.0000,Cervical Adenoid Cystic Carcinoma,0.8907,Breast Adenoid Cystic Carcinoma,0.8256,Lung Adenoid Cystic Carcinoma,0.8176,Adenosarcoma,0.7265
ADENOID CYSTIC CARCINOMA OF THE LUNG,Lung Adenoid Cystic Carcinoma,1,2,Lung Adenoid Cystic Carcinoma,0.9754,Adenoid Cystic Carcinoma,0.7913,Lung Adenosquamous Carcinoma,0.7851,Lung Papillary Adenocarcinoma,0.7638,Cervical Adenoid Cystic Carcinoma,0.7474
ADENOSARCOMA,Adenosarcoma,1,2,Adenosarcoma,1.0000,Angiosarcoma,0.7806,Chondrosarcoma,0.7608,Sarcomatoid Carcinoma,0.7549,Mesenchymal Chondrosarcoma,0.7332
ADENOSQUAMOUS,Adenosquamous Carcinoma,1,2,Adenosquamous Carcinoma,0.8799,Cervical Adenosquamous Carcinoma,0.7777,Lung Adenosquamous Carcinoma,0.7511,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.6839,Adenosarcoma,0.6685
ADENOSQUAMOUS CARCINOMA,Adenosquamous Carcinoma,1,2,Adenosquamous Carcinoma,1.0000,Cervical Adenosquamous Carcinoma,0.8972,Lung Adenosquamous Carcinoma,0.8640,Squamous Cell Carcinoma<;>Poorly Differentiated,0.7827,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.7657
ADENOSQUAMOUS CARCINOMA OF GALLBLADDER,Gallbladder Adenosquamous Carcinoma,1,2,Gallbladder Adenosquamous Carcinoma,0.9803,Gallbladder Squamous Cell Carcinoma,0.8900,Gallbladder Adenocarcinoma,0.7794,Gallbladder Carcinoma,0.7315,Gallbladder Small Cell Neuroendocrine Carcinoma,0.7178
ADENOSQUAMOUS CARCINOMA OF THE GALLBLADDER,Gallbladder Adenosquamous Carcinoma,1,2,Gallbladder Adenosquamous Carcinoma,0.9722,Gallbladder Squamous Cell Carcinoma,0.8772,Gallbladder Adenocarcinoma,0.7618,Gallbladder Carcinoma,0.7095,Gallbladder Small Cell Neuroendocrine Carcinoma,0.6996
ADENOSQUAMOUS CARCINOMA OF THE PANCREAS,Pancreatic Adenosquamous Carcinoma,1,2,Pancreatic Adenosquamous Carcinoma,0.9458,Pancreatic Ductal Adenocarcinoma<;>Pancreatic Adenosquamous Carcinoma,0.8972,Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland,0.8765,Pancreatic Adenosquamous Carcinoma<;>Ductal,0.8485,Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland<;>Ductal,0.8180
ADENOSQUAMOUS CARCINOMA OF THE STOMACH,Gastric Adenosquamous Carcinoma,1,2,Gastric Adenosquamous Carcinoma,0.9418,Esophageal Adenosquamous Carcinoma,0.7374,Adenosquamous Carcinoma,0.7339,Cervical Adenosquamous Carcinoma,0.7075,Gastric Poorly Cohesive Adenocarcinoma,0.6834
ADRENAL,Adrenal Gland,1,2,Adrenal Gland,0.8910,Adrenal Gland Neoplasm,0.6469,Adrenal Gland Carcinoma,0.5933,Endocrine,0.5563,Adrenal Cortical Carcinoma,0.5494
ADRENAL GLAND,Adrenal Gland,1,2,Adrenal Gland,1.0000,Adrenal Gland Neoplasm,0.7051,Adrenal Gland Carcinoma,0.6499,Exocrine Gland,0.6132,Adrenal Cortical Carcinoma,0.6008
ADRENAL TUMOR,Adrenal Gland Neoplasm,1,2,Adrenal Gland Neoplasm,0.9686,Adrenal Cortical Adenoma,0.7441,Adrenal Gland Carcinoma,0.7119,Adrenal Gland,0.6739,Adrenal Cortical Carcinoma,0.6523
ADRENAL_CARCINOMA,Adrenal Gland Carcinoma,1,2,Adrenal Gland Carcinoma,0.9570,Adrenal Cortical Carcinoma,0.9067,Adrenal Cortical Oncocytic Carcinoma,0.7541,Adrenal Gland Neoplasm,0.7191,Adrenal Cortical Adenoma,0.7031
ADRENOCORTICAL ADENOMA,Adrenal Cortical Adenoma,1,2,Adrenal Cortical Adenoma,0.9381,Adrenal Cortical Carcinoma,0.7032,Adrenal Gland Neoplasm,0.7031,Adrenal Gland Carcinoma,0.6542,Adrenal Cortical Oncocytic Carcinoma,0.6478
ADRENOCORTICAL CARCINOMA,Adrenal Cortical Carcinoma,1,2,Adrenal Cortical Carcinoma,0.9155,Adrenal Gland Carcinoma,0.8838,Adrenal Cortical Oncocytic Carcinoma,0.8067,Adrenal Cortical Adenoma,0.7955,Adrenal Cortical Myxoid Carcinoma,0.7321
ADRENOCORTICAL CARCINOMA- MYXOID TYPE,Adrenal Cortical Myxoid Carcinoma,1,2,Adrenal Cortical Myxoid Carcinoma,0.9339,Adrenal Cortical Oncocytic Carcinoma,0.7283,Myxoid Liposarcoma,0.6549,Adrenal Cortical Carcinoma,0.6460,Myxofibrosarcoma,0.6188
ADRENOCORTICAL CARCINOMA- ONCOCYTIC TYPE,Adrenal Cortical Oncocytic Carcinoma,1,2,Adrenal Cortical Oncocytic Carcinoma,0.9390,Adrenal Cortical Carcinoma,0.7725,Adrenal Cortical Myxoid Carcinoma,0.7678,Kidney Oncocytoma,0.7507,Thyroid Gland Oncocytic Carcinoma,0.7406
ADRENOCORTICAL CARCINOMA- USUAL TYPE,Adrenal Cortical Carcinoma,1,2,Adrenal Cortical Carcinoma,0.7465,Adrenal Cortical Oncocytic Carcinoma,0.7354,Adrenal Cortical Myxoid Carcinoma,0.7330,Adrenal Gland Carcinoma,0.6752,Adrenal Cortical Adenoma,0.6690
ADULT T-CELL LEUKEMIA/LYMPHOMA,Adult T-Cell Leukemia/Lymphoma,1,2,Adult T-Cell Leukemia/Lymphoma,1.0000,T-Cell Non-Hodgkin Lymphoma,0.7761,T Lymphoblastic Leukemia/Lymphoma,0.7722,T Acute Lymphoblastic Leukemia,0.7494,Early T Acute Lymphoblastic Leukemia,0.6986
ADULT_T_CELL_LYMPHOMA-LEUKAEMIA,Adult T-Cell Leukemia/Lymphoma,1,2,Adult T-Cell Leukemia/Lymphoma,0.9398,T Acute Lymphoblastic Leukemia,0.7711,T Lymphoblastic Leukemia/Lymphoma,0.7614,T-Cell Non-Hodgkin Lymphoma,0.7585,Early T Acute Lymphoblastic Leukemia,0.7196
AGGRESSIVE DIGITAL PAPILLARY ADENOCARCINOMA,Digital Papillary Adenocarcinoma,1,2,Digital Papillary Adenocarcinoma,0.9205,Papillary Adenocarcinoma,0.6124,Acinar Cell Carcinoma<;>Papillary,0.6111,Papillary Transitional Cell Carcinoma,0.5845,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.5818
ALL,Acute Lymphoblastic Leukemia,1,2,Acute Lymphoblastic Leukemia,0.7755,B Lymphoblastic Leukemia/Lymphoma,0.7376,Lymphoblastic Lymphoma,0.7286,B Acute Lymphoblastic Leukemia,0.7186,Leukemia,0.6992
ALL CELLS WERE TAKEN WHEN PATIENT WAS IN RELAPSE,Acute Lymphoblastic Leukemia<;>Recurrent Disease,3,2,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,0.5601,Relapse,0.5437,Acute Lymphoblastic Leukemia<;>Recurrent Disease,0.5408,First Relapse,0.5327,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.5278
ALVEOLAR,Alveolar,1,2,Alveolar,1.0000,Gingiva,0.6149,Bone,0.5417,Ductal,0.5351,Alveolar Rhabdomyosarcoma,0.5231
ALVEOLAR RHABDOMYOSARCOMA,Alveolar Rhabdomyosarcoma,1,2,Alveolar Rhabdomyosarcoma,1.0000,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.8649,Sclerosing Rhabdomyosarcoma,0.8045,Rhabdomyosarcoma,0.7968,Alveolar Soft Part Sarcoma,0.7761
ALVEOLAR SOFT PART SARCOMA,Alveolar Soft Part Sarcoma,1,2,Alveolar Soft Part Sarcoma,1.0000,Alveolar Rhabdomyosarcoma,0.7761,Undifferentiated Soft Tissue Sarcoma,0.7500,Clear Cell Sarcoma of Soft Tissue,0.7390,Soft Tissue Sarcoma,0.7153
AMELANOTIC,Amelanotic Melanoma,1,2,Amelanotic Melanoma,0.7565,Adamantinoma,0.5879,Acute Leukemia of Ambiguous Lineage,0.5258,Oral Epithelial Dysplasia,0.5254,Astrocytoma,0.5244
AMELANOTIC NODULAR,Cutaneous Nodular Melanoma,3,2,Amelanotic Melanoma,0.7318,Adamantinoma,0.6622,Cutaneous Nodular Melanoma,0.6534,Nodular Neoplasm,0.6160,Keratoacanthoma,0.5879
AML,Acute Myeloid Leukemia,1,2,Acute Myeloid Leukemia,0.8335,Acute Myeloid Leukemia Not Otherwise Specified,0.8321,Acute Myeloid Leukemia with Maturation,0.7536,Acute Myelomonocytic Leukemia,0.7277,Acute Leukemia of Ambiguous Lineage,0.7273
AML WITH BIALLELIC MUTATIONS OF CEBPA,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA,1,2,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA,0.9592,Acute Myeloid Leukemia with Mutated CEBPA,0.8849,Acute Myeloid Leukemia with Mutated RUNX1,0.7598,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.7406,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.7261
AML WITH INV(16)(P13.1Q22) OR T(16;16)(P13.1;Q22); CBFB-MYH11,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,1,2,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.9276,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.8337,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.8337,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.8155,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.7927
AML WITH INV(3)(Q21Q26.2) OR T(3;3)(Q21;Q26.2); RPN1-EVI1,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",2,2,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.9303,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.9303,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.8351,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.8128,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.8128
AML WITH INV16P13.1;Q22 OR T16:16P13.1:Q22;  CBFB-MYH11,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,1,2,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.8935,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.8199,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.8199,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.7896,Acute Myeloid Leukemia with Mutated RUNX1,0.7825
AML WITH INV16P13.1Q22 OR T16;16P13.1;Q22; CBFB-MYH11,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,1,2,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.8683,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.8223,Acute Myeloid Leukemia with Mutated RUNX1,0.8023,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.8017,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.7931
AML WITH INV16P13.1Q22 OR T16;16P13.1;Q22;CBFB-MYH11,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,1,2,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.8683,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.8223,Acute Myeloid Leukemia with Mutated RUNX1,0.8023,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.8017,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.7931
"AML WITH INV3Q21.3;Q26.2 OR T3;3Q21.3;Q26.2; GATA2, MECOM","Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",1,2,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.8974,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.8974,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.8179,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.7858,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.7858
"AML WITH INV3Q21.3Q26.2 OR T3;3Q21.3;Q26.2; GATA2, MECOM","Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",1,2,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.8935,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.8935,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.8249,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.7946,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.7928
AML WITH INV3Q21;Q26.2 OR T3;3Q21;Q26.2; RPN1-EVI1,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",1,2,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.8890,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.8890,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.8244,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.7931,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.7931
AML WITH INV3Q21Q26.2 OR T3;3Q21;Q26.2; RPN1-EVI1,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",1,2,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.8404,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.8404,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.7817,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.7680,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.7680
AML WITH MATURATION,Acute Myeloid Leukemia with Maturation,1,2,Acute Myeloid Leukemia with Maturation,0.9355,Acute Myeloid Leukemia without Maturation,0.8356,Acute Myeloid Leukemia,0.7817,Acute Myeloid Leukemia with Maturation<;>Auer Rods Present,0.7714,Acute Myeloid Leukemia with Multilineage Dysplasia,0.7619
AML WITH MINIMAL DIFFERENTIATION,Acute Myeloid Leukemia with Minimal Differentiation,1,2,Acute Myeloid Leukemia with Minimal Differentiation,0.9466,Acute Myeloid Leukemia without Maturation,0.8112,Acute Myeloid Leukemia with Maturation,0.7883,Acute Myeloid Leukemia with Multilineage Dysplasia,0.7700,Acute Myeloid Leukemia Not Otherwise Specified,0.7265
AML WITH MUTATED CEBPA,Acute Myeloid Leukemia with Mutated CEBPA,1,2,Acute Myeloid Leukemia with Mutated CEBPA,0.9526,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA,0.8803,Acute Myeloid Leukemia with Mutated RUNX1,0.8205,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.7614,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.7400
AML WITH MUTATED NPM1,Acute Myeloid Leukemia with Mutated NPM1,1,2,Acute Myeloid Leukemia with Mutated NPM1,0.9428,Acute Myeloid Leukemia with Mutated CEBPA,0.7355,Acute Myeloid Leukemia with Mutated RUNX1,0.7299,Acute Promyelocytic Leukemia with PML-RARA,0.7212,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.7140
AML WITH MUTATED RUNX1,Acute Myeloid Leukemia with Mutated RUNX1,1,2,Acute Myeloid Leukemia with Mutated RUNX1,0.9673,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.8929,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.8623,Acute Myeloid Leukemia with Mutated CEBPA,0.8241,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.7943
AML WITH MYELODYSPLASIA-RELATED CHANGES,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,1,2,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,0.9297,Acute Myeloid Leukemia with Multilineage Dysplasia,0.8592,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.8127,Myelodysplastic Syndrome with Excess Blasts,0.7746,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.7663
AML WITH RECURRENT GENETIC ABNORMALITIES,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,1,2,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.9266,Recurrent Acute Myeloid Leukemia,0.7984,Acute Myeloid Leukemia with Mutated RUNX1,0.7542,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,0.7348,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.7343
AML WITH T(6;9)(P23;Q34); DEK-NUP214,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,2,2,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,0.8672,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,0.8590,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.7835,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.7818,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.7818
AML WITH T(8;21)(Q22;Q22); RUNX1-RUNX1T1,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,1,2,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.9585,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.9569,Acute Myeloid Leukemia with Mutated RUNX1,0.8659,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.7908,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.7908
AML WITH T(9;11)(P22;Q23); MLLT3-MLL,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,1,2,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9199,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9199,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.8307,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.8307,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM",0.8108
AML WITH T6:9P23:Q34.1; DEK-NUP214,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,1,2,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,0.8315,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,0.8207,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.7614,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.7590,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.7590
AML WITH T6;9P23;Q34.1;DEK-NUP214,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,1,2,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,0.8226,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,0.8130,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.7828,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.7828,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.7790
AML WITH T6;9P23;Q34; DEK-NUP214,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,1,2,Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214,0.8132,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,0.8031,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.7648,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.7648,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.7540
AML WITH T8;21Q22;Q22.1; RUNX1-RUNX1T1,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,1,2,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.8811,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.8775,Acute Myeloid Leukemia with Mutated RUNX1,0.8041,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.7464,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.7464
AML WITH T8;21Q22;Q22.1;RUNX1-RUNX1T1,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,1,2,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.8811,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.8775,Acute Myeloid Leukemia with Mutated RUNX1,0.8041,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.7464,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.7464
AML WITH T8;21Q22;Q22; RUNX1-RUNX1T1,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,1,2,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.8675,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.8660,Acute Myeloid Leukemia with Mutated RUNX1,0.7863,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.7374,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.7374
AML WITH T9;11P22;Q23;  MLLT3-MLL,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,2,2,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9044,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9044,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.8169,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.8130,Acute Myeloid Leukemia with MLL Rearrangement,0.7939
AML WITH T9;11P22;Q23; MLLT3-MLL,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,2,2,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.9044,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.9044,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.8169,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.8130,Acute Myeloid Leukemia with MLL Rearrangement,0.7939
AML WITHOUT MATURATION,Acute Myeloid Leukemia without Maturation,1,2,Acute Myeloid Leukemia without Maturation,0.9153,Acute Myeloid Leukemia with Maturation,0.8756,Acute Myeloid Leukemia with Maturation<;>Auer Rods Present,0.7740,Acute Myeloid Leukemia Not Otherwise Specified,0.7715,Acute Myeloid Leukemia without Maturation<;>Auer Rods Present,0.7714
"AML, NOS",Acute Myeloid Leukemia Not Otherwise Specified,2,2,Acute Myeloid Leukemia,0.8344,Acute Myeloid Leukemia Not Otherwise Specified,0.8280,Acute Myeloid Leukemia with Maturation,0.7443,Acute Leukemia of Ambiguous Lineage,0.7232,Acute Monocytic Leukemia,0.7195
AML-MDS,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,1,2,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.8297,Acute Myeloid Leukemia with Multilineage Dysplasia,0.8161,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,0.8149,Myelodysplastic Syndrome with Excess Blasts,0.7960,Myelodysplastic Syndrome with Excess Blasts-1,0.7878
AMLM,Acute Myeloid Leukemia,5,2,Acute Myeloid Leukemia with Multilineage Dysplasia,0.7069,Acute Megakaryoblastic Leukemia,0.7064,Acute Myeloid Leukemia Not Otherwise Specified,0.7059,Acute Myelomonocytic Leukemia,0.7020,Acute Myeloid Leukemia,0.7011
AMPULLARY CANCER,Ampulla of Vater Carcinoma,1,2,Ampulla of Vater Carcinoma,0.7701,Ampulla of Vater Pancreatobiliary Type Adenocarcinoma,0.6451,Pancreatic Carcinoma,0.6165,Pancreatic Adenocarcinoma,0.5832,Anal Carcinoma,0.5619
AMPULLARY CARCINOMA,Ampulla of Vater Carcinoma,1,2,Ampulla of Vater Carcinoma,0.8402,Ampulla of Vater Pancreatobiliary Type Adenocarcinoma,0.7084,Pancreatic Carcinoma,0.6213,Pancreatic Adenocarcinoma,0.6093,Pancreatic Acinar Cell Carcinoma,0.5841
ANAL CANCER,Anal Carcinoma,1,2,Anal Carcinoma,0.9524,Anal Glands Adenocarcinoma,0.7834,Anal Squamous Cell Carcinoma,0.7644,Mucosal Melanoma<;>Anorectal,0.6618,Rectal Adenocarcinoma,0.6606
ANAL GLAND ADENOCARCINOMA,Anal Glands Adenocarcinoma,1,2,Anal Glands Adenocarcinoma,0.9874,Anal Carcinoma,0.8933,Anal Squamous Cell Carcinoma,0.8255,Rectal Adenocarcinoma,0.7235,Mucosal Melanoma<;>Anorectal,0.6883
ANAL SQUAMOUS CELL,Anal Squamous Cell Carcinoma,1,2,Anal Squamous Cell Carcinoma,0.9264,Anal Carcinoma,0.8244,Anal Glands Adenocarcinoma,0.7513,Mucosal Melanoma<;>Anorectal,0.6405,Urethral Squamous Cell Carcinoma,0.6372
ANAL SQUAMOUS CELL CARCINOMA,Anal Squamous Cell Carcinoma,1,2,Anal Squamous Cell Carcinoma,1.0000,Anal Carcinoma,0.8656,Anal Glands Adenocarcinoma,0.7947,Urethral Squamous Cell Carcinoma,0.6659,Mucosal Melanoma<;>Anorectal,0.6490
ANAPLASTIC,Anaplastic,1,2,Anaplastic,1.0000,Anaplastic Carcinoma,0.8427,Anaplastic Lesion<;>Diffuse,0.8360,Anaplastic Lesion<;>Focal,0.7497,Undifferentiated Malignant Neoplasm,0.7457
ANAPLASTIC ASTROCYTOMA,Anaplastic Astrocytoma,1,2,Anaplastic Astrocytoma,1.0000,Malignant Glioma<;>Anaplastic Astrocytoma,0.9621,"Anaplastic Astrocytoma, IDH-Wildtype",0.8635,Astrocytoma,0.8605,Diffuse Astrocytoma,0.8497
"ANAPLASTIC ASTROCYTOMA, IDH-MUTANT","Astrocytoma, IDH-Mutant, Grade 3",2,2,"Anaplastic Astrocytoma, IDH-Wildtype",0.9590,"Astrocytoma, IDH-Mutant, Grade 3",0.9161,"Astrocytoma, IDH-Mutant, Grade 2",0.8825,"Astrocytoma, IDH-Mutant, Grade 4",0.8701,"Glioblastoma, IDH-Wildtype",0.8269
"ANAPLASTIC ASTROCYTOMA, IDH-WILDTYPE","Anaplastic Astrocytoma, IDH-Wildtype",1,2,"Anaplastic Astrocytoma, IDH-Wildtype",1.0000,"Astrocytoma, IDH-Mutant, Grade 3",0.8934,"Astrocytoma, IDH-Mutant, Grade 2",0.8703,"Glioblastoma, IDH-Wildtype",0.8640,Anaplastic Astrocytoma,0.8635
ANAPLASTIC EPENDYMOMA,Anaplastic Ependymoma,1,2,Anaplastic Ependymoma,1.0000,Ependymoma,0.8515,Myxopapillary Ependymoma,0.8176,Ependymal Tumor,0.7676,Supratentorial Ependymoma<;>Subependymoma,0.7529
ANAPLASTIC GANGLIOGLIOMA,Anaplastic Ganglioglioma,1,2,Anaplastic Ganglioglioma,1.0000,Anaplastic Oligoastrocytoma,0.8037,Glioblastoma<;>Undifferentiated,0.7756,Anaplastic Astrocytoma,0.7697,Gliosarcoma,0.7689
ANAPLASTIC LARGE CELL LYMPHOMA,Anaplastic Large Cell Lymphoma,1,2,Anaplastic Large Cell Lymphoma,1.0000,"Anaplastic Large Cell Lymphoma, ALK-Positive",0.7842,"Anaplastic Large Cell Lymphoma, ALK-Negative",0.7801,Anaplastic,0.7382,Large Cell Carcinoma<;>Undifferentiated,0.7081
ANAPLASTIC LARGE-CELL LYMPHOMA ALK NEGATIVE,"Anaplastic Large Cell Lymphoma, ALK-Negative",1,2,"Anaplastic Large Cell Lymphoma, ALK-Negative",0.9377,"Anaplastic Large Cell Lymphoma, ALK-Positive",0.8166,Anaplastic Large Cell Lymphoma,0.6588,"Anaplastic Astrocytoma, IDH-Wildtype",0.5710,Anaplastic,0.5537
ANAPLASTIC LARGE-CELL LYMPHOMA ALK POSITIVE,"Anaplastic Large Cell Lymphoma, ALK-Positive",1,2,"Anaplastic Large Cell Lymphoma, ALK-Positive",0.9508,"Anaplastic Large Cell Lymphoma, ALK-Negative",0.8230,Anaplastic Large Cell Lymphoma,0.6986,Anaplastic,0.5665,Anaplastic Lesion<;>Diffuse,0.5198
ANAPLASTIC MEDULLOBLASTOMA,Anaplastic Medulloblastoma,1,2,Anaplastic Medulloblastoma,1.0000,Large Cell/Anaplastic Medulloblastoma,0.8843,Medulloblastoma,0.8565,"Medulloblastoma, Non-WNT/Non-SHH, Group 3",0.8375,Primitive Neuroectodermal Tumor<;>Medulloblastoma,0.8275
ANAPLASTIC MENINGIOMA,Anaplastic (Malignant) Meningioma,1,2,Anaplastic (Malignant) Meningioma,0.9746,Atypical Meningioma,0.8837,Anaplastic Astrocytoma,0.7559,Meningioma,0.7471,Malignant Glioma<;>Anaplastic Astrocytoma,0.7276
ANAPLASTIC OLIGOASTROCYTOMA,Anaplastic Oligoastrocytoma,1,2,Anaplastic Oligoastrocytoma,1.0000,Oligoastrocytoma,0.8752,Anaplastic Oligodendroglioma,0.8288,Anaplastic Ganglioglioma,0.8037,Anaplastic Astrocytoma,0.8023
ANAPLASTIC OLIGODENDROGLIOMA,Anaplastic Oligodendroglioma,1,2,Anaplastic Oligodendroglioma,1.0000,Oligodendroglioma,0.9014,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.8322,Anaplastic Oligoastrocytoma,0.8288,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.8172
"ANAPLASTIC OLIGODENDROGLIOMA, IDH-MUTANT AND 1P/19Q CO-DELETED","Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1,2,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.9827,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.9198,Anaplastic Oligodendroglioma,0.7846,Anaplastic Oligoastrocytoma,0.7345,"Anaplastic Astrocytoma, IDH-Wildtype",0.7075
"ANAPLASTIC OLIGODENDROGLIOMA, IDH-MUTANT AND 1P/19Q-CODELETED","Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1,2,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1.0000,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.9449,Anaplastic Oligodendroglioma,0.8322,Anaplastic Oligoastrocytoma,0.7592,"Anaplastic Astrocytoma, IDH-Wildtype",0.7377
ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA,Anaplastic Pleomorphic Xanthoastrocytoma,1,2,Anaplastic Pleomorphic Xanthoastrocytoma,1.0000,Pleomorphic Xanthoastrocytoma,0.9298,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,0.7691,Undifferentiated Pleomorphic Sarcoma,0.7375,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,0.7217
ANAPLASTIC THYROID CANCER,Thyroid Gland Anaplastic Carcinoma,1,2,Thyroid Gland Anaplastic Carcinoma,0.9772,Poorly Differentiated Thyroid Gland Carcinoma,0.8022,Differentiated Thyroid Gland Carcinoma,0.7743,Anaplastic Carcinoma,0.7722,Thyroid Gland Oncocytic Carcinoma,0.7371
ANAPLASTIC THYROID CARCINOMA,Thyroid Gland Anaplastic Carcinoma,1,2,Thyroid Gland Anaplastic Carcinoma,0.9831,Poorly Differentiated Thyroid Gland Carcinoma,0.8087,Anaplastic Carcinoma,0.8032,Differentiated Thyroid Gland Carcinoma,0.7805,Thyroid Gland Oncocytic Carcinoma,0.7594
ANAPLASTIC_CARCINOMA,Anaplastic Carcinoma,1,2,Anaplastic Carcinoma,0.9791,Undifferentiated Carcinoma,0.8665,Adenocarcinoma<;>Undifferentiated Carcinoma,0.8552,Carcinoma<;>Undifferentiated,0.8462,Anaplastic,0.8458
ANAPLASTIC_LARGE_CELL_LYMPHOMA,Anaplastic Large Cell Lymphoma,1,2,Anaplastic Large Cell Lymphoma,0.9783,"Anaplastic Large Cell Lymphoma, ALK-Positive",0.7590,"Anaplastic Large Cell Lymphoma, ALK-Negative",0.7424,Anaplastic,0.7362,Large Cell Carcinoma<;>Undifferentiated,0.7277
ANGIOCENTRIC GLIOMA,Angiocentric Glioma,1,2,Angiocentric Glioma,1.0000,Visual Pathway Glioma,0.7593,Astrocytoma,0.7343,Central Neurocytoma,0.7172,Diffuse Midline Glioma,0.7152
ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA,Angioimmunoblastic T-Cell Lymphoma,1,2,Angioimmunoblastic T-Cell Lymphoma,1.0000,Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma,0.7213,T-Cell Non-Hodgkin Lymphoma,0.7085,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.7021,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.6822
ANGIOSARCOMA,Angiosarcoma,1,2,Angiosarcoma,1.0000,Adenosarcoma,0.7806,Hemangioblastoma,0.7489,Breast Angiosarcoma,0.6968,Sarcomatoid Carcinoma,0.6886
ANORECTAL MUCOSAL MELANOMA,Mucosal Melanoma<;>Anorectal,1,2,Mucosal Melanoma<;>Anorectal,0.9774,Anal Glands Adenocarcinoma,0.6661,Anal Carcinoma,0.6630,Rectal Mucinous Adenocarcinoma,0.6467,Anal Squamous Cell Carcinoma,0.6462
ANSC,Anal Squamous Cell Carcinoma,99,2,nan,0.5943,Not Otherwise Specified,0.4889,Acute Undifferentiated Leukemia,0.4751,Neuroblastoma,0.4749,Arm,0.4650
APAD,Appendix Adenocarcinoma,99,2,Adamantinoma,0.5268,Adamantinomatous Craniopharyngioma,0.4998,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.4665,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.4609,SPOP Gene,0.4523
APL WITH PML-RARA,Acute Promyelocytic Leukemia with PML-RARA,1,2,Acute Promyelocytic Leukemia with PML-RARA,0.9099,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.7382,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.7253,Acute Myeloid Leukemia with MLL Rearrangement,0.7146,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA,0.7105
APPENDICEAL ADENOCARCINOMA,Appendix Adenocarcinoma,1,2,Appendix Adenocarcinoma,0.9335,Appendix Carcinoma,0.8761,Appendix Mucinous Adenocarcinoma,0.7774,Appendix Goblet Cell Adenocarcinoma,0.7521,Cecum Adenocarcinoma,0.7030
APPENDICEAL CANCER,Appendix Carcinoma,1,2,Appendix Carcinoma,0.8814,Appendix Adenocarcinoma,0.7815,Appendix Neuroendocrine Tumor,0.6420,skin appendage carcinoma,0.6283,Malignant Peritoneal Neoplasm,0.6213
ARM,Arm,1,2,Arm,1.0000,Breast,0.5621,Thigh,0.5333,Abdomen,0.5265,Distal,0.5045
ASCENDING COLON,Ascending Colon,1,2,Ascending Colon,1.0000,Descending Colon,0.8431,Transverse Colon,0.8127,Sigmoid Colon,0.8027,Colon,0.7125
ASPS,Alveolar Soft Part Sarcoma,1,2,Alveolar Soft Part Sarcoma,0.5051,SPOP Gene,0.4819,Anaplastic Astrocytoma,0.4606,nan,0.4541,Pancreatic Adenosquamous Carcinoma,0.4528
ASTOMOSIS RECURRENCE,Anastomosis<;>Recurrence,4,2,Recurrence,0.6289,Recurrent,0.6272,Relapse,0.6167,Anastomosis<;>Recurrence,0.6160,First Relapse,0.5996
ASTROBLASTOMA,"Astroblastoma, MN1-Altered",1,2,"Astroblastoma, MN1-Altered",0.8672,Central Neurocytoma,0.7476,Angiocentric Glioma,0.7405,Glioneuronal Tumor,0.7401,Astrocytoma,0.7244
ASTROCYTOMA,Astrocytoma,1,2,Astrocytoma,1.0000,Diffuse Astrocytoma,0.8898,Anaplastic Astrocytoma,0.8605,Pilocytic Astrocytoma,0.8370,High Grade Astrocytic Tumor,0.8235
"ASTROCYTOMA, ANAPLASTIC",Anaplastic Astrocytoma,1,2,Anaplastic Astrocytoma,0.9925,Malignant Glioma<;>Anaplastic Astrocytoma,0.9584,Astrocytoma,0.8632,"Anaplastic Astrocytoma, IDH-Wildtype",0.8570,Diffuse Astrocytoma,0.8479
"ASTROCYTOMA, SUBTYPE INDETERMINATE",Astrocytoma,1,2,Astrocytoma,0.8393,Diffuse Astrocytoma,0.8206,Anaplastic Astrocytoma,0.8058,Pilocytic Astrocytoma,0.7882,Low Grade Glioma<;>Low Grade Astrocytoma,0.7876
ASTROCYTOMA_GRADE_III,Astrocytoma,1,2,Astrocytoma,0.8885,Anaplastic Astrocytoma,0.8880,Diffuse Astrocytoma,0.8729,Malignant Glioma<;>Anaplastic Astrocytoma,0.8621,High Grade Astrocytic Tumor,0.8100
ASTROCYTOMA_GRADE_III-IV,High Grade Astrocytic Tumor,5,2,Anaplastic Astrocytoma,0.8864,Astrocytoma,0.8724,Malignant Glioma<;>Anaplastic Astrocytoma,0.8673,Diffuse Astrocytoma,0.8657,High Grade Astrocytic Tumor,0.8204
ASTROCYTOMA_GRADE_IV,Astrocytoma,3,2,Anaplastic Astrocytoma,0.8703,Diffuse Astrocytoma,0.8554,Astrocytoma,0.8530,Malignant Glioma<;>Anaplastic Astrocytoma,0.8435,"Astrocytoma, IDH-Mutant, Grade 4",0.8237
ATL,Adult T-Cell Leukemia/Lymphoma,4,2,T Acute Lymphoblastic Leukemia,0.5990,T Lymphoblastic Leukemia/Lymphoma,0.5901,Angioimmunoblastic T-Cell Lymphoma,0.5889,Adult T-Cell Leukemia/Lymphoma,0.5806,Early T Acute Lymphoblastic Leukemia,0.5650
ATRT,Atypical Teratoid/Rhabdoid Tumor,1,2,Atypical Teratoid/Rhabdoid Tumor,0.5756,Extrarenal Rhabdoid Tumor,0.5235,Rhabdoid Tumor,0.5218,Arm,0.4863,"Astroblastoma, MN1-Altered",0.4594
ATYPICAL CHOROID PLEXUS PAPILLOMA,Atypical Choroid Plexus Papilloma,1,2,Atypical Choroid Plexus Papilloma,1.0000,Choroid Plexus Papilloma,0.8351,Urothelial Papilloma,0.6173,"Posterior Fossa Ependymoma, Group A (PFA)",0.5958,Papillary Transitional Cell Carcinoma,0.5928
"ATYPICAL CHRONIC MYELOID LEUKAEMIA, BCR-ABL1 NEGATIVE","Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative",1,2,"Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative",0.9963,Atypical Chronic Myeloid Leukemia,0.9062,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.7548,Chronic Myelogenous Leukemia,0.6784,"Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.6682
"ATYPICAL CHRONIC MYELOID LEUKEMIA, BCR-ABL1-","Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative",1,2,"Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative",0.9398,Atypical Chronic Myeloid Leukemia,0.8851,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.8459,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.7615,"Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.7444
ATYPICAL GRANULAR CELL TUMOR,Granular Cell Tumor<;>Atypical,1,2,Granular Cell Tumor<;>Atypical,0.9684,Granular Cell Tumor,0.8720,Anaplastic Ganglioglioma,0.6892,Giant Cell Tumor,0.6508,Ganglioneuroblastoma,0.6468
ATYPICAL LUNG CARCINOID,Lung Atypical Carcinoid Tumor,1,2,Lung Atypical Carcinoid Tumor,0.9731,Lung Carcinoid Tumor,0.8738,Carcinoid Tumor,0.7516,Adenocarcinoma with Neuroendocrine Differentiation,0.7360,Neuroendocrine Carcinoma<;>Poorly Differentiated,0.7067
ATYPICAL MENINGIOMA,Atypical Meningioma,1,2,Atypical Meningioma,1.0000,Anaplastic (Malignant) Meningioma,0.8474,Meningioma,0.7504,Anaplastic Astrocytoma,0.6503,"Astroblastoma, MN1-Altered",0.6388
ATYPICAL NEVUS,Dysplastic Nevus,1,2,Dysplastic Nevus,0.8522,Blue Nevus,0.6729,Neurocutaneous Melanosis,0.6232,Melanotic Schwannoma,0.5901,Atypical Meningioma,0.5732
ATYPICAL SPINDLED AND EPITHELIOID MELANOCYTIC PROLIFERATION,Atypical Spindle Melanocyte<;>Epithelioid Melanocyte,1,2,Atypical Spindle Melanocyte<;>Epithelioid Melanocyte,0.8508,Spitz Melanoma,0.6985,Melanotic Schwannoma,0.6749,Amelanotic Melanoma,0.6591,Anaplastic Pleomorphic Xanthoastrocytoma,0.6368
ATYPICAL TERATOID RHABDOID TUMOR ATRT,Atypical Teratoid/Rhabdoid Tumor,1,2,Atypical Teratoid/Rhabdoid Tumor,0.8695,Rhabdoid Tumor,0.7983,Extrarenal Rhabdoid Tumor,0.7936,Rhabdoid Tumor<;>Extracranial,0.6823,Trilateral Retinoblastoma,0.6155
ATYPICAL TERATOID/RHABDOID TUMOR,Atypical Teratoid/Rhabdoid Tumor,1,2,Atypical Teratoid/Rhabdoid Tumor,1.0000,Rhabdoid Tumor,0.8687,Extrarenal Rhabdoid Tumor,0.8406,Rhabdoid Tumor<;>Extracranial,0.7612,Desmoplastic Small Round Cell Tumor,0.6850
B-CELL,B-Lymphocyte,1,2,B-Lymphocyte,0.9684,B-Cell Neoplasm,0.7274,Mature B-Cell Neoplasm,0.7086,germinal center B cell,0.7004,B-Cell Non-Hodgkin Lymphoma,0.6537
B-CELL ACUTE LYMPHOID LEUKEMIA,B Acute Lymphoblastic Leukemia,1,2,B Acute Lymphoblastic Leukemia,0.8769,B Lymphoblastic Leukemia/Lymphoma,0.8132,B-Cell Prolymphocytic Leukemia,0.8092,Burkitt Lymphoma,0.7402,Lymphoblastic Lymphoma,0.7266
B-CELL NON-HODGKIN LYMPHOMA,B-Cell Non-Hodgkin Lymphoma,1,2,B-Cell Non-Hodgkin Lymphoma,1.0000,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.8528,B-Cell Neoplasm,0.8430,Mature B-Cell Non-Hodgkin Lymphoma,0.8396,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.8376
"B-CELL, HODGKINS",Hodgkin Lymphoma,1,2,Hodgkin Lymphoma,0.8177,Classic Hodgkin Lymphoma,0.7844,B-Cell Non-Hodgkin Lymphoma,0.7684,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.7629,Burkitt Lymphoma,0.7001
"B-CELL, NON-HODGKINS",B-Cell Non-Hodgkin Lymphoma,1,2,B-Cell Non-Hodgkin Lymphoma,0.9270,Mature B-Cell Non-Hodgkin Lymphoma,0.8485,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.8035,B-Cell Neoplasm,0.8001,B-Cell Non-Hodgkin Lymphoma<;>Undifferentiated,0.7952
"B-CELL, NON-HODGKINS, BURKITTS",B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,1,2,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9593,Burkitt Lymphoma,0.9117,B-Cell Non-Hodgkin Lymphoma,0.8331,Mature B-Cell Non-Hodgkin Lymphoma,0.8181,B-Cell Non-Hodgkin Lymphoma<;>Undifferentiated,0.7955
"B-CELL, NON-HODGKINS, FOLLICULAR",B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,1,2,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.9001,Follicular Lymphoma,0.7837,Mature B-Cell Non-Hodgkin Lymphoma,0.7125,B-Cell Non-Hodgkin Lymphoma,0.6783,Mature B-Cell Neoplasm,0.6533
"B-CELL, NON-HODGKINS, MANTLE CELL",B-Cell Non-Hodgkin Lymphoma<;>Mantle Cell Lymphoma,1,2,B-Cell Non-Hodgkin Lymphoma<;>Mantle Cell Lymphoma,0.9361,Mantle Cell Lymphoma,0.8399,Mature B-Cell Non-Hodgkin Lymphoma,0.8397,Mature B-Cell Neoplasm,0.7611,B-Cell Non-Hodgkin Lymphoma,0.7240
"B-CELL, NON-HODGKINS, MEDIASTINAL LARGE",B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,2,2,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.8022,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.7691,Mature B-Cell Non-Hodgkin Lymphoma,0.6937,Monoclonal B-Cell Lymphocytosis,0.6797,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.6139
"B-CELL, NON-HODGKINS, PRIMARY EFFUSION",B-Cell Non-Hodgkin Lymphoma<;>Primary Effusion Lymphoma,1,2,B-Cell Non-Hodgkin Lymphoma<;>Primary Effusion Lymphoma,0.9497,Primary Effusion Lymphoma,0.7778,B-Cell Prolymphocytic Leukemia,0.6209,Mature B-Cell Non-Hodgkin Lymphoma,0.6157,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.6015
B-CELL_ALL,B Acute Lymphoblastic Leukemia,3,2,B Lymphoblastic Leukemia/Lymphoma,0.8376,B-Cell Non-Hodgkin Lymphoma,0.8184,B Acute Lymphoblastic Leukemia,0.7944,Burkitt Lymphoma,0.7862,B-Cell Neoplasm,0.7815
B-CELL_LYMPHOMA_OTHER,B-Cell Neoplasm,3,2,B-Cell Non-Hodgkin Lymphoma,0.8378,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.7803,B-Cell Neoplasm,0.7336,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.7191,Mature B-Cell Non-Hodgkin Lymphoma,0.7064
B-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA,B Lymphoblastic Leukemia/Lymphoma,1,2,B Lymphoblastic Leukemia/Lymphoma,0.9945,Lymphoblastic Lymphoma,0.8737,B Acute Lymphoblastic Leukemia,0.8655,Acute Lymphoblastic Leukemia,0.7805,Chronic Lymphoblastic Lymphoma,0.7774
B-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA WITH T9;22Q34.1;Q11.2,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,1,2,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,0.9628,B Acute Lymphoblastic Leukemia with t(9<;>22)(q34.1<;>q11.2)<;> BCR-ABL1,0.8871,B Lymphoblastic Leukemia/Lymphoma,0.7062,T Lymphoblastic Leukemia/Lymphoma,0.6854,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,0.6795
B-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA WITH T9;22Q34.1;Q11.2;BCR-ABL1,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,1,2,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,0.9160,B Acute Lymphoblastic Leukemia with t(9<;>22)(q34.1<;>q11.2)<;> BCR-ABL1,0.8208,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.7783,B Lymphoblastic Leukemia/Lymphoma,0.6887,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,0.6626
"B-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA, BCR-ABL1 LIKE","B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",1,2,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.9907,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.7175,B Lymphoblastic Leukemia/Lymphoma,0.6856,"Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.6677,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,0.6637
B-PROLYMPHOCYTIC_LEUKEMIA,B-Cell Prolymphocytic Leukemia,1,2,B-Cell Prolymphocytic Leukemia,0.9710,B Lymphoblastic Leukemia/Lymphoma,0.7612,B Acute Lymphoblastic Leukemia,0.7146,Plasma Cell Leukemia,0.7093,B-Cell Non-Hodgkin Lymphoma,0.6884
B1,Thymoma Type B1,2,2,Basal,0.5590,Thymoma Type B1,0.5403,Arm,0.4999,Thymoma Type B1<;>Thymoma Type B2,0.4831,Claudin-Low,0.4714
B2,Thymoma Type B2,1,2,Thymoma Type B2,0.5814,Bilateral,0.5693,Basal,0.5367,B-Lymphocyte,0.5309,Thymoma Type B2<;>Thymoma Type B3,0.5130
B3,Thymoma Type B3,1,2,Thymoma Type B3,0.5807,Basal,0.5325,Thymoma Type B2<;>Thymoma Type B3,0.5304,Bilateral,0.5147,Thymoma Type B2,0.4906
BARRETT_ASSOCIATED_ADENOCARCINOMA,Barrett Adenocarcinoma,1,2,Barrett Adenocarcinoma,0.9561,Gastroesophageal Junction Adenocarcinoma,0.6636,Gastric Tubular Adenocarcinoma,0.6362,Gastric Intestinal-Type Adenocarcinoma,0.6295,Gastric Papillary Adenocarcinoma,0.5929
BASAL,Basal,1,2,Basal,1.0000,Basaloid Cell,0.6171,Basal-Like Breast Carcinoma,0.5857,Superficial,0.5600,Bilateral,0.5346
BASAL CELL ADENOCARCINOMA,Salivary Gland Basal Cell Adenocarcinoma,4,2,Basal Cell Carcinoma,0.8982,Squamous Cell Carcinoma<;>Basaloid Cell,0.8465,Head and Neck Basaloid Carcinoma,0.7952,Salivary Gland Basal Cell Adenocarcinoma,0.7884,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.7355
BASAL CELL CARCINOMA,Basal Cell Carcinoma,1,2,Basal Cell Carcinoma,1.0000,Squamous Cell Carcinoma<;>Basaloid Cell,0.8631,Head and Neck Basaloid Carcinoma,0.8009,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.7165,Squamous Cell Carcinoma,0.6901
BASAL-LIKE,Basal-Like Breast Carcinoma,3,2,Basal,0.8099,Basaloid Cell,0.7015,Basal-Like Breast Carcinoma,0.6178,Basal Cell Carcinoma,0.5468,Squamous Cell Carcinoma<;>Basaloid Cell,0.5048
BASALOID,Basaloid Cell,1,2,Basaloid Cell,0.8350,Basal,0.6754,Squamous Cell Carcinoma<;>Basaloid Cell,0.6042,Cribriform,0.6040,Organoid,0.6015
BASALOID LARGE CELL CARCINOMA OF THE LUNG,Lung Basaloid Large Cell Carcinoma,1,2,Lung Basaloid Large Cell Carcinoma,0.9725,Lung Large Cell Carcinoma,0.7593,"Lung Large Cell Carcinoma, Clear Cell Variant",0.7374,Lung Mucoepidermoid Carcinoma,0.7110,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.7058
BASALOID PENILE SQUAMOUS CELL CARCINOMA,Basaloid Squamous Cell Carcinoma of the Penis,1,2,Basaloid Squamous Cell Carcinoma of the Penis,0.9456,Squamous Cell Carcinoma of the Penis,0.7608,Squamous Cell Carcinoma<;>Basaloid Cell,0.7137,Head and Neck Basaloid Carcinoma,0.7082,Penile Carcinoma,0.6781
BCP-ALL,B Acute Lymphoblastic Leukemia,2,2,Chronic Lymphoblastic Lymphoma,0.7661,B Acute Lymphoblastic Leukemia,0.7558,Lymphoblastic Lymphoma,0.7480,Acute Lymphoblastic Leukemia,0.7323,B Lymphoblastic Leukemia/Lymphoma,0.7315
BCR-ABL1,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",1,2,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.8989,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.7538,"Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.6783,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive<;>Blastic Phase",0.6272,"Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative",0.5709
BENIGN INSULINOMA,Pancreatic Insulinoma<;>Benign,1,2,Pancreatic Insulinoma<;>Benign,0.9680,Pancreatoblastoma,0.6820,Pancreatic Neuroendocrine Tumor,0.6706,Granular Cell Tumor<;>Atypical,0.6010,Somatostatin-Producing Neuroendocrine Tumor,0.5998
BENIGN PHYLLODES TUMOR OF THE BREAST,Benign Breast Phyllodes Tumor,1,2,Benign Breast Phyllodes Tumor,0.9803,Phyllodes Tumor,0.8558,Borderline Breast Phyllodes Tumor,0.8229,Malignant Breast Phyllodes Tumor,0.8097,Normal Breast-Like Subtype of Breast Carcinoma,0.5936
BENIGN PT,Benign Breast Phyllodes Tumor,3,2,Benign Neoplasm,0.7392,Benign Prostatic Hyperplasia,0.6416,Benign Breast Phyllodes Tumor,0.5967,Borderline Breast Phyllodes Tumor,0.5897,Normal Breast-Like Subtype of Breast Carcinoma,0.5467
BENIGN_NEOPLASIA,Benign Neoplasm,1,2,Benign Neoplasm,0.8857,Neoplasm,0.7191,Benign Prostatic Hyperplasia,0.6110,Neuroepithelial Neoplasm,0.6087,Primary Neoplasm,0.6058
BILATERAL,Bilateral,1,2,Bilateral,1.0000,Unilateral,0.6835,Diffuse,0.5447,Basal,0.5346,Primary,0.5152
BILE_DUCT,Bile Duct,1,2,Bile Duct,0.9744,Biliary Tract,0.7994,Proximal Bile Duct,0.7848,Duct,0.7769,Ductal,0.6966
BILIARY TRACT,Biliary Tract,1,2,Biliary Tract,1.0000,Bile Duct,0.8131,Proximal Bile Duct,0.6469,Intestine,0.5900,Intestinal,0.5892
BILIARY TRACT CANCER,Liver and Intrahepatic Bile Duct Carcinoma,2,2,Biliary Tract,0.7668,Liver and Intrahepatic Bile Duct Carcinoma,0.7198,Pancreatobiliary Carcinoma,0.7077,Cholangiocarcinoma,0.6876,Gallbladder Carcinoma,0.6588
"BILIARY TRACT CANCER, NOS",Liver and Intrahepatic Bile Duct Carcinoma,2,2,Biliary Tract,0.7703,Liver and Intrahepatic Bile Duct Carcinoma,0.7120,Pancreatobiliary Carcinoma,0.6976,Cholangiocarcinoma,0.6884,Gallbladder Carcinoma,0.6541
BIOPSY,Biopsy Specimen,1,2,Biopsy Specimen,0.8989,Paracentesis<;>Biopsy,0.6663,Resection,0.6180,Surgical Procedure,0.5386,Tissue,0.5376
BIOPSY/PARACENTESIS,Paracentesis<;>Biopsy,1,2,Paracentesis<;>Biopsy,0.9404,Biopsy Specimen,0.6568,Leukapheresis,0.5239,Resection,0.5071,Cystectomy,0.5026
BIPHASIC MESOTHELIOMA,Biphasic Mesothelioma,1,2,Biphasic Mesothelioma,1.0000,Pleural Biphasic Mesothelioma,0.9037,Sarcomatoid Mesothelioma,0.8327,Diffuse Malignant Mesothelioma,0.8216,Epithelioid Mesothelioma,0.8216
BLADDER,Bladder,1,2,Bladder,1.0000,Bladder Carcinoma,0.7012,Urinary System,0.6946,Malignant Urinary System Neoplasm,0.5934,Bladder Adenocarcinoma,0.5640
BLADDER ADENOCARCINOMA,Bladder Adenocarcinoma,1,2,Bladder Adenocarcinoma,1.0000,Bladder Carcinoma,0.8839,Bladder Urothelial Carcinoma,0.7967,Bladder Urachal Adenocarcinoma,0.7947,Bladder Squamous Cell Carcinoma,0.7696
BLADDER CANCER,Bladder Carcinoma,1,2,Bladder Carcinoma,0.9650,Bladder Adenocarcinoma,0.8187,Bladder Urothelial Carcinoma,0.8004,Bladder,0.7607,Urothelial Carcinoma,0.7504
BLADDER SQUAMOUS CELL CARCINOMA,Bladder Squamous Cell Carcinoma,1,2,Bladder Squamous Cell Carcinoma,1.0000,Bladder Urothelial Carcinoma,0.8229,Bladder Carcinoma,0.7804,Bladder Urachal Carcinoma,0.7784,Bladder Adenocarcinoma,0.7696
BLADDER UROTHELIAL,Bladder Urothelial Carcinoma,2,2,Bladder Urothelial Cell,0.9356,Bladder Urothelial Carcinoma,0.7907,Urothelial Carcinoma,0.7404,Urothelial Papilloma,0.7071,upper tract urothelial carcinoma,0.6933
BLADDER UROTHELIAL CARCINOMA,Bladder Urothelial Carcinoma,1,2,Bladder Urothelial Carcinoma,1.0000,Urothelial Carcinoma,0.9431,upper tract urothelial carcinoma,0.9056,Bladder Carcinoma,0.8575,Bladder Urachal Carcinoma,0.8386
BLADDER/URINARY TRACT,Urinary System,2,2,Bladder,0.9175,Urinary System,0.8092,Bladder Carcinoma,0.6678,Malignant Urinary System Neoplasm,0.6664,Biliary Tract,0.5713
BLADDER/URINARY TRACT CANCER,Bladder Carcinoma,1,2,Bladder Carcinoma,0.8119,Malignant Urinary System Neoplasm,0.8095,Bladder Urothelial Carcinoma,0.7129,Urothelial Carcinoma,0.7082,Bladder,0.6886
"BLADDER/URINARY TRACT CANCER, NOS",Malignant Urinary System Neoplasm,2,2,Bladder Carcinoma,0.8210,Malignant Urinary System Neoplasm,0.8040,Bladder Urothelial Carcinoma,0.7221,Urothelial Carcinoma,0.7118,Bladder,0.6961
BLADDER_CANCER,Bladder Carcinoma,1,2,Bladder Carcinoma,0.9023,Bladder,0.7848,Bladder Urothelial Carcinoma,0.7579,Bladder Adenocarcinoma,0.7499,Malignant Urinary System Neoplasm,0.7228
BLADDER_CARCINOMA,Bladder Carcinoma,1,2,Bladder Carcinoma,0.9567,Bladder Urothelial Carcinoma,0.8292,Bladder Adenocarcinoma,0.8275,Urothelial Carcinoma,0.7925,Bladder Squamous Cell Carcinoma,0.7350
BLADDER_SQUAMOUS,Bladder Squamous Cell Carcinoma,1,2,Bladder Squamous Cell Carcinoma,0.7596,Bladder Carcinoma,0.6754,Bladder,0.6666,Bladder Urothelial Carcinoma,0.6505,Urothelial Papilloma,0.6473
BLADDER_TRANSITIONAL_CELL,Bladder Urothelial Cell,1,2,Bladder Urothelial Cell,0.8570,Transitional Cells,0.8015,Transitional Cell Carcinoma,0.6961,"Kidney Carcinoma, Transitional Cells",0.6888,Bladder Urothelial Carcinoma,0.6775
BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM,Blastic Plasmacytoid Dendritic Cell Neoplasm,1,2,Blastic Plasmacytoid Dendritic Cell Neoplasm,1.0000,Pleuropulmonary Blastoma,0.7014,Plasma Cell Leukemia,0.6797,Plasmacytoma,0.6785,Centroblastic Lymphoma,0.6642
BLAST_CRISIS,Blastic Phase,1,2,Blastic Phase,0.8408,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive<;>Blastic Phase",0.7971,"Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.7683,Myelodysplastic Syndrome with Excess Blasts,0.7308,Myelodysplastic Syndrome with Excess Blasts-1,0.6800
BLAST_PHASE_CHRONIC_MYELOID_LEUKAEMIA,"Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",2,2,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive<;>Blastic Phase",0.9060,"Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.8759,Blastic Phase,0.8256,Chronic Myelogenous Leukemia,0.7597,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.7406
BLCA,Bladder Urothelial Carcinoma,99,2,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.5535,Basal-Like Breast Carcinoma,0.5391,Activated B-Cell Positive,0.5361,Centroblastic Lymphoma,0.5314,Diffuse Large B-Cell Lymphoma,0.5026
BLL,B Lymphoblastic Leukemia/Lymphoma,3,2,B-Cell Prolymphocytic Leukemia,0.6422,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.6350,B Lymphoblastic Leukemia/Lymphoma,0.6312,B-Cell Non-Hodgkin Lymphoma,0.6254,Diffuse Large B-Cell Lymphoma,0.6092
BLOOD CANCER,Liquid Tumor,99,2,Leukemia,0.6879,Myeloid Neoplasm,0.6463,Malignant Neoplasm,0.6418,Hematopoietic and Lymphoid Cell Neoplasm,0.6170,Carcinoma,0.6150
"BLOOD CANCER, NOS",Liquid Tumor,99,2,Leukemia,0.6958,Myeloid Neoplasm,0.6515,Malignant Neoplasm,0.6182,Hematopoietic and Lymphoid Cell Neoplasm,0.6161,Myeloid Sarcoma,0.6118
BLUE NEVUS,Blue Nevus,1,2,Blue Nevus,1.0000,Dysplastic Nevus,0.6707,Neurocutaneous Melanosis,0.6507,Cutaneous Nodular Melanoma,0.6266,Lentigo Maligna,0.6216
BONE,Bone,1,2,Bone,1.0000,Malignant Bone Neoplasm,0.6559,Bone<;>Site of Metastasis,0.6482,Soft Tissue,0.5799,Bone Sarcoma,0.5774
BONE CANCER,Malignant Bone Neoplasm,1,2,Malignant Bone Neoplasm,0.9269,Bone Sarcoma,0.8371,Osteosarcoma,0.7433,Bone<;>Site of Metastasis,0.7347,Bone,0.6826
BONE SARCOMA,Bone Sarcoma,1,2,Bone Sarcoma,1.0000,Malignant Bone Neoplasm,0.8505,Sarcoma,0.8243,Osteosarcoma,0.8242,Extraskeletal Osteosarcoma,0.7732
BONE SARCOMA OTHER,Bone Sarcoma,1,2,Bone Sarcoma,0.8415,Extraskeletal Osteosarcoma,0.7103,Sarcoma,0.6977,Malignant Bone Neoplasm,0.6927,Osteosarcoma,0.6849
BONE_CANCER,Malignant Bone Neoplasm,1,2,Malignant Bone Neoplasm,0.9041,Bone Sarcoma,0.8199,Bone<;>Site of Metastasis,0.7449,Osteosarcoma,0.7072,Bone,0.6942
BORDERLINE PHYLLODES TUMOR OF THE BREAST,Borderline Breast Phyllodes Tumor,1,2,Borderline Breast Phyllodes Tumor,0.9844,Benign Breast Phyllodes Tumor,0.8232,Malignant Breast Phyllodes Tumor,0.7944,Phyllodes Tumor,0.7852,Normal Breast-Like Subtype of Breast Carcinoma,0.5954
BORDERLINE PT,Borderline Breast Phyllodes Tumor,1,2,Borderline Breast Phyllodes Tumor,0.6534,Borderline Ovarian Serous Tumor,0.5631,Occult Stage,0.5523,Poorly Differentiated,0.5516,Limited Stage<;>Primary,0.5500
BOTRYOID,Botryoid-Type Embryonal Rhabdomyosarcoma,1,2,Botryoid-Type Embryonal Rhabdomyosarcoma,0.5995,Organoid,0.4531,Granular Cell Tumor,0.4443,Pineoblastoma,0.4335,Myxoma,0.4300
BOWEL,Intestine,2,2,Intestinal,0.8930,Intestine,0.8855,Colon,0.7164,Colorectal,0.6835,Malignant Intestinal Neoplasm,0.6782
"BOWEL CANCER, NOS",Malignant Intestinal Neoplasm,1,2,Malignant Intestinal Neoplasm,0.8785,Colorectal,0.7706,Colon,0.7315,Colorectal Carcinoma,0.7280,Intestine,0.7008
BRAIN,Brain,1,2,Brain,1.0000,Central Nervous System<;>Brain,0.9412,Malignant Brain Neoplasm,0.7472,Brain Neoplasm,0.7299,Cerebral Cortex,0.6877
BRAIN CANCER,Malignant Brain Neoplasm,1,2,Malignant Brain Neoplasm,0.9383,Brain Neoplasm,0.8325,Malignant Central Nervous System Neoplasm,0.8010,Brain,0.7575,Central Nervous System<;>Brain,0.7572
BRAIN_CANCER,Malignant Brain Neoplasm,1,2,Malignant Brain Neoplasm,0.8983,Brain Neoplasm,0.8013,Brain,0.7687,Malignant Central Nervous System Neoplasm,0.7684,Central Nervous System<;>Brain,0.7567
BRCA,Breast Carcinoma,1,2,Breast Carcinoma,0.5657,Basal-Like Breast Carcinoma,0.5627,Breast Sarcoma,0.5550,Retinoblastoma,0.5498,Microinvasive Breast Carcinoma,0.5469
BRCA_BASAL,Basal,99,2,Basal-Like Breast Carcinoma,0.7046,Normal Breast-Like Subtype of Breast Carcinoma,0.6524,Luminal B Breast Carcinoma,0.6110,Breast Metaplastic Carcinoma,0.5955,Microinvasive Breast Carcinoma,0.5758
BRCA_HER2,HER2-Positive Breast Carcinoma,1,2,HER2-Positive Breast Carcinoma,0.8198,Estrogen Receptor Positive<;>HER2/Neu Positive<;>HER2-Positive Breast Carcinoma,0.7653,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.7527,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.7041,Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.6896
BRCA_LUMA,Luminal A Breast Carcinoma,99,2,Normal Breast-Like Subtype of Breast Carcinoma,0.6379,Basal-Like Breast Carcinoma,0.5926,Luminal B Breast Carcinoma,0.5738,Breast Metaplastic Carcinoma,0.5712,Breast Sarcoma,0.5681
BRCA_LUMB,Luminal B Breast Carcinoma,5,2,Normal Breast-Like Subtype of Breast Carcinoma,0.6331,Basal-Like Breast Carcinoma,0.5798,Microinvasive Breast Carcinoma,0.5721,Breast Sarcoma,0.5664,Luminal B Breast Carcinoma,0.5647
BRCA_NORMAL,Breast Carcinoma,99,2,Normal Breast-Like Subtype of Breast Carcinoma,0.7357,Breast Ductal Carcinoma In Situ,0.5738,Benign Neoplasm,0.5667,Basal-Like Breast Carcinoma,0.5592,Microinvasive Breast Carcinoma,0.5547
BREAST,Breast,1,2,Breast,1.0000,Breast Neoplasm,0.7077,Breast Carcinoma,0.6915,Breast Sarcoma,0.6287,Invasive Breast Carcinoma,0.5929
BREAST ANGIOSARCOMA,Breast Angiosarcoma,1,2,Breast Angiosarcoma,1.0000,Breast Sarcoma,0.7682,Angiosarcoma,0.6968,Breast Medullary Carcinoma,0.6647,Breast Carcinoma with Chondroid Metaplasia,0.6168
BREAST CANCER,Breast Carcinoma,1,2,Breast Carcinoma,0.9575,Breast Neoplasm,0.8155,Breast Adenocarcinoma,0.7986,Breast Sarcoma,0.7839,Breast,0.7619
"BREAST CANCER, NOS",Breast Carcinoma,1,2,Breast Carcinoma,0.9576,Breast Neoplasm,0.8095,Breast Adenocarcinoma,0.8024,Breast Sarcoma,0.7795,Breast,0.7523
BREAST CARCINOMA,Breast Carcinoma,1,2,Breast Carcinoma,1.0000,Breast Adenocarcinoma,0.8508,Breast Neoplasm,0.7844,Invasive Breast Carcinoma,0.7823,Breast Ductal Carcinoma,0.7606
BREAST CARCINOMA OTHER,Breast Carcinoma,1,2,Breast Carcinoma,0.7560,Invasive Breast Carcinoma of No Special Type,0.6660,Breast Sarcoma,0.6645,Invasive Breast Carcinoma,0.6609,Breast Adenocarcinoma,0.6528
BREAST DUCTAL CARCINOMA,Breast Ductal Carcinoma,1,2,Breast Ductal Carcinoma,1.0000,Breast Ductal Carcinoma In Situ,0.7843,Breast Adenocarcinoma,0.7651,Breast Carcinoma,0.7606,Invasive Breast Carcinoma,0.7252
BREAST DUCTAL CARCINOMA IN SITU,Breast Ductal Carcinoma In Situ,1,2,Breast Ductal Carcinoma In Situ,1.0000,Breast Ductal Carcinoma,0.7843,Invasive Breast Carcinoma of No Special Type,0.7197,Microinvasive Breast Carcinoma,0.7020,Invasive Breast Carcinoma,0.6799
BREAST DUCTAL HR+HER2+,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,1,2,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.7789,HER2-Positive Breast Carcinoma,0.7718,Estrogen Receptor Positive<;>HER2/Neu Positive<;>HER2-Positive Breast Carcinoma,0.7706,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.7606,Estrogen Receptor Positive<;>HER2/Neu Positive,0.7316
BREAST DUCTAL HR+HER2-,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,3,2,Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.7565,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.7546,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.7536,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.7515,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.7376
BREAST DUCTAL HR-HER2+,Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,5,2,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.8052,HER2-Positive Breast Carcinoma,0.7958,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.7792,Estrogen Receptor Positive<;>HER2/Neu Positive<;>HER2-Positive Breast Carcinoma,0.7753,Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.7523
BREAST DUCTAL TRIPLE NEGATIVE,Breast Ductal Carcinoma<;>Triple-Negative Breast Cancer Finding,1,2,Breast Ductal Carcinoma<;>Triple-Negative Breast Cancer Finding,0.9364,Triple-Negative Breast Cancer Finding,0.8292,Invasive Breast Carcinoma of No Special Type<;>Triple-Negative Breast Cancer Finding,0.7996,Breast Ductal Carcinoma In Situ,0.7111,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.7072
"BREAST INVASIVE CANCER, NOS",Invasive Breast Carcinoma,1,2,Invasive Breast Carcinoma,0.9661,Invasive Breast Carcinoma of No Special Type,0.8908,Breast Carcinoma,0.8182,Breast Adenocarcinoma,0.7470,Breast Ductal Carcinoma,0.7214
BREAST INVASIVE CARCINOMA,Invasive Breast Carcinoma,1,2,Invasive Breast Carcinoma,0.9873,Invasive Breast Carcinoma of No Special Type,0.9296,Breast Carcinoma,0.8131,Breast Adenocarcinoma,0.7580,Breast Ductal Carcinoma,0.7376
BREAST INVASIVE CARCINOMA BRCA,Invasive Breast Carcinoma,2,2,Basal-Like Breast Carcinoma,0.6739,Invasive Breast Carcinoma,0.6613,Invasive Breast Carcinoma of No Special Type,0.6533,Microinvasive Breast Carcinoma,0.6515,Breast Metaplastic Carcinoma,0.6405
BREAST INVASIVE CARCINOMA NOS,Invasive Breast Carcinoma,1,2,Invasive Breast Carcinoma,0.9864,Invasive Breast Carcinoma of No Special Type,0.9278,Breast Carcinoma,0.8032,Breast Adenocarcinoma,0.7449,Breast Ductal Carcinoma,0.7292
"BREAST INVASIVE CARCINOMA, NOS",Invasive Breast Carcinoma of No Special Type,2,2,Invasive Breast Carcinoma,0.9837,Invasive Breast Carcinoma of No Special Type,0.9245,Breast Carcinoma,0.8159,Breast Adenocarcinoma,0.7568,Breast Ductal Carcinoma,0.7418
"BREAST INVASIVE CARCINOSARCOMA, NOS",Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,99,2,Breast Sarcoma,0.7348,Breast Metaplastic Carcinoma,0.7293,Invasive Breast Carcinoma,0.7210,Invasive Breast Carcinoma of No Special Type,0.6945,Breast Medullary Carcinoma,0.6867
BREAST INVASIVE DUCTAL CARCINOMA,Invasive Breast Carcinoma of No Special Type,4,2,Breast Ductal Carcinoma,0.8957,Invasive Breast Carcinoma,0.8547,Breast Ductal Carcinoma In Situ,0.8391,Invasive Breast Carcinoma of No Special Type,0.8283,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.7748
BREAST INVASIVE LOBULAR CARCINOMA,Invasive Breast Lobular Carcinoma,1,2,Invasive Breast Lobular Carcinoma,0.9947,Breast Lobular Carcinoma,0.9254,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.8490,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.8356,Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma,0.7547
BREAST INVASIVE MIXED MUCINOUS CARCINOMA,Breast Mucinous Carcinoma,2,2,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.8400,Breast Mucinous Carcinoma,0.8255,Breast Metaplastic Carcinoma,0.7390,Breast Mixed Ductal and Lobular Carcinoma,0.7334,Breast Metaplastic Carcinoma<;>Epithelial,0.7193
BREAST LOBULAR HR+,Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma,1,2,Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma,0.8679,Breast Lobular Carcinoma,0.6752,Invasive Breast Lobular Carcinoma,0.6733,Invasive Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.6668,Luminal B Breast Carcinoma,0.6526
BREAST MICROINVASIVE CARCINOMA,Microinvasive Breast Carcinoma,1,2,Microinvasive Breast Carcinoma,0.9881,Invasive Breast Carcinoma of No Special Type,0.7518,Invasive Breast Carcinoma,0.7202,Breast Ductal Carcinoma In Situ,0.7193,Breast Metaplastic Carcinoma,0.7087
BREAST MIXED DUCTAL AND LOBULAR CARCINOMA,Breast Mixed Ductal and Lobular Carcinoma,1,2,Breast Mixed Ductal and Lobular Carcinoma,1.0000,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.8489,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.8002,Breast Lobular Carcinoma,0.7660,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.7627
"BREAST NEOPLASM, NOS",Breast Neoplasm,1,2,Breast Neoplasm,0.9936,Breast Carcinoma,0.7860,Breast,0.7087,Breast Sarcoma,0.6590,Uterine Neoplasm,0.6297
BREAST SARCOMA,Breast Sarcoma,1,2,Breast Sarcoma,1.0000,Breast Angiosarcoma,0.7682,Breast Carcinoma,0.7520,Breast Adenocarcinoma,0.6880,Breast Neoplasm,0.6610
BREAST_ADENOCARCINOMA,Breast Adenocarcinoma,1,2,Breast Adenocarcinoma,0.9637,Breast Carcinoma,0.8127,Breast Ductal Carcinoma,0.7734,Adenocarcinoma,0.7377,Invasive Breast Carcinoma,0.7236
BREAST_CANCER,Breast Carcinoma,1,2,Breast Carcinoma,0.9072,Breast Neoplasm,0.7844,Breast,0.7621,Breast Adenocarcinoma,0.7598,Breast Sarcoma,0.7577
BREAST_CARCINOMA,Breast Carcinoma,1,2,Breast Carcinoma,0.9621,Breast Adenocarcinoma,0.8211,Invasive Breast Carcinoma,0.7748,Breast Neoplasm,0.7701,Breast Ductal Carcinoma,0.7639
BREAST_DUCTAL_CARCINOMA,Breast Ductal Carcinoma,1,2,Breast Ductal Carcinoma,0.9749,Breast Ductal Carcinoma In Situ,0.8060,Ductal,0.7383,Breast Carcinoma,0.7256,Breast Adenocarcinoma,0.7149
BRENNER TUMOR,Brenner Tumor,1,2,Brenner Tumor,1.0000,Breast Medullary Carcinoma,0.6228,PEComa,0.6201,Phyllodes Tumor,0.6171,Malignant Myoepithelioma,0.6005
BRENNER_TUMOR,Brenner Tumor,1,2,Brenner Tumor,0.9517,PEComa,0.6058,Malignant Myoepithelioma,0.5982,Malignant Mixed Mesodermal (Mullerian) Tumor,0.5957,Breast Medullary Carcinoma,0.5956
BRENNER_TUMOUR,Brenner Tumor,1,2,Brenner Tumor,0.9516,PEComa,0.6103,Malignant Myoepithelioma,0.6069,Breast Medullary Carcinoma,0.6067,Epithelial-Myoepithelial Carcinoma,0.6023
BRONCHIOALVEOLAR_CARCINOMA,Lung Adenocarcinoma In Situ,99,2,Lung Adenocarcinoma,0.7259,Lung Adenoid Cystic Carcinoma,0.6996,Solid Lung Adenocarcinoma,0.6907,Lung Non-Mucinous Adenocarcinoma,0.6821,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.6809
BRONCHIOALVEOLAR_CARCINOMA; NON-SMALL_CELL LUNG_CANCER,Lung Adenocarcinoma In Situ<;>Lung Non-Small Cell Carcinoma,99,2,Lung Non-Mucinous Adenocarcinoma,0.7425,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.7155,Lung Non-Small Cell Carcinoma,0.6980,Lung Adenocarcinoma,0.6652,Minimally Invasive Lung Non-Mucinous Adenocarcinoma,0.6620
BRONCHIOLOALVEOLAR_ADENOCARCINOMA,Minimally Invasive Lung Adenocarcinoma,99,2,Lung Acinar Adenocarcinoma,0.7790,Lung Adenocarcinoma,0.7580,Lung Non-Mucinous Adenocarcinoma,0.7549,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.7489,Lung Papillary Adenocarcinoma,0.7438
BUCCAL_MUCOSA,Buccal Mucosa,1,2,Buccal Mucosa,0.9571,Mucosa,0.7828,Buccal Mucosa Squamous Cell Carcinoma,0.6089,Gingiva,0.5651,Epithelial,0.5373
BURKITT LYMPHOMA,Burkitt Lymphoma,1,2,Burkitt Lymphoma,1.0000,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9161,B-Cell Non-Hodgkin Lymphoma,0.7812,Centroblastic Lymphoma,0.7543,B-Cell Non-Hodgkin Lymphoma<;>Undifferentiated,0.7486
BURKITTS LYMPHOMA,Burkitt Lymphoma,1,2,Burkitt Lymphoma,0.9958,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9102,B-Cell Non-Hodgkin Lymphoma,0.7708,Centroblastic Lymphoma,0.7505,B-Cell Non-Hodgkin Lymphoma<;>Undifferentiated,0.7407
BURKITT_LYMPHOMA,Burkitt Lymphoma,1,2,Burkitt Lymphoma,0.9798,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9136,B-Cell Non-Hodgkin Lymphoma,0.7851,B-Cell Non-Hodgkin Lymphoma<;>Undifferentiated,0.7531,B Lymphoblastic Leukemia/Lymphoma,0.7494
B_CELL,B-Lymphocyte,1,2,B-Lymphocyte,0.9294,B-Cell Neoplasm,0.7103,Mature B-Cell Neoplasm,0.6829,germinal center B cell,0.6681,Lymphoid,0.6631
B_CELL_BURKITT,Burkitt Lymphoma,1,2,Burkitt Lymphoma,0.9199,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.8868,B-Cell Non-Hodgkin Lymphoma,0.8000,Mature B-Cell Non-Hodgkin Lymphoma,0.7828,B-Cell Non-Hodgkin Lymphoma<;>Undifferentiated,0.7598
B_CELL_FOLLICULAR,Follicular Lymphoma,1,2,Follicular Lymphoma,0.7489,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.7409,B-Lymphocyte,0.7222,germinal center B cell,0.7205,Follicle,0.6297
B_CELL_LYMPHOMA_UNSPECIFIED,B-Cell Non-Hodgkin Lymphoma,2,2,B-Cell Neoplasm,0.9066,B-Cell Non-Hodgkin Lymphoma,0.9025,Mature B-Cell Neoplasm,0.8264,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.8214,Lymphoma,0.8146
B_CELL_MANTLE_CELL,Mantle Cell Lymphoma,2,2,B-Cell Non-Hodgkin Lymphoma<;>Mantle Cell Lymphoma,0.7601,Mantle Cell Lymphoma,0.7509,Mature B-Cell Non-Hodgkin Lymphoma,0.7065,Mature B-Cell Neoplasm,0.7029,germinal center B cell,0.7024
B_CELL_MEDIASTINAL_LARGE,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,1,2,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.7401,Monoclonal B-Cell Lymphocytosis,0.7289,Mature B-Cell Non-Hodgkin Lymphoma,0.6937,Mature B-Cell Neoplasm,0.6827,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.6326
B_CELL_NON_HODGKIN_LYMPHOMA,B-Cell Non-Hodgkin Lymphoma,1,2,B-Cell Non-Hodgkin Lymphoma,0.9548,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.8449,B-Cell Neoplasm,0.8227,Mature B-Cell Non-Hodgkin Lymphoma,0.8120,Non-Hodgkin Lymphoma,0.8059
B_CELL_PRIMARY_EFFUSION,Primary Effusion Lymphoma,2,2,B-Cell Non-Hodgkin Lymphoma<;>Primary Effusion Lymphoma,0.8726,Primary Effusion Lymphoma,0.8242,Monoclonal B-Cell Lymphocytosis,0.6512,Plasma Cell Leukemia,0.6390,Plasmacytoma,0.6347
CAECUM ADENOCARCINOMA,Cecum Adenocarcinoma,1,2,Cecum Adenocarcinoma,0.8965,Colorectal Adenocarcinoma,0.7813,Colon Adenocarcinoma,0.7587,Appendix Adenocarcinoma,0.7103,Colon Mucinous Adenocarcinoma,0.7051
CAECUM_ADENOCARCINOMA,Cecum Adenocarcinoma,1,2,Cecum Adenocarcinoma,0.8774,Colorectal Adenocarcinoma,0.7734,Colon Adenocarcinoma,0.7437,Colon Mucinous Adenocarcinoma,0.7151,Appendix Adenocarcinoma,0.6910
CANCER IDENTIFICATION IDC,Invasive Breast Carcinoma of No Special Type,99,2,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.5895,Cervical Adenocarcinoma In Situ,0.5746,Well Differentiated Lesion<;>Invasive,0.5534,Microinvasive Breast Carcinoma,0.5508,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.5478
CANCER IDENTIFICATION ILC,Invasive Breast Lobular Carcinoma,99,2,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.5503,Colon Adenocarcinoma<;>Chromosomal Instability,0.5364,Rectal Adenocarcinoma<;>Chromosomal Instability,0.5310,Gastric Adenocarcinoma<;>Chromosomal Instability,0.5277,With Tumor,0.5206
CANCER IDENTIFICATION MIDLC,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,99,2,Microinvasive Breast Carcinoma,0.5450,Hypermutated Colorectal Carcinoma,0.5232,Metastasis,0.5083,Malignant Neoplasm,0.5039,Cytology Specimen Type,0.4947
CANCER OF UNKNOWN PRIMARY,Malignant Neoplasm,99,2,Melanoma of Unknown Primary,0.8508,Primary Neoplasm<;>Unpaired,0.7651,Primary Neoplasm,0.6620,Unclassified Renal Cell Carcinoma,0.6162,Primary Neoplasm<;>Paired,0.6101
"CANCER OF UNKNOWN PRIMARY, NOS",Carcinoma,99,2,Melanoma of Unknown Primary,0.8530,Primary Neoplasm<;>Unpaired,0.7808,Primary Neoplasm,0.6730,Unclassified Renal Cell Carcinoma,0.6208,Primary Neoplasm<;>Paired,0.6163
CARCINOID,Carcinoid Tumor,1,2,Carcinoid Tumor,0.9787,Neuroendocrine Tumor,0.7970,Neuroendocrine Neoplasm,0.7773,Lung Carcinoid Tumor,0.7733,Carcinosarcoma,0.7666
CARCINOID TUMOR,Carcinoid Tumor,1,2,Carcinoid Tumor,1.0000,Neuroendocrine Tumor,0.8168,Lung Carcinoid Tumor,0.7953,Neuroendocrine Neoplasm,0.7899,Neuroendocrine Carcinoma,0.7682
CARCINOID-ENDOCRINE TUMOUR,Carcinoid Tumor,1,2,Carcinoid Tumor,0.9633,Neuroendocrine Tumor,0.8413,Neuroendocrine Neoplasm,0.8132,Pituitary Neuroendocrine Tumor,0.7624,Lung Carcinoid Tumor,0.7620
CARCINOMA,Carcinoma,1,2,Carcinoma,1.0000,Malignant Neoplasm,0.8438,Adenocarcinoma,0.8372,Carcinoma<;>Undifferentiated,0.7691,Undifferentiated Carcinoma,0.7618
CARCINOMA OF UTERINE CERVIX,Cervical Carcinoma,1,2,Cervical Carcinoma,0.9171,Cervical Adenocarcinoma,0.8363,Cervical Squamous Cell Carcinoma,0.8299,Cervix Uteri,0.7844,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.7501
CARCINOMA PATIENT WITH METASTATIC CARCINOMA OF THE PROSTATE AND A 3 YEAR HISTORY OF LYMPHOCYTIC LEUKEMIA.,Metastatic Prostate Carcinoma<;>Lymphoid Leukemia,1,2,Metastatic Prostate Carcinoma<;>Lymphoid Leukemia,0.7226,Brain<;>Site of Metastasis<;>Metastatic Prostate Carcinoma<;>Lymphoid Leukemia,0.6771,Castration-Resistant Prostate Carcinoma<;>Metastatic Prostate Carcinoma,0.5374,Aggressive Variant Prostate Carcinoma,0.5243,Castration-Resistant Prostate Carcinoma<;>Non-Metastatic Prostate Carcinoma,0.5125
CARCINOMA SMALL CELL,Small Cell Neuroendocrine Carcinoma,4,2,"Malignant Tumor, Small Cell Type",0.9428,Small Cell Adenocarcinoma,0.9190,Lung Small Cell Carcinoma,0.8729,Small Cell Neuroendocrine Carcinoma,0.8692,Small Cell,0.8506
CARCINOMA WITH CHONDROID METAPLASIA,Breast Carcinoma with Chondroid Metaplasia,1,2,Breast Carcinoma with Chondroid Metaplasia,0.8203,Chondrosarcoma,0.7950,Metaplastic Carcinoma,0.7759,Mesenchymal Chondrosarcoma,0.7680,Dedifferentiated Chondrosarcoma,0.7644
CARCINOMA WITH OSSEOUS METAPLASIA,Breast Carcinoma with Osseous Metaplasia,1,2,Breast Carcinoma with Osseous Metaplasia,0.8326,Osteosarcoma,0.7538,Osteoblastic Osteosarcoma,0.7154,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0.6991,Periosteal Osteosarcoma,0.6861
CARCINOMA WITH SQUAMOUS DIFFERENTIATION,Gallbladder Squamous Cell Carcinoma,99,2,Squamous Cell Carcinoma,0.9402,Skin Squamous Cell Carcinoma,0.8434,Squamous Cell Carcinoma<;>Poorly Differentiated,0.8353,Cervical Squamous Cell Carcinoma,0.7640,Adenosquamous Carcinoma,0.7546
"CARCINOMA, ANAPLASTIC",Anaplastic Carcinoma,1,2,Anaplastic Carcinoma,0.9879,Undifferentiated Carcinoma,0.8667,Adenocarcinoma<;>Undifferentiated Carcinoma,0.8549,Anaplastic,0.8451,Carcinoma<;>Undifferentiated,0.8430
"CARCINOMA, BRENNER",Brenner Tumor,1,2,Brenner Tumor,0.8547,Breast Medullary Carcinoma,0.7059,Tubulolobular Breast Carcinoma,0.6696,Medullary Carcinoma,0.6642,Signet Ring Cell Carcinoma,0.6624
"CARCINOMA, FOLLICULAR",Thyroid Gland Follicular Carcinoma,1,2,Thyroid Gland Follicular Carcinoma,0.8891,Follicular Lymphoma,0.8231,Thyroid Gland Follicular Carcinoma<;>Thyroid Gland Oncocytic Carcinoma,0.7281,Thyroid Gland Papillary and Follicular Carcinoma,0.7033,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.6872
"CARCINOMA, GIANT CELL",Giant Cell Carcinoma,1,2,Giant Cell Carcinoma,0.9907,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0.8549,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells<;>Sarcomatoid Carcinoma,0.7977,Giant Cell Tumor,0.7902,Large Cell Carcinoma<;>Undifferentiated,0.7466
"CARCINOMA, GINGIVAL",Gingival Carcinoma,1,2,Gingival Carcinoma,0.9810,Odontogenic Carcinoma,0.6574,Giant Cell Carcinoma,0.5973,Salivary Gland Carcinoma,0.5940,Clear Cell Odontogenic Carcinoma,0.5897
"CARCINOMA, MUCOEPIDERMOID",Mucoepidermoid Carcinoma,1,2,Mucoepidermoid Carcinoma,0.9845,Lung Mucoepidermoid Carcinoma,0.7688,Lung Non-Small Cell Carcinoma<;>Lung Mucoepidermoid Carcinoma,0.7374,Skin Metatypical Carcinoma,0.6889,Epithelial-Myoepithelial Carcinoma,0.6880
"CARCINOMA, PAPILLARY",Papillary Carcinoma,1,2,Papillary Carcinoma,0.9851,Papillary Adenocarcinoma,0.9121,Thyroid Gland Papillary Carcinoma,0.8560,Classic Thyroid Gland Papillary Carcinoma,0.8228,Acinar Cell Carcinoma<;>Papillary,0.7956
"CARCINOMA, VULVAR",Vulvar Carcinoma,1,2,Vulvar Carcinoma,0.9873,Vulvar Squamous Cell Carcinoma,0.8972,Vulvar Carcinoma<;>Vaginal Carcinoma,0.8790,Vaginal Carcinoma,0.6814,Vaginal Squamous Cell Carcinoma,0.6430
CARCINOMA-UD,Carcinoma<;>Undifferentiated,4,2,Carcinoma,0.8372,Malignant Neoplasm,0.7410,Undifferentiated Carcinoma,0.7254,Carcinoma<;>Undifferentiated,0.7183,Adenocarcinoma,0.7092
CARCINOMA-VPD,Carcinoma<;>Poorly Differentiated,99,2,Malignant PEComa,0.6433,Neuroendocrine Carcinoma<;>Poorly Differentiated,0.6106,Mixed Carcinoma,0.6060,Prostate Neuroendocrine Carcinoma,0.6021,Prostate Small Cell Neuroendocrine Carcinoma,0.5960
CARCINOSARCOMA-MALIGNANT_MESODERMAL_MIXED_TUMOUR,Carcinosarcoma,4,2,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.8577,"Uterine Carcinosarcoma, Heterologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.8456,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.8447,Carcinosarcoma,0.8352,Malignant Mixed Mesodermal (Mullerian) Tumor,0.8145
CARCINOSARCOMA-MAMMARY GLAND,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,99,2,Breast Sarcoma,0.7682,Carcinosarcoma,0.7141,Breast Angiosarcoma,0.6849,Breast Secretory Carcinoma,0.6848,Uterine Carcinosarcoma,0.6695
CARCINOSARCOMA-MAMMARY GLAND; BREAST,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,99,2,Breast Sarcoma,0.8317,Breast Angiosarcoma,0.7409,Breast Metaplastic Carcinoma,0.7040,Breast Carcinoma with Chondroid Metaplasia,0.6915,Breast Adenocarcinoma,0.6846
CASTLEMAN'S DISEASE,Castleman Disease,1,2,Castleman Disease,0.9922,Erdheim-Chester Disease,0.6181,Monoclonal B-Cell Lymphocytosis,0.6119,Plasmacytoma,0.6038,Waldenstrom Macroglobulinemia,0.5913
CASTRATION-RESISTANT PROSTATE CANCER,Castration-Resistant Prostate Carcinoma,1,2,Castration-Resistant Prostate Carcinoma,0.9951,Castration-Resistant Prostate Carcinoma<;>Prostate Adenocarcinoma,0.9358,Castration-Resistant Prostate Carcinoma<;>Metastatic Prostate Carcinoma,0.9275,Castration-Sensitive Prostate Carcinoma,0.9197,Castration-Resistant Prostate Carcinoma<;>Non-Metastatic Prostate Carcinoma,0.9179
CBFB-MYH11,CBFB-MYH11 Fusion Protein Expression,1,2,CBFB-MYH11 Fusion Protein Expression,0.6006,Chronic Myelomonocytic Leukemia-2,0.5392,Chronic Myelomonocytic Leukemia-1,0.5354,Acute Myeloid Leukemia with Mutated RUNX1,0.5165,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.5039
CCOV,Malignant Ovarian Clear Cell Tumor,99,2,Hepatitis C Virus,0.5259,Cytology Specimen Type,0.5023,"Ovarian Small Cell Carcinoma, Hypercalcemic Type",0.4926,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,0.4852,"Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type",0.4776
CCRCC,Clear Cell Renal Cell Carcinoma,1,2,Clear Cell Renal Cell Carcinoma,0.7743,Renal Cell Carcinoma,0.7565,Chromophobe Renal Cell Carcinoma,0.7517,Papillary Renal Cell Carcinoma,0.7484,Classic Variant of Chromophobe Renal Cell Carcinoma,0.7483
CD30+_ANAPLASTIC_LARGE_CELL_LYMPHOMA,Anaplastic Large Cell Lymphoma,1,2,Anaplastic Large Cell Lymphoma,0.7810,"Anaplastic Large Cell Lymphoma, ALK-Positive",0.7598,"Anaplastic Large Cell Lymphoma, ALK-Negative",0.6963,Anaplastic,0.5898,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.5849
CECUM,Cecum,1,2,Cecum,1.0000,Colon,0.6936,Ascending Colon,0.6483,Colorectal,0.6404,Cecum Adenocarcinoma,0.6255
CELL LINE,Cell Line,1,2,Cell Line,1.0000,immortal epithelial cell line cell,0.6132,Undifferentiated,0.6052,Germ Cell,0.5920,immortal fibroblast cell line cell,0.5764
CELLULAR SCHWANNOMA,Cellular Schwannoma,1,2,Cellular Schwannoma,1.0000,Schwannoma,0.9192,Melanotic Schwannoma,0.8355,Plexiform Schwannoma,0.7960,Nerve Sheath Neoplasm,0.7461
CENTRAL NEUROCYTOMA,Central Neurocytoma,1,2,Central Neurocytoma,1.0000,Extraventricular Neurocytoma,0.8045,Glioneuronal Tumor,0.7579,Central Nervous System Medulloepithelioma,0.7404,Angiocentric Glioma,0.7172
CENTROBLASTIC,Centroblastic Lymphoma,1,2,Centroblastic Lymphoma,0.8724,Blastic Phase,0.6882,germinal center B cell,0.6695,B-Lymphocyte,0.6487,Mature B-Cell Neoplasm,0.6478
CERVICAL ADENOCARCINOMA,Cervical Adenocarcinoma,1,2,Cervical Adenocarcinoma,1.0000,Cervical Carcinoma,0.9027,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.9012,Cervical Squamous Cell Carcinoma,0.8078,Cervical Adenosquamous Carcinoma,0.7478
CERVICAL ADENOCARCINOMA IN SITU,Cervical Adenocarcinoma In Situ,1,2,Cervical Adenocarcinoma In Situ,1.0000,Cervical Adenocarcinoma,0.7345,Cervical Carcinoma,0.7080,Cervix Uteri,0.6720,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.6697
CERVICAL ADENOID CYSTIC CARCINOMA,Cervical Adenoid Cystic Carcinoma,1,2,Cervical Adenoid Cystic Carcinoma,1.0000,Adenoid Cystic Carcinoma,0.8907,Breast Adenoid Cystic Carcinoma,0.8058,Lung Adenoid Cystic Carcinoma,0.7583,Cervical Adenosquamous Carcinoma,0.7393
CERVICAL ADENOSQUAMOUS CARCINOMA,Cervical Adenosquamous Carcinoma,1,2,Cervical Adenosquamous Carcinoma,1.0000,Adenosquamous Carcinoma,0.8972,Cervical Squamous Cell Carcinoma,0.8075,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.8022,Lung Adenosquamous Carcinoma,0.7717
CERVICAL CANCER,Cervical Carcinoma,1,2,Cervical Carcinoma,0.9658,Cervical Adenocarcinoma,0.8401,Cervical Squamous Cell Carcinoma,0.7866,Cervix Uteri,0.7482,Cervical Squamous Neoplasm,0.7371
"CERVICAL CANCER, NOS",Cervical Carcinoma,1,2,Cervical Carcinoma,0.9664,Cervical Adenocarcinoma,0.8432,Cervical Squamous Cell Carcinoma,0.7996,Cervix Uteri,0.7477,Cervical Squamous Neoplasm,0.7336
CERVICAL CLEAR CELL CARCINOMA,"Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type",1,2,"Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type",0.8255,Cervical Squamous Cell Carcinoma,0.7830,Clear Cell Adenocarcinoma,0.7722,Adenocarcinoma Clear Cell,0.7542,Cervical Adenocarcinoma,0.7485
CERVICAL ENDOMETRIOID CARCINOMA,Cervical Endometrioid Adenocarcinoma,1,2,Cervical Endometrioid Adenocarcinoma,0.9685,Endometrial Endometrioid Adenocarcinoma,0.8808,Endometrioid Adenocarcinoma,0.8760,Cystadenocarcinoma<;>Endometrioid Adenocarcinoma,0.8590,Ovarian Endometrioid Adenocarcinoma,0.8275
CERVICAL NEUROENDOCRINE TUMOR,Cervical Neuroendocrine Tumor,1,2,Cervical Neuroendocrine Tumor,1.0000,Neuroendocrine Carcinoma,0.7922,Neuroendocrine Tumor,0.7699,Neuroendocrine Neoplasm,0.7672,Esophageal Neuroendocrine Tumor,0.7595
CERVICAL SQUAMOUS CELL,Cervical Squamous Cell Carcinoma,1,2,Cervical Squamous Cell Carcinoma,0.9254,Cervical Squamous Neoplasm,0.9022,Cervical Carcinoma,0.8083,Squamous Cell Carcinoma,0.7993,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.7800
CERVICAL SQUAMOUS CELL CARCINOMA,Cervical Squamous Cell Carcinoma,1,2,Cervical Squamous Cell Carcinoma,1.0000,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.8756,Cervical Squamous Neoplasm,0.8506,Cervical Carcinoma,0.8438,Squamous Cell Carcinoma,0.8203
CERVICAL_ADENOCARCINOMA,Cervical Adenocarcinoma,1,2,Cervical Adenocarcinoma,0.9712,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.8808,Cervical Carcinoma,0.8784,Cervical Squamous Cell Carcinoma,0.7773,Cervical Adenocarcinoma In Situ,0.7702
CERVICAL_CARCINOMA,Cervical Carcinoma,1,2,Cervical Carcinoma,0.9675,Cervical Adenocarcinoma,0.8686,Cervical Squamous Cell Carcinoma,0.8016,Carcinoma,0.7787,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.7518
CERVICAL_SMALL_CELL,Cervical Small Cell Neuroendocrine Carcinoma,1,2,Cervical Small Cell Neuroendocrine Carcinoma,0.8039,Small Cell,0.7740,"Malignant Tumor, Small Cell Type",0.7318,Cervical Squamous Cell Carcinoma,0.7120,Cervical Carcinoma,0.7018
CERVICAL_SQUAMOUS,Cervical Squamous Neoplasm,1,2,Cervical Squamous Neoplasm,0.8692,Cervical Squamous Cell Carcinoma,0.8044,Cervical Carcinoma,0.7508,Squamous Cell Carcinoma,0.7505,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.7045
CERVICOMEDULLARY HEMANGIOBLASTOMA,Hemangioblastoma<;>Cervicomedullary Junction,1,2,Hemangioblastoma<;>Cervicomedullary Junction,0.9303,Hemangioblastoma,0.5923,Pseudomyogenic Hemangioendothelioma,0.5746,Epithelioid Hemangioendothelioma,0.5632,Plexiform Fibrohistiocytic Tumor,0.5395
CERVIX,Cervix Uteri,1,2,Cervix Uteri,0.9513,Cervical Carcinoma,0.7324,Cervical Adenocarcinoma In Situ,0.6677,Cervical Adenocarcinoma,0.6378,Cervical Squamous Neoplasm,0.6255
CESC,Cervical Squamous Cell Carcinoma,99,2,Endometrial Neuroendocrine Carcinoma,0.5161,uterine corpus endometrial carcinoma<;>Copy Number<;>High,0.5098,immortal epithelial cell line cell,0.5060,Endometrial Carcinoma<;>Microsatellite Instability,0.4927,uterine corpus endometrial carcinoma<;>Copy Number<;>Low,0.4850
CESC_ADENOCARCINOMA,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,99,2,"Mucinous Adenocarcinoma, Endocervical Type",0.7066,Epithelial-Myoepithelial Carcinoma,0.6984,Adenocarcinoma,0.6613,Adenocarcinoma with Neuroendocrine Differentiation,0.6584,Barrett Adenocarcinoma,0.6501
CESC_SQUAMOUSCARCINOMA,Cervical Squamous Cell Carcinoma,99,2,Skin Metatypical Carcinoma,0.6660,Epithelial-Myoepithelial Carcinoma,0.6646,Metaplastic Carcinoma,0.6552,Mucoepidermoid Carcinoma,0.6444,PEComa,0.6428
CHOL,Cholangiocarcinoma,3,2,Bile Duct,0.5336,Biliary Tract,0.5304,Cholangiocarcinoma,0.5094,Cytology Specimen Type,0.4992,Liver,0.4925
CHOL EXTRA,Extrahepatic Bile Duct Adenocarcinoma,99,2,Extrahepatic,0.5199,Biliary Tract,0.5115,Bile Duct,0.4906,Proximal Bile Duct,0.4682,Cholangiocarcinoma,0.4505
CHOL INTRA,Intrahepatic Cholangiocarcinoma,3,2,Intrahepatic,0.6397,Bile Duct,0.5372,Intrahepatic Cholangiocarcinoma,0.5340,Biliary Tract,0.5308,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.5250
CHOLANGIO EXTRAHEPATIC,Extrahepatic Bile Duct Adenocarcinoma,5,2,Cholangiocarcinoma<;>Extrahepatic,0.7454,Proximal Bile Duct,0.7269,Bile Duct,0.6878,Biliary Tract,0.6718,Extrahepatic Bile Duct Adenocarcinoma,0.6708
CHOLANGIO INTRAHEPATIC,Intrahepatic Cholangiocarcinoma,1,2,Intrahepatic Cholangiocarcinoma,0.7613,Intrahepatic,0.7595,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.7064,Bile Duct,0.6915,Proximal Bile Duct,0.6850
CHOLANGIOCARCINOMA,Cholangiocarcinoma,1,2,Cholangiocarcinoma,1.0000,Intrahepatic Cholangiocarcinoma,0.8704,Hilar Cholangiocarcinoma,0.8450,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.8184,Cholangiocarcinoma<;>Extrahepatic,0.8156
"CHOLANGIOCARCINOMA, EXTRAHEPATIC",Cholangiocarcinoma<;>Extrahepatic,1,2,Cholangiocarcinoma<;>Extrahepatic,0.9831,Intrahepatic Cholangiocarcinoma,0.8680,Hilar Cholangiocarcinoma,0.8571,Cholangiocarcinoma,0.8362,Extrahepatic Bile Duct Adenocarcinoma,0.8097
"CHOLANGIOCARCINOMA, INTRAHEPATIC",Intrahepatic Cholangiocarcinoma,1,2,Intrahepatic Cholangiocarcinoma,0.9915,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9406,Cholangiocarcinoma,0.8845,Hilar Cholangiocarcinoma,0.8587,Cholangiocarcinoma<;>Extrahepatic,0.8520
CHOLANGIOCARCINOMA; DISTAL,Distal Bile Duct Adenocarcinoma,5,2,Cholangiocarcinoma<;>Extrahepatic,0.8825,Cholangiocarcinoma,0.8321,Hilar Cholangiocarcinoma,0.8211,Intrahepatic Cholangiocarcinoma,0.8140,Distal Bile Duct Adenocarcinoma,0.7786
CHOLANGIOCARCINOMA; HILAR/PERIHILAR,Hilar Cholangiocarcinoma,1,2,Hilar Cholangiocarcinoma,0.9293,Intrahepatic Cholangiocarcinoma,0.8295,Cholangiocarcinoma,0.8256,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.8155,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.8146
CHOLANGIOCARCINOMA; INTRAHEPATIC,Intrahepatic Cholangiocarcinoma,1,2,Intrahepatic Cholangiocarcinoma,0.9895,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9400,Cholangiocarcinoma,0.8732,Cholangiocarcinoma<;>Extrahepatic,0.8640,Hilar Cholangiocarcinoma,0.8506
CHONDROBLASTIC OSTEOSARCOMA,Chondroblastic Osteosarcoma,1,2,Chondroblastic Osteosarcoma,1.0000,Fibroblastic Osteosarcoma,0.8295,Mesenchymal Chondrosarcoma,0.8232,Osteoblastic Osteosarcoma,0.8140,Chondrosarcoma,0.8128
CHONDROBLASTOMA,Chondroblastoma,1,2,Chondroblastoma,1.0000,Chondrosarcoma,0.8384,Mesenchymal Chondrosarcoma,0.8342,Chondroblastic Osteosarcoma,0.7447,Dedifferentiated Chondrosarcoma,0.7282
CHONDROSARCOMA,Chondrosarcoma,1,2,Chondrosarcoma,1.0000,Mesenchymal Chondrosarcoma,0.9258,Chondroblastoma,0.8384,Chondroblastic Osteosarcoma,0.8128,Dedifferentiated Chondrosarcoma,0.7978
CHORDOMA,Chordoma,1,2,Chordoma,1.0000,Sacral Chordoma,0.7755,Myxoma,0.5906,Teratoma,0.5771,Mature Teratoma,0.5455
"CHORDOMA, SACRAL",Sacral Chordoma,1,2,Sacral Chordoma,0.9870,Chordoma,0.7992,Sacrococcygeal Teratoma,0.6462,Sex Cord-Stromal Tumor,0.4874,"Ganglioneuroblastoma, Intermixed",0.4628
CHORDOMA_SACRAL,Sacral Chordoma,1,2,Sacral Chordoma,0.9797,Chordoma,0.8130,Sacrococcygeal Teratoma,0.6345,Sex Cord-Stromal Tumor,0.4880,Cribriform,0.4526
CHORIOCARCINOMA,Choriocarcinoma,1,2,Choriocarcinoma,1.0000,Choriocarcinoma<;>Nonseminomatous,0.8831,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor<;>Choriocarcinoma,0.7528,Embryonal Carcinoma,0.6654,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.6300
CHORIOCARCINOMANON-SEMINOMA,Choriocarcinoma<;>Nonseminomatous,99,2,Choriocarcinoma<;>Nonseminomatous<;>Seminoma,0.9037,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.8539,Embryonal Carcinoma<;>Seminoma,0.7808,Yolk Sac Tumor<;>Seminoma,0.7802,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.7619
CHOROID PLEXUS PAPILLOMA,Choroid Plexus Papilloma,1,2,Choroid Plexus Papilloma,1.0000,Atypical Choroid Plexus Papilloma,0.8351,Choroid Plexus Neoplasm,0.7317,Gallbladder Intracholecystic Papillary Neoplasm,0.6314,Urothelial Papilloma,0.6249
CHOROID PLEXUS TUMOR,Choroid Plexus Neoplasm,1,2,Choroid Plexus Neoplasm,0.9777,Choroid Plexus Papilloma,0.7711,Ependymal Tumor,0.6721,Pineal Region Neoplasm,0.6163,Ependymoma,0.5974
CHROMOPHOBE,Chromophobe Renal Cell Carcinoma,3,2,Clear Cell,0.6154,Chromothripsis,0.6005,Chromophobe Renal Cell Carcinoma,0.6003,Classic Variant of Chromophobe Renal Cell Carcinoma,0.5953,Signet Ring Cell,0.5901
CHROMOPHOBE KIDNEY RENAL CELL CARCINOMA,Chromophobe Renal Cell Carcinoma,1,2,Chromophobe Renal Cell Carcinoma,0.9917,Classic Variant of Chromophobe Renal Cell Carcinoma,0.8887,Clear Cell Renal Cell Carcinoma,0.8709,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.8475,Papillary Renal Cell Carcinoma,0.8255
CHROMOPHOBE RENAL CELL CARCINOMA,Chromophobe Renal Cell Carcinoma,1,2,Chromophobe Renal Cell Carcinoma,1.0000,Classic Variant of Chromophobe Renal Cell Carcinoma,0.8975,Clear Cell Renal Cell Carcinoma,0.8842,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.8541,Papillary Renal Cell Carcinoma,0.8335
CHROMOPHOBE RENAL CELL CARCINOMA,Chromophobe Renal Cell Carcinoma,1,2,Chromophobe Renal Cell Carcinoma,0.8941,Classic Variant of Chromophobe Renal Cell Carcinoma,0.8660,Clear Cell Renal Cell Carcinoma,0.7883,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.7822,Papillary Renal Cell Carcinoma,0.7611
"CHROMOPHOBE, CLASSIC",Classic Variant of Chromophobe Renal Cell Carcinoma,1,2,Classic Variant of Chromophobe Renal Cell Carcinoma,0.7459,Chromophobe Renal Cell Carcinoma,0.6626,Classic Thyroid Gland Papillary Carcinoma,0.6339,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0.6047,Clear Cell,0.6027
"CHROMOPHOBE, EOSINOPHILIC",Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,1,2,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0.7829,Classic Variant of Chromophobe Renal Cell Carcinoma,0.6667,Chromophobe Renal Cell Carcinoma,0.6559,Clear Cell,0.6354,Pleomorphic Xanthoastrocytoma,0.6097
CHROMOTHRIPSIS,Chromothripsis,1,2,Chromothripsis,1.0000,Complex Karyotype,0.5165,Diploidy,0.4964,Mastocytosis,0.4901,Near-Haploidy,0.4796
"CHRONIC LYMPHOBLASTIC LEUKEMIA CLL, B-CELL",Chronic Lymphoblastic Lymphoma,1,2,Chronic Lymphoblastic Lymphoma,0.8584,Chronic Lymphocytic Leukemia,0.8498,B-Cell Prolymphocytic Leukemia,0.7927,B Lymphoblastic Leukemia/Lymphoma,0.7832,Lymphoblastic Lymphoma,0.7452
CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,1,2,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,1.0000,Chronic Lymphocytic Leukemia,0.8149,Chronic Lymphoblastic Lymphoma,0.6661,Lymphocytic Neoplasm,0.6117,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,0.6048
CHRONIC MYELOGENOUS LEUKEMIA,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",3,2,Chronic Myelogenous Leukemia,1.0000,Chronic Myelomonocytic Leukemia,0.8498,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.7813,Atypical Chronic Myeloid Leukemia,0.7454,Chronic Myelomonocytic Leukemia-1,0.7406
CHRONIC MYELOGENOUS LEUKEMIA CML,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",2,2,Chronic Myelogenous Leukemia,0.9272,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.8279,Chronic Myelomonocytic Leukemia,0.8158,Atypical Chronic Myeloid Leukemia,0.7492,"Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative",0.7254
"CHRONIC MYELOGENOUS LEUKEMIA CML, BLAST CRISIS","Chronic Myelogenous Leukemia, BCR-ABL1 Positive<;>Blastic Phase",1,2,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive<;>Blastic Phase",0.9318,"Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.9149,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.7945,Chronic Myelogenous Leukemia,0.7333,Blastic Phase,0.7314
"CHRONIC MYELOID LEUKEMIA, BCR-ABL1+","Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1,2,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.9716,"Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.8613,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive<;>Blastic Phase",0.8085,"Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative",0.8043,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.7795
CHRONIC MYELOMONOCYTIC LEUKAEMIA,Chronic Myelomonocytic Leukemia,1,2,Chronic Myelomonocytic Leukemia,0.9901,Chronic Myelomonocytic Leukemia-1,0.8517,Chronic Myelogenous Leukemia,0.8499,Chronic Myelomonocytic Leukemia-2,0.8181,Acute Myelomonocytic Leukemia,0.7825
CHRONIC MYELOMONOCYTIC LEUKEMIA,Chronic Myelomonocytic Leukemia,1,2,Chronic Myelomonocytic Leukemia,1.0000,Chronic Myelomonocytic Leukemia-1,0.8628,Chronic Myelogenous Leukemia,0.8498,Chronic Myelomonocytic Leukemia-2,0.8321,Acute Myelomonocytic Leukemia,0.7947
CHRONIC MYELOMONOCYTIC LEUKEMIA 1,Chronic Myelomonocytic Leukemia-1,1,2,Chronic Myelomonocytic Leukemia-1,0.9656,Chronic Myelomonocytic Leukemia,0.8657,Chronic Myelomonocytic Leukemia-2,0.8613,Chronic Myelogenous Leukemia,0.7559,Acute Myelomonocytic Leukemia,0.7314
CHRONIC MYELOMONOCYTIC LEUKEMIA 2,Chronic Myelomonocytic Leukemia-2,1,2,Chronic Myelomonocytic Leukemia-2,0.9663,Chronic Myelomonocytic Leukemia-1,0.8755,Chronic Myelomonocytic Leukemia,0.8131,Chronic Myelogenous Leukemia,0.6900,Acute Myelomonocytic Leukemia,0.6769
CHRONIC_LYMPHOCYTIC_LEUKAEMIA-SMALL_LYMPHOCYTIC_LYMPHOMA,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,1,2,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,0.9292,Chronic Lymphocytic Leukemia,0.8648,Chronic Lymphoblastic Lymphoma,0.7143,Lymphocytic Neoplasm,0.6514,Centroblastic Lymphoma,0.6363
CHRONIC_MYELOID_LEUKAEMIA,Chronic Myelogenous Leukemia,1,2,Chronic Myelogenous Leukemia,0.9225,Chronic Myelomonocytic Leukemia,0.7949,Atypical Chronic Myeloid Leukemia,0.7735,Myeloid Sarcoma,0.7322,Acute Myeloid Leukemia,0.7264
CILIATED MUCONODULAR PAPILLARY TUMOR OF THE LUNG,Bronchiolar Adenoma/Ciliated Muconodular Papillary Tumor,1,2,Bronchiolar Adenoma/Ciliated Muconodular Papillary Tumor,0.8174,Lung Inflammatory Myofibroblastic Tumor,0.7171,Lung Mucoepidermoid Carcinoma,0.6886,Lung Lymphoepithelial Carcinoma,0.6878,Congenital Peribronchial Myofibroblastic Tumor,0.6693
CIN,Chromosomal Instability,4,2,Cervical Adenocarcinoma In Situ,0.6671,Cervical Carcinoma,0.6016,Microinvasive Breast Carcinoma,0.5886,Chromosomal Instability,0.5791,Neuroepithelial Neoplasm<;>High Grade,0.5707
CLASSIC,Classic Histology,1,2,Classic Histology,0.7708,Primary,0.5808,Well Differentiated,0.5723,Classic Thyroid Gland Papillary Carcinoma,0.5674,Undifferentiated,0.5547
CLASSICAL,Classic Histology,1,2,Classic Histology,0.7472,Primary,0.5726,Invasive,0.5682,Diffuse,0.5579,Undifferentiated,0.5466
CLASSICAL HCA,Hepatocellular Adenoma,2,2,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.6245,Hepatocellular Adenoma,0.6128,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.5954,Classic Histology,0.5720,Hepatocellular Carcinoma,0.5534
CLASSICAL HODGKIN LYMPHOMA,Classic Hodgkin Lymphoma,1,2,Classic Hodgkin Lymphoma,0.9812,Hodgkin Lymphoma,0.9299,Non-Hodgkin Lymphoma,0.6799,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,0.6053,"Malignant Lymphoma, Histiocytic, Diffuse",0.5860
CLAUDIN-LOW,Claudin-Low,1,2,Claudin-Low,1.0000,Basal,0.4716,Microsatellite Stable,0.4674,Microsatellite Stable Colorectal Carcinoma,0.4627,Superficial,0.4601
CLEAR CELL ADENOCARCINOMA,Clear Cell Adenocarcinoma,1,2,Clear Cell Adenocarcinoma,1.0000,Adenocarcinoma Clear Cell,0.9847,Clear Cell Renal Cell Carcinoma,0.8564,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.8021,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.7965
CLEAR CELL BORDERLINE OVARIAN TUMOR,Borderline Ovarian Clear Cell Tumor,1,2,Borderline Ovarian Clear Cell Tumor,0.9731,Ovarian Clear Cell Tumor,0.8191,Malignant Ovarian Clear Cell Tumor,0.8091,Ovarian Clear Cell Cystadenocarcinoma,0.7287,Borderline Ovarian Serous Tumor,0.7120
CLEAR CELL CARCINOMA,Clear Cell Adenocarcinoma,1,2,Clear Cell Adenocarcinoma,0.9461,Adenocarcinoma Clear Cell,0.9293,Clear Cell Renal Cell Carcinoma,0.9163,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.8221,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.8140
CLEAR CELL CARCINOMA OF THE LUNG,"Lung Large Cell Carcinoma, Clear Cell Variant",1,2,"Lung Large Cell Carcinoma, Clear Cell Variant",0.8649,Clear Cell Renal Cell Carcinoma,0.8036,Clear Cell Adenocarcinoma,0.7964,Adenocarcinoma Clear Cell,0.7739,Lung Large Cell Carcinoma,0.7679
CLEAR CELL ODONTOGENIC CARCINOMA,Clear Cell Odontogenic Carcinoma,1,2,Clear Cell Odontogenic Carcinoma,1.0000,Odontogenic Carcinoma,0.8533,Clear Cell Adenocarcinoma,0.7319,Adenocarcinoma Clear Cell,0.7088,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0.7045
CLEAR CELL OVARIAN CANCER,Ovarian Clear Cell Tumor,2,2,Malignant Ovarian Clear Cell Tumor,0.9433,Ovarian Clear Cell Tumor,0.9121,Ovarian Clear Cell Cystadenocarcinoma,0.8659,Ovarian Adenocarcinoma,0.7861,Ovarian Carcinoma,0.7805
CLEAR CELL PAPILLARY RENAL CELL CARCINOMA,Clear Cell Papillary Renal Neoplasm,3,2,Clear Cell Renal Cell Carcinoma,0.9246,Papillary Renal Cell Carcinoma,0.9235,Clear Cell Papillary Renal Neoplasm,0.9107,Chromophobe Renal Cell Carcinoma,0.8936,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.8753
CLEAR CELL RENAL CELL CARCINOMA,Clear Cell Renal Cell Carcinoma,1,2,Clear Cell Renal Cell Carcinoma,1.0000,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.9122,Renal Cell Carcinoma,0.9119,Chromophobe Renal Cell Carcinoma,0.8842,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.8570
CLEAR CELL SARCOMA,Clear Cell Sarcoma of Soft Tissue,1,2,Clear Cell Sarcoma of Soft Tissue,0.9028,Clear Cell Adenocarcinoma,0.8377,Adenocarcinoma Clear Cell,0.8166,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.8096,Clear Cell Renal Cell Carcinoma,0.7938
CLEAR_CELL,Clear Cell,1,2,Clear Cell,0.8877,Columnar Cell,0.6243,Hairy Cell,0.5963,Mixed<;>Serous<;>Clear Cells,0.5937,Adenocarcinoma Clear Cell,0.5697
CLEAR_CELL_CARCINOMA,Clear Cell Adenocarcinoma,1,2,Clear Cell Adenocarcinoma,0.9100,Adenocarcinoma Clear Cell,0.8960,Clear Cell Renal Cell Carcinoma,0.8591,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.7757,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.7681
CLEAR_CELL_RENAL_CELL_CARCINOMA,Clear Cell Renal Cell Carcinoma,1,2,Clear Cell Renal Cell Carcinoma,0.9693,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.8862,Renal Cell Carcinoma,0.8847,Clear Cell Adenocarcinoma,0.8637,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.8523
CLL,Chronic Lymphocytic Leukemia,1,2,Chronic Lymphocytic Leukemia,0.8327,Chronic Lymphoblastic Lymphoma,0.7345,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,0.7279,Centroblastic Lymphoma,0.6896,Lymphoma,0.6701
CML,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",4,2,Chronic Myelogenous Leukemia,0.7743,Atypical Chronic Myeloid Leukemia,0.6843,Chronic Myelomonocytic Leukemia,0.6760,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0.6652,Leukemia,0.6419
CMML,Chronic Myelomonocytic Leukemia,1,2,Chronic Myelomonocytic Leukemia,0.7558,Chronic Myelogenous Leukemia,0.7164,Chronic Myelomonocytic Leukemia-1,0.6876,Chronic Myelomonocytic Leukemia-2,0.6501,Myeloid Sarcoma,0.6140
CNS,Malignant Central Nervous System Neoplasm,4,2,Central Nervous System<;>Brain,0.7752,Brain,0.7168,Central Nervous System Disorder,0.6641,Malignant Central Nervous System Neoplasm,0.6606,Central Nervous System Neoplasm,0.6336
CNS CANCER,Malignant Central Nervous System Neoplasm,1,2,Malignant Central Nervous System Neoplasm,0.8917,Central Nervous System Neoplasm,0.8436,Malignant Brain Neoplasm,0.8052,Brain Neoplasm,0.7222,Central Nervous System Melanoma,0.7190
CNS DISEASE,Central Nervous System Disorder,1,2,Central Nervous System Disorder,0.9224,Central Nervous System Neoplasm,0.6816,Central Nervous System<;>Brain,0.6602,Malignant Central Nervous System Neoplasm,0.6214,Brain,0.6022
CNS EFT-CIC,Central Nervous System Ewing Sarcoma<;>CIC Gene Rearrangement,1,2,Central Nervous System Ewing Sarcoma<;>CIC Gene Rearrangement,0.6014,Central Nervous System Solitary Fibrous Tumor,0.5313,Central Nervous System<;>Brain,0.5028,"Supratentorial Ependymoma, ZFTA-RELA Fusion-Positive",0.5010,Central Neurocytoma,0.4843
CNS EMBRYONAL NOS,Central Nervous System Embryonal Tumor,1,2,Central Nervous System Embryonal Tumor,0.8756,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.8484,Embryonal Neoplasm,0.7455,Brain Neoplasm,0.7019,Central Nervous System Neoplasm,0.6966
"CNS EMBRYONAL TUMOR, NOS","Central Nervous System Embryonal Tumor, Not Otherwise Specified",2,2,Central Nervous System Embryonal Tumor,0.9503,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.9268,Embryonal Neoplasm,0.7623,Brain Neoplasm,0.7077,Central Nervous System Neoplasm,0.6902
CNS GERMINOMA,Central Nervous System Germinoma,1,2,Central Nervous System Germinoma,0.9452,Germinoma,0.7942,Glioneuronal Tumor,0.7064,Central Neurocytoma,0.6977,Central Nervous System Medulloepithelioma,0.6923
CNS/BRAIN,Central Nervous System<;>Brain,1,2,Central Nervous System<;>Brain,0.9181,Brain,0.8899,Malignant Brain Neoplasm,0.7124,Head and Neck,0.7105,Brain Neoplasm,0.7096
COAD,Colon Adenocarcinoma,99,2,MiT Family Translocation-Associated Renal Cell Carcinoma,0.5060,Colon Adenocarcinoma<;>Chromosomal Instability,0.4888,Hypermutated Colorectal Carcinoma,0.4857,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.4840,Minimally Invasive Lung Adenocarcinoma,0.4737
COAD_CIN,Colon Adenocarcinoma<;>Chromosomal Instability,3,2,Cervical Adenocarcinoma In Situ,0.5532,With Tumor,0.5478,Colon Adenocarcinoma<;>Chromosomal Instability,0.5340,Colorectal,0.5317,Hypermutated Colorectal Carcinoma,0.5209
COAD_GS,Colon Adenocarcinoma,99,2,Cytology Specimen Type,0.4922,Adenocarcinoma,0.4808,Colorectal,0.4806,With Tumor,0.4793,Colon,0.4791
COAD_MSI,Colon Adenocarcinoma<;>Microsatellite Instability,1,2,Colon Adenocarcinoma<;>Microsatellite Instability,0.7189,Hypermutated Colorectal Carcinoma,0.6714,Gastric Adenocarcinoma<;>Microsatellite Instability,0.6493,Microsatellite Stable Colorectal Carcinoma,0.6491,Rectal Adenocarcinoma<;>Microsatellite Instability,0.6483
COAD_POLE,Colon Adenocarcinoma<;>POLE Gene Mutation,1,2,Colon Adenocarcinoma<;>POLE Gene Mutation,0.6097,Esophageal Adenocarcinoma<;>POLE Gene Mutation,0.5978,Rectal Adenocarcinoma<;>POLE Gene Mutation,0.5956,Endometrial Carcinoma<;>POLE Gene Mutation,0.5839,Gastric Adenocarcinoma<;>POLE Gene Mutation,0.5756
COLLECTING DUCT RENAL CELL CARCINOMA,Collecting Duct Carcinoma,1,2,Collecting Duct Carcinoma,0.9442,Clear Cell Renal Cell Carcinoma,0.8441,Renal Cell Carcinoma,0.8400,Chromophobe Renal Cell Carcinoma,0.7947,Kidney Medullary Carcinoma,0.7922
COLON,Colon,1,2,Colon,1.0000,Colorectal,0.8120,Colon Carcinoma,0.7815,Colorectal Carcinoma,0.7153,Ascending Colon,0.7125
COLON ADENOCARCINOMA,Colon Adenocarcinoma,1,2,Colon Adenocarcinoma,1.0000,Colon Carcinoma,0.9015,Colorectal Adenocarcinoma,0.8835,Colorectal Carcinoma,0.7876,Colon Carcinoma<;>Melanoma,0.7803
COLON ADENOCARCINOMA IN SITU,Colon Adenocarcinoma,1,2,Colon Adenocarcinoma,0.7330,Colon Carcinoma,0.6746,Colon,0.6705,Colon Adenocarcinoma<;>Chromosomal Instability,0.6545,Colon Adenocarcinoma<;>Microsatellite Instability,0.6496
COLON CANCER,Colon Carcinoma,1,2,Colon Carcinoma,0.9720,Colorectal Carcinoma,0.8721,Colon Adenocarcinoma,0.8576,Colon,0.8280,Colorectal Adenocarcinoma,0.7768
COLON CARCINOMA,Colon Carcinoma,1,2,Colon Carcinoma,1.0000,Colon Adenocarcinoma,0.9015,Colorectal Carcinoma,0.8861,Colorectal Adenocarcinoma,0.8079,Colon Carcinoma<;>Melanoma,0.8066
COLON MUCINOUS ADENOCARCINOMA,Colon Mucinous Adenocarcinoma,1,2,Colon Mucinous Adenocarcinoma,1.0000,Rectal Mucinous Adenocarcinoma<;>Colon Mucinous Adenocarcinoma,0.8735,Appendix Mucinous Adenocarcinoma,0.7986,Colon Adenocarcinoma,0.7659,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.7467
COLONIC TYPE ADENOCARCINOMA OF THE APPENDIX,Appendix Adenocarcinoma,1,2,Appendix Adenocarcinoma,0.8174,Colon Mucinous Adenocarcinoma,0.7819,Appendix Goblet Cell Adenocarcinoma,0.7697,Colon Adenocarcinoma,0.7666,Appendix Carcinoma,0.7564
COLON_CANCER,Colon Carcinoma,1,2,Colon Carcinoma,0.8772,Colon,0.8424,Colorectal Carcinoma,0.8231,Colon Adenocarcinoma,0.7879,Colorectal,0.7807
COLON_CARCINOMA,Colon Carcinoma,1,2,Colon Carcinoma,0.9419,Colorectal Carcinoma,0.8637,Colon Adenocarcinoma,0.8624,Colon,0.8220,Colorectal Adenocarcinoma,0.7938
COLON_CARCINOMA AND MELANOMA,Colon Carcinoma<;>Melanoma,1,2,Colon Carcinoma<;>Melanoma,0.7605,Colon Carcinoma,0.7240,Colorectal Carcinoma,0.7126,Colon Adenocarcinoma,0.6830,Colorectal,0.6793
COLORECTAL,Colorectal,1,2,Colorectal,1.0000,Colorectal Carcinoma,0.8599,Colon,0.8120,Colorectal Adenocarcinoma,0.7527,Rectum,0.7458
COLORECTAL ADENOCARCINOMA,Colorectal Adenocarcinoma,1,2,Colorectal Adenocarcinoma,1.0000,Colorectal Carcinoma,0.9090,Colon Adenocarcinoma,0.8835,Colon Carcinoma,0.8079,Rectal Adenocarcinoma,0.7889
COLORECTAL CANCER,Colorectal Carcinoma,1,2,Colorectal Carcinoma,0.9740,Colorectal,0.9019,Colorectal Adenocarcinoma,0.8659,Colon Carcinoma,0.8511,Colon,0.7447
COLORECTAL CARCINOMA,Colorectal Carcinoma,1,2,Colorectal Carcinoma,1.0000,Colorectal Adenocarcinoma,0.9090,Colon Carcinoma,0.8861,Colorectal,0.8599,Colon Adenocarcinoma,0.7876
COLORECTAL CARCINOMA OTHER,Colorectal Carcinoma,1,2,Colorectal Carcinoma,0.7973,Colorectal,0.7687,Colorectal Adenocarcinoma,0.7191,Metastatic Colorectal Carcinoma<;>Primary,0.7017,Metastatic Colorectal Carcinoma,0.7012
COLORECTAL HYPERMUTATED,Microsatellite Stable Colorectal Carcinoma,5,2,Hypermutated Colorectal Carcinoma,0.8683,Rectal Adenocarcinoma<;>Microsatellite Instability,0.6524,Colon Adenocarcinoma<;>Microsatellite Instability,0.6436,Rectal Adenocarcinoma<;>Chromosomal Instability,0.6403,Microsatellite Stable Colorectal Carcinoma,0.6354
COLORECTAL MSS,Microsatellite Stable Colorectal Carcinoma,1,2,Microsatellite Stable Colorectal Carcinoma,0.8348,Hypermutated Colorectal Carcinoma,0.8157,Colon Adenocarcinoma<;>Microsatellite Instability,0.7974,Rectal Adenocarcinoma<;>Microsatellite Instability,0.7722,Colorectal Carcinoma,0.7334
COLORECTAL NEUROENDOCRINE TUMOR,Colorectal Neuroendocrine Tumor,1,2,Colorectal Neuroendocrine Tumor,1.0000,Colorectal Neuroendocrine Carcinoma,0.9344,Digestive System Neuroendocrine Tumor,0.8239,Rectal Neuroendocrine Tumor<;>Well Differentiated,0.7836,Small Intestinal Neuroendocrine Neoplasm,0.7714
COLORECTAL_ADENOCARCINOMA,Colorectal Adenocarcinoma,1,2,Colorectal Adenocarcinoma,0.9656,Colorectal Carcinoma,0.8722,Colon Adenocarcinoma,0.8449,Colorectal,0.7777,Adenocarcinoma,0.7688
COLORECTAL_CANCER,Colorectal Carcinoma,1,2,Colorectal Carcinoma,0.9101,Colorectal,0.9019,Colorectal Adenocarcinoma,0.8129,Colon Carcinoma,0.7753,Colon,0.7404
COLUMNAR,Columnar Cell,1,2,Columnar Cell,0.8136,Lobular,0.6207,Tubular,0.5592,Transitional Cells,0.5338,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,0.5299
COLUMNAR CELL VARIANT,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,2,2,Columnar Cell,0.8117,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,0.7042,Clear Cell,0.5532,Basaloid Cell,0.5483,Transitional Cells,0.5446
COMBINED ADENOCARCINOMA - HIGH GRADE NEUROENDOCRINE CARCINOMA OF SMALL CELL TYPE,High Grade<;>Small Cell Neuroendocrine Carcinoma<;>Small Cell Adenocarcinoma,1,2,High Grade<;>Small Cell Neuroendocrine Carcinoma<;>Small Cell Adenocarcinoma,0.8853,Small Cell Neuroendocrine Carcinoma,0.8278,Adenocarcinoma with Neuroendocrine Differentiation,0.8028,Combined Lung Small Cell Carcinoma,0.7514,Neuroendocrine Carcinoma<;>Poorly Differentiated,0.7380
COMBINED HGNEC/AC,Esophageal Neuroendocrine Carcinoma<;>Adenocarcinoma,99,2,Oligoastrocytoma,0.5489,Digestive System Mixed Adenoneuroendocrine Carcinoma,0.5267,uterine corpus endometrial carcinoma<;>Copy Number<;>High,0.5039,ovary mixed epithelial carcinoma,0.4944,Endometrial Carcinoma<;>Mixed,0.4912
COMBINED SMALL CELL LUNG CARCINOMA,Combined Lung Small Cell Carcinoma,1,2,Combined Lung Small Cell Carcinoma,0.9917,Lung Small Cell Carcinoma,0.8475,Lung Sarcomatoid Carcinoma,0.7874,Small Cell Adenocarcinoma,0.7508,Lung Spindle Cell Carcinoma,0.7384
COMPLEX CYTOGENETICS,Complex Karyotype,1,2,Complex Karyotype,0.8561,Chromosomal Instability,0.6258,Cytology Specimen Type,0.6048,Cytogenetic Abnormality<;>Intermediate Risk,0.5969,Cytogenetic Abnormality<;>Low Risk,0.5937
CONGENITAL FIBROSARCOMA,Congenital Peribronchial Myofibroblastic Tumor,99,2,Infantile Fibrosarcoma,0.8390,Fibrosarcoma,0.7569,Infantile Sarcoma,0.7057,Myxoinflammatory Fibroblastic Sarcoma,0.6772,Solitary Fibrous Tumor,0.6670
CONVENTIONAL LEIOMYOSARCOMA,Conventional Leiomyosarcoma,1,2,Conventional Leiomyosarcoma,1.0000,Well Differentiated Leiomyosarcoma,0.9278,Leiomyosarcoma,0.9203,Uterine Corpus Leiomyosarcoma,0.8042,Uterine Corpus Myxoid Leiomyosarcoma,0.7578
COPY-NUMBER HIGH SEROUS-LIKE,Endometrial Serous Adenocarcinoma,99,2,Cystadenocarcinoma<;>High Grade<;>Serous,0.5886,Serous Adenocarcinoma<;>High Grade,0.5858,Serous Cystadenocarcinoma,0.5731,Papillary Serous Cystadenocarcinoma,0.5565,Serous,0.5509
COPY-NUMBER LOW ENDOMETRIOD,Endometrial Endometrioid Adenocarcinoma,99,2,uterine corpus endometrial carcinoma<;>Copy Number<;>Low,0.7817,uterine corpus endometrial carcinoma<;>Copy Number<;>High,0.6186,Endometrial Carcinoma<;>Microsatellite Instability,0.5811,POLE-Ultramutated Endometrial Endometrioid Adenocarcinoma,0.5431,Cytogenetic Abnormality<;>Low Risk,0.5258
CORTICAL,Cerebral Cortex,1,2,Cerebral Cortex,0.9288,Brain,0.6499,Central Nervous System<;>Brain,0.6132,Adrenal Cortical Carcinoma,0.5719,Adrenal Gland,0.5486
CRANIOPHARYNGIOMA,Craniopharyngioma,1,2,Craniopharyngioma,1.0000,Adamantinomatous Craniopharyngioma,0.7841,Paraganglioma,0.6120,Adrenal Gland Pheochromocytoma<;>Paraganglioma,0.6101,Sellar Region Neoplasm,0.6057
"CRANIOPHARYNGIOMA, ADAMANTINOMATOUS TYPE",Adamantinomatous Craniopharyngioma,1,2,Adamantinomatous Craniopharyngioma,0.9818,Craniopharyngioma,0.7766,Adamantinoma,0.7655,Angiocentric Glioma,0.5630,Extra-Adrenal Pheochromocytoma,0.5552
CRC HM,Microsatellite Stable Colorectal Carcinoma,2,2,Hypermutated Colorectal Carcinoma,0.7973,Microsatellite Stable Colorectal Carcinoma,0.6745,Colorectal Neuroendocrine Carcinoma,0.6591,Colon Medullary Carcinoma,0.6564,Colorectal Carcinoma,0.6439
CRC MSS,Microsatellite Stable Colorectal Carcinoma,1,2,Microsatellite Stable Colorectal Carcinoma,0.8210,Colon Adenocarcinoma<;>Microsatellite Instability,0.7783,Hypermutated Colorectal Carcinoma,0.7258,Rectal Adenocarcinoma<;>Microsatellite Instability,0.7183,Microsatellite Stable,0.6752
CRIBIFORM MORULAR,Thyroid Gland Cribriform Morular Carcinoma,4,2,Cribriform,0.6755,Cribriform<;>Solid,0.5476,Cribriform<;>Solid<;>Tubular,0.5466,Thyroid Gland Cribriform Morular Carcinoma,0.5455,Breast Tubular Carcinoma<;>Cribriform,0.4537
CRIBRIFORM,Cribriform,1,2,Cribriform,1.0000,Cribriform<;>Solid,0.8262,Cribriform<;>Solid<;>Tubular,0.7886,Breast Tubular Carcinoma<;>Cribriform,0.5953,Thyroid Gland Cribriform Morular Carcinoma,0.5406
CRIBRIFORM/SOLID,Cribriform<;>Solid,1,2,Cribriform<;>Solid,0.8597,Cribriform,0.7842,Cribriform<;>Solid<;>Tubular,0.7793,Breast Tubular Carcinoma<;>Cribriform,0.6764,Solid,0.6474
CRIBRIFORM/SOLID/TUBULAR,Cribriform<;>Solid<;>Tubular,1,2,Cribriform<;>Solid<;>Tubular,0.8048,Breast Tubular Carcinoma<;>Cribriform,0.7536,Breast Tubular Carcinoma<;>Cribriform Pattern,0.7381,Cribriform<;>Solid,0.7259,Cribriform,0.7055
CRIBRIFORM/TUBULAR,Breast Tubular Carcinoma<;>Cribriform,3,2,Cribriform<;>Solid<;>Tubular,0.8639,Cribriform,0.7961,Breast Tubular Carcinoma<;>Cribriform,0.7207,Cribriform<;>Solid,0.7054,Breast Tubular Carcinoma<;>Cribriform Pattern,0.6876
CRPC-ADENO,Castration-Resistant Prostate Carcinoma<;>Prostate Adenocarcinoma,1,2,Castration-Resistant Prostate Carcinoma<;>Prostate Adenocarcinoma,0.6397,Castration-Resistant Prostate Carcinoma<;>Prostate Neuroendocrine Neoplasm,0.6043,Castration-Resistant Prostate Carcinoma,0.6042,Adenosarcoma,0.5850,Aggressive Variant Prostate Carcinoma,0.5701
CRPC-NE,Castration-Resistant Prostate Carcinoma<;>Prostate Neuroendocrine Neoplasm,1,2,Castration-Resistant Prostate Carcinoma<;>Prostate Neuroendocrine Neoplasm,0.8038,Castration-Resistant Prostate Carcinoma,0.7083,Prostate Neuroendocrine Carcinoma,0.7074,Castration-Resistant Prostate Carcinoma<;>Non-Metastatic Prostate Carcinoma,0.7008,Castration-Resistant Prostate Carcinoma<;>Prostate Adenocarcinoma,0.6981
CSCC,Skin Squamous Cell Carcinoma,99,2,Cholangiocarcinoma,0.6135,Microsatellite Stable Colorectal Carcinoma,0.5858,Sebaceous Carcinoma,0.5782,Metaplastic Carcinoma,0.5773,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.5735
CUTANEOUS MALIGNANCY OF HAIR MATRIX CELLS,Pilomatrical Carcinoma,1,2,Pilomatrical Carcinoma,0.7147,Skin Metatypical Carcinoma,0.6649,Merkel Cell Carcinoma,0.6301,Hairy Cell,0.6208,Sweat Gland Carcinoma,0.6202
CUTANEOUS MELANOMA,Cutaneous Melanoma,1,2,Cutaneous Melanoma,1.0000,Melanoma,0.8935,Skin Carcinoma,0.7763,Mucosal Melanoma,0.7655,Malignant Skin Neoplasm,0.7654
CUTANEOUS SQUAMOUS CELL,Skin Squamous Cell Carcinoma,1,2,Skin Squamous Cell Carcinoma,0.8901,Squamous Cell Carcinoma,0.8325,Skin Carcinoma,0.7583,Cervical Squamous Neoplasm,0.7260,Squamous Cell Carcinoma<;>Poorly Differentiated,0.7107
CUTANEOUS SQUAMOUS CELL CARCINOMA,Skin Squamous Cell Carcinoma,1,2,Skin Squamous Cell Carcinoma,0.9665,Squamous Cell Carcinoma,0.8893,Skin Carcinoma,0.8039,Cervical Squamous Cell Carcinoma,0.7446,Squamous Cell Carcinoma<;>Poorly Differentiated,0.7390
CUTANEOUS T CELL LYMPHOMA,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,2,2,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9304,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.8640,T-Cell Non-Hodgkin Lymphoma,0.7710,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.7426,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.7296
CYSTADENOCARCINOMA,Cystadenocarcinoma,1,2,Cystadenocarcinoma,1.0000,Mucinous Cystadenocarcinoma,0.8175,Cystadenocarcinoma<;>Poorly Differentiated,0.8120,Serous Cystadenocarcinoma,0.7529,Cystadenocarcinoma<;>High Grade<;>Serous,0.7292
"CYSTADENOCARCINOMA, CLEAR CELL",Ovarian Clear Cell Cystadenocarcinoma,2,2,Clear Cell Adenocarcinoma,0.8933,Ovarian Clear Cell Cystadenocarcinoma,0.8902,Adenocarcinoma Clear Cell,0.8805,Clear Cell Renal Cell Carcinoma,0.8217,Cystadenocarcinoma,0.7912
"CYSTADENOCARCINOMA, ENDOMETRIOID",Cystadenocarcinoma<;>Endometrioid Adenocarcinoma,1,2,Cystadenocarcinoma<;>Endometrioid Adenocarcinoma,0.9797,Endometrioid Adenocarcinoma,0.8902,Endometrial Endometrioid Adenocarcinoma,0.8887,Cervical Endometrioid Adenocarcinoma,0.8796,Ovarian Endometrioid Adenocarcinoma,0.8610
"CYSTADENOCARCINOMA, HIGH GRADE SEROUS",Cystadenocarcinoma<;>High Grade<;>Serous,1,2,Cystadenocarcinoma<;>High Grade<;>Serous,0.9756,Serous Cystadenocarcinoma,0.9366,Serous Adenocarcinoma<;>High Grade,0.9039,Papillary Serous Cystadenocarcinoma,0.8732,Ovarian High Grade Serous Adenocarcinoma,0.8477
"CYSTADENOCARCINOMA, MUCINOUS",Mucinous Cystadenocarcinoma,1,2,Mucinous Cystadenocarcinoma,0.9889,Mucinous Adenocarcinoma,0.8865,Cystadenocarcinoma,0.7993,"Mucinous Adenocarcinoma, Endocervical Type",0.7631,Breast Mucinous Carcinoma,0.7611
CYSTECTOMY,Cystectomy,1,2,Cystectomy,1.0000,Resection,0.6252,Bladder Carcinoma,0.5018,Transurethral Resection of Bladder Tumor,0.4968,Bladder Adenocarcinoma,0.4963
CYSTOADENOCARCINOMA-PD,Cystadenocarcinoma<;>Poorly Differentiated,2,2,Cystadenocarcinoma,0.7074,Cystadenocarcinoma<;>Poorly Differentiated,0.6760,Mucinous Cystadenocarcinoma,0.6653,Pancreatic Colloid Carcinoma,0.6624,Pancreatic Mucinous-Cystic Neoplasm,0.6399
CYTOLOGY,Cytology Specimen Type,1,2,Cytology Specimen Type,0.8462,Classic Histology,0.6402,Cell Line,0.6023,Metaplasia,0.5760,Metaplastic,0.5442
DEDIFFERENTIATED,Dedifferentiated Chondrosarcoma,99,2,Poorly Differentiated,0.8293,Undifferentiated,0.7723,Well Differentiated,0.7701,Moderately Differentiated,0.7211,Solid<;>Carcinoma Exhibiting Undifferentiated or Dedifferentiated Features,0.7199
DEDIFFERENTIATED CHONDROSARCOMA,Dedifferentiated Chondrosarcoma,1,2,Dedifferentiated Chondrosarcoma,1.0000,Mesenchymal Chondrosarcoma,0.8478,Chondrosarcoma,0.7978,Extraskeletal Myxoid Chondrosarcoma,0.7919,Chondroblastic Osteosarcoma,0.7842
DEDIFFERENTIATED LIPOSARCOMA,Dedifferentiated Liposarcoma,1,2,Dedifferentiated Liposarcoma,1.0000,Well Differentiated Liposarcoma,0.8834,Pleomorphic Liposarcoma,0.8634,Liposarcoma,0.8207,Myxoid Liposarcoma,0.8198
DENSE/DIFFUSE ANAPLASIA,Anaplastic Lesion<;>Diffuse,1,2,Anaplastic Lesion<;>Diffuse,0.7228,"Malignant Lymphoma, Histiocytic, Diffuse",0.6795,Diffuse Glioma,0.6342,Diffuse Astrocytoma,0.6301,Anaplastic,0.6244
DERMATOFIBROMA,Skin Fibrous Histiocytoma,2,2,Dermatofibrosarcoma Protuberans,0.8263,Skin Fibrous Histiocytoma,0.7946,Plexiform Fibrohistiocytic Tumor,0.7308,Skin Fibroblastic Neoplasm,0.7255,Fibrothecoma,0.7206
DERMATOFIBROSARCOMA PROTUBERANS,Dermatofibrosarcoma Protuberans,1,2,Dermatofibrosarcoma Protuberans,1.0000,Skin Fibrous Histiocytoma,0.7396,Follicular Dendritic Cell Sarcoma,0.7179,Myxoinflammatory Fibroblastic Sarcoma,0.7172,Plexiform Fibrohistiocytic Tumor,0.7062
DESCENDING COLON,Descending Colon,1,2,Descending Colon,1.0000,Ascending Colon,0.8431,Transverse Colon,0.8402,Sigmoid Colon,0.7686,Colon,0.7073
DESMOID FIBROMATOSIS,Desmoid Fibromatosis,1,2,Desmoid Fibromatosis,1.0000,Desmoplastic,0.8282,Fibromatosis,0.7921,Solitary Fibrous Tumor,0.7142,Skin Fibrous Histiocytoma,0.6974
DESMOID TUMOR,Desmoid Fibromatosis,1,2,Desmoid Fibromatosis,0.9005,Desmoplastic,0.8821,Desmoplastic Small Round Cell Tumor,0.7733,Desmoplastic Melanoma,0.7705,Desmoplastic Neurotropic Melanoma,0.7408
DESMOID/AGGRESSIVE FIBROMATOSIS,Desmoid Fibromatosis,1,2,Desmoid Fibromatosis,0.9406,Desmoplastic,0.8171,Fibromatosis,0.7375,Solitary Fibrous Tumor,0.7154,Desmoplastic Neurotropic Melanoma,0.7121
DESMOPLASTIC,Desmoplastic,1,2,Desmoplastic,1.0000,Desmoid Fibromatosis,0.8282,Fibromatosis,0.7401,Desmoplastic Melanoma,0.7203,Desmoplastic Small Round Cell Tumor,0.6813
DESMOPLASTIC MELANOMA,Desmoplastic Melanoma,1,2,Desmoplastic Melanoma,1.0000,Desmoplastic Neurotropic Melanoma,0.9056,Desmoplastic Small Round Cell Tumor,0.7653,Desmoplastic,0.7203,Spitz Melanoma,0.7202
DESMOPLASTIC SMALL ROUND CELL TUMOR,Desmoplastic Small Round Cell Tumor,1,2,Desmoplastic Small Round Cell Tumor,1.0000,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,0.7822,Round Cell Sarcoma,0.7721,Desmoplastic Melanoma,0.7653,Desmoplastic Neurotropic Melanoma,0.7653
DESMOPLASTIC SMALL-ROUND-CELL TUMOR,Desmoplastic Small Round Cell Tumor,1,2,Desmoplastic Small Round Cell Tumor,0.9932,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,0.7891,Desmoplastic Neurotropic Melanoma,0.7712,Desmoplastic Melanoma,0.7681,Round Cell Sarcoma,0.7575
DESMOPLASTIC/NODULAR MEDULLOBLASTOMA,Desmoplastic/Nodular Medulloblastoma,1,2,Desmoplastic/Nodular Medulloblastoma,1.0000,Medulloblastoma,0.8458,"Medulloblastoma, Non-WNT/Non-SHH, Group 3",0.8366,Primitive Neuroectodermal Tumor<;>Medulloblastoma,0.8294,Anaplastic Medulloblastoma,0.8238
DIABETES DIAGNOSIS INDICATOR,Diabetes Mellitus,1,2,Diabetes Mellitus,0.7715,Ductal,0.4764,Distant,0.4718,Breast Ductal Carcinoma In Situ,0.4674,Diffuse,0.4660
DIAPHRAGM,Diaphragm,1,2,Diaphragm,1.0000,Peritoneum,0.5943,Pleura,0.5552,Abdomen,0.5226,Abdominal Wall,0.5181
DIFFSE LARGE B-CELL LYMPHOMA,Diffuse Large B-Cell Lymphoma,1,2,Diffuse Large B-Cell Lymphoma,0.8499,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.7743,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.7408,Burkitt Lymphoma,0.7353,Centroblastic Lymphoma,0.7257
DIFFUSE,Diffuse,1,2,Diffuse,1.0000,Anaplastic Lesion<;>Diffuse,0.6738,Distant,0.6736,Diffuse Glioma,0.6476,Localized,0.6301
DIFFUSE (LINITUS-PLASTICUS),Linitis Plastica,1,2,Linitis Plastica,0.8212,Diffuse,0.6293,Dedifferentiated Liposarcoma,0.5790,Pleomorphic Liposarcoma,0.5716,Diffuse Glioma,0.5551
DIFFUSE ANAPLASIA,Anaplastic Lesion<;>Diffuse,1,2,Anaplastic Lesion<;>Diffuse,0.8163,"Malignant Lymphoma, Histiocytic, Diffuse",0.7256,Diffuse Glioma,0.6985,Anaplastic,0.6957,Diffuse Astrocytoma,0.6868
DIFFUSE ASTROCYTOMA,Diffuse Astrocytoma,1,2,Diffuse Astrocytoma,1.0000,Astrocytoma,0.8898,Anaplastic Astrocytoma,0.8497,Diffuse Glioma,0.8400,High Grade Astrocytic Tumor,0.8137
"DIFFUSE ASTROCYTOMA, IDH-MUTANT","Astrocytoma, IDH-Mutant, Grade 2",2,2,"Astrocytoma, IDH-Mutant, Grade 3",0.8989,"Astrocytoma, IDH-Mutant, Grade 2",0.8929,"Anaplastic Astrocytoma, IDH-Wildtype",0.8918,"Astrocytoma, IDH-Mutant, Grade 4",0.8611,"Glioblastoma, IDH-Wildtype",0.8418
DIFFUSE GLIOMA,Diffuse Glioma,1,2,Diffuse Glioma,1.0000,Glioma,0.8447,Diffuse Astrocytoma,0.8400,Diffuse Midline Glioma,0.7965,Malignant Glioma,0.7806
DIFFUSE INTRINSIC PONTINE GLIOMA,Diffuse Intrinsic Pontine Glioma,1,2,Diffuse Intrinsic Pontine Glioma,1.0000,Diffuse Midline Glioma,0.7477,Diffuse Leptomeningeal Glioneuronal Tumor,0.7080,"Glioblastoma, IDH-Wildtype<;>Glioblastoma with Primitive Neuronal Component",0.6897,Diffuse Glioma,0.6878
DIFFUSE LARGE B-CELL LYMPHOMA,Diffuse Large B-Cell Lymphoma,1,2,Diffuse Large B-Cell Lymphoma,1.0000,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.8367,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.8275,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.8023,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.7989
DIFFUSE LARGE B-CELL LYMPHOMA DLBCL,Diffuse Large B-Cell Lymphoma,1,2,Diffuse Large B-Cell Lymphoma,0.9277,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.8086,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.8029,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.7745,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.7553
DIFFUSE LARGE B-CELL LYMPHOMA DLBCL NOS ANY ANATOMIC SITE NODAL OR EXTRANODAL,Diffuse Large B-Cell Lymphoma,1,2,Diffuse Large B-Cell Lymphoma,0.7833,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.7224,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.7205,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.6818,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.6536
"DIFFUSE LARGE B-CELL LYMPHOMA, NOS",Diffuse Large B-Cell Lymphoma,1,2,Diffuse Large B-Cell Lymphoma,0.9952,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.8334,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.8236,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.8005,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.7852
DIFFUSE LARGE CELL LYMPHOMA NON-CLEAVED TYPE,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",1,2,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.9568,Diffuse Large B-Cell Lymphoma,0.8392,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.7532,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.7347,"Malignant Lymphoma, Histiocytic, Diffuse",0.7156
DIFFUSE LEPTOMENINGEAL  GLIONEURONAL TUMOR,Diffuse Leptomeningeal Glioneuronal Tumor,1,2,Diffuse Leptomeningeal Glioneuronal Tumor,1.0000,Diffuse Midline Glioma,0.8029,Glioneuronal Tumor,0.7663,Diffuse Glioma,0.7467,Diffuse Intrinsic Pontine Glioma,0.7080
DIFFUSE LINITUS-PLASTICUS,Linitis Plastica,1,2,Linitis Plastica,0.8475,Dedifferentiated Liposarcoma,0.6050,Pleomorphic Liposarcoma,0.5951,Well Differentiated Liposarcoma,0.5622,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,0.5519
DIFFUSE MALIGNANT MESOTHELIOMA - NOS,Diffuse Malignant Mesothelioma,1,2,Diffuse Malignant Mesothelioma,0.9882,Sarcomatoid Mesothelioma,0.8330,Mesothelioma,0.8074,Biphasic Mesothelioma,0.8013,Epithelioid Mesothelioma,0.7827
DIFFUSE MIDLINE GLIOMA,Diffuse Midline Glioma,1,2,Diffuse Midline Glioma,1.0000,Diffuse Leptomeningeal Glioneuronal Tumor,0.8029,Diffuse Glioma,0.7965,Diffuse Intrinsic Pontine Glioma,0.7477,Angiocentric Glioma,0.7152
"DIFFUSE MIDLINE GLIOMA, H3K27M MUTANT","Diffuse Midline Glioma, H3 K27M-Mutant",1,2,"Diffuse Midline Glioma, H3 K27M-Mutant",0.8827,Diffuse Midline Glioma,0.6922,"Astrocytoma, IDH-Mutant, Grade 3",0.6215,Diffuse Leptomeningeal Glioneuronal Tumor,0.6196,"Astrocytoma, IDH-Mutant, Grade 2",0.6104
DIFFUSE SCLEROSING VARIANT,Diffuse Sclerosing Variant Thyroid Gland Papillary Carcinoma,1,2,Diffuse Sclerosing Variant Thyroid Gland Papillary Carcinoma,0.7085,Anaplastic Lesion<;>Spindle Cell/Sclerosing Rhabdomyosarcoma<;>Diffuse,0.6542,"Malignant Lymphoma, Histiocytic, Diffuse",0.6454,Sclerosing Epithelioid Fibrosarcoma,0.6327,Disseminated Juvenile Xanthogranuloma,0.6232
DIFFUSE TYPE STOMACH ADENOCARCINOMA,Gastric Diffuse Adenocarcinoma,1,2,Gastric Diffuse Adenocarcinoma,0.9654,Gastric Adenocarcinoma,0.7879,Gastric Intestinal-Type Adenocarcinoma,0.7642,Gastric Poorly Cohesive Adenocarcinoma,0.7513,Gastric Tubular Adenocarcinoma,0.7503
DIFFUSE_ADENOCARCINOMA,Gastric Diffuse Adenocarcinoma,3,2,Adenocarcinoma<;>Undifferentiated,0.8220,Adenocarcinoma,0.8213,Gastric Diffuse Adenocarcinoma,0.8184,Poorly Differentiated Adenocarcinoma,0.8077,Adenocarcinoma<;>Well Differentiated,0.8022
DIFFUSE_GASTRIC,Gastric Diffuse Adenocarcinoma,1,2,Gastric Diffuse Adenocarcinoma,0.7266,Gastric,0.7190,Diffuse,0.6686,Stomach,0.6505,Gastric Carcinoma,0.6210
DIFFUSE_HISTIOCYTIC_LYMPHOMA,"Malignant Lymphoma, Histiocytic, Diffuse",1,2,"Malignant Lymphoma, Histiocytic, Diffuse",0.9659,True Histiocytic Lymphoma,0.8735,Diffuse Large B-Cell Lymphoma,0.8129,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.7814,Histiocytic Sarcoma,0.7642
DIFFUSE_LARGE_B_CELL_LYMPHOMA,Diffuse Large B-Cell Lymphoma,1,2,Diffuse Large B-Cell Lymphoma,0.9744,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.8504,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.8057,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.8031,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.7666
DIPG,Diffuse Intrinsic Pontine Glioma,1,2,Diffuse Intrinsic Pontine Glioma,0.5421,Diffuse Glioma,0.5020,Low Grade Glioma,0.4743,"Astrocytoma, IDH-Mutant, Grade 2",0.4725,"Glioblastoma, IDH-Wildtype",0.4681
DIPLOID,Diploidy,1,2,Diploidy,0.9241,Near-Haploidy,0.7668,Normal Karyotype,0.6781,Hypodiploidy,0.6661,Hyperdiploidy,0.6492
DISSEMINATED JUVENILE XANTHOGRANULOMA,Disseminated Juvenile Xanthogranuloma,1,2,Disseminated Juvenile Xanthogranuloma,1.0000,Pleomorphic Xanthoastrocytoma,0.7085,Anaplastic Pleomorphic Xanthoastrocytoma,0.6573,Langerhans Cell Histiocytosis,0.6151,Follicular Dendritic Cell Sarcoma,0.5933
DISTAL,Distal,1,2,Distal,1.0000,Distant,0.7511,Distant Metastasis,0.5920,Extrahepatic,0.5831,Metastatic,0.5791
DISTANT,Distant,1,2,Distant,1.0000,Distant Metastasis,0.8234,Distal,0.7511,Metastatic,0.7292,Metastasis,0.7286
DISTANT METASTASIS,Distant Metastasis,1,2,Distant Metastasis,1.0000,Metastasis,0.8905,Metastatic,0.8783,Metastatic Lesion,0.8382,Distant,0.8234
DISTANT METASTASIS: LUNG,Distant Metastasis<;>Lung,1,2,Distant Metastasis<;>Lung,0.9874,Distant Metastasis,0.7623,Metastatic Lesion,0.6507,Metastatic Malignant Neoplasm in the Regional Lymph Nodes,0.6492,Metastatic,0.6355
DISTANT METASTASIS: S.C.,Distant Metastasis,1,2,Distant Metastasis,0.7656,Metastatic Lesion,0.6875,Distant Metastasis<;>Lung,0.6865,Metastatic,0.6666,Metastatic Lesion<;>Recurrent,0.6382
DISTANT METS,Distant Metastasis,1,2,Distant Metastasis,0.7722,Distant,0.7130,Metastatic,0.7080,Metastatic Lesion,0.6980,Metastasis,0.6824
DLBC,Diffuse Large B-Cell Lymphoma,1,2,Diffuse Large B-Cell Lymphoma,0.5723,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.5591,Breast Ductal Carcinoma In Situ,0.5492,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.5351,Basal,0.5209
DLBCL,Diffuse Large B-Cell Lymphoma,1,2,Diffuse Large B-Cell Lymphoma,0.8559,Centroblastic Lymphoma,0.7959,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.7949,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.7589,B-Cell Non-Hodgkin Lymphoma,0.7509
DOWN SYNDROME,Down Syndrome,1,2,Down Syndrome,1.0000,Hypodiploidy,0.5851,Myeloid Leukemia Associated with Down Syndrome,0.5381,Masked Near-Haploidy,0.4969,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,0.4895
DOWN SYNDROME; ACUTE MEGAKARYOBLASTIC LEUKAEMIA,Myeloid Leukemia Associated with Down Syndrome,3,2,Acute Megakaryoblastic Leukemia<;>Down Syndrome,0.9672,Acute Megakaryoblastic Leukemia,0.8516,Myeloid Leukemia Associated with Down Syndrome,0.7698,Acute Myeloid Leukemia with Multilineage Dysplasia,0.7208,Acute Myelomonocytic Leukemia,0.7046
DUCT,Duct,1,2,Duct,1.0000,Ductal,0.9098,Bile Duct,0.7276,Tubular,0.6579,Breast Ductal Carcinoma In Situ,0.5726
DUCTAL,Ductal,1,2,Ductal,1.0000,Duct,0.9098,Breast Ductal Carcinoma,0.6927,Breast Ductal Carcinoma In Situ,0.6671,Tubular,0.6549
DUCTAL ADENOCARCINOMA,Pancreatic Ductal Adenocarcinoma,2,2,Breast Ductal Carcinoma,0.8804,Pancreatic Ductal Adenocarcinoma,0.8313,Prostate Ductal Adenocarcinoma,0.8046,Adenocarcinoma,0.7706,Breast Adenocarcinoma,0.7613
"DUCTAL ADENOCARCINOMA, EXOCRINE",Pancreatic Ductal Adenocarcinoma<;>Exocrine Gland,1,2,Pancreatic Ductal Adenocarcinoma<;>Exocrine Gland,0.9308,Pancreatic Ductal Adenocarcinoma,0.8655,Acinar Cell Carcinoma,0.7974,Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland<;>Ductal,0.7879,Pancreatic Mixed Acinar-Ductal Carcinoma,0.7642
DUCTAL ADENOSQUAMOUS CARCINOMA,Pancreatic Adenosquamous Carcinoma<;>Ductal,1,2,Pancreatic Adenosquamous Carcinoma<;>Ductal,0.8128,Adenosquamous Carcinoma,0.7905,Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland<;>Ductal,0.7608,Pancreatic Ductal Adenocarcinoma<;>Pancreatic Adenosquamous Carcinoma,0.7240,Cervical Adenosquamous Carcinoma,0.7238
"DUCTAL ADENOSQUAMOUS CARCINOMA, EXOCRINE",Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland<;>Ductal,1,2,Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland<;>Ductal,0.9088,Pancreatic Adenosquamous Carcinoma<;>Ductal,0.8626,Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland,0.8483,Pancreatic Ductal Adenocarcinoma<;>Exocrine Gland,0.8385,Pancreatic Ductal Adenocarcinoma<;>Pancreatic Adenosquamous Carcinoma,0.7881
DUCTAL AND LOBULAR,Breast Mixed Ductal and Lobular Carcinoma,99,2,Ductal,0.8180,Lobular,0.7691,Duct,0.7057,Breast Ductal Carcinoma,0.6868,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.6701
DUCTAL AND LOBULAR FEATURES,Breast Mixed Ductal and Lobular Carcinoma,99,2,Lobular,0.7632,Ductal,0.7386,Duct,0.6580,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.6395,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.6097
DUCTAL AND MICROPAPILLARY,Ductal<;>Micropapillary Growth Pattern,1,2,Ductal<;>Micropapillary Growth Pattern,0.8065,Ductal,0.7015,Micropapillary Growth Pattern,0.6959,Pancreatic Intraductal Tubulopapillary Neoplasm,0.6381,Breast Ductal Carcinoma,0.6235
DUCTAL CARCINOMA,Breast Ductal Carcinoma,1,2,Breast Ductal Carcinoma,0.9431,Breast Ductal Carcinoma In Situ,0.7550,Ductal,0.7458,Pancreatic Ductal Adenocarcinoma,0.7335,Invasive Breast Carcinoma,0.7151
DUCTAL CARCINOMA IN SITU DCIS,Breast Ductal Carcinoma In Situ,1,2,Breast Ductal Carcinoma In Situ,0.9138,Microinvasive Breast Carcinoma,0.7095,Breast Ductal Carcinoma,0.6963,Invasive Breast Carcinoma of No Special Type,0.6867,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.6755
DUCTAL CARCINOMA- MAMMARY GLAND,Breast Ductal Carcinoma,1,2,Breast Ductal Carcinoma,0.9511,Breast Ductal Carcinoma In Situ,0.7493,Breast Adenocarcinoma,0.7490,Breast Carcinoma,0.7345,Invasive Breast Carcinoma,0.7140
DUCTAL CARCINOMA- MAMMARY GLAND; BREAST; DUCT; METASTATIC SITE: PLEURAL EFFUSION;,Breast Ductal Carcinoma<;>Pleural Effusion<;>Site of Metastasis,1,2,Breast Ductal Carcinoma<;>Pleural Effusion<;>Site of Metastasis,0.8689,Breast Adenocarcinoma<;>Pleural Effusion<;>Site of Metastasis,0.7607,Pleural Effusion<;>Site of Metastasis,0.6809,Breast Papillary Ductal Carcinoma with Invasion,0.5557,Distant Metastasis<;>Lung,0.5451
DUCTAL/LOBULAR,Breast Mixed Ductal and Lobular Carcinoma,99,2,Ductal,0.8191,Lobular,0.7868,Duct,0.7019,Breast Ductal Carcinoma,0.6888,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.6748
DUCTAL/NST,Breast Ductal Carcinoma,4,2,Ductal,0.7420,Duct,0.6476,Breast Ductal Carcinoma In Situ,0.6413,Breast Ductal Carcinoma,0.6123,Pancreatic Intraductal Tubulopapillary Neoplasm,0.6070
DUCTAL_CARCINOMA,Breast Ductal Carcinoma,1,2,Breast Ductal Carcinoma,0.9217,Ductal,0.7817,Breast Ductal Carcinoma In Situ,0.7638,Pancreatic Ductal Adenocarcinoma,0.7062,Prostate Ductal Adenocarcinoma,0.6882
DUODENAL ADENOCARCINOMA,Duodenal Adenocarcinoma,1,2,Duodenal Adenocarcinoma,1.0000,Pancreatic Ductal Adenocarcinoma,0.6862,Distal Bile Duct Adenocarcinoma,0.6644,Gastric Intestinal-Type Adenocarcinoma,0.6583,Gastric Diffuse Adenocarcinoma,0.6299
DUODENAL_ADENOCARCINOMA,Duodenal Adenocarcinoma,1,2,Duodenal Adenocarcinoma,0.9745,Pancreatic Ductal Adenocarcinoma,0.6792,Gastric Intestinal-Type Adenocarcinoma,0.6510,Gastric Diffuse Adenocarcinoma,0.6296,Distal Bile Duct Adenocarcinoma,0.6219
DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR,Dysembryoplastic Neuroepithelial Tumor,1,2,Dysembryoplastic Neuroepithelial Tumor,1.0000,Primitive Neuroectodermal Tumor,0.7733,Neuroepithelial Neoplasm,0.7427,Peripheral Primitive Neuroectodermal Tumor,0.7174,Polymorphous Low Grade Neuroepithelial Tumor of the Young,0.7131
DYSGERMINOMA,Ovarian Dysgerminoma,1,2,Ovarian Dysgerminoma,0.7907,Ovarian Dysgerminoma<;>Yolk Sac Tumor,0.6314,Ganglioglioma,0.6189,Ganglioneuroblastoma,0.6147,Dysembryoplastic Neuroepithelial Tumor,0.5990
EARLY STAGE PRIMARY,Limited Stage<;>Primary,1,2,Limited Stage<;>Primary,0.7793,Primary,0.7246,Primary Neoplasm,0.6532,Primary Neoplasm<;>Unpaired,0.5952,Occult Stage,0.5920
EARLY T-CELL PRECURSOR LYMPHOBLASTIC LEUKEMIA,Early T Acute Lymphoblastic Leukemia,1,2,Early T Acute Lymphoblastic Leukemia,0.9241,T Acute Lymphoblastic Leukemia,0.8259,T Lymphoblastic Leukemia/Lymphoma,0.7916,Acute Lymphoblastic Leukemia,0.7165,Adult T-Cell Leukemia/Lymphoma,0.6843
EBER+ - LIKELY II,Epstein-Barr Virus Early RNA Positive,1,2,Epstein-Barr Virus Early RNA Positive,0.5784,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.5276,Myelodysplastic Syndrome with Excess Blasts-2,0.5033,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.5007,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.4882
EBER+ II,Epstein-Barr Virus Early RNA Positive,2,2,Myelodysplastic Syndrome with Excess Blasts-2,0.5951,Epstein-Barr Virus Early RNA Positive,0.5761,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.5622,Pure Erythroid Leukemia,0.5322,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.5167
EBER+ III,Epstein-Barr Virus Early RNA Positive,2,2,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.5654,Epstein-Barr Virus Early RNA Positive,0.5638,Myelodysplastic Syndrome with Excess Blasts-2,0.5363,Pure Erythroid Leukemia,0.5207,Embryonal Tumor with Multilayered Rosettes,0.5205
EBV,Epstein-Barr Virus,1,2,Epstein-Barr Virus,0.9059,EBV-Related Lymphoma,0.7761,Gastric Adenocarcinoma<;>Epstein-Barr Virus,0.5812,Hepatitis B Virus,0.5453,B-Cell Neoplasm,0.4953
EBV-ASSOCIATED,EBV-Related Lymphoma,2,2,Epstein-Barr Virus,0.8196,EBV-Related Lymphoma,0.7609,Gastric Adenocarcinoma<;>Epstein-Barr Virus,0.6023,Epstein-Barr Virus Early RNA Positive,0.5360,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.4717
EMBRYONAL,Embryonal Carcinoma,2,2,Embryonal Neoplasm,0.8727,Embryonal Carcinoma,0.7907,Embryonal Carcinoma<;>Nonseminomatous,0.7121,Embryonal Rhabdomyosarcoma,0.6959,Central Nervous System Embryonal Tumor,0.6537
EMBRYONAL CARCINOMA,Embryonal Carcinoma,1,2,Embryonal Carcinoma,1.0000,Embryonal Neoplasm,0.8865,Germ Cell Tumor<;>Embryonal Carcinoma,0.8864,Embryonal Carcinoma<;>Nonseminomatous,0.8828,Embryonal Rhabdomyosarcoma,0.8036
EMBRYONAL CARCINOMANON-SEMINOMA,Embryonal Carcinoma<;>Nonseminomatous,99,2,Embryonal Carcinoma<;>Seminoma,0.9282,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.9112,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8713,Seminoma,0.8474,Testicular Seminoma,0.8410
EMBRYONAL CARCINOMASEMINOMA,Embryonal Carcinoma<;>Seminoma,99,2,Embryonal Carcinoma<;>Nonseminomatous,0.8823,Embryonal Carcinoma,0.8689,Germ Cell Tumor<;>Embryonal Carcinoma,0.8243,Embryonal Tumor with Multilayered Rosettes,0.8015,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma,0.7919
EMBRYONAL CARCINOMA[NOT AVAILABLE],Embryonal Carcinoma,1,2,Embryonal Carcinoma,0.8635,Embryonal Carcinoma<;>Nonseminomatous,0.8400,Embryonal Neoplasm,0.7838,Germ Cell Tumor<;>Embryonal Carcinoma,0.7822,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.7568
EMBRYONAL CARCINOMA[NOT AVAILABLE][NOT AVAILABLE][NOT AVAILABLE],Embryonal Carcinoma,2,2,Embryonal Carcinoma<;>Nonseminomatous,0.7477,Embryonal Carcinoma,0.7473,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.7070,Embryonal Neoplasm,0.7044,Germ Cell Tumor<;>Embryonal Carcinoma,0.6778
EMBRYONAL RHABDOMYOSARCOMA,Embryonal Rhabdomyosarcoma,1,2,Embryonal Rhabdomyosarcoma,1.0000,Rhabdomyosarcoma,0.8649,Embryonal Carcinoma,0.8036,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.7838,Embryonal Carcinoma<;>Nonseminomatous,0.7655
EMBRYONAL TUMOR,Embryonal Neoplasm,1,2,Embryonal Neoplasm,0.9875,Embryonal Carcinoma,0.9019,Embryonal Carcinoma<;>Nonseminomatous,0.8265,Central Nervous System Embryonal Tumor,0.7856,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.7817
EMBRYONAL TUMOR WITH ABUNDANT NEUROPIL AND TRUE ROSETTES,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",2,2,Embryonal Tumor with Multilayered Rosettes,0.9100,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.8403,Primitive Neuroectodermal Tumor,0.7630,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.7626,Embryonal Carcinoma,0.7516
EMBRYO_CARCINOMA,Embryonal Carcinoma,1,2,Embryonal Carcinoma,0.9287,Embryonal Neoplasm,0.8550,Germ Cell Tumor<;>Embryonal Carcinoma,0.8040,Embryonal Carcinoma<;>Nonseminomatous,0.7976,Choriocarcinoma,0.7113
EMBT,Embryonal Neoplasm,99,2,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.6009,Embryonal Tumor with Multilayered Rosettes,0.5473,Epithelial-to-Mesenchymal Transition,0.5404,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.5372,Embryonal Rhabdomyosarcoma,0.5200
EMT,Epithelial-to-Mesenchymal Transition,1,2,Epithelial-to-Mesenchymal Transition,0.8413,Epithelial,0.5643,Epithelial-Myoepithelial Carcinoma,0.5551,Epithelioid Trophoblastic Tumor,0.5537,immortal epithelial cell line cell,0.5345
ENCAPSULATED GLIOMA,Glioma,1,2,Glioma,0.7424,Glioblastoma,0.7354,Angiocentric Glioma,0.7239,Low Grade Glioma,0.7003,Malignant Glioma,0.6998
ENDOCERVICAL ADENOCARCINOMA,Cervical Adenocarcinoma,1,2,Cervical Adenocarcinoma,0.8035,"Mucinous Adenocarcinoma, Endocervical Type",0.7896,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.7445,Endometrial Carcinoma,0.7337,Cervical Endometrioid Adenocarcinoma,0.7304
ENDOCERVICAL ADENOCARCINOMA OF THE USUAL TYPE,Cervical Adenocarcinoma,99,2,"Mucinous Adenocarcinoma, Endocervical Type",0.7725,"Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type",0.7100,Endometrial Adenocarcinoma<;>Well Differentiated,0.6931,Cervical Endometrioid Adenocarcinoma,0.6803,Cervical Carcinoma<;>Mixed,0.6581
ENDOCERVICAL TYPE OF ADENOCARCINOMA,Cervical Adenocarcinoma,2,2,"Mucinous Adenocarcinoma, Endocervical Type",0.7961,Cervical Adenocarcinoma,0.7940,Cervical Carcinoma,0.7320,Cervical Squamous Cell Carcinoma<;>Cervical Adenocarcinoma,0.7284,Endometrial Carcinoma,0.7169
ENDOCRINE,Endocrine,1,2,Endocrine,1.0000,Extrahepatic,0.5435,Exocrine Gland,0.5218,Extranodal Disease,0.5172,Intestinal,0.5003
ENDOMETRIAL ADENOCARCINOMA,Endometrial Adenocarcinoma,1,2,Endometrial Adenocarcinoma,1.0000,Endometrial Carcinoma,0.9256,Endometrial Endometrioid Adenocarcinoma,0.8941,Endometrioid Adenocarcinoma,0.8797,Cervical Endometrioid Adenocarcinoma,0.8573
ENDOMETRIAL ADENOSQUAMOUS CARCINOMA,Endometrial Adenosquamous Carcinoma,1,2,Endometrial Adenosquamous Carcinoma,1.0000,Endometrial Squamous Cell Carcinoma,0.8576,Cervical Endometrioid Adenocarcinoma,0.8149,Endometrial Endometrioid Adenocarcinoma,0.8145,Endometrial Clear Cell Adenocarcinoma,0.7998
ENDOMETRIAL CANCER,Endometrial Carcinoma,1,2,Endometrial Carcinoma,0.9665,Endometrial Adenocarcinoma,0.8768,uterine corpus endometrial carcinoma,0.8544,Endometrial Carcinoma<;>Uterine Corpus Cancer,0.8319,Endometrial Squamous Cell Carcinoma,0.7900
ENDOMETRIAL CARCINOMA,Endometrial Carcinoma,1,2,Endometrial Carcinoma,1.0000,Endometrial Adenocarcinoma,0.9256,uterine corpus endometrial carcinoma,0.8854,Endometrial Carcinoma<;>Uterine Corpus Cancer,0.8565,Endometrial Squamous Cell Carcinoma,0.8274
ENDOMETRIAL SQUAMOUS CELL CARCINOMA,Endometrial Squamous Cell Carcinoma,1,2,Endometrial Squamous Cell Carcinoma,1.0000,Endometrial Adenosquamous Carcinoma,0.8576,Endometrial Carcinoma,0.8274,Endometrial Serous Adenocarcinoma,0.8001,Endometrial Adenocarcinoma,0.7914
ENDOMETRIAL STROMAL SARCOMA,Endometrioid Stromal Sarcoma,1,2,Endometrioid Stromal Sarcoma,0.9386,Low Grade Endometrioid Stromal Sarcoma,0.8690,Endometrioid Stromal Sarcoma<;>High Grade,0.8603,Endometrial Squamous Cell Carcinoma,0.7469,Uterine Corpus Undifferentiated Sarcoma,0.7411
ENDOMETRIAL_ADENOCARCINOMA,Endometrial Adenocarcinoma,1,2,Endometrial Adenocarcinoma,0.9725,Endometrial Carcinoma,0.9038,Endometrial Endometrioid Adenocarcinoma,0.8884,Endometrioid Adenocarcinoma,0.8799,Endometrial Adenocarcinoma<;>Well Differentiated,0.8585
ENDOMETRIAL_ADENOSQUAMOUS,Endometrial Adenosquamous Carcinoma,1,2,Endometrial Adenosquamous Carcinoma,0.8783,Endometrial Endometrioid Adenocarcinoma,0.7931,Endometrioid Tumor,0.7694,Endometrioid Adenocarcinoma,0.7630,Endometrial Adenocarcinoma,0.7624
ENDOMETRIAL_SQUAMOUS,Endometrial Squamous Cell Carcinoma,1,2,Endometrial Squamous Cell Carcinoma,0.7986,Endometrium,0.7756,Endometrial Adenosquamous Carcinoma,0.7508,Endometrial Carcinoma,0.7495,Endometrioid Tumor,0.7123
ENDOMETRIAL_STROMAL_SARCOMA,Endometrioid Stromal Sarcoma,1,2,Endometrioid Stromal Sarcoma,0.9163,Endometrioid Stromal Sarcoma<;>High Grade,0.8572,Low Grade Endometrioid Stromal Sarcoma,0.8400,Uterine Corpus Undifferentiated Sarcoma,0.7353,Uterine Corpus Sarcoma<;>Mesenchymal,0.7340
ENDOMETRIOID,Endometrioid Tumor,1,2,Endometrioid Tumor,0.9520,Endometrioid Adenocarcinoma,0.8918,Endometrial Endometrioid Adenocarcinoma,0.8401,Cervical Endometrioid Adenocarcinoma,0.7654,Cystadenocarcinoma<;>Endometrioid Adenocarcinoma,0.7559
ENDOMETRIOID ADENOCARCINOMA OF ENDOCERVIX,Cervical Endometrioid Adenocarcinoma,1,2,Cervical Endometrioid Adenocarcinoma,0.8925,Endometrial Endometrioid Adenocarcinoma,0.8536,Cystadenocarcinoma<;>Endometrioid Adenocarcinoma,0.8239,"Mucinous Adenocarcinoma, Endocervical Type",0.8092,Endometrioid Adenocarcinoma,0.7963
ENDOMETRIOID CARCINOMA,Endometrioid Adenocarcinoma,1,2,Endometrioid Adenocarcinoma,0.9726,Endometrioid Tumor,0.9468,Endometrial Endometrioid Adenocarcinoma,0.9231,Cervical Endometrioid Adenocarcinoma,0.8980,Cystadenocarcinoma<;>Endometrioid Adenocarcinoma,0.8829
ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA,Endometrial Endometrioid Adenocarcinoma,1,2,Endometrial Endometrioid Adenocarcinoma,0.9920,Endometrioid Adenocarcinoma,0.9630,Cervical Endometrioid Adenocarcinoma,0.9236,Ovarian Endometrioid Adenocarcinoma,0.9132,Cystadenocarcinoma<;>Endometrioid Adenocarcinoma,0.8992
ENDOMETRIOID OVARIAN CANCER,Ovarian Endometrioid Adenocarcinoma,1,2,Ovarian Endometrioid Adenocarcinoma,0.9324,Endometrioid Adenocarcinoma,0.8853,Endometrioid Tumor,0.8675,Endometrial Endometrioid Adenocarcinoma,0.8621,Cervical Endometrioid Adenocarcinoma,0.8308
ENDOMETRIOID_CARCINOMA,Endometrioid Adenocarcinoma,1,2,Endometrioid Adenocarcinoma,0.9510,Endometrioid Tumor,0.9477,Endometrial Endometrioid Adenocarcinoma,0.8991,Cervical Endometrioid Adenocarcinoma,0.8678,Cystadenocarcinoma<;>Endometrioid Adenocarcinoma,0.8617
ENDOMETRIUM,Endometrium,1,2,Endometrium,1.0000,Endometrial Carcinoma,0.6918,uterine corpus endometrial carcinoma,0.6365,Endometrioid Tumor,0.6335,Endometrial Carcinoma<;>Uterine Corpus Cancer,0.6246
EPENDYMOBLASTOMA,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",99,2,Ependymoma,0.9347,Ependymal Tumor,0.8963,Anaplastic Ependymoma,0.8701,Myxopapillary Ependymoma,0.8274,Supratentorial Ependymoma<;>Subependymoma,0.8040
EPENDYMOMA,Ependymoma,1,2,Ependymoma,1.0000,Ependymal Tumor,0.9316,Anaplastic Ependymoma,0.8515,Myxopapillary Ependymoma,0.8497,Supratentorial Ependymoma<;>Subependymoma,0.8164
EPENDYMOMAL TUMOR,Ependymal Tumor,1,2,Ependymal Tumor,0.9607,Ependymoma,0.9433,Myxopapillary Ependymoma,0.8334,Supratentorial Ependymoma<;>Subependymoma,0.8003,Anaplastic Ependymoma,0.7831
EPITHELIAL,Epithelial,1,2,Epithelial,1.0000,immortal epithelial cell line cell,0.6992,Mucosa,0.6626,Epithelioid Cell,0.6581,Epithelial-to-Mesenchymal Transition,0.6296
EPITHELIAL TYPE METAPLASTIC BREAST CANCER,Breast Metaplastic Carcinoma<;>Epithelial,1,2,Breast Metaplastic Carcinoma<;>Epithelial,0.9581,Breast Metaplastic Carcinoma,0.8997,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.8325,Metaplastic Carcinoma,0.7278,Invasive Breast Carcinoma of No Special Type,0.6997
EPITHELIAL-MYOEPITHELIAL CARCINOMA,Epithelial-Myoepithelial Carcinoma,1,2,Epithelial-Myoepithelial Carcinoma,1.0000,Malignant Myoepithelioma,0.7919,Mucoepidermoid Carcinoma,0.7095,Breast Metaplastic Carcinoma<;>Epithelial,0.7028,Undifferentiated Carcinoma,0.6962
EPITHELIOID,Epithelioid Cell,1,2,Epithelioid Cell,0.9274,Epithelioid Sarcoma,0.7610,Epithelial,0.7155,Epithelioid Mesothelioma,0.7078,Epithelioid Hemangioendothelioma,0.6785
EPITHELIOID CELL,Epithelioid Cell,1,2,Epithelioid Cell,1.0000,Epithelioid Sarcoma,0.6988,Epithelioid Mesothelioma,0.6888,Basaloid Cell,0.6751,Epithelioid Hemangioendothelioma,0.6695
EPITHELIOID CELL TUMOR,Malignant PEComa,99,2,Epithelioid Sarcoma,0.8361,Epithelioid Mesothelioma,0.8201,Epithelioid Cell,0.8181,Epithelioid Cell<;>Spindle Cell Neoplasm,0.8070,Epithelioid Hemangioendothelioma,0.7594
EPITHELIOID CELLSPINDLE CELL,Epithelioid Cell<;>Spindle Cell Neoplasm,99,2,Epithelioid Cell,0.8673,Basaloid Cell,0.7345,immortal epithelial cell line cell,0.6810,Columnar Cell,0.6385,Signet Ring Cell,0.6313
EPITHELIOID FIBROSARCOMA,Sclerosing Epithelioid Fibrosarcoma,1,2,Sclerosing Epithelioid Fibrosarcoma,0.8557,Epithelioid Sarcoma,0.8303,Proximal-Type Epithelioid Sarcoma,0.7689,Epithelioid Hemangioendothelioma,0.7401,Epithelioid Mesothelioma,0.7227
EPITHELIOID HEMANGIOENDOTHELIOMA,Epithelioid Hemangioendothelioma,1,2,Epithelioid Hemangioendothelioma,1.0000,Pseudomyogenic Hemangioendothelioma,0.7835,Epithelioid Sarcoma,0.7586,Epithelioid Mesothelioma,0.7317,Epithelioid Cell<;>Spindle Cell Neoplasm,0.6892
EPITHELIOID MESOTHELIOMA,Epithelioid Mesothelioma,1,2,Epithelioid Mesothelioma,1.0000,Pleural Epithelioid Mesothelioma,0.8667,Sarcomatoid Mesothelioma,0.8562,Biphasic Mesothelioma,0.8216,Epithelioid Sarcoma,0.8117
EPITHELIOID SARCOMA,Epithelioid Sarcoma,1,2,Epithelioid Sarcoma,1.0000,Proximal-Type Epithelioid Sarcoma,0.8340,Epithelioid Mesothelioma,0.8117,Sarcomatoid Carcinoma,0.7744,undifferentiated sarcoma,0.7637
EPITHELIOID TROPHOBLASTIC TUMOR,Epithelioid Trophoblastic Tumor,1,2,Epithelioid Trophoblastic Tumor,1.0000,Gestational Trophoblastic Disorder,0.6745,Epithelioid Mesothelioma,0.6664,Epithelioid Hemangioendothelioma,0.6664,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.6540
EPITHELIOID_SARCOMA,Epithelioid Sarcoma,1,2,Epithelioid Sarcoma,0.9711,Proximal-Type Epithelioid Sarcoma,0.8113,undifferentiated sarcoma,0.7918,Epithelioid Mesothelioma,0.7849,Sarcomatoid Carcinoma,0.7644
EPM,Ependymoma,3,2,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.5969,Epithelial-to-Mesenchymal Transition,0.5665,Ependymoma,0.5628,Embryonal Tumor with Multilayered Rosettes,0.5490,Anaplastic Ependymoma,0.5481
ER+,Estrogen Receptor Positive,1,2,Estrogen Receptor Positive,0.8801,Estrogen Receptor Positive<;>HER2/Neu Positive,0.6834,Estrogen Receptor Positive<;>HER2/Neu Negative,0.6775,Estrogen Receptor Negative<;>HER2/Neu Positive,0.6448,Estrogen Receptor Negative<;>HER2/Neu Negative,0.6234
ER+HER2+,Estrogen Receptor Positive<;>HER2/Neu Positive<;>HER2-Positive Breast Carcinoma,2,2,Estrogen Receptor Positive<;>HER2/Neu Positive,0.8843,Estrogen Receptor Positive<;>HER2/Neu Positive<;>HER2-Positive Breast Carcinoma,0.8501,Estrogen Receptor Positive<;>HER2/Neu Negative,0.8162,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.8090,Estrogen Receptor Negative<;>HER2/Neu Positive,0.7967
ERDHEIM-CHESTER DISEASE,Erdheim-Chester Disease,1,2,Erdheim-Chester Disease,1.0000,Castleman Disease,0.6257,Langerhans Cell Histiocytosis,0.5964,Disseminated Juvenile Xanthogranuloma,0.5728,Histiocytosis,0.5620
ERNEG_HER2NEG,Estrogen Receptor Negative<;>HER2/Neu Negative,3,2,Estrogen Receptor Negative<;>HER2/Neu Positive,0.8695,Estrogen Receptor Positive<;>HER2/Neu Negative,0.8543,Estrogen Receptor Negative<;>HER2/Neu Negative,0.8492,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.7867,Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.7837
ERNEG_HER2POS,Estrogen Receptor Negative<;>HER2/Neu Positive,3,2,Estrogen Receptor Positive<;>HER2/Neu Positive,0.8027,Estrogen Receptor Positive<;>HER2/Neu Positive<;>HER2-Positive Breast Carcinoma,0.7869,Estrogen Receptor Negative<;>HER2/Neu Positive,0.7634,Estrogen Receptor Positive<;>HER2/Neu Negative,0.7553,HER2-Positive Breast Carcinoma,0.7545
ERPOS_HER2NEG,Estrogen Receptor Positive<;>HER2/Neu Negative,3,2,Estrogen Receptor Negative<;>HER2/Neu Positive,0.7819,Estrogen Receptor Negative<;>HER2/Neu Negative,0.7775,Estrogen Receptor Positive<;>HER2/Neu Negative,0.7754,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.7138,Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.6962
ERPOS_HER2POS,Estrogen Receptor Positive<;>HER2/Neu Positive,1,2,Estrogen Receptor Positive<;>HER2/Neu Positive,0.6954,Estrogen Receptor Positive<;>HER2/Neu Positive<;>HER2-Positive Breast Carcinoma,0.6950,Estrogen Receptor Positive<;>HER2/Neu Negative,0.6634,Estrogen Receptor Negative<;>HER2/Neu Positive,0.6630,HER2-Positive Breast Carcinoma,0.6471
ERYTHROLEUKEMIA,Erythroleukemia,1,2,Erythroleukemia,1.0000,Pure Erythroid Leukemia,0.8568,Acute Erythroid Leukemia,0.8057,Leukemia,0.7133,Polycythemia Vera,0.6899
ES,Ewing Sarcoma,1,2,Ewing Sarcoma,0.6344,Epithelioid Sarcoma,0.5852,Sarcoma,0.5657,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.5582,undifferentiated sarcoma,0.5539
ESCA,Esophageal Carcinoma,99,2,Ependymoma,0.5163,Endometrial Squamous Cell Carcinoma,0.5082,Epithelial,0.5054,Epithelial-Myoepithelial Carcinoma,0.4972,Anaplastic Ependymoma,0.4954
ESCA_CIN,Esophageal Adenocarcinoma<;>Chromosomal Instability,99,2,immortal epithelial cell line cell,0.5398,Epithelial-Myoepithelial Carcinoma,0.5218,Cervical Adenocarcinoma In Situ,0.5124,Endometrial Carcinoma<;>Microsatellite Instability,0.5098,Endometrial Neuroendocrine Carcinoma,0.5098
ESCA_ESCC,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,1,2,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.6098,Epithelial-Myoepithelial Carcinoma,0.6016,Esophageal Adenocarcinoma<;>Microsatellite Instability,0.5986,Esophageal Neuroendocrine Carcinoma<;>Adenocarcinoma,0.5907,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.5851
ESCA_GS,Esophageal Adenocarcinoma,99,2,immortal epithelial cell line cell,0.4909,Endometrial Squamous Cell Carcinoma,0.4886,Epithelioid Sarcoma,0.4801,Serous,0.4792,Endometrial Adenosquamous Carcinoma,0.4769
ESCA_MSI,Esophageal Adenocarcinoma<;>Microsatellite Instability,2,2,Endometrial Carcinoma<;>Microsatellite Instability,0.6471,Esophageal Adenocarcinoma<;>Microsatellite Instability,0.5904,Microsatellite Stable,0.5675,Epithelial-Myoepithelial Carcinoma,0.5601,Microsatellite Instability,0.5419
ESCA_POLE,Esophageal Adenocarcinoma<;>POLE Gene Mutation,99,2,POLE-Ultramutated Endometrial Endometrioid Adenocarcinoma,0.5607,immortal epithelial cell line cell,0.5036,immortal embryo-derived fibroblast cell line cell,0.4811,Endometrial Carcinoma<;>POLE Gene Mutation,0.4781,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.4748
ESOPHAGEAL ADENOCARCINOMA,Esophageal Adenocarcinoma,1,2,Esophageal Adenocarcinoma,1.0000,Esophageal Carcinoma,0.8922,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.8822,Esophageal Squamous Cell Carcinoma,0.7916,Esophageal Neuroendocrine Carcinoma<;>Adenocarcinoma,0.7711
ESOPHAGEAL ADENOCARINOMA,Esophageal Adenocarcinoma,4,2,Esophageal Neuroendocrine Carcinoma<;>Adenocarcinoma,0.7262,Esophageal Neuroendocrine Tumor,0.6749,Esophageal Adenosquamous Carcinoma,0.6735,Esophageal Adenocarcinoma,0.6569,Adenoid Cystic Carcinoma,0.6460
ESOPHAGEAL ADENOSQUAMOUS CARCINOMA,Esophageal Adenosquamous Carcinoma,1,2,Esophageal Adenosquamous Carcinoma,1.0000,Esophageal Squamous Cell Carcinoma,0.8140,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.8113,Adenosquamous Carcinoma,0.7432,Cervical Adenosquamous Carcinoma,0.7416
ESOPHAGEAL CANCER,Esophageal Carcinoma,1,2,Esophageal Carcinoma,0.9584,Esophageal Adenocarcinoma,0.8268,Esophageal Squamous Cell Carcinoma,0.7793,Esophageal Melanoma,0.7366,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.7270
ESOPHAGEAL CARCINOMA,Esophageal Carcinoma,1,2,Esophageal Carcinoma,1.0000,Esophageal Adenocarcinoma,0.8922,Esophageal Squamous Cell Carcinoma,0.8451,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.7979,Esophageal Melanoma,0.7486
ESOPHAGEAL CARCINOMA OTHER,Esophageal Carcinoma,1,2,Esophageal Carcinoma,0.7300,Esophageal Adenocarcinoma,0.6475,Esophageal Neuroendocrine Carcinoma<;>Adenocarcinoma,0.6299,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.6061,Esophageal Squamous Cell Carcinoma,0.6003
ESOPHAGEAL LN,Esophageal Lymph Node,1,2,Esophageal Lymph Node,0.8949,Esophageal Neuroendocrine Tumor,0.5791,Esophagus,0.5476,Lymph Node,0.5250,Esophageal Melanoma,0.4780
ESOPHAGEAL NEUROENDOCRINE TUMOR,Esophageal Neuroendocrine Tumor,1,2,Esophageal Neuroendocrine Tumor,1.0000,Esophageal Neuroendocrine Carcinoma<;>Adenocarcinoma,0.7785,Cervical Neuroendocrine Tumor,0.7595,Gastric Neuroendocrine Tumor,0.7221,Neuroendocrine Tumor,0.7161
ESOPHAGEAL POORLY DIFFERENTIATED CARCINOMA,Esophageal Carcinoma,3,2,Esophageal Neuroendocrine Carcinoma<;>Adenocarcinoma,0.7522,Esophageal Adenosquamous Carcinoma,0.7496,Esophageal Carcinoma,0.7259,Esophageal Squamous Cell Carcinoma,0.7254,Esophageal Adenocarcinoma,0.7230
ESOPHAGEAL SQUAMOUS CELL CARCINOMA,Esophageal Squamous Cell Carcinoma,1,2,Esophageal Squamous Cell Carcinoma,1.0000,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.9021,Esophageal Carcinoma,0.8451,Esophageal Adenosquamous Carcinoma,0.8140,Esophageal Adenocarcinoma,0.7916
"ESOPHAGEAL/STOMACH CANCER, NOS",Esophageal Carcinoma,2,2,Gastroesophageal Cancer,0.7818,Esophageal Carcinoma,0.7176,Gastroesophageal Cancer<;>Primary Neoplasm,0.7099,Gastric Carcinoma,0.6939,Esophageal Adenocarcinoma,0.6361
ESOPHAGOGASTRIC ADENOCARCINOMA,Gastroesophageal Junction Adenocarcinoma,1,2,Gastroesophageal Junction Adenocarcinoma,0.8604,Esophageal Adenocarcinoma,0.7999,Gastroesophageal Cancer,0.7798,Gastric Adenocarcinoma,0.7753,Esophageal Neuroendocrine Carcinoma<;>Adenocarcinoma,0.7478
ESOPHAGOGASTRIC CANCER,Gastroesophageal Cancer,1,2,Gastroesophageal Cancer,0.8812,Gastroesophageal Cancer<;>Primary Neoplasm,0.7485,Esophageal Carcinoma,0.7284,Gastric Carcinoma,0.7097,Gastroesophageal Junction Adenocarcinoma,0.7023
ESOPHAGOGASTRIC CARCINOMA,Gastroesophageal Cancer,1,2,Gastroesophageal Cancer,0.8588,Gastroesophageal Junction Adenocarcinoma,0.7673,Esophageal Carcinoma,0.7640,Gastroesophageal Cancer<;>Primary Neoplasm,0.7247,Gastric Carcinoma,0.7216
ESOPHAGUS,Esophagus,1,2,Esophagus,1.0000,Esophageal Carcinoma,0.6282,Stomach,0.6113,Rectum,0.5371,Gastric,0.5285
"ESOPHAGUS ADENOCARCINOMA, NOS",Esophageal Adenocarcinoma,1,2,Esophageal Adenocarcinoma,0.9560,Esophageal Carcinoma,0.8729,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.8453,Esophageal Squamous Cell Carcinoma,0.7620,Esophageal Neuroendocrine Carcinoma<;>Adenocarcinoma,0.7433
ESOPHAGUS SQUAMOUS CELL CARCINOMA,Esophageal Squamous Cell Carcinoma,1,2,Esophageal Squamous Cell Carcinoma,0.9690,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.8695,Esophageal Carcinoma,0.8311,Esophageal Adenocarcinoma,0.7649,Esophageal Adenosquamous Carcinoma,0.7504
ESOPHAGUS/STOMACH,Esophageal Carcinoma,99,2,Esophagus,0.8146,Stomach,0.7854,Gastric,0.7325,Gastroesophageal Cancer,0.6489,Gastroesophageal Cancer<;>Primary Neoplasm,0.5659
ESOPHAGUS_ADENOCARCINOMA,Esophageal Adenocarcinoma,1,2,Esophageal Adenocarcinoma,0.9340,Esophageal Carcinoma,0.8512,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.8375,Esophageal Neuroendocrine Carcinoma<;>Adenocarcinoma,0.7501,Esophageal Squamous Cell Carcinoma,0.7405
ESOPHAGUS_SQUAMOUS,Esophageal Squamous Cell Carcinoma,2,2,Esophagus,0.7631,Esophageal Squamous Cell Carcinoma,0.7225,Esophageal Carcinoma,0.6760,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.6697,Esophageal Adenosquamous Carcinoma,0.6063
ESSENTIAL THROMBOCYTHAEMIA,Essential Thrombocythemia,1,2,Essential Thrombocythemia,0.9876,Essential Thrombocythemia<;>Myelofibrosis,0.8187,Polycythemia Vera,0.6642,Polycythemia Vera<;>Myelofibrosis,0.6520,Overt Primary Myelofibrosis,0.6107
ESSENTIAL THROMBOCYTHEMIA,Essential Thrombocythemia,1,2,Essential Thrombocythemia,1.0000,Essential Thrombocythemia<;>Myelofibrosis,0.8388,Polycythemia Vera<;>Myelofibrosis,0.6616,Polycythemia Vera,0.6591,Overt Primary Myelofibrosis,0.6335
ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS,Essential Thrombocythemia<;>Myelofibrosis,1,2,Essential Thrombocythemia<;>Myelofibrosis,0.9811,Essential Thrombocythemia,0.8301,Overt Primary Myelofibrosis,0.8139,Primary Myelofibrosis,0.8086,Polycythemia Vera<;>Myelofibrosis,0.8035
ESSENTIAL_THROMBOCYTHAEMIA,Essential Thrombocythemia,1,2,Essential Thrombocythemia,0.9659,Essential Thrombocythemia<;>Myelofibrosis,0.8007,Polycythemia Vera,0.6564,Polycythemia Vera<;>Myelofibrosis,0.6288,Overt Primary Myelofibrosis,0.6053
ETMR,Embryonal Tumor with Multilayered Rosettes,4,2,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.6350,ETV1 Gene,0.5924,Endometrial Carcinoma<;>Microsatellite Instability,0.5918,Embryonal Tumor with Multilayered Rosettes,0.5749,ETV4 Gene,0.5732
ETP-ALL,Early T Acute Lymphoblastic Leukemia,1,2,Early T Acute Lymphoblastic Leukemia,0.6893,T Acute Lymphoblastic Leukemia,0.6233,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.6194,Myelodysplastic Syndrome with Excess Blasts-1,0.6162,Acute Lymphoblastic Leukemia,0.6145
EWING FAMILY TUMOR,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,2,2,Ewing Sarcoma,0.9422,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.8727,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,0.7817,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.6532,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.6361
EWING SARCOMA,Ewing Sarcoma,1,2,Ewing Sarcoma,1.0000,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.8714,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,0.8324,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.7053,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.6548
EWING'S SARCOMA,Ewing Sarcoma,1,2,Ewing Sarcoma,0.9814,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.8658,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,0.8230,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.6891,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.6269
EWING-LIKE SARCOMA,Round Cell Sarcoma with EWSR1-non-ETS Fusion,4,2,Ewing Sarcoma,0.9767,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.8648,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,0.8363,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.7325,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.6562
EWINGS SARCOMA,Ewing Sarcoma,1,2,Ewing Sarcoma,0.9907,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.8609,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,0.8294,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.6960,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.6477
EWINGS SARCOMA-PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOUR,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,1,2,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.9682,Ewing Sarcoma,0.8571,Peripheral Primitive Neuroectodermal Tumor,0.7967,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,0.7656,Primitive Neuroectodermal Tumor,0.7385
EWINGS_SARCOMA,Ewing Sarcoma,1,2,Ewing Sarcoma,0.9769,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.8564,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,0.8080,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.6762,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.6493
EWING_SARCOMA,Ewing Sarcoma,1,2,Ewing Sarcoma,0.9834,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.8646,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,0.8092,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.6769,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.6759
EWS-ERG,Ewing Sarcoma<;>ERG Gene Rearrangement,1,2,Ewing Sarcoma<;>ERG Gene Rearrangement,0.8040,ERG Gene,0.7102,Ewing Sarcoma,0.6724,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.6543,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.6528
EWS-FLI1,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,1,2,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.8035,FLI1 Gene,0.7224,Ewing Sarcoma,0.6707,Ewing Sarcoma<;>ERG Gene Rearrangement,0.6292,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.6226
EXOCRINE,Exocrine Gland,1,2,Exocrine Gland,0.8844,Pancreas,0.6483,Endocrine,0.6346,Acinar Cell,0.6097,Extrahepatic,0.5980
EXOCRINE_ADENOCARCINOMA,Pancreatic Ductal Adenocarcinoma<;>Exocrine Gland,1,2,Pancreatic Ductal Adenocarcinoma<;>Exocrine Gland,0.8201,Acinar Cell Carcinoma,0.7957,Pancreatic Adenocarcinoma,0.7825,Adenocarcinoma,0.7684,Pancreatic Acinar Cell Carcinoma,0.7580
EXOCRINE_ADENOSQUAMOUS,Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland,2,2,Exocrine Gland,0.7176,Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland,0.7134,Pancreatic Adenosquamous Carcinoma<;>Exocrine Gland<;>Ductal,0.6737,Adenosquamous Carcinoma,0.6546,Pancreatic Ductal Adenocarcinoma<;>Exocrine Gland,0.6282
EXTRA GONADAL GERM CELL TUMOR,Extragonadal Germ Cell Tumor,1,2,Extragonadal Germ Cell Tumor,0.9127,Testicular Germ Cell Tumor,0.8007,Ovarian Germ Cell Tumor,0.7886,Germ Cell Tumor,0.7775,Nongerminomatous Germ Cell Tumor,0.7452
EXTRA-ADRENAL PHEOCHROMOCYTOMA,Extra-Adrenal Sympathetic Paraganglioma,4,2,Extra-Adrenal Pheochromocytoma,1.0000,Adrenal Gland Pheochromocytoma,0.9231,Adrenal Gland Pheochromocytoma<;>Paraganglioma,0.8883,Extra-Adrenal Sympathetic Paraganglioma,0.8381,Paraganglioma,0.7861
EXTRACRANIAL RHABDOID,Rhabdoid Tumor<;>Extracranial,1,2,Rhabdoid Tumor<;>Extracranial,0.9174,Extrarenal Rhabdoid Tumor,0.8448,Rhabdoid Tumor,0.7903,Atypical Teratoid/Rhabdoid Tumor,0.7410,Undifferentiated Round Cell Sarcoma,0.6622
EXTRAGONADAL GERM CELL TUMOR,Extragonadal Germ Cell Tumor,1,2,Extragonadal Germ Cell Tumor,1.0000,Nongerminomatous Germ Cell Tumor,0.8038,Germ Cell Tumor,0.7787,Nongerminomatous Germ Cell Tumor<;>Mixed Germ Cell Tumor,0.7496,Mixed Germ Cell Tumor,0.7269
EXTRAHEPATIC,Extrahepatic,1,2,Extrahepatic,1.0000,Extranodal Disease,0.6720,Abdomen,0.6136,Intrahepatic,0.5915,Occult Stage,0.5887
EXTRAHEPATIC CHOLANGIOCARCINOMA,Extrahepatic Bile Duct Adenocarcinoma,5,2,Cholangiocarcinoma<;>Extrahepatic,0.9808,Intrahepatic Cholangiocarcinoma,0.8656,Hilar Cholangiocarcinoma,0.8572,Cholangiocarcinoma,0.8231,Extrahepatic Bile Duct Adenocarcinoma,0.8229
EXTRAMAMMARY PAGET DISEASE,Extramammary Paget Disease,1,2,Extramammary Paget Disease,1.0000,Nipple Paget Disease,0.7580,Periosteal Osteosarcoma,0.5306,Erdheim-Chester Disease,0.5260,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.5208
EXTRANODAL DISEASE,Extranodal Disease,1,2,Extranodal Disease,1.0000,Extrahepatic,0.6720,Distant,0.5607,Metastatic Lesion,0.5566,Distant Metastasis,0.5565
EXTRANODAL MARGINAL ZONE LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID TISSUE MALT LYMPHOMA,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,1,2,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.9384,Nodal Marginal Zone Lymphoma,0.8020,Marginal Zone Lymphoma,0.7886,Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma,0.6891,Mantle Cell Lymphoma,0.6854
EXTRANODAL_DISEASE,Extranodal Disease,1,2,Extranodal Disease,0.9814,Extrahepatic,0.6745,Occult Stage,0.5506,Distant,0.5503,Metastatic Lesion,0.5415
EXTRARENAL RHABDOID TUMOR,Extrarenal Rhabdoid Tumor,1,2,Extrarenal Rhabdoid Tumor,1.0000,Rhabdoid Tumor,0.8970,Rhabdoid Tumor<;>Extracranial,0.8709,Atypical Teratoid/Rhabdoid Tumor,0.8406,Peripheral Primitive Neuroectodermal Tumor,0.6623
EXTRASKELETAL MYXOID CHONDROSARCOMA,Extraskeletal Myxoid Chondrosarcoma,1,2,Extraskeletal Myxoid Chondrosarcoma,1.0000,Mesenchymal Chondrosarcoma,0.8242,Dedifferentiated Chondrosarcoma,0.7919,Chondrosarcoma,0.7632,Chondroblastic Osteosarcoma,0.7401
EXTRASKELETAL OSTEOSARCOMA,Extraskeletal Osteosarcoma,1,2,Extraskeletal Osteosarcoma,1.0000,Osteosarcoma,0.8955,Osteoblastic Osteosarcoma,0.8121,Parosteal Osteosarcoma,0.8065,Small Cell Osteosarcoma,0.7961
EXTRAVENTRICULAR NEUROCYTOMA,Extraventricular Neurocytoma,1,2,Extraventricular Neurocytoma,1.0000,Central Neurocytoma,0.8045,Angiocentric Glioma,0.7048,Anaplastic Ependymoma,0.6858,Ependymoma,0.6715
FATTY LIVER DISEASE,fatty liver disease,1,2,fatty liver disease,1.0000,Linitis Plastica,0.5826,"Non-B, Non-C Hepatitis",0.5693,Liver,0.5348,Liposarcoma,0.5056
FH-DEFICIENT RENAL CELL CARCINOMA,Fumarate Hydratase-Deficient Renal Cell Carcinoma,1,2,Fumarate Hydratase-Deficient Renal Cell Carcinoma,0.9139,Classic Variant of Chromophobe Renal Cell Carcinoma,0.7452,Chromophobe Renal Cell Carcinoma,0.7433,Clear Cell Renal Cell Carcinoma,0.7304,Renal Cell Carcinoma,0.7166
FIBROBLASTIC MYOFIBROBLASTIC TUMOR,Inflammatory Myofibroblastic Tumor,1,2,Inflammatory Myofibroblastic Tumor,0.8525,Myofibroma,0.8439,Solitary Fibrous Tumor,0.8301,Infantile Myofibroma,0.8106,Myxoinflammatory Fibroblastic Sarcoma,0.7361
FIBROBLASTIC OSTEOSARCOMA,Fibroblastic Osteosarcoma,1,2,Fibroblastic Osteosarcoma,1.0000,Osteosarcoma,0.8422,Osteoblastic Osteosarcoma,0.8370,Chondroblastic Osteosarcoma,0.8295,Small Cell Osteosarcoma,0.8126
FIBROBLAST_BONE,Bone Marrow-Derived Fibroblasts,2,2,Fibroblast<;>Soft Tissue,0.7941,Bone Marrow-Derived Fibroblasts,0.7710,fibroblast of breast,0.7228,Fibroblast<;>Urinary System,0.7127,fibroblast of lung,0.7034
FIBROBLAST_BREAST,fibroblast of breast,1,2,fibroblast of breast,0.9311,Bone Marrow-Derived Fibroblasts,0.7599,Fibroblast<;>Soft Tissue,0.7369,fibroblast of lung,0.7273,Fibroblast<;>upper aerodigestive tract,0.7106
FIBROBLAST_COLORECTAL,Fibroblast<;>Colorectal,1,2,Fibroblast<;>Colorectal,0.9270,Neoplastic Fibroblast-Like Cell,0.7311,Fibroblast<;>upper aerodigestive tract,0.7202,Fibroblast<;>Soft Tissue,0.7157,Fibroblast<;>Urinary System,0.6955
FIBROBLAST_LIKE,Neoplastic Fibroblast-Like Cell,1,2,Neoplastic Fibroblast-Like Cell,0.7467,Fibroblast<;>Soft Tissue,0.7412,Fibroblast<;>Urinary System,0.7118,fibroblast of lung,0.7111,Bone Marrow-Derived Fibroblasts,0.6868
FIBROBLAST_LUNG,fibroblast of lung,1,2,fibroblast of lung,0.9110,Fibroblast<;>upper aerodigestive tract,0.7681,Fibroblast<;>Urinary System,0.7378,Neoplastic Fibroblast-Like Cell,0.7280,Fibroblast<;>Soft Tissue,0.7270
FIBROBLAST_LYMPHOCYTE,Fibroblast<;>Lymphocyte,1,2,Fibroblast<;>Lymphocyte,0.9113,Neoplastic Fibroblast-Like Cell,0.7448,fibroblast of lung,0.7276,immortal fibroblast cell line cell,0.7225,Fibroblast<;>Soft Tissue,0.7073
FIBROBLAST_SKIN,Skin Fibroblastic Neoplasm,2,2,Fibroblast<;>Soft Tissue,0.8275,Skin Fibroblastic Neoplasm,0.7888,Fibroblast<;>Urinary System,0.7672,fibroblast of lung,0.7575,Fibroblast<;>upper aerodigestive tract,0.7536
FIBROBLAST_SOFT_TISSUE,Fibroblast<;>Soft Tissue,1,2,Fibroblast<;>Soft Tissue,0.9537,Neoplastic Fibroblast-Like Cell,0.7341,Fibroblast<;>upper aerodigestive tract,0.7336,fibroblast of breast,0.7292,Fibroblast<;>Urinary System,0.7269
FIBROBLAST_UPPER_AERODIGESTIVE,Fibroblast<;>upper aerodigestive tract,1,2,Fibroblast<;>upper aerodigestive tract,0.9449,Fibroblast<;>Urinary System,0.7770,fibroblast of lung,0.7560,Fibroblast<;>Soft Tissue,0.7514,immortal fibroblast cell line cell,0.6854
FIBROBLAST_URINARY_TRACT,Fibroblast<;>Urinary System,1,2,Fibroblast<;>Urinary System,0.9292,Fibroblast<;>upper aerodigestive tract,0.8180,Fibroblast<;>Soft Tissue,0.7155,fibroblast of lung,0.6833,Neoplastic Fibroblast-Like Cell,0.6794
FIBROLAMELLAR CARCINOMA,Fibrolamellar Carcinoma,1,2,Fibrolamellar Carcinoma,1.0000,Clear Cell Adenocarcinoma,0.7179,Adenocarcinoma Clear Cell,0.6970,Pilomatrical Carcinoma,0.6814,Mixed Carcinoma,0.6702
FIBROLAMELLAR HEPATOCELLUAR CARCINOMA,Fibrolamellar Carcinoma,1,2,Fibrolamellar Carcinoma,0.8118,Pleomorphic Hepatocellular Carcinoma,0.7957,Hepatocellular Carcinoma,0.7292,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.7141,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.7030
FIBROMATOSIS,Fibromatosis,1,2,Fibromatosis,1.0000,Fibrothecoma,0.7970,Desmoid Fibromatosis,0.7921,Desmoplastic,0.7401,Myofibroma,0.7264
FIBROSARCOMA,Fibrosarcoma,1,2,Fibrosarcoma,1.0000,Infantile Fibrosarcoma,0.7816,Sarcoma,0.6849,Sarcomatoid Carcinoma,0.6806,Fibroblastic Osteosarcoma,0.6798
FIBROSARCOMA_CANCER,Fibrosarcoma,1,2,Fibrosarcoma,0.9629,Infantile Fibrosarcoma,0.7421,Sarcoma,0.6694,Sarcomatoid Carcinoma,0.6619,Fibroblastic Osteosarcoma,0.6521
FIBROTHECOMA,Fibrothecoma,1,2,Fibrothecoma,1.0000,Fibromatosis,0.7970,Myofibroma,0.7639,Myxoma,0.7028,Ovarian Fibrothecoma,0.6903
FIRST RECURRENCE,First Relapse,1,2,First Relapse,0.9243,Recurrence,0.7749,"Neoplasm Recurrence, Local",0.7271,Locally Recurrent Malignant Neoplasm,0.7237,Recurrent,0.7198
FL,Follicular Lymphoma,3,2,FLI1 Gene,0.5428,Thigh,0.4921,Follicular Lymphoma,0.4682,Local-Regional,0.4642,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.4599
FOCAL ANAPLASIA,Anaplastic Lesion<;>Focal,1,2,Anaplastic Lesion<;>Focal,0.7792,Anaplastic Lesion<;>Diffuse,0.6802,Anaplastic,0.6438,Diffuse Astrocytoma,0.6081,Anaplastic Carcinoma,0.6021
FOCAL MUCINOUS FEATURES,Mucinous,1,2,Mucinous,0.7912,Mucinous Adenocarcinoma,0.6952,Signet Ring Cell<;>Mucinous,0.6288,Pancreatic Mucinous-Cystic Neoplasm,0.5958,Micropapillary Growth Pattern,0.5955
FOCAL NEUROENDOCRINE COMPONENT,Neuroendocrine Neoplasm,1,2,Neuroendocrine Neoplasm,0.6588,Neuroendocrine Tumor,0.6565,Pituitary Neuroendocrine Tumor,0.6217,Neuroendocrine Carcinoma,0.6139,Somatostatin-Producing Neuroendocrine Tumor,0.6064
FOCAL SIGNET RING,Signet Ring Cell,1,2,Signet Ring Cell,0.7105,Signet Ring Cell<;>Mucinous,0.5823,Micropapillary Growth Pattern,0.5812,Signet Ring Adenocarcinoma Cell,0.5773,Non-Papillary Pattern,0.5727
FOLLICULAR,Follicle,1,2,Follicle,0.8642,Follicular Lymphoma,0.6294,Ovary,0.5922,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.5615,Organoid,0.5377
FOLLICULAR CARCINOMA,Thyroid Gland Follicular Carcinoma,1,2,Thyroid Gland Follicular Carcinoma,0.8921,Follicular Lymphoma,0.8394,Thyroid Gland Follicular Carcinoma<;>Thyroid Gland Oncocytic Carcinoma,0.7452,Thyroid Gland Papillary and Follicular Carcinoma,0.7137,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.7071
FOLLICULAR DENDRITIC CELL SARCOMA,Follicular Dendritic Cell Sarcoma,1,2,Follicular Dendritic Cell Sarcoma,1.0000,Follicular Lymphoma,0.7256,Dermatofibrosarcoma Protuberans,0.7179,Follicular Helper T-Cell Lymphoma,0.7143,Myxoinflammatory Fibroblastic Sarcoma,0.6911
FOLLICULAR IN MET,Thyroid Gland Follicular Carcinoma<;>Metastasis,99,2,Follicle,0.6755,Mature,0.5333,Follicular Lymphoma,0.5160,Blastic Phase,0.5146,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.5014
FOLLICULAR LYMPHOMA,Follicular Lymphoma,1,2,Follicular Lymphoma,1.0000,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.8995,Follicular Helper T-Cell Lymphoma,0.7712,Follicular Dendritic Cell Sarcoma,0.7256,Thyroid Gland Follicular Carcinoma,0.6880
FOLLICULAR THYROID CANCER,Thyroid Gland Follicular Carcinoma,1,2,Thyroid Gland Follicular Carcinoma,0.9653,Thyroid Gland Papillary and Follicular Carcinoma,0.8126,Thyroid Gland Follicular Carcinoma<;>Thyroid Gland Oncocytic Carcinoma,0.8091,Follicular Variant Thyroid Gland Papillary Carcinoma,0.7889,Thyroid Gland Follicular Carcinoma<;>Metastasis,0.7654
FOLLICULAR THYROID CARCINOMA,Thyroid Gland Follicular Carcinoma,1,2,Thyroid Gland Follicular Carcinoma,0.9891,Thyroid Gland Follicular Carcinoma<;>Thyroid Gland Oncocytic Carcinoma,0.8355,Thyroid Gland Papillary and Follicular Carcinoma,0.8254,Follicular Variant Thyroid Gland Papillary Carcinoma,0.8012,Thyroid Gland Follicular Carcinoma<;>Metastasis,0.7616
"FOLLICULAR, HURTHLE",Thyroid Gland Follicular Carcinoma<;>Thyroid Gland Oncocytic Carcinoma,99,2,Follicle,0.6622,Follicular Lymphoma,0.5194,Hairy Cell,0.5165,Cribriform,0.5029,Thyroid Gland Oncocytic Adenoma,0.4830
"FOLLICULAR, PAPILLARY",Thyroid Gland Papillary and Follicular Carcinoma,99,2,Papillary,0.7692,Non-Papillary Pattern,0.6341,Follicular Variant Thyroid Gland Papillary Carcinoma,0.6139,Papillary Carcinoma,0.6052,Follicle,0.5944
FOLLICULAR_CARCINOMA,Thyroid Gland Follicular Carcinoma,1,2,Thyroid Gland Follicular Carcinoma,0.8836,Follicular Lymphoma,0.8377,Thyroid Gland Follicular Carcinoma<;>Thyroid Gland Oncocytic Carcinoma,0.7401,Thyroid Gland Papillary and Follicular Carcinoma,0.7361,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.7113
FOURTH RECURRENCE,Recurrence,4,2,Regional<;>Recurrence,0.7423,Recurrent,0.7375,Metastatic Lesion<;>Recurrent,0.7374,Recurrence,0.7371,Relapse,0.6854
FUSION+ RMS,Fusion-Positive Rhabdomyosarcoma,1,2,Fusion-Positive Rhabdomyosarcoma,0.8846,Fusion-Negative Rhabdomyosarcoma,0.7909,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.6280,Supratentorial Ependymoma YAP1 Fusion-Positive,0.6134,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.6113
FUSION- RMS,Fusion-Negative Rhabdomyosarcoma,2,2,Fusion-Positive Rhabdomyosarcoma,0.8856,Fusion-Negative Rhabdomyosarcoma,0.8089,Rhabdomyosarcoma,0.6460,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.6361,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.6189
GALLBLADDER ADENOCARCINOMA,Gallbladder Adenocarcinoma,1,2,Gallbladder Adenocarcinoma,1.0000,Gallbladder Carcinoma,0.9268,Gallbladder Squamous Cell Carcinoma,0.8060,Gallbladder Adenosquamous Carcinoma,0.8012,Gallbladder Large Cell Neuroendocrine Carcinoma,0.7137
"GALLBLADDER ADENOCARCINOMA, NOS",Gallbladder Adenocarcinoma,1,2,Gallbladder Adenocarcinoma,0.9931,Gallbladder Carcinoma,0.9304,Gallbladder Squamous Cell Carcinoma,0.8088,Gallbladder Adenosquamous Carcinoma,0.7993,Gallbladder Large Cell Neuroendocrine Carcinoma,0.6982
GALLBLADDER ADENOSQUAMOUS CARCINOMA,Gallbladder Adenosquamous Carcinoma,1,2,Gallbladder Adenosquamous Carcinoma,1.0000,Gallbladder Squamous Cell Carcinoma,0.9010,Gallbladder Adenocarcinoma,0.8012,Gallbladder Small Cell Neuroendocrine Carcinoma,0.7601,Gallbladder Large Cell Neuroendocrine Carcinoma,0.7567
GALLBLADDER CANCER,Gallbladder Carcinoma,1,2,Gallbladder Carcinoma,0.9657,Gallbladder Adenocarcinoma,0.8773,Gallbladder Squamous Cell Carcinoma,0.7534,Gallbladder Adenosquamous Carcinoma,0.6941,Gallbladder Large Cell Neuroendocrine Carcinoma,0.6712
GALLBLADDER CARCINOMA,Gallbladder Carcinoma,1,2,Gallbladder Carcinoma,1.0000,Gallbladder Adenocarcinoma,0.9268,Gallbladder Squamous Cell Carcinoma,0.8114,Gallbladder Adenosquamous Carcinoma,0.7460,Gallbladder Large Cell Neuroendocrine Carcinoma,0.7244
GALLBLADDER CARCINOMA OTHER,Gallbladder Carcinoma,1,2,Gallbladder Carcinoma,0.7746,Gallbladder Adenocarcinoma,0.6941,Gallbladder Neuroendocrine Tumor,0.6315,Gallbladder Large Cell Neuroendocrine Carcinoma,0.6170,Gallbladder Small Cell Neuroendocrine Carcinoma,0.5913
GALLBLADDER NEUROENDOCRINE TUMOR,Gallbladder Neuroendocrine Tumor,1,2,Gallbladder Neuroendocrine Tumor,1.0000,Gallbladder Large Cell Neuroendocrine Carcinoma,0.8574,Gallbladder Small Cell Neuroendocrine Carcinoma,0.8408,Gastric Neuroendocrine Tumor,0.6979,Appendix Neuroendocrine Tumor,0.6738
GALLBLADDER_ADENOCARCINOMA,Gallbladder Adenocarcinoma,1,2,Gallbladder Adenocarcinoma,0.9749,Gallbladder Carcinoma,0.9054,Gallbladder Adenosquamous Carcinoma,0.8082,Gallbladder Squamous Cell Carcinoma,0.7938,Gallbladder Large Cell Neuroendocrine Carcinoma,0.7186
GANGLIOGLIOMA,Ganglioglioma,1,2,Ganglioglioma,1.0000,Ganglioneuroma,0.8117,Ganglioneuroblastoma,0.7600,Anaplastic Ganglioglioma,0.7578,Glioneuronal Tumor,0.7091
GANGLIONEUROBLASTOMA,Ganglioneuroblastoma,1,2,Ganglioneuroblastoma,1.0000,"Ganglioneuroblastoma, Nodular",0.9165,"Ganglioneuroblastoma, Intermixed",0.8862,Ganglioneuroma,0.8823,Maturing Ganglioneuroma<;>Ganglioneuroblastoma<;>Well Differentiated,0.8526
"GANGLIONEUROBLASTOMA, INTERMIXED","Ganglioneuroblastoma, Intermixed",1,2,"Ganglioneuroblastoma, Intermixed",1.0000,Ganglioneuroblastoma,0.8862,"Ganglioneuroblastoma, Nodular",0.8607,Maturing Ganglioneuroma<;>Ganglioneuroblastoma<;>Well Differentiated,0.8313,Ganglioneuroma,0.7692
"GANGLIONEUROBLASTOMA, NODULAR","Ganglioneuroblastoma, Nodular",1,2,"Ganglioneuroblastoma, Nodular",1.0000,Ganglioneuroblastoma,0.9165,"Ganglioneuroblastoma, Intermixed",0.8607,Maturing Ganglioneuroma<;>Ganglioneuroblastoma<;>Well Differentiated,0.8195,Ganglioneuroma,0.8093
GANGLIONEUROMA,Ganglioneuroma,1,2,Ganglioneuroma,1.0000,Ganglioneuroblastoma,0.8823,Ganglioglioma,0.8117,"Ganglioneuroblastoma, Nodular",0.8093,Maturing Ganglioneuroma<;>Ganglioneuroblastoma<;>Well Differentiated,0.7697
"GANGLIONEUROMA, MATURING SUBTYPE OR GANGLIONEUROBLASTOMA, WELL DIFFERENTIATED",Maturing Ganglioneuroma<;>Ganglioneuroblastoma<;>Well Differentiated,1,2,Maturing Ganglioneuroma<;>Ganglioneuroblastoma<;>Well Differentiated,0.9694,Ganglioneuroblastoma,0.8641,"Ganglioneuroblastoma, Intermixed",0.8433,"Ganglioneuroblastoma, Nodular",0.8197,Ganglioneuroma,0.8137
GASTRIC,Gastric,1,2,Gastric,1.0000,Stomach,0.9274,Gastric Carcinoma,0.6993,Gastroesophageal Cancer,0.6149,Gastric Adenocarcinoma,0.5881
GASTRIC ADENOCARCINOMA,Gastric Adenocarcinoma,1,2,Gastric Adenocarcinoma,1.0000,Gastric Carcinoma,0.8911,Gastric Diffuse Adenocarcinoma,0.8383,Gastric Tubular Adenocarcinoma,0.8213,Gastric Intestinal-Type Adenocarcinoma,0.7989
GASTRIC CANCER,Gastric Carcinoma,1,2,Gastric Carcinoma,0.9639,Gastric Adenocarcinoma,0.8341,Gastroesophageal Cancer,0.7789,Gastric,0.7572,Gastric Undifferentiated Carcinoma,0.7312
GASTRIC CARCINOMA OTHER,Gastric Carcinoma,1,2,Gastric Carcinoma,0.7321,Gastric Adenocarcinoma,0.6384,Gastroesophageal Cancer,0.6320,Gastric Undifferentiated Carcinoma,0.6300,Gastroesophageal Cancer<;>Primary Neoplasm,0.5796
GASTRIC NEUROENDOCRINE TUMOR,Gastric Neuroendocrine Tumor,1,2,Gastric Neuroendocrine Tumor,1.0000,Digestive System Neuroendocrine Tumor,0.8079,Gastric Small Cell Neuroendocrine Carcinoma,0.7601,Neuroendocrine Tumor,0.7589,Neuroendocrine Neoplasm,0.7344
GASTRIC TYPE MUCINOUS CARCINOMA,Mucinous gastric carcinoma,1,2,Mucinous gastric carcinoma,0.9826,Gastric Mucinous Adenocarcinoma,0.9647,Mucinous Adenocarcinoma,0.8116,Gastric Poorly Cohesive Adenocarcinoma,0.7675,Gastric Undifferentiated Carcinoma,0.7454
GASTRIC_ADENOCARCINOMA,Gastric Adenocarcinoma,1,2,Gastric Adenocarcinoma,0.9641,Gastric Carcinoma,0.8606,Gastric Diffuse Adenocarcinoma,0.8445,Gastric Tubular Adenocarcinoma,0.8066,Gastric Undifferentiated Carcinoma,0.8014
GASTRIC_CANCER,Gastric Carcinoma,1,2,Gastric Carcinoma,0.8950,Gastroesophageal Cancer,0.7712,Gastric Adenocarcinoma,0.7693,Gastric,0.7564,Stomach,0.7186
GASTRIC_SMALL_CELL,Gastric Small Cell Neuroendocrine Carcinoma,1,2,Gastric Small Cell Neuroendocrine Carcinoma,0.8111,Small Cell,0.7801,Gastric Undifferentiated Carcinoma,0.7630,"Malignant Tumor, Small Cell Type",0.7235,Gastric Carcinoma<;>Poorly Differentiated,0.7206
GASTROINTESTINAL NEUROENDOCRINE,Digestive System Neuroendocrine Tumor,1,2,Digestive System Neuroendocrine Tumor,0.8186,Gastric Neuroendocrine Tumor,0.7767,Neuroendocrine Neoplasm,0.7302,Neuroendocrine Tumor,0.7195,Pancreatic Neuroendocrine Tumor,0.6772
GASTROINTESTINAL NEUROENDOCRINE TUMOR,Digestive System Neuroendocrine Tumor,1,2,Digestive System Neuroendocrine Tumor,0.9460,Gastric Neuroendocrine Tumor,0.8656,Colorectal Neuroendocrine Tumor,0.8480,Neuroendocrine Tumor,0.8269,Neuroendocrine Neoplasm,0.8048
GASTROINTESTINAL NEUROENDOCRINE TUMORS,Digestive System Neuroendocrine Tumor,1,2,Digestive System Neuroendocrine Tumor,0.9384,Gastric Neuroendocrine Tumor,0.8570,Colorectal Neuroendocrine Tumor,0.8295,Neuroendocrine Tumor,0.8186,Neuroendocrine Neoplasm,0.8006
GASTROINTESTINAL STROMAL,Gastrointestinal Stromal Tumor,1,2,Gastrointestinal Stromal Tumor,0.9137,Digestive System Neuroendocrine Tumor,0.6643,Sex Cord-Stromal Tumor,0.6164,Digestive System Mixed Adenoneuroendocrine Carcinoma,0.6095,Colorectal Neuroendocrine Tumor,0.5955
GASTROINTESTINAL STROMAL TUMOR,Gastrointestinal Stromal Tumor,1,2,Gastrointestinal Stromal Tumor,1.0000,Digestive System Neuroendocrine Tumor,0.7295,Colorectal Neuroendocrine Tumor,0.6555,Sex Cord-Stromal Tumor,0.6499,Gastric Neuroendocrine Tumor,0.6148
GB,Glioblastoma,99,2,Gastric,0.5846,Basal,0.5774,Stomach,0.5705,Breast,0.5471,Bilateral,0.5432
GBC,Gallbladder Carcinoma,1,2,Gallbladder Carcinoma,0.5868,Gallbladder Neuroendocrine Tumor,0.5369,Gallbladder Large Cell Neuroendocrine Carcinoma,0.5363,Gallbladder Adenocarcinoma,0.5136,Gallbladder Squamous Cell Carcinoma,0.5069
GBM,Glioblastoma,1,2,Glioblastoma,0.7984,Malignant Glioma,0.7484,Glioblastoma<;>Undifferentiated,0.7330,Glioma,0.7268,Glioblastoma<;>De Novo,0.7139
GBM_IDHMUT-NON-CODEL,Glioblastoma<;>IDH Gene Family Mutation,99,2,"Glioblastoma, IDH-Wildtype",0.7970,Glioblastoma<;>IDH Family Wildtype,0.7845,Low Grade Glioma<;>IDH Family Wildtype,0.7454,Gliosarcoma<;>IDH Family Wildtype,0.7452,"Glioblastoma, IDH-Wildtype<;>Glioblastoma with Primitive Neuronal Component",0.7179
GBM_IDHWT,Glioblastoma<;>IDH Family Wildtype,2,2,"Glioblastoma, IDH-Wildtype",0.8714,Glioblastoma<;>IDH Family Wildtype,0.8356,Gliosarcoma<;>IDH Family Wildtype,0.7906,Low Grade Glioma<;>IDH Family Wildtype,0.7796,"Anaplastic Astrocytoma, IDH-Wildtype",0.7583
GCB,germinal center B cell,2,2,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.5505,germinal center B cell,0.5435,Basal,0.4695,Basaloid Cell,0.4644,Glioblastoma,0.4551
GERM CELL,Germ Cell,1,2,Germ Cell,1.0000,Germ Cell Tumor,0.6292,Fibroblast<;>Lymphocyte,0.5972,Cell Line,0.5920,Transitional Cells,0.5907
GERM CELL TUMOR,Germ Cell Tumor,1,2,Germ Cell Tumor,1.0000,Nongerminomatous Germ Cell Tumor,0.8276,Germinoma,0.7906,Extragonadal Germ Cell Tumor,0.7787,Testicular Germ Cell Tumor,0.7718
GERM CELL TUMOR (EMBRYONAL CARCINOMA),Embryonal Carcinoma,3,2,Germ Cell Tumor<;>Embryonal Carcinoma,0.9580,Germ Cell Tumor,0.8485,Embryonal Carcinoma,0.8478,Embryonal Carcinoma<;>Nonseminomatous,0.7852,Embryonal Neoplasm,0.7850
GERM CELL TUMOR EMBRYONAL CARCINOMA,Germ Cell Tumor<;>Embryonal Carcinoma,1,2,Germ Cell Tumor<;>Embryonal Carcinoma,0.9822,Embryonal Carcinoma,0.8931,Embryonal Carcinoma<;>Nonseminomatous,0.8265,Embryonal Rhabdomyosarcoma,0.7593,Embryonal Carcinoma<;>Seminoma,0.7393
GERM CELL TUMOR WITH SOMATIC-TYPE MALIGNANCY,Mediastinal Germ Cell Tumor with Somatic-Type Malignancy,3,2,Germ Cell Tumor,0.7870,Mixed Germ Cell Tumor,0.7478,Mediastinal Germ Cell Tumor with Somatic-Type Malignancy,0.7371,Nongerminomatous Germ Cell Tumor,0.7087,Nongerminomatous Germ Cell Tumor<;>Mixed Germ Cell Tumor,0.7065
"GERM CELL TUMOR, BRAIN",Childhood Brain Germ Cell Tumor,1,2,Childhood Brain Germ Cell Tumor,0.8741,Central Nervous System Germinoma,0.8005,Extragonadal Germ Cell Tumor,0.7331,Pineal Region Germ Cell Tumor,0.7300,Germ Cell Tumor,0.7003
GERMINAL CENTER B-CELL TYPE,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,2,2,germinal center B cell,0.9674,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.7751,Lymphoid,0.6083,B-Lymphocyte,0.6065,Mature B-Cell Neoplasm,0.5869
GERMINAL CENTER B-CELL-LIKE GCB DLBCL,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,1,2,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.9034,germinal center B cell,0.7287,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.7130,High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0.7124,Diffuse Large B-Cell Lymphoma,0.7020
GERMINOMA,Germinoma,1,2,Germinoma,1.0000,Germ Cell Tumor,0.7906,Central Nervous System Germinoma,0.7749,Nongerminomatous Germ Cell Tumor,0.7043,Mixed Germ Cell Tumor,0.6908
GESTATIONAL TROPHOBLASTIC DISEASE,Gestational Trophoblastic Disorder,1,2,Gestational Trophoblastic Disorder,0.9790,Epithelioid Trophoblastic Tumor,0.7017,Choriocarcinoma,0.6263,Yolk Sac Tumor,0.5803,Nongerminomatous Germ Cell Tumor<;>Yolk Sac Tumor,0.5237
GIANT CELL 'MFH' / UNDIFFERENTIATED PLEOMORPHIC SARCOMA WITH GIANT CELLS,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,1,2,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,0.7717,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,0.7287,Myxoinflammatory Fibroblastic Sarcoma,0.6924,Undifferentiated Pleomorphic Sarcoma,0.6838,Giant Cell Tumor,0.6829
GIANT CELL TUMOR OF BONE,Giant Cell Tumor of Bone,1,2,Giant Cell Tumor of Bone,1.0000,Giant Cell Tumor,0.8952,Ossifying Fibromyxoid Tumor,0.7749,Giant Cell Carcinoma,0.6858,Giant Cell,0.6791
GIANT CELL TUMOUR,Giant Cell Tumor,1,2,Giant Cell Tumor,0.9951,Giant Cell Tumor of Bone,0.9071,Giant Cell,0.7996,Giant Cell Carcinoma,0.7765,Granular Cell Tumor,0.7103
GIANT_CELL,Giant Cell,1,2,Giant Cell,0.9706,Giant Cell Tumor,0.7530,Giant Cell Tumor of Bone,0.6248,Neoplastic Fibroblast-Like Cell,0.6183,Giant Cell Carcinoma,0.6129
GIANT_CELL_TUMOUR,Giant Cell Tumor,1,2,Giant Cell Tumor,0.9713,Giant Cell Tumor of Bone,0.8656,Giant Cell,0.8291,Giant Cell Carcinoma,0.7927,Granular Cell Tumor,0.7140
GINET,Digestive System Neuroendocrine Tumor,1,2,Digestive System Neuroendocrine Tumor,0.6997,Gastrointestinal Stromal Tumor,0.6959,Gastric Neuroendocrine Tumor,0.6318,Digestive System Mixed Adenoneuroendocrine Carcinoma,0.6258,Colorectal Neuroendocrine Tumor,0.6243
GINGIVAL,Gingiva,1,2,Gingiva,0.8549,Gingival Carcinoma,0.5957,Alveolar,0.5768,Mucosa,0.5576,Gastric,0.5192
GIST,Gastrointestinal Stromal Tumor,1,2,Gastrointestinal Stromal Tumor,0.8264,Digestive System Neuroendocrine Tumor,0.6486,Gastric Neuroendocrine Tumor,0.6273,Granular Cell Tumor,0.6266,Carcinosarcoma,0.6211
GLIAL CELL NEOPLASM,Neoplastic Glial Cell,1,2,Neoplastic Glial Cell,0.9202,Glioma,0.8035,Glioneuronal Tumor,0.7862,Malignant Glioma,0.7077,Gliosarcoma,0.7063
GLIOBLASTOMA,Glioblastoma,1,2,Glioblastoma,1.0000,Glioblastoma<;>Undifferentiated,0.8853,Glioblastoma<;>De Novo,0.8679,Malignant Glioma,0.8490,Gliosarcoma,0.7912
GLIOBLASTOMA MULTIFORME,Glioblastoma,1,2,Glioblastoma,0.8801,Glioblastoma<;>De Novo,0.8170,Glioblastoma<;>Undifferentiated,0.8137,Malignant Glioma<;>Anaplastic Astrocytoma,0.7503,Malignant Glioma,0.7496
GLIOBLASTOMA MULTIFORME GBM,Glioblastoma,1,2,Glioblastoma,0.8498,Glioblastoma<;>De Novo,0.7926,Glioblastoma<;>Undifferentiated,0.7862,Malignant Glioma,0.7487,High Grade Astrocytic Tumor,0.7386
"GLIOBLASTOMA WITH PRIMITIVE NEURONAL COMPONENT, IDH-WILDTYPE","Glioblastoma, IDH-Wildtype<;>Glioblastoma with Primitive Neuronal Component",1,2,"Glioblastoma, IDH-Wildtype<;>Glioblastoma with Primitive Neuronal Component",0.9568,"Glioblastoma, IDH-Wildtype",0.9102,Glioblastoma<;>IDH Family Wildtype,0.8354,"Anaplastic Astrocytoma, IDH-Wildtype",0.8032,Gliosarcoma<;>IDH Family Wildtype,0.7857
"GLIOBLASTOMA, IDH-MUTANT","Astrocytoma, IDH-Mutant, Grade 4",4,2,"Glioblastoma, IDH-Wildtype",0.9217,"Astrocytoma, IDH-Mutant, Grade 3",0.8554,Glioblastoma<;>IDH Family Wildtype,0.8524,"Astrocytoma, IDH-Mutant, Grade 4",0.8415,"Astrocytoma, IDH-Mutant, Grade 2",0.8272
"GLIOBLASTOMA, IDH-WILDTPYE","Glioblastoma, IDH-Wildtype",1,2,"Glioblastoma, IDH-Wildtype",0.9345,Glioblastoma<;>IDH Family Wildtype,0.8578,"Glioblastoma, IDH-Wildtype<;>Glioblastoma with Primitive Neuronal Component",0.8482,"Anaplastic Astrocytoma, IDH-Wildtype",0.8136,"Astrocytoma, IDH-Mutant, Grade 3",0.8100
"GLIOBLASTOMA, IDH-WILDTYPE","Glioblastoma, IDH-Wildtype",1,2,"Glioblastoma, IDH-Wildtype",1.0000,Glioblastoma<;>IDH Family Wildtype,0.9513,Gliosarcoma<;>IDH Family Wildtype,0.8860,"Anaplastic Astrocytoma, IDH-Wildtype",0.8640,Low Grade Glioma<;>IDH Family Wildtype,0.8491
"GLIOBLASTOMA, UD",Glioblastoma<;>Undifferentiated,3,2,Glioblastoma,0.9182,Glioblastoma<;>De Novo,0.8507,Glioblastoma<;>Undifferentiated,0.8481,Malignant Glioma,0.7785,High Grade Astrocytic Tumor,0.7173
"GLIOBLASTOMA,UD",Glioblastoma<;>Undifferentiated,3,2,Glioblastoma,0.9182,Glioblastoma<;>De Novo,0.8507,Glioblastoma<;>Undifferentiated,0.8481,Malignant Glioma,0.7785,High Grade Astrocytic Tumor,0.7173
GLIOBLASTOMA_MULTIFORME,Glioblastoma,1,2,Glioblastoma,0.8853,Glioblastoma<;>De Novo,0.8348,Glioblastoma<;>Undifferentiated,0.8113,Malignant Glioma,0.7687,Malignant Glioma<;>Anaplastic Astrocytoma,0.7349
GLIOMA,Glioma,1,2,Glioma,1.0000,Malignant Glioma,0.9094,Diffuse Glioma,0.8447,Low Grade Glioma,0.8021,Neoplastic Glial Cell,0.7973
GLIONEURONAL TUMOR,Glioneuronal Tumor,1,2,Glioneuronal Tumor,1.0000,Gliosarcoma,0.7716,Diffuse Leptomeningeal Glioneuronal Tumor,0.7663,Neoplastic Glial Cell,0.7643,Central Neurocytoma,0.7579
GLIOSARCOMA,Gliosarcoma,1,2,Gliosarcoma,1.0000,Glioblastoma<;>Undifferentiated,0.7919,Glioblastoma,0.7912,Malignant Glioma,0.7839,Glioma,0.7764
"GLIOSARCOMA, IDH-WILDTYPE",Gliosarcoma<;>IDH Family Wildtype,1,2,Gliosarcoma<;>IDH Family Wildtype,0.9338,"Glioblastoma, IDH-Wildtype",0.8986,Glioblastoma<;>IDH Family Wildtype,0.8410,Gliosarcoma,0.8339,"Anaplastic Astrocytoma, IDH-Wildtype",0.8163
GLOMANGIOSARCOMA,Malignant Glomus Tumor,1,2,Malignant Glomus Tumor,0.7708,Sarcomatoid Carcinoma,0.7502,undifferentiated sarcoma,0.7446,Gliosarcoma,0.7349,Carcinosarcoma,0.7294
GOBLET CELL ADENOCARCINOMA OF THE APPENDIX,Appendix Goblet Cell Adenocarcinoma,1,2,Appendix Goblet Cell Adenocarcinoma,0.9810,Appendix Mucinous Adenocarcinoma,0.7966,Appendix Adenocarcinoma,0.7215,Colon Mucinous Adenocarcinoma,0.7211,Gastric Mucinous Adenocarcinoma,0.6826
GOBLET CELL CARCINOID OF THE APPENDIX,Appendix Goblet Cell Adenocarcinoma,1,2,Appendix Goblet Cell Adenocarcinoma,0.8648,Appendix Neuroendocrine Tumor,0.7512,Appendix Mucinous Adenocarcinoma,0.6978,Appendix Signet Ring Cell Carcinoma,0.6477,Colon Mucinous Adenocarcinoma,0.6143
GRANULAR CELL TUMOR,Granular Cell Tumor,1,2,Granular Cell Tumor,1.0000,Granular Cell Tumor<;>Atypical,0.8740,Giant Cell Tumor,0.7223,Ganglioneuroblastoma,0.6891,Ganglioneuroma,0.6825
GRANULOSA CELL TUMOR,Granulosa Cell Tumor,1,2,Granulosa Cell Tumor,1.0000,Ovarian Granulosa Cell Tumor,0.9381,Juvenile Granulosa Cell Tumor,0.8443,Ovarian Germ Cell Tumor,0.7419,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0.7045
GRANULOSA_CELL_TUMOR,Granulosa Cell Tumor,1,2,Granulosa Cell Tumor,0.9730,Ovarian Granulosa Cell Tumor,0.9010,Juvenile Granulosa Cell Tumor,0.8171,Ovarian Germ Cell Tumor,0.7259,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0.7012
GRANULOSA_CELL_TUMOUR,Granulosa Cell Tumor,1,2,Granulosa Cell Tumor,0.9692,Ovarian Granulosa Cell Tumor,0.8998,Juvenile Granulosa Cell Tumor,0.8081,Ovarian Germ Cell Tumor,0.7240,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0.6953
GS,Genomic Stability,99,2,Gastric,0.5708,Stomach,0.5460,Sarcoma,0.5363,Gliosarcoma,0.5319,Rhabdomyosarcoma,0.5056
HAEMATOPOIETIC NEOPLASM,Hematopoietic and Lymphoid Cell Neoplasm,1,2,Hematopoietic and Lymphoid Cell Neoplasm,0.8227,Myeloid Neoplasm,0.7763,Leukemia,0.6426,Myeloid Sarcoma,0.5593,Neoplasm,0.5503
HAIRY CELL,Hairy Cell,1,2,Hairy Cell,1.0000,Basaloid Cell,0.7149,Columnar Cell,0.6792,Clear Cell,0.6552,Hairy Cell Leukemia,0.6318
HAIRY CELL LEUKEMIA,Hairy Cell Leukemia,1,2,Hairy Cell Leukemia,1.0000,Erythroleukemia,0.6517,Hairy Cell,0.6318,Follicular Helper T-Cell Lymphoma,0.6222,T-Cell Large Granular Lymphocyte Leukemia,0.6130
HAIRY_CELL_LEUKEMIA,Hairy Cell Leukemia,1,2,Hairy Cell Leukemia,0.9760,Erythroleukemia,0.6516,Hairy Cell,0.6300,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,0.6136,Follicular Helper T-Cell Lymphoma,0.6107
HBS_ANTIGEN_CARRIER,Hepatitis B Virus Surface Antigen Positive,1,2,Hepatitis B Virus Surface Antigen Positive,0.6719,Hepatitis B Virus,0.6164,Hepatitis C Virus,0.5123,Hereditary Spherocytosis,0.4712,"Non-B, Non-C Hepatitis",0.4553
HBV,Hepatitis B Virus,1,2,Hepatitis B Virus,0.8938,Hepatitis C Virus,0.7337,"Non-B, Non-C Hepatitis",0.6501,Hepatitis B Virus Surface Antigen Positive,0.5715,Liver,0.5345
HCA/HCC,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,2,2,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.7811,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.7352,Hepatocellular Carcinoma,0.7213,Hepatocellular Adenoma,0.6639,Pleomorphic Hepatocellular Carcinoma,0.6500
HCC,Hepatocellular Carcinoma,1,2,Hepatocellular Carcinoma,0.8219,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.7672,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.7561,Pleomorphic Hepatocellular Carcinoma,0.7086,Hepatocellular Adenoma,0.6815
HCC ON HCA,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,1,2,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.6439,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.6254,Hepatocellular Adenoma,0.5819,Hepatocellular Carcinoma,0.5721,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.5482
HCV,Hepatitis C Virus,1,2,Hepatitis C Virus,0.8949,Hepatitis B Virus,0.7311,"Non-B, Non-C Hepatitis",0.6950,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.5144,Hepatocellular Carcinoma,0.5090
HEAD & NECK SQUAMOUS CELL CARCINOMA,Head and Neck Squamous Cell Carcinoma,1,2,Head and Neck Squamous Cell Carcinoma,0.9852,Head and Neck Carcinoma,0.8711,Squamous Cell Carcinoma,0.7938,Malignant Head and Neck Neoplasm,0.7448,Cervical Squamous Cell Carcinoma,0.7436
HEAD & NECK SQUAMOUS CELL CARCINOMA BASALOID TYPE,Head and Neck Basaloid Carcinoma,1,2,Head and Neck Basaloid Carcinoma,0.9343,Squamous Cell Carcinoma<;>Basaloid Cell,0.8903,Basal Cell Carcinoma,0.7692,Head and Neck Squamous Cell Carcinoma,0.6712,Salivary Gland Basal Cell Adenocarcinoma,0.6705
"HEAD & NECK SQUAMOUS CELL CARCINOMA, SPINDLE CELL VARIANT",Head and Neck Squamous Cell Carcinoma<;>Spindle Cell Squamous Cell Carcinoma,1,2,Head and Neck Squamous Cell Carcinoma<;>Spindle Cell Squamous Cell Carcinoma,0.9521,Head and Neck Squamous Cell Carcinoma,0.7136,Spindle Cell Sarcoma,0.7093,Spindle Cell Neoplasm,0.6812,Head and Neck Basaloid Carcinoma,0.6517
HEAD AND NECK,Head and Neck,1,2,Head and Neck,1.0000,Malignant Head and Neck Neoplasm,0.7829,Head and Neck Carcinoma,0.7296,Central Nervous System<;>Brain,0.6639,Brain,0.6481
HEAD AND NECK CANCER,Malignant Head and Neck Neoplasm,2,2,Head and Neck Carcinoma,0.9696,Malignant Head and Neck Neoplasm,0.9277,Head and Neck,0.8072,Head and Neck Squamous Cell Carcinoma,0.8008,Head and Neck Neuroendocrine Carcinoma,0.6723
"HEAD AND NECK CANCER, NOS",Malignant Head and Neck Neoplasm,2,2,Head and Neck Carcinoma,0.9654,Malignant Head and Neck Neoplasm,0.9205,Head and Neck Squamous Cell Carcinoma,0.8082,Head and Neck,0.7976,Head and Neck Neuroendocrine Carcinoma,0.6658
HEAD AND NECK CARCINOMA,Head and Neck Carcinoma,1,2,Head and Neck Carcinoma,1.0000,Malignant Head and Neck Neoplasm,0.8961,Head and Neck Squamous Cell Carcinoma,0.8653,Head and Neck,0.7296,Head and Neck Neuroendocrine Carcinoma,0.7111
HEAD AND NECK CARCINOMA OTHER,Malignant Head and Neck Neoplasm,2,2,Head and Neck Carcinoma,0.7574,Malignant Head and Neck Neoplasm,0.7140,Head and Neck Squamous Cell Carcinoma,0.6380,Head and Neck Neuroendocrine Carcinoma,0.6261,Head and Neck,0.6135
"HEAD AND NECK CARCINOMA, OTHER",Malignant Head and Neck Neoplasm,2,2,Head and Neck Carcinoma,0.7703,Malignant Head and Neck Neoplasm,0.7224,Head and Neck Squamous Cell Carcinoma,0.6449,Head and Neck Neuroendocrine Carcinoma,0.6265,Head and Neck,0.6181
HEAD AND NECK MUCOSAL MELANOMA,Mucosal Melanoma of the Head and Neck,1,2,Mucosal Melanoma of the Head and Neck,0.9720,Mucosal Melanoma,0.8101,Lentigo Maligna Melanoma,0.7137,Head and Neck Squamous Cell Carcinoma,0.6786,Cutaneous Melanoma,0.6691
HEAD AND NECK NEUROENDOCRINE CARCINOMA,Head and Neck Neuroendocrine Carcinoma,1,2,Head and Neck Neuroendocrine Carcinoma,1.0000,Neuroendocrine Carcinoma,0.8150,Large Cell Neuroendocrine Carcinoma,0.7562,Cervical Neuroendocrine Tumor,0.7494,Neuroendocrine Carcinoma<;>Poorly Differentiated,0.7465
HEAD AND NECK SQUAMOUS,Head and Neck Squamous Cell Carcinoma,1,2,Head and Neck Squamous Cell Carcinoma,0.8746,Squamous Cell Carcinoma,0.8092,Cervical Squamous Neoplasm,0.7906,Head and Neck Carcinoma,0.7606,Skin Squamous Cell Carcinoma,0.7452
HEAD AND NECK SQUAMOUS CELL CARCINOMA,Head and Neck Squamous Cell Carcinoma,1,2,Head and Neck Squamous Cell Carcinoma,1.0000,Head and Neck Carcinoma,0.8653,Squamous Cell Carcinoma,0.8033,Hypopharyngeal Squamous Cell Carcinoma,0.7654,Cervical Squamous Cell Carcinoma,0.7568
HEAD AND NECK SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY,Head and Neck Squamous Cell Carcinoma,1,2,Head and Neck Squamous Cell Carcinoma,0.6687,Melanoma of Unknown Primary,0.6635,Head and Neck Squamous Cell Carcinoma<;>Spindle Cell Squamous Cell Carcinoma,0.5897,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Positive,0.5868,Head and Neck Basaloid Carcinoma,0.5826
HEAD AND NECK SQUAMOUS CELL CARCINOMA,Head and Neck Squamous Cell Carcinoma,1,2,Head and Neck Squamous Cell Carcinoma,0.8258,Head and Neck Carcinoma,0.7473,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Positive,0.6929,Head and Neck Squamous Cell Carcinoma<;>Spindle Cell Squamous Cell Carcinoma,0.6529,Malignant Head and Neck Neoplasm,0.6462
HEAD_NECK_CANCER,Head and Neck Carcinoma,1,2,Head and Neck Carcinoma,0.9166,Malignant Head and Neck Neoplasm,0.8944,Head and Neck,0.7906,Head and Neck Squamous Cell Carcinoma,0.7618,Head and Neck Neuroendocrine Carcinoma,0.6612
HEMANGIOBLASTOMA,Hemangioblastoma,1,2,Hemangioblastoma,1.0000,Hemangioma,0.8857,Angiosarcoma,0.7489,Pseudomyogenic Hemangioendothelioma,0.7251,Epithelioid Hemangioendothelioma,0.6798
HEMANGIOMA,Hemangioma,1,2,Hemangioma,1.0000,Hemangioblastoma,0.8857,Angiosarcoma,0.6586,Pseudomyogenic Hemangioendothelioma,0.6461,Myxoma,0.5975
HEMANGIOPERICYTOMA OF THE CENTRAL NERVOUS SYSTEM,Meningeal Solitary Fibrous Tumor,4,2,Central Neurocytoma,0.7236,Central Nervous System Solitary Fibrous Tumor,0.6815,Extraventricular Neurocytoma,0.6548,Meningeal Solitary Fibrous Tumor,0.5952,Angiocentric Glioma,0.5876
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,Hemophagocytic Lymphohistiocytosis,1,2,Hemophagocytic Lymphohistiocytosis,1.0000,Langerhans Cell Histiocytosis,0.6745,Histiocytosis,0.6290,True Histiocytic Lymphoma,0.5932,Hairy Cell Leukemia,0.5717
HEPATIC FLEXURE,Hepatic Flexure,1,2,Hepatic Flexure,1.0000,Splenic Flexure,0.8875,Ascending Colon,0.7125,Transverse Colon,0.6693,Descending Colon,0.6417
HEPATOBILIARY CANCER,Liver and Intrahepatic Bile Duct Carcinoma,1,2,Liver and Intrahepatic Bile Duct Carcinoma,0.8148,Pancreatobiliary Carcinoma,0.7313,Liver and Intrahepatic Bile Duct Neoplasm,0.7022,Hepatocellular Carcinoma,0.6838,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.6689
HEPATOBLASTOMA,Hepatoblastoma,1,2,Hepatoblastoma,1.0000,Hepatocellular Carcinoma,0.7511,Hepatocellular Adenoma,0.7501,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.7299,Pleomorphic Hepatocellular Carcinoma,0.6313
HEPATOCELLULAR ADENOMA,Hepatocellular Adenoma,1,2,Hepatocellular Adenoma,1.0000,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.9153,Hepatocellular Carcinoma,0.7688,Hepatoblastoma,0.7501,Pleomorphic Hepatocellular Carcinoma,0.6514
HEPATOCELLULAR CARCINOMA,Hepatocellular Carcinoma,1,2,Hepatocellular Carcinoma,1.0000,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.8945,Hepatocellular Adenoma,0.7688,Hepatoblastoma,0.7511,Pleomorphic Hepatocellular Carcinoma,0.7412
HEPATOCELLULAR CARCINOMA PLUS INTRAHEPATIC CHOLANGIOCARCINOMA,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,2,2,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.9362,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.8951,Intrahepatic Cholangiocarcinoma,0.8422,Liver and Intrahepatic Bile Duct Carcinoma,0.7896,Hilar Cholangiocarcinoma,0.7592
"HEPATOCELLULAR CARCINOMA, HBS-ANTIGEN CARRIER",Hepatitis B Virus Surface Antigen Positive,4,2,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.6231,Hepatitis C Virus,0.6052,Hepatocellular Carcinoma,0.5910,Hepatitis B Virus Surface Antigen Positive,0.5870,Hepatitis B Virus,0.5834
HEPATOCELLULAR_CANCER,Hepatocellular Carcinoma,1,2,Hepatocellular Carcinoma,0.9371,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.8429,Hepatocellular Adenoma,0.7600,Hepatoblastoma,0.7489,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.7222
HEPATOCELLULAR_CARCINOMA,Hepatocellular Carcinoma,1,2,Hepatocellular Carcinoma,0.9792,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.8880,Hepatocellular Adenoma,0.7754,Hepatoblastoma,0.7457,Pleomorphic Hepatocellular Carcinoma,0.7354
HEPATOCHOLANGIOCARCINOMA MIXED,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,1,2,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.7330,Pleomorphic Hepatocellular Carcinoma,0.7133,Mixed Carcinoma,0.6880,Mixed Cell Adenocarcinoma,0.6650,Breast Mixed Ductal and Lobular Carcinoma,0.6524
HEPTOCELLULAR CARCINOMA,Hepatocellular Carcinoma,3,2,Large Cell Carcinoma,0.7092,Mixed Carcinoma,0.7067,Hepatocellular Carcinoma,0.6929,Giant Cell Carcinoma,0.6880,Clear Cell Adenocarcinoma,0.6824
HER2,HER2-Positive Breast Carcinoma,1,2,HER2-Positive Breast Carcinoma,0.8534,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.8130,HER2/Neu Positive,0.7741,Estrogen Receptor Positive<;>HER2/Neu Positive<;>HER2-Positive Breast Carcinoma,0.7717,Estrogen Receptor Positive<;>HER2/Neu Positive,0.7501
HER2+,HER2/Neu Positive,1,2,HER2/Neu Positive,0.9367,Estrogen Receptor Positive<;>HER2/Neu Positive,0.9152,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.9151,HER2-Positive Breast Carcinoma,0.8902,Estrogen Receptor Positive<;>HER2/Neu Positive<;>HER2-Positive Breast Carcinoma,0.8490
HER2-ENRICHED,HER2-Positive Breast Carcinoma,1,2,HER2-Positive Breast Carcinoma,0.8684,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.8430,Estrogen Receptor Positive<;>HER2/Neu Positive<;>HER2-Positive Breast Carcinoma,0.8428,Estrogen Receptor Positive<;>HER2/Neu Positive,0.8368,HER2/Neu Positive,0.8175
HEREDITARY SPHEROCYTOSIS,Hereditary Spherocytosis,1,2,Hereditary Spherocytosis,1.0000,Systemic Mastocytosis,0.5817,Mastocytosis,0.5416,Langerhans Cell Histiocytosis,0.5408,Histiocytosis,0.5240
HGGNOS,Malignant Glioma,99,2,nan,0.4879,Genomic Stability,0.4753,Ovarian Dysgerminoma,0.4747,Ovarian Granulosa Cell Tumor,0.4681,Oncocytic Neoplasm,0.4680
HGS,Ovarian High Grade Serous Adenocarcinoma,4,2,Gastric,0.5123,Hodgkin Lymphoma,0.5015,Serous,0.4986,Ovarian High Grade Serous Adenocarcinoma,0.4967,Hereditary Spherocytosis,0.4893
HGSOC,Ovarian High Grade Serous Adenocarcinoma,1,2,Ovarian High Grade Serous Adenocarcinoma,0.5130,IDH1 Gene,0.5024,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.4910,Serous Adenocarcinoma<;>High Grade,0.4701,Ovarian Seromucinous Carcinoma,0.4611
"HIGH-GRADE B-CELL LYMPHOMA, NOS","High Grade B-Cell Lymphoma, Not Otherwise Specified",1,2,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.9738,B-Cell Non-Hodgkin Lymphoma,0.8441,High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0.8199,Diffuse Large B-Cell Lymphoma,0.8059,Mature B-Cell Non-Hodgkin Lymphoma,0.7772
"HIGH-GRADE B-CELL LYMPHOMA, WITH MYC AND BCL2 AND/OR BCL6 REARRANGEMENTS",High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,1,2,High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0.9944,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.8406,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.7390,Mature B-Cell Non-Hodgkin Lymphoma,0.6833,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.6808
HIGH-GRADE ENDOMETRIAL STROMAL SARCOMA,Endometrioid Stromal Sarcoma<;>High Grade,1,2,Endometrioid Stromal Sarcoma<;>High Grade,0.9288,Endometrioid Stromal Sarcoma,0.8896,Low Grade Endometrioid Stromal Sarcoma,0.8697,Endometrial Adenosquamous Carcinoma,0.7079,Uterine Corpus Undifferentiated Sarcoma,0.7005
"HIGH-GRADE GLIOMA, NOS",Malignant Glioma,1,2,Malignant Glioma,0.8798,Glioma,0.8547,Low Grade Glioma,0.8370,High Grade Astrocytic Tumor,0.8238,Glioblastoma,0.7934
HIGH-GRADE GLIOMA/ASTROCYTOMA,Malignant Glioma<;>Anaplastic Astrocytoma,99,2,High Grade Astrocytic Tumor,0.9015,Astrocytoma,0.8106,Diffuse Astrocytoma,0.7839,Low Grade Glioma<;>Low Grade Astrocytoma,0.7822,Malignant Glioma,0.7652
HIGH-GRADE NEUROENDOCRINE CARCINOMA OF THE COLON AND RECTUM,Colorectal Neuroendocrine Carcinoma,1,2,Colorectal Neuroendocrine Carcinoma,0.8361,Colorectal Neuroendocrine Tumor,0.7896,Rectal Neuroendocrine Tumor<;>Well Differentiated,0.7718,Hypermutated Colorectal Carcinoma,0.7038,Colon Medullary Carcinoma,0.6471
HIGH-GRADE NEUROENDOCRINE CARCINOMA OF THE OVARY,Ovarian Neuroendocrine Carcinoma<;>High Grade,1,2,Ovarian Neuroendocrine Carcinoma<;>High Grade,0.9373,Ovarian Carcinosarcoma,0.7517,ovary mixed epithelial carcinoma,0.7425,"Ovarian Small Cell Carcinoma, Hypercalcemic Type",0.7409,Endometrial Neuroendocrine Carcinoma,0.6903
HIGH-GRADE NEUROEPITHELIAL TUMOR,Neuroepithelial Neoplasm<;>High Grade,1,2,Neuroepithelial Neoplasm<;>High Grade,0.9374,Neuroepithelial Neoplasm,0.7990,Dysembryoplastic Neuroepithelial Tumor,0.7945,Primitive Neuroectodermal Tumor,0.7786,Glioneuronal Tumor,0.7685
HIGH-GRADE SEROUS FALLOPIAN TUBE CANCER,Fallopian Tube High Grade Serous Adenocarcinoma,1,2,Fallopian Tube High Grade Serous Adenocarcinoma,0.9235,Ovarian High Grade Serous Adenocarcinoma,0.7138,Serous Adenocarcinoma<;>High Grade,0.6626,Cystadenocarcinoma<;>High Grade<;>Serous,0.6465,Endometrioid Stromal Sarcoma<;>High Grade,0.6441
HIGH-GRADE SEROUS OVARIAN CANCER,Ovarian High Grade Serous Adenocarcinoma,1,2,Ovarian High Grade Serous Adenocarcinoma,0.9300,Serous Adenocarcinoma<;>High Grade,0.8653,Ovarian Serous Adenocarcinoma,0.8372,Ovarian Low Grade Serous Adenocarcinoma,0.8344,Cystadenocarcinoma<;>High Grade<;>Serous,0.8107
HIGH_GRADE_SEROUS,Ovarian High Grade Serous Adenocarcinoma,4,2,Serous Adenocarcinoma<;>High Grade,0.8685,Cystadenocarcinoma<;>High Grade<;>Serous,0.8153,Serous,0.7714,Ovarian High Grade Serous Adenocarcinoma,0.7684,Serous Adenocarcinoma,0.7607
HILAR/PERIHILAR,Proximal Bile Duct,99,2,Hilar Cholangiocarcinoma,0.5667,Lobular,0.5265,Local-Regional,0.4974,Pleomorphic Hepatocellular Carcinoma,0.4684,Localized,0.4681
HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS,Histiocytic and Dendritic Cell Neoplasm,1,2,Histiocytic and Dendritic Cell Neoplasm,0.9955,True Histiocytic Lymphoma,0.7765,Histiocytosis,0.7538,Langerhans Cell Histiocytosis,0.7499,Histiocytic Sarcoma,0.7286
HISTIOCYTIC DENDRITIC CELL SARCOMA,Histiocytic and Dendritic Cell Neoplasm,3,2,Follicular Dendritic Cell Sarcoma,0.8418,Histiocytic Sarcoma,0.8219,Histiocytic and Dendritic Cell Neoplasm,0.7933,True Histiocytic Lymphoma,0.7643,"Malignant Lymphoma, Histiocytic, Diffuse",0.7637
HISTIOCYTIC SARCOMA,Histiocytic Sarcoma,1,2,Histiocytic Sarcoma,1.0000,True Histiocytic Lymphoma,0.8769,"Malignant Lymphoma, Histiocytic, Diffuse",0.7983,Undifferentiated Pleomorphic Sarcoma,0.7292,Histiocytic and Dendritic Cell Neoplasm,0.7276
HISTIOCYTIC_LYMPHOMA,True Histiocytic Lymphoma,1,2,True Histiocytic Lymphoma,0.9477,"Malignant Lymphoma, Histiocytic, Diffuse",0.8695,Histiocytic Sarcoma,0.8644,Histiocytosis,0.7983,Histiocytic and Dendritic Cell Neoplasm,0.7917
HISTIOCYTOSIS,Histiocytosis,1,2,Histiocytosis,1.0000,Langerhans Cell Histiocytosis,0.8507,True Histiocytic Lymphoma,0.7808,Histiocytic and Dendritic Cell Neoplasm,0.7421,Histiocytic Sarcoma,0.7161
HNSC,Head and Neck Squamous Cell Carcinoma,99,2,Head and Neck Neuroendocrine Carcinoma,0.6786,Sinonasal Undifferentiated Carcinoma,0.6219,Neuroendocrine Carcinoma,0.6164,Prostate Neuroendocrine Carcinoma,0.5919,Large Cell Neuroendocrine Carcinoma,0.5899
HNSC_HPV+,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Positive,1,2,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Positive,0.7231,Human Papillomavirus Positive<;>Squamous Cell Carcinoma,0.6768,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Negative,0.6384,"Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type",0.5531,uterine corpus endometrial carcinoma<;>Copy Number<;>High,0.5353
HNSC_HPV-,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Negative,3,2,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Positive,0.6448,Human Papillomavirus Positive<;>Squamous Cell Carcinoma,0.6328,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Negative,0.6049,"Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type",0.5408,Hepatitis C Virus,0.5320
HODGKIN LYMPHOMA,Hodgkin Lymphoma,1,2,Hodgkin Lymphoma,1.0000,Classic Hodgkin Lymphoma,0.9188,Non-Hodgkin Lymphoma,0.6869,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,0.6166,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.5791
HODGKIN LYMPHOMA-LIKE PTLD,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,1,2,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,0.8527,Classic Hodgkin Lymphoma,0.6748,Hodgkin Lymphoma,0.6480,Post-Transplant Lymphoproliferative Disorder,0.6301,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.5692
HODGKINS,Hodgkin Lymphoma,1,2,Hodgkin Lymphoma,0.9121,Classic Hodgkin Lymphoma,0.8675,Non-Hodgkin Lymphoma,0.7126,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.6223,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,0.6143
HODGKIN_LYMPHOMA,Hodgkin Lymphoma,1,2,Hodgkin Lymphoma,0.9814,Classic Hodgkin Lymphoma,0.8995,Non-Hodgkin Lymphoma,0.7102,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,0.6118,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.6059
HPV+ SCC I OR II,Human Papillomavirus Positive<;>Squamous Cell Carcinoma,1,2,Human Papillomavirus Positive<;>Squamous Cell Carcinoma,0.8115,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Positive,0.7806,Head and Neck Squamous Cell Carcinoma<;>Human Papillomavirus Negative,0.6470,"Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type",0.5721,Cervical Carcinoma<;>Mixed,0.5717
HR+/HER2-,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,3,2,Estrogen Receptor Negative<;>HER2/Neu Positive,0.8202,Estrogen Receptor Positive<;>HER2/Neu Negative,0.8194,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.8147,Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.8136,Estrogen Receptor Positive<;>HER2/Neu Positive,0.8054
HURTHLE,Thyroid Gland Oncocytic Carcinoma,99,2,Kataegis,0.5122,Keratoacanthoma,0.4225,Gingiva,0.4224,Thyroid Gland Oncocytic Adenoma,0.4196,Mature,0.4189
HURTHLE CELL THYROID CANCER,Thyroid Gland Oncocytic Carcinoma,1,2,Thyroid Gland Oncocytic Carcinoma,0.7820,Thyroid Gland Anaplastic Carcinoma,0.7364,Thyroid Gland Follicular Carcinoma<;>Thyroid Gland Oncocytic Carcinoma,0.7195,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.7135,Thyroid Gland Cribriform Morular Carcinoma,0.6962
HYPERDIPLOID,Hyperdiploidy,1,2,Hyperdiploidy,0.9739,Hypodiploidy,0.7669,Diploidy,0.6803,Near-Haploidy,0.6784,Complex Karyotype,0.6418
HYPERMUTATED,Hypermutated Colorectal Carcinoma,1,2,Hypermutated Colorectal Carcinoma,0.5724,High-Frequency Microsatellite Instability,0.5596,Hyperdiploidy,0.5536,Microsatellite Instability,0.5219,Microsatellite Stable,0.5219
HYPERNEPHROMA-PD,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,99,2,Mesonephric Adenocarcinoma,0.6725,Clear Cell Papillary Renal Neoplasm,0.6678,Kidney Oncocytoma,0.6469,Papillary Renal Cell Carcinoma,0.6428,Classic Variant of Chromophobe Renal Cell Carcinoma,0.6332
HYPERTENSION DIAGNOSIS,Hypertension,1,2,Hypertension,0.8980,Hyperdiploidy,0.4651,With Tumor,0.4591,Philadelphia Chromosome Positive,0.4336,Diabetes Mellitus,0.4272
HYPODIPLOID,Hypodiploidy,1,2,Hypodiploidy,0.9739,Hyperdiploidy,0.7500,Near-Haploidy,0.7495,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,0.6599,Diploidy,0.6541
HYPOPHARYNGEAL,Hypopharyngeal Squamous Cell Carcinoma,2,2,Pharynx,0.7138,Hypopharyngeal Squamous Cell Carcinoma,0.5996,Head and Neck,0.5617,Oral,0.5580,Laryngeal,0.5537
HYPOPHARYNX SQUAMOUS CELL CARCINOMA,Hypopharyngeal Squamous Cell Carcinoma,1,2,Hypopharyngeal Squamous Cell Carcinoma,0.9813,Head and Neck Squamous Cell Carcinoma,0.7785,Pharyngeal Squamous Cell Carcinoma,0.7694,Oropharyngeal Squamous Cell Carcinoma,0.7516,Oral Cavity Squamous Cell Carcinoma,0.7229
IDC,Invasive Breast Carcinoma of No Special Type,3,2,Breast Ductal Carcinoma In Situ,0.6782,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.6362,Invasive Breast Carcinoma of No Special Type,0.6001,Invasive Breast Carcinoma,0.5900,Microinvasive Breast Carcinoma,0.5856
IDC HR+HER2+,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,1,2,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.8496,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.8276,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.8010,Estrogen Receptor Positive<;>HER2/Neu Positive<;>HER2-Positive Breast Carcinoma,0.7966,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.7961
IDC HR+HER2-,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,2,2,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.8698,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.8654,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.8456,Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.8325,Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.8275
IDC HR-HER2+,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,2,2,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.8642,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.8577,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.8289,Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.8285,HER2-Positive Breast Carcinoma,0.8277
IDC TN,Invasive Breast Carcinoma of No Special Type<;>Triple-Negative Breast Cancer Finding,1,2,Invasive Breast Carcinoma of No Special Type<;>Triple-Negative Breast Cancer Finding,0.6316,Breast Ductal Carcinoma<;>Triple-Negative Breast Cancer Finding,0.5879,Microinvasive Breast Carcinoma,0.5840,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.5694,Breast Ductal Carcinoma In Situ,0.5640
ILC HR+HER2-,Invasive Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,1,2,Invasive Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.8016,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.7832,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Positive,0.7715,Invasive Breast Carcinoma of No Special Type<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.7710,Hormone Receptor-Negative Breast Carcinoma<;>HER2/Neu Positive,0.7373
IMMATURE TERATOMA,Immature Teratoma,1,2,Immature Teratoma,1.0000,Mature Teratoma,0.9278,Nonseminomatous<;>Immature Teratoma,0.9042,Teratoma,0.8632,Nonseminomatous<;>Mature Teratoma,0.8620
IMMORTALIZED_EMBRYONIC_FIBROBLAST,immortal embryo-derived fibroblast cell line cell,1,2,immortal embryo-derived fibroblast cell line cell,0.8724,immortal fibroblast cell line cell,0.7992,immortal epithelial cell line cell,0.7260,Bone Marrow-Derived Fibroblasts,0.6516,Fibroblast<;>Urinary System,0.6300
IMMORTALIZED_EPITHELIAL,immortal epithelial cell line cell,1,2,immortal epithelial cell line cell,0.8533,immortal embryo-derived fibroblast cell line cell,0.7145,Epithelial,0.7113,Epithelial-to-Mesenchymal Transition,0.7076,Epithelial-Myoepithelial Carcinoma,0.6536
IMMORTALIZED_FIBROBLAST,immortal fibroblast cell line cell,1,2,immortal fibroblast cell line cell,0.8756,immortal embryo-derived fibroblast cell line cell,0.8394,immortal epithelial cell line cell,0.7131,Bone Marrow-Derived Fibroblasts,0.6840,Neoplastic Fibroblast-Like Cell,0.6734
IMMUNOBLASTIC,Immunoblastic Lymphoma,1,2,Immunoblastic Lymphoma,0.9389,Centroblastic Lymphoma,0.6629,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.6358,Blastic Plasmacytoid Dendritic Cell Neoplasm,0.6321,Diffuse Large B-Cell Lymphoma,0.6279
INCIDENTAL PROSTATE CANCER,Prostate Carcinoma<;>Incidental Finding,1,2,Prostate Carcinoma<;>Incidental Finding,0.9432,Castration-Resistant Prostate Carcinoma<;>Non-Metastatic Prostate Carcinoma,0.6400,Prostate Carcinoma,0.6182,Aggressive Variant Prostate Carcinoma,0.6107,Prostate Adenocarcinoma,0.6062
INFANTILE FIBROSARCOMA,Infantile Fibrosarcoma,1,2,Infantile Fibrosarcoma,1.0000,Infantile Sarcoma,0.8185,Fibrosarcoma,0.7816,Infantile Myofibroma,0.7755,Myxoinflammatory Fibroblastic Sarcoma,0.6854
INFANTILE MYOFIBROMA,Infantile Myofibroma,1,2,Infantile Myofibroma,1.0000,Myofibroma,0.8436,Inflammatory Myofibroblastic Tumor,0.8157,Infantile Fibrosarcoma,0.7755,Solitary Fibrous Tumor,0.7285
INFANTILE SARCOMA,Infantile Sarcoma,1,2,Infantile Sarcoma,1.0000,Infantile Fibrosarcoma,0.8185,Sarcoma,0.7299,undifferentiated sarcoma,0.7165,Round Cell Sarcoma,0.6887
INFILTRATING CARCINOMA NOS,Invasive Breast Carcinoma,3,2,Adenocarcinoma<;>Invasive,0.7786,Invasive,0.7472,Invasive Breast Carcinoma,0.7070,Carcinoma,0.6972,Infiltrating Urothelial Carcinoma,0.6924
INFILTRATING DUCTAL & LOBULAR,Breast Mixed Ductal and Lobular Carcinoma,4,2,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.8749,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.8682,Invasive Breast Lobular Carcinoma,0.7416,Breast Mixed Ductal and Lobular Carcinoma,0.7218,Invasive Breast Carcinoma of No Special Type,0.6622
INFILTRATING DUCTAL AND LOBULAR CARCINOMA,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,1,2,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9283,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9166,Invasive Breast Lobular Carcinoma,0.8092,Breast Mixed Ductal and Lobular Carcinoma,0.7941,Invasive Breast Carcinoma of No Special Type,0.7108
INFILTRATING DUCTAL CARCINOMA,Invasive Breast Carcinoma of No Special Type,4,2,Breast Ductal Carcinoma,0.7769,Invasive Breast Carcinoma,0.7697,Breast Ductal Carcinoma In Situ,0.7664,Invasive Breast Carcinoma of No Special Type,0.7635,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.7375
INFILTRATING LOBULAR CARCINOMA,Invasive Breast Lobular Carcinoma,1,2,Invasive Breast Lobular Carcinoma,0.9286,Breast Lobular Carcinoma,0.8404,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.7820,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.7619,Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma,0.7421
INFILTRATING TUBULAR CARCINOMA,Breast Tubular Carcinoma,3,2,Tubular Adenocarcinoma,0.8393,Tubular Adenocarcinoma<;>Moderately Differentiated,0.7441,Breast Tubular Carcinoma,0.7315,Infiltrating Urothelial Carcinoma,0.7183,Tubular Adenocarcinoma<;>Well Differentiated Adenocarcinoma Cell,0.7157
INFILTRATING TUBULO-LOBULAR CARCINOMA,Tubulolobular Breast Carcinoma,5,2,Invasive Breast Lobular Carcinoma,0.8058,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.7002,Breast Lobular Carcinoma,0.6986,Infiltrating Urothelial Carcinoma,0.6950,Tubulolobular Breast Carcinoma,0.6935
INFLAMMATORY BREAST CANCER,Breast Inflammatory Carcinoma,1,2,Breast Inflammatory Carcinoma,0.9572,Breast Metaplastic Carcinoma,0.7262,Breast Carcinoma with Osseous Metaplasia,0.6715,Breast Metaplastic Carcinoma<;>Epithelial,0.6710,Breast Secretory Carcinoma,0.6704
INFLAMMATORY MYOFIBROBLASTIC LUNG TUMOR,Lung Inflammatory Myofibroblastic Tumor,1,2,Lung Inflammatory Myofibroblastic Tumor,0.9829,Inflammatory Myofibroblastic Tumor,0.8390,Congenital Peribronchial Myofibroblastic Tumor,0.7537,Infantile Myofibroma,0.7046,Plexiform Fibrohistiocytic Tumor,0.6741
INFLAMMATORY MYOFIBROBLASTIC TUMOR,Inflammatory Myofibroblastic Tumor,1,2,Inflammatory Myofibroblastic Tumor,1.0000,Infantile Myofibroma,0.8157,Myofibroma,0.8036,Lung Inflammatory Myofibroblastic Tumor,0.7790,Solitary Fibrous Tumor,0.7111
INITIAL CNS TUMOR,Central Nervous System Neoplasm,99,2,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.6010,Glioblastoma<;>De Novo,0.5948,Brain<;>Site of Metastasis,0.5942,Central Nervous System Embryonal Tumor,0.5920,Malignant Brain Neoplasm,0.5756
INITIAL CNS TUMOR FIRST HGG RECORD,Central Nervous System Neoplasm,99,2,First Relapse,0.5732,Glioblastoma<;>De Novo,0.4697,Glioblastoma<;>IDH Gene Family Mutation,0.4548,Low Grade Glioma<;>IDH Family Wildtype,0.4442,Glioblastoma<;>IDH Family Wildtype,0.4415
INITIAL CNS TUMOR LAST INITIAL,Central Nervous System Neoplasm,99,2,First Relapse,0.5909,Glioblastoma<;>De Novo,0.5115,Malignant Glioma<;>Progressive,0.4881,Recurrent Malignant Glioma,0.4686,Brain<;>Site of Metastasis,0.4620
INITIAL CNS TUMOR NEW LOCATION,Central Nervous System Neoplasm,99,2,First Relapse,0.5826,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.5413,Primary Neoplasm,0.5285,Glioblastoma<;>De Novo,0.5234,Metastatic Lesion,0.5209
INTERMEDIATE RISK CYTOGENETIC ABNORMALITY,Cytogenetic Abnormality<;>Intermediate Risk,1,2,Cytogenetic Abnormality<;>Intermediate Risk,0.9714,Cytogenetic Abnormality<;>Low Risk,0.7970,Atypical Chronic Myeloid Leukemia,0.5936,Chromosomal Instability,0.5899,MLL Gene Translocation<;>Low Risk,0.5787
INTERMEDIATELY DIFFERENTIATED ADENOCARCINOMA,Moderately Differentiated Adenocarcinoma Cell,2,2,Adenocarcinoma<;>Moderately Differentiated,0.8590,Moderately Differentiated Adenocarcinoma Cell,0.8464,Poorly Differentiated Adenocarcinoma,0.8458,Adenocarcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.8411,Adenocarcinoma<;>Poorly Differentiated,0.8365
INTESTINAL,Intestinal,1,2,Intestinal,1.0000,Intestine,0.9644,Malignant Intestinal Neoplasm,0.7360,Colon,0.6411,Colorectal,0.6243
INTESTINAL TYPE MUCINOUS CARCINOMA,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",1,2,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.8593,Colon Mucinous Adenocarcinoma,0.7839,Mucinous Adenocarcinoma,0.7649,Rectal Mucinous Adenocarcinoma<;>Colon Mucinous Adenocarcinoma,0.7388,Mucinous gastric carcinoma,0.7377
INTESTINAL TYPE STOMACH ADENOCARCINOMA,Gastric Intestinal-Type Adenocarcinoma,1,2,Gastric Intestinal-Type Adenocarcinoma,0.9687,Gastric Adenocarcinoma,0.7626,Gastric Diffuse Adenocarcinoma,0.7577,Gastric Tubular Adenocarcinoma,0.7364,Gastric Poorly Cohesive Adenocarcinoma,0.6955
INTESTINAL_ADENOCARCINOMA,Gastric Intestinal-Type Adenocarcinoma,1,2,Gastric Intestinal-Type Adenocarcinoma,0.8094,Colorectal Adenocarcinoma,0.7469,Malignant Intestinal Neoplasm,0.7350,Colon Adenocarcinoma,0.6903,Small Intestinal Adenocarcinoma,0.6900
INTIMAL SARCOMA,Intimal Sarcoma,1,2,Intimal Sarcoma,1.0000,Proximal-Type Epithelioid Sarcoma,0.6327,Infantile Sarcoma,0.6104,Telangiectatic Osteosarcoma,0.5996,Angiosarcoma,0.5933
INTRACHOLECYSTIC PAPILLARY NEOPLASM,Gallbladder Intracholecystic Papillary Neoplasm,1,2,Gallbladder Intracholecystic Papillary Neoplasm,0.9082,Pancreatic Intraductal Tubulopapillary Neoplasm,0.6735,Choroid Plexus Papilloma,0.6684,Papillary Carcinoma,0.6647,Papillary Adenocarcinoma,0.6207
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM,Pancreatic Intraductal Papillary-Mucinous Neoplasm,1,2,Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.9466,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,0.8031,Pancreatic Intraductal Tubulopapillary Neoplasm,0.7452,Pancreatic Mucinous-Cystic Neoplasm,0.6962,Breast Papillary Ductal Carcinoma with Invasion,0.6042
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM WITH AN ASSOCIATED INVASIVE CARCINOMA,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,1,2,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,0.9483,Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.8138,Breast Papillary Ductal Carcinoma with Invasion,0.7242,Pancreatic Intraductal Tubulopapillary Neoplasm,0.6271,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.5934
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM WITH INVASION,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,1,2,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,0.8916,Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.8224,Breast Papillary Ductal Carcinoma with Invasion,0.7446,Pancreatic Intraductal Tubulopapillary Neoplasm,0.6562,Invasive Lung Mucinous Adenocarcinoma,0.5461
INTRADUCTAL TUBULOPAPILLARY NEOPLASM,Pancreatic Intraductal Tubulopapillary Neoplasm,1,2,Pancreatic Intraductal Tubulopapillary Neoplasm,0.9430,Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.7025,Gallbladder Intracholecystic Papillary Neoplasm,0.6510,Solid Pseudopapillary Neoplasm of the Pancreas,0.5947,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,0.5912
INTRAHEPATIC,Intrahepatic,1,2,Intrahepatic,1.0000,Liver,0.6399,Intrahepatic Cholangiocarcinoma,0.6172,Intestinal,0.5971,Extrahepatic,0.5915
INTRAHEPATIC CHOLANGIOCARCINOMA,Intrahepatic Cholangiocarcinoma,1,2,Intrahepatic Cholangiocarcinoma,1.0000,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.9479,Cholangiocarcinoma,0.8704,Hilar Cholangiocarcinoma,0.8669,Cholangiocarcinoma<;>Extrahepatic,0.8516
INVASIVE,Invasive,1,2,Invasive,1.0000,Metastatic,0.7301,Metastasis,0.7146,Well Differentiated Lesion<;>Invasive,0.7123,Invasive Breast Carcinoma,0.6852
INVASIVE ADENOCARCINOMA,Adenocarcinoma<;>Invasive,1,2,Adenocarcinoma<;>Invasive,0.9803,Adenocarcinoma,0.8798,Poorly Differentiated Adenocarcinoma,0.8045,Adenocarcinoma<;>Well Differentiated,0.8002,Adenocarcinoma<;>Undifferentiated,0.7949
INVASIVE BREAST CANCER,Invasive Breast Carcinoma,1,2,Invasive Breast Carcinoma,0.9819,Invasive Breast Carcinoma of No Special Type,0.9155,Breast Carcinoma,0.7963,Breast Adenocarcinoma,0.7216,Breast Ductal Carcinoma,0.7118
INVASIVE BREAST CARCINOMA,Invasive Breast Carcinoma,1,2,Invasive Breast Carcinoma,1.0000,Invasive Breast Carcinoma of No Special Type,0.9466,Breast Carcinoma,0.7823,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.7257,Breast Ductal Carcinoma,0.7252
INVASIVE DUCTAL AND LOBULAR CARCINOMA,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,1,2,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9576,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9505,Invasive Breast Lobular Carcinoma,0.8154,Breast Mixed Ductal and Lobular Carcinoma,0.8025,Invasive Breast Carcinoma of No Special Type,0.7463
INVASIVE MIXED DUCTAL AND LOBULAR CARCINOMA,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,3,2,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9000,Breast Mixed Ductal and Lobular Carcinoma,0.8950,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.8864,Invasive Breast Lobular Carcinoma,0.7915,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.6939
INVASIVE MUCINOUS ADCA,Invasive Lung Mucinous Adenocarcinoma,4,2,Mucinous Adenocarcinoma,0.8027,Mucinous Cystadenocarcinoma,0.7742,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.7692,Invasive Lung Mucinous Adenocarcinoma,0.7658,Appendix Mucinous Adenocarcinoma,0.7038
INVASIVE MUCINOUS ADENOCARCINOMA 82533,Invasive Lung Mucinous Adenocarcinoma,3,2,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.6480,Mucinous Cystadenocarcinoma,0.6278,Invasive Lung Mucinous Adenocarcinoma,0.6258,"Mucinous Adenocarcinoma, Endocervical Type",0.6014,Mucinous Adenocarcinoma,0.5931
"INVASIVE, WELL-DIFFERENTIATED",Well Differentiated Lesion<;>Invasive,1,2,Well Differentiated Lesion<;>Invasive,0.9322,Well Differentiated,0.8039,Poorly Differentiated,0.7961,Invasive,0.7785,Moderately Differentiated,0.7465
INVASIVE-MUCINOUS,Invasive Lung Mucinous Adenocarcinoma,99,2,Mucinous,0.8376,Mucinous Adenocarcinoma,0.8184,Mucinous Cystadenocarcinoma,0.7314,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.7210,Signet Ring Cell<;>Mucinous,0.7175
INVASIVE_DUCTAL_CARCINOMA,Invasive Breast Carcinoma of No Special Type,4,2,Invasive Breast Carcinoma,0.8320,Breast Ductal Carcinoma,0.8230,Breast Ductal Carcinoma In Situ,0.8135,Invasive Breast Carcinoma of No Special Type,0.8002,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.7511
ISLET CELL TUMOR,Pancreatic Neuroendocrine Tumor,2,2,Pancreatic Insulinoma<;>Benign,0.8260,Pancreatic Neuroendocrine Tumor,0.8226,Pancreatoblastoma,0.7799,Neuroendocrine Tumor,0.7070,Paraganglioma,0.6823
JEJUNUM,Jejunum,1,2,Jejunum,1.0000,Intestine,0.6449,Intestinal,0.6052,Cecum,0.6001,Rectosigmoid Region,0.5944
JUVENILE GRANULOSA CELL TUMOR,Juvenile Granulosa Cell Tumor,1,2,Juvenile Granulosa Cell Tumor,1.0000,Granulosa Cell Tumor,0.8443,Ovarian Granulosa Cell Tumor,0.8019,Nongerminomatous Germ Cell Tumor<;>Yolk Sac Tumor,0.6734,Ovarian Dysgerminoma<;>Yolk Sac Tumor,0.6716
JUVENILE SECRETORY CARCINOMA OF THE BREAST,Breast Secretory Carcinoma,1,2,Breast Secretory Carcinoma,0.8686,Breast Metaplastic Carcinoma,0.7141,Breast Mucinous Carcinoma,0.6969,Breast Inflammatory Carcinoma,0.6879,Breast Adenoid Cystic Carcinoma,0.6806
KATAEGIS,Kataegis,1,2,Kataegis,1.0000,Angiocentric Glioma,0.4075,Keratoacanthoma,0.4073,Malignant Glioma,0.4067,Linitis Plastica,0.4058
KERATOACANTHOMA,Keratoacanthoma,1,2,Keratoacanthoma,1.0000,Merkel Cell Carcinoma,0.7342,Pilomatrical Carcinoma,0.7239,Skin Acantholytic Squamous Cell Carcinoma,0.6807,Basal Cell Carcinoma,0.6592
KICH,Chromophobe Renal Cell Carcinoma,99,2,Kataegis,0.5024,nan,0.4680,Jejunum,0.4541,FOXA1 Gene,0.4521,Neurocutaneous Melanosis,0.4235
KIDNEY,Kidney,1,2,Kidney,1.0000,Kidney Carcinoma,0.6744,Urinary System,0.6297,Liver,0.5925,Pancreas,0.5776
KIDNEY CANCER,Kidney Carcinoma,1,2,Kidney Carcinoma,0.9671,Renal Cell Carcinoma,0.8584,Clear Cell Renal Cell Carcinoma,0.7316,Kidney,0.7303,Kidney Medullary Carcinoma,0.7127
"KIDNEY CANCER, NOS",Kidney Carcinoma,1,2,Kidney Carcinoma,0.9681,Renal Cell Carcinoma,0.8635,Clear Cell Renal Cell Carcinoma,0.7398,Kidney,0.7205,Kidney Medullary Carcinoma,0.7112
KIDNEY CHROMOPHOBE,Chromophobe Renal Cell Carcinoma,1,2,Chromophobe Renal Cell Carcinoma,0.7901,Classic Variant of Chromophobe Renal Cell Carcinoma,0.7526,Kidney Oncocytoma,0.6877,Kidney Angiomyolipoma,0.6849,Clear Cell Papillary Renal Neoplasm,0.6821
KIDNEY CLEAR CELL RENAL CARCINOMA,Clear Cell Renal Cell Carcinoma,1,2,Clear Cell Renal Cell Carcinoma,0.9849,Renal Cell Carcinoma,0.9132,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.9016,Chromophobe Renal Cell Carcinoma,0.8878,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.8376
KIDNEY PAPILLARY RENAL CELL CARCINOMA,Papillary Renal Cell Carcinoma,1,2,Papillary Renal Cell Carcinoma,0.9799,Clear Cell Papillary Renal Neoplasm,0.8754,Chromophobe Renal Cell Carcinoma,0.8377,Renal Cell Carcinoma,0.8376,Clear Cell Renal Cell Carcinoma,0.8202
KIDNEY RENAL CELL CARCINOMA,Renal Cell Carcinoma,1,2,Renal Cell Carcinoma,0.9781,Kidney Carcinoma,0.9412,Clear Cell Renal Cell Carcinoma,0.8973,Sarcomatoid Renal Cell Carcinoma,0.8253,Chromophobe Renal Cell Carcinoma,0.8200
KIDNEY RENAL CELL CARCINOMA OTHER,Renal Cell Carcinoma,3,2,Unclassified Renal Cell Carcinoma,0.7785,Kidney Carcinoma,0.7612,Renal Cell Carcinoma,0.7289,Clear Cell Renal Cell Carcinoma,0.6871,Clear Cell Papillary Renal Neoplasm,0.6710
KIDNEY_CANCER,Kidney Carcinoma,1,2,Kidney Carcinoma,0.8920,Renal Cell Carcinoma,0.7789,Kidney,0.7472,Unclassified Renal Cell Carcinoma,0.7040,Clear Cell Renal Cell Carcinoma,0.6789
KIRC,Clear Cell Renal Cell Carcinoma,5,2,MiT Family Translocation-Associated Renal Cell Carcinoma,0.4982,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,0.4974,Polymorphous Low Grade Neuroepithelial Tumor of the Young,0.4623,Papillary Renal Cell Carcinoma,0.4522,Clear Cell Renal Cell Carcinoma,0.4516
KIRP,Papillary Renal Cell Carcinoma,99,2,Claudin-Low,0.4633,ERG Gene,0.4364,MiT Family Translocation-Associated Renal Cell Carcinoma,0.4292,nan,0.4270,Polymorphous Low Grade Neuroepithelial Tumor of the Young,0.4269
LAML,Acute Myeloid Leukemia,99,2,Adamantinoma,0.4927,Nephroblastomatosis,0.4599,Lung Basaloid Large Cell Carcinoma,0.4450,Arm,0.4437,Lentigo Maligna,0.4393
LANGERHANS CELL HISTIOCYTOSIS,Langerhans Cell Histiocytosis,1,2,Langerhans Cell Histiocytosis,1.0000,Histiocytosis,0.8507,True Histiocytic Lymphoma,0.7457,Histiocytic and Dendritic Cell Neoplasm,0.7447,"Malignant Lymphoma, Histiocytic, Diffuse",0.6952
LARGE CELL CARCINOMA-UD,Large Cell Carcinoma<;>Undifferentiated,2,2,Large Cell Carcinoma,0.8671,Large Cell Carcinoma<;>Undifferentiated,0.8056,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.7386,Lung Large Cell Carcinoma,0.7351,Large Cell Neuroendocrine Carcinoma,0.7210
LARGE CELL LUNG CARCINOMA,Lung Large Cell Carcinoma,1,2,Lung Large Cell Carcinoma,0.9916,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9405,"Lung Large Cell Carcinoma, Clear Cell Variant",0.8416,Large Cell Carcinoma,0.8235,Lung Sarcomatoid Carcinoma,0.8185
LARGE CELL NEUROENDOCRINE CARCINOMA,Large Cell Neuroendocrine Carcinoma,1,2,Large Cell Neuroendocrine Carcinoma,1.0000,Neuroendocrine Carcinoma,0.8747,Small Cell Neuroendocrine Carcinoma,0.8162,Neuroendocrine Carcinoma<;>Poorly Differentiated,0.7939,Adenocarcinoma with Neuroendocrine Differentiation,0.7720
LARGE CELL NEUROENDOCRINE CARCINOMA OF GALLBLADDER,Gallbladder Large Cell Neuroendocrine Carcinoma,1,2,Gallbladder Large Cell Neuroendocrine Carcinoma,0.9884,Gallbladder Small Cell Neuroendocrine Carcinoma,0.8846,Gallbladder Neuroendocrine Tumor,0.8378,Gallbladder Squamous Cell Carcinoma,0.7683,Gallbladder Adenosquamous Carcinoma,0.7553
LARGE CELL-UD,Large Cell Carcinoma<;>Undifferentiated,2,2,Large Cell Carcinoma,0.7803,Large Cell Carcinoma<;>Undifferentiated,0.7758,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.6971,Large Cell Neuroendocrine Carcinoma,0.6960,Lung Large Cell Carcinoma,0.6775
LARGE CELL/ANAPLASTIC MEDULLOBLASTOMA,Large Cell/Anaplastic Medulloblastoma,1,2,Large Cell/Anaplastic Medulloblastoma,1.0000,Anaplastic Medulloblastoma,0.8843,"Medulloblastoma, Non-WNT/Non-SHH, Group 3",0.8193,Desmoplastic/Nodular Medulloblastoma,0.8189,Medulloblastoma,0.8013
LARGE_CELL_CARCINOMA,Large Cell Carcinoma,1,2,Large Cell Carcinoma,0.9628,Large Cell Carcinoma<;>Undifferentiated,0.8484,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.7945,Lung Large Cell Carcinoma,0.7802,Large Cell Neuroendocrine Carcinoma,0.7565
LARGE_CELL_LUNG_CANCER,Lung Large Cell Carcinoma,2,2,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.8910,Lung Large Cell Carcinoma,0.8900,Large Cell Carcinoma,0.7918,Lung Non-Small Cell Carcinoma,0.7859,"Lung Large Cell Carcinoma, Clear Cell Variant",0.7801
LARYNGEAL,Laryngeal,1,2,Laryngeal,1.0000,Tongue,0.5756,Laryngeal Squamous Cell Carcinoma,0.5356,Pharynx,0.5328,Lung,0.5302
LARYNX SQUAMOUS CELL CARCINOMA,Laryngeal Squamous Cell Carcinoma,1,2,Laryngeal Squamous Cell Carcinoma,0.9589,Tongue Squamous Cell Carcinoma,0.7240,Lung Squamous Cell Carcinoma,0.6420,Pharyngeal Squamous Cell Carcinoma,0.6336,Cervical Squamous Cell Carcinoma,0.6302
LEIOMYOSARCOMA,Leiomyosarcoma,1,2,Leiomyosarcoma,1.0000,Conventional Leiomyosarcoma,0.9203,Well Differentiated Leiomyosarcoma,0.9087,Uterine Corpus Leiomyosarcoma,0.8675,Uterine Corpus Myxoid Leiomyosarcoma,0.7650
LEIOMYOSARCOMA LMS,Leiomyosarcoma,1,2,Leiomyosarcoma,0.9025,Conventional Leiomyosarcoma,0.8671,Well Differentiated Leiomyosarcoma,0.8663,Uterine Corpus Leiomyosarcoma,0.8195,Uterine Corpus Myxoid Leiomyosarcoma,0.7814
LENTIGO MALIGNA,Lentigo Maligna,1,2,Lentigo Maligna,1.0000,Lentigo Maligna Melanoma,0.8429,Acral Lentiginous Melanoma,0.6971,Neurocutaneous Melanosis,0.6303,Blue Nevus,0.6216
LENTIGO MALIGNA MELANOMA,Lentigo Maligna Melanoma,1,2,Lentigo Maligna Melanoma,1.0000,Acral Lentiginous Melanoma,0.8564,Lentigo Maligna,0.8429,Cutaneous Melanoma,0.7381,Cutaneous Nodular Melanoma,0.7187
LEPIDIC,Lepidic Adenocarcinoma,1,2,Lepidic Adenocarcinoma,0.6400,Mixed,0.5352,Classic Histology,0.5311,Laryngeal,0.5224,Primary,0.5134
LEPIDIC ADENOCARCINOMA 82503,Lepidic Adenocarcinoma,1,2,Lepidic Adenocarcinoma,0.6919,Serous Adenocarcinoma<;>High Grade,0.5881,Papillary Serous Cystadenocarcinoma,0.5799,Mixed Cell Adenocarcinoma,0.5790,Proximal-Type Epithelioid Sarcoma,0.5709
LEUKAEMIA,Leukemia,1,2,Leukemia,0.9797,Erythroleukemia,0.7156,Myeloid Neoplasm,0.7057,Lymphoma,0.6941,Myeloid Sarcoma,0.6648
LEUKAPHERESIS,Leukapheresis,1,2,Leukapheresis,1.0000,Histiocytosis,0.5201,Paracentesis<;>Biopsy,0.5127,Leukemia,0.4962,Mastocytosis,0.4759
LEUKEMIA,Leukemia,1,2,Leukemia,1.0000,Myeloid Neoplasm,0.7202,Erythroleukemia,0.7133,Lymphoma,0.7094,Myeloid Sarcoma,0.6691
LEUKEMIA_OTHER,Leukemia,1,2,Leukemia,0.7925,Acute Myeloid Leukemia Not Otherwise Specified,0.6331,Acute Undifferentiated Leukemia,0.6255,Acute Leukemia of Ambiguous Lineage,0.6240,Myeloid Neoplasm,0.6020
LGG,Low Grade Glioma,99,2,T-Cell Large Granular Lymphocyte Leukemia,0.5484,Giant Cell,0.5250,Gastric,0.5166,Glioma,0.4956,Granular Cell Tumor<;>Atypical,0.4815
LGG_IDHMUT-CODEL,Low Grade Glioma<;>IDH Gene Family Mutation,1,2,Low Grade Glioma<;>IDH Gene Family Mutation,0.6757,Glioblastoma<;>IDH Gene Family Mutation,0.6492,Low Grade Glioma<;>IDH Family Wildtype,0.6288,"Glioblastoma, IDH-Wildtype",0.6182,Glioblastoma<;>IDH Family Wildtype,0.6080
LGG_IDHMUT-NON-CODEL,Low Grade Glioma<;>IDH Gene Family Mutation,5,2,Low Grade Glioma<;>IDH Family Wildtype,0.7236,Glioblastoma<;>IDH Family Wildtype,0.6971,"Glioblastoma, IDH-Wildtype",0.6912,Gliosarcoma<;>IDH Family Wildtype,0.6814,Low Grade Glioma<;>IDH Gene Family Mutation,0.6157
LGG_IDHWT,Low Grade Glioma<;>IDH Family Wildtype,1,2,Low Grade Glioma<;>IDH Family Wildtype,0.6397,"Glioblastoma, IDH-Wildtype",0.6220,Low Grade Glioma<;>IDH Gene Family Mutation,0.6125,Glioblastoma<;>IDH Family Wildtype,0.6001,Gliosarcoma<;>IDH Family Wildtype,0.5846
LGSOC,Ovarian Low Grade Serous Adenocarcinoma,99,2,T-Cell Large Granular Lymphocyte Leukemia,0.4763,Mixed<;>Serous<;>Clear Cells,0.4657,Microsatellite Stable,0.4651,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.4631,Conventional Leiomyosarcoma,0.4604
LIHB,Hepatoblastoma,99,2,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.5293,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.5103,Diffuse Large B-Cell Lymphoma,0.5019,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,0.4943,High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0.4760
LIHC,Hepatocellular Carcinoma,99,2,Hairy Cell Leukemia,0.4858,Invasive Breast Lobular Carcinoma,0.4766,IDH1 Gene,0.4749,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.4733,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.4697
LIPOFIBROMATOSIS-LIKE NEURAL TUMOR,NTRK-Rearranged Spindle Cell Neoplasm,99,2,Plexiform Fibrohistiocytic Tumor,0.7245,Plexiform Schwannoma,0.7179,Skin Fibrous Histiocytoma,0.7104,Plexiform Neurofibroma,0.6897,Cellular Schwannoma,0.6888
LIPOSARCOMA,Liposarcoma,1,2,Liposarcoma,1.0000,Well Differentiated Liposarcoma,0.8825,Myxoid Liposarcoma,0.8378,Dedifferentiated Liposarcoma,0.8207,Pleomorphic Liposarcoma,0.8135
LIVER,Liver,1,2,Liver,1.0000,Intrahepatic,0.6399,Hepatocellular Carcinoma,0.6217,Hepatoblastoma,0.6212,Lung,0.6063
"LIVER CANCER, NOS",Liver and Intrahepatic Bile Duct Carcinoma,2,2,Hepatocellular Carcinoma,0.8215,Liver and Intrahepatic Bile Duct Carcinoma,0.7606,Liver,0.7391,Hepatoblastoma,0.6931,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.6732
LIVER HEPATOCELLULAR CARCINOMA,Hepatocellular Carcinoma,1,2,Hepatocellular Carcinoma,0.9671,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.8684,Hepatoblastoma,0.7522,Hepatocellular Adenoma,0.7305,Liver and Intrahepatic Bile Duct Carcinoma,0.7105
LIVER HEPATOCELLULAR CARCINOMA PLUS INTRAHEPATIC CHOLANGIOCARCINOMA,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,2,2,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.9134,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.8777,Intrahepatic Cholangiocarcinoma,0.8215,Liver and Intrahepatic Bile Duct Carcinoma,0.8104,Hilar Cholangiocarcinoma,0.7359
LIVER TUMOR,Liver and Intrahepatic Bile Duct Neoplasm,1,2,Liver and Intrahepatic Bile Duct Neoplasm,0.7618,Liver,0.6949,Hepatoblastoma,0.6909,Hepatocellular Carcinoma,0.6301,Liver and Intrahepatic Bile Duct Carcinoma,0.6299
LIVER_CANCER,Liver and Intrahepatic Bile Duct Carcinoma,3,2,Hepatocellular Carcinoma,0.7917,Liver,0.7577,Liver and Intrahepatic Bile Duct Carcinoma,0.7510,Hepatoblastoma,0.6932,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.6581
LNET,Lung Carcinoid Tumor,99,2,Polymorphous Low Grade Neuroepithelial Tumor of the Young,0.5383,nan,0.5216,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.5172,Neuroblastoma,0.4854,Lymph Node,0.4814
LOBULAR,Lobular,1,2,Lobular,1.0000,Localized,0.6483,Breast Lobular Carcinoma,0.6425,Invasive Breast Lobular Carcinoma,0.6276,Local-Regional,0.6153
LOBULAR CARCINOMA,Breast Lobular Carcinoma,1,2,Breast Lobular Carcinoma,0.9347,Invasive Breast Lobular Carcinoma,0.8828,Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma,0.7468,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.7342,Breast Mixed Ductal and Lobular Carcinoma,0.7328
LOBULAR CARCINOMA WITH DUCTAL FEATURES,Breast Mixed Ductal and Lobular Carcinoma,2,2,Breast Lobular Carcinoma,0.8490,Breast Mixed Ductal and Lobular Carcinoma,0.8365,Invasive Breast Lobular Carcinoma,0.8322,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.8161,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.7664
LOBULAR/DUCTAL,Breast Mixed Ductal and Lobular Carcinoma,4,2,Lobular,0.8313,Ductal,0.7795,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.7010,Breast Mixed Ductal and Lobular Carcinoma,0.6765,Duct,0.6663
LOCAL RECURRENCE,"Neoplasm Recurrence, Local",1,2,"Neoplasm Recurrence, Local",0.9692,Locally Recurrent Malignant Neoplasm,0.9233,Recurrence,0.8081,Regional<;>Recurrence,0.8044,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",0.7832
LOCALIZED,Localized,1,2,Localized,1.0000,Local-Regional,0.7888,Limited Stage<;>Primary,0.6578,Lobular,0.6483,Distant,0.6373
LOCALLY ADVANCED,Locally Advanced Malignant Neoplasm,1,2,Locally Advanced Malignant Neoplasm,0.9474,Metastatic,0.7337,Locally Recurrent Malignant Neoplasm,0.7280,Invasive,0.6942,Local-Regional,0.6940
LOCOREGIONAL,Local-Regional,1,2,Local-Regional,0.8398,Localized,0.7445,Locally Advanced Malignant Neoplasm,0.6444,Distant,0.6346,"Neoplasm Recurrence, Local",0.6231
LOCOREGIONAL & DISTANT,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",2,2,Local-Regional,0.7415,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",0.7264,Distant Metastasis,0.7087,Locally Recurrent Malignant Neoplasm,0.7045,Distant,0.7033
LOCOREGIONAL AND DISTANT RECURRENCE,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",1,2,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",0.8431,Locally Recurrent Malignant Neoplasm,0.8342,Regional<;>Recurrence,0.8328,"Neoplasm Recurrence, Local",0.7907,Recurrence,0.7743
LOCOREGIONAL RECURRENCE,Locally Recurrent Malignant Neoplasm,1,2,Locally Recurrent Malignant Neoplasm,0.8825,Regional<;>Recurrence,0.8783,"Neoplasm Recurrence, Local",0.8667,Recurrence,0.8108,"Locally Recurrent Malignant Neoplasm<;>Recurrent Disease, Distant Site",0.7950
LOW GRADE FIBROMYXOID SARCOMA,Low Grade Fibromyxoid Sarcoma,1,2,Low Grade Fibromyxoid Sarcoma,1.0000,Myxoinflammatory Fibroblastic Sarcoma,0.7814,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,0.7444,Myxofibrosarcoma,0.7421,Undifferentiated Soft Tissue Sarcoma,0.7327
LOW HYPODIPLOID,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,2,2,Hypodiploidy,0.9051,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,0.7257,Cytogenetic Abnormality<;>Low Risk,0.7132,Near-Haploidy,0.6695,Hyperdiploidy,0.6511
LOW-GRADE ENDOMETRIAL STROMAL SARCOMA,Low Grade Endometrioid Stromal Sarcoma,1,2,Low Grade Endometrioid Stromal Sarcoma,0.9520,Endometrioid Stromal Sarcoma,0.9021,Endometrioid Stromal Sarcoma<;>High Grade,0.8699,Uterine Corpus Epithelioid Leiomyosarcoma,0.6895,Uterine Corpus Undifferentiated Sarcoma,0.6807
LOW-GRADE FIBROMYXOID SARCOMA,Low Grade Fibromyxoid Sarcoma,1,2,Low Grade Fibromyxoid Sarcoma,0.9972,Myxoinflammatory Fibroblastic Sarcoma,0.7856,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,0.7478,Myxofibrosarcoma,0.7446,Undifferentiated Soft Tissue Sarcoma,0.7372
LOW-GRADE GLIOMA NOS,Low Grade Glioma,1,2,Low Grade Glioma,0.9910,Low Grade Glioma<;>Low Grade Astrocytoma,0.8597,Low Grade Glioma<;>Pediatric,0.8204,Glioma,0.7945,Malignant Glioma,0.7788
"LOW-GRADE GLIOMA, NOS",Low Grade Glioma,1,2,Low Grade Glioma,0.9895,Low Grade Glioma<;>Low Grade Astrocytoma,0.8601,Low Grade Glioma<;>Pediatric,0.8132,Glioma,0.7976,Malignant Glioma,0.7778
LOW-GRADE GLIOMA/ASTROCYTOMA,Low Grade Glioma<;>Low Grade Astrocytoma,1,2,Low Grade Glioma<;>Low Grade Astrocytoma,0.9396,Low Grade Glioma,0.8616,Astrocytoma,0.8074,Diffuse Astrocytoma,0.7836,High Grade Astrocytic Tumor,0.7824
LOW-GRADE NEUROEPITHELIAL TUMOR,Polymorphous Low Grade Neuroepithelial Tumor of the Young,3,2,Neuroepithelial Neoplasm<;>High Grade,0.8344,Neuroepithelial Neoplasm,0.8183,Polymorphous Low Grade Neuroepithelial Tumor of the Young,0.7964,Dysembryoplastic Neuroepithelial Tumor,0.7961,Primitive Neuroectodermal Tumor,0.7809
LOW-GRADE SEROUS OVARIAN CANCER,Ovarian Low Grade Serous Adenocarcinoma,1,2,Ovarian Low Grade Serous Adenocarcinoma,0.9251,Ovarian High Grade Serous Adenocarcinoma,0.8522,Ovarian Serous Adenocarcinoma,0.8246,Borderline Ovarian Serous Tumor,0.8170,Serous Adenocarcinoma<;>High Grade,0.7700
LOW_GRADE_SEROUS,Ovarian Low Grade Serous Adenocarcinoma,4,2,Serous,0.7895,Borderline Ovarian Serous Tumor,0.7818,Serous Adenocarcinoma<;>High Grade,0.7780,Ovarian Low Grade Serous Adenocarcinoma,0.7685,Serous Adenocarcinoma,0.7645
LUAD,Lung Adenocarcinoma,99,2,Ovarian Dysgerminoma,0.5086,Luminal A Breast Carcinoma,0.4860,Myelodysplastic Syndrome,0.4843,Myelodysplastic Syndrome with Excess Blasts,0.4839,Myelodysplastic Syndrome with Excess Blasts-1,0.4836
LUMA,Luminal A Breast Carcinoma,1,2,Luminal A Breast Carcinoma,0.5073,Normal Breast-Like Subtype of Breast Carcinoma,0.4869,Luminal B Breast Carcinoma,0.4828,Breast,0.4762,Basal-Like Breast Carcinoma,0.4672
LUMB,Luminal B Breast Carcinoma,1,2,Luminal B Breast Carcinoma,0.5523,Normal Breast-Like Subtype of Breast Carcinoma,0.5300,Basal-Like Breast Carcinoma,0.5039,Breast,0.4947,Microinvasive Breast Carcinoma,0.4914
LUMINAL A,Luminal A Breast Carcinoma,1,2,Luminal A Breast Carcinoma,0.7489,Luminal B Breast Carcinoma,0.5678,Lobular,0.5167,Basal,0.5152,Arm,0.5100
LUMINAL B,Luminal B Breast Carcinoma,1,2,Luminal B Breast Carcinoma,0.8238,Luminal A Breast Carcinoma,0.7468,Normal Breast-Like Subtype of Breast Carcinoma,0.6394,Basal-Like Breast Carcinoma,0.6106,Basal,0.5874
LUMINALA,Luminal A Breast Carcinoma,1,2,Luminal A Breast Carcinoma,0.6927,Luminal B Breast Carcinoma,0.5743,Basal,0.5459,Lobular,0.5159,Ductal,0.4897
LUMINALB,Luminal B Breast Carcinoma,1,2,Luminal B Breast Carcinoma,0.6649,Luminal A Breast Carcinoma,0.6297,Basal,0.5333,Claudin-Low,0.5170,Normal Breast-Like Subtype of Breast Carcinoma,0.4848
LUNG,Lung,1,2,Lung,1.0000,Lung Carcinoma,0.6364,Liver,0.6063,Lung Non-Small Cell Carcinoma,0.5753,Lung Adenocarcinoma In Situ,0.5577
LUNG ACINAR ADENOCARCINOMA,Lung Acinar Adenocarcinoma,1,2,Lung Acinar Adenocarcinoma,1.0000,Acinar Cell Carcinoma,0.8525,Prostate Acinar Adenocarcinoma,0.8379,Pancreatic Acinar Cell Carcinoma,0.8110,Lung Papillary Adenocarcinoma,0.7937
LUNG ADENOCARCINOMA,Lung Adenocarcinoma,1,2,Lung Adenocarcinoma,1.0000,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9058,Solid Lung Adenocarcinoma,0.8777,Lung Carcinoma,0.8726,Lung Non-Mucinous Adenocarcinoma,0.8265
LUNG ADENOCARCINOMA IN SITU,Lung Adenocarcinoma In Situ,1,2,Lung Adenocarcinoma In Situ,1.0000,Lung Adenocarcinoma In Situ<;>Lung Non-Small Cell Carcinoma,0.8981,Minimally Invasive Lung Adenocarcinoma,0.7679,Minimally Invasive Lung Non-Mucinous Adenocarcinoma,0.7314,Lung Non-Mucinous Adenocarcinoma,0.7299
LUNG ADENOCARCINOMA MIXED SUBTYPE,"Lung Adenocarcinoma, Mixed Subtype",1,2,"Lung Adenocarcinoma, Mixed Subtype",0.9948,Mixed Cell Adenocarcinoma,0.8405,Lung Non-Mucinous Adenocarcinoma,0.7877,Lung Mucinous Adenocarcinoma,0.7713,Lung Pleomorphic Carcinoma,0.7608
LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED NOS,Lung Adenocarcinoma,1,2,Lung Adenocarcinoma,0.9675,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9201,Lung Non-Mucinous Adenocarcinoma,0.8733,Solid Lung Adenocarcinoma,0.8546,Lung Carcinoma,0.8030
LUNG ADENOSQUAMOUS CARCINOMA,Lung Adenosquamous Carcinoma,1,2,Lung Adenosquamous Carcinoma,1.0000,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9242,Adenosquamous Carcinoma,0.8640,Lung Squamous Cell Carcinoma,0.8105,Lung Adenoid Cystic Carcinoma,0.7913
LUNG BRONCHIOLOALVEOLAR CARCINOMA MUCINOUS,Lung Mucinous Adenocarcinoma,1,2,Lung Mucinous Adenocarcinoma,0.8569,Invasive Lung Mucinous Adenocarcinoma,0.7988,Minimally Invasive Lung Non-Mucinous Adenocarcinoma,0.7116,Lung Non-Mucinous Adenocarcinoma,0.7094,Lung Colloid Adenocarcinoma,0.7067
LUNG BRONCHIOLOALVEOLAR CARCINOMA NONMUCINOUS,Lung Non-Mucinous Adenocarcinoma,2,2,Minimally Invasive Lung Non-Mucinous Adenocarcinoma,0.7939,Lung Non-Mucinous Adenocarcinoma,0.7855,Minimally Invasive Lung Adenocarcinoma,0.7082,Lung Adenocarcinoma In Situ<;>Lung Non-Small Cell Carcinoma,0.6919,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.6603
LUNG CANCER,Lung Carcinoma,1,2,Lung Carcinoma,0.9482,Lung Non-Small Cell Carcinoma,0.8418,Lung Adenocarcinoma,0.8069,Lung Squamous Cell Carcinoma,0.7518,Lung Large Cell Carcinoma,0.6922
"LUNG CANCER, NOS",Lung Carcinoma,1,2,Lung Carcinoma,0.9506,Lung Non-Small Cell Carcinoma,0.8390,Lung Adenocarcinoma,0.8112,Lung Squamous Cell Carcinoma,0.7627,Lung Large Cell Carcinoma,0.6920
LUNG CARCINOID,Lung Carcinoid Tumor,1,2,Lung Carcinoid Tumor,0.9815,Lung Atypical Carcinoid Tumor,0.8709,Carcinoid Tumor,0.8241,Neuroendocrine Carcinoma,0.7158,Adenocarcinoma with Neuroendocrine Differentiation,0.6884
LUNG MICROPAPILLARY ADENOCARCINOMA,Lung Micropapillary Adenocarcinoma,1,2,Lung Micropapillary Adenocarcinoma,1.0000,Minimally Invasive Lung Adenocarcinoma,0.8354,Lung Papillary Adenocarcinoma,0.8207,Lung Colloid Adenocarcinoma,0.7940,Lung Mucinous Adenocarcinoma,0.7776
LUNG MUCINOUS ADENOCARCINOMA,Lung Colloid Adenocarcinoma,3,2,Lung Mucinous Adenocarcinoma,1.0000,Invasive Lung Mucinous Adenocarcinoma,0.9054,Lung Colloid Adenocarcinoma,0.8404,Lung Non-Mucinous Adenocarcinoma,0.8373,Solid Lung Adenocarcinoma,0.7831
LUNG NEUROENDOCRINE,Lung Carcinoid Tumor,1,2,Lung Carcinoid Tumor,0.7568,Neuroendocrine Neoplasm,0.7413,Lung Atypical Carcinoid Tumor,0.7239,Neuroendocrine Tumor,0.7232,Pituitary Neuroendocrine Tumor,0.7031
LUNG NEUROENDOCRINE TUMOR,Lung Carcinoid Tumor,1,2,Lung Carcinoid Tumor,0.8874,Lung Atypical Carcinoid Tumor,0.8249,Neuroendocrine Tumor,0.7637,Neuroendocrine Carcinoma,0.7624,Neuroendocrine Neoplasm,0.7449
LUNG PAPILLARY ADENOCARCINOMA,Lung Papillary Adenocarcinoma,1,2,Lung Papillary Adenocarcinoma,1.0000,Lung Micropapillary Adenocarcinoma,0.8207,Papillary Adenocarcinoma,0.8109,Lung Acinar Adenocarcinoma,0.7937,Lung Colloid Adenocarcinoma,0.7906
LUNG SQUAMOUS CELL CARCINOMA,Lung Squamous Cell Carcinoma,1,2,Lung Squamous Cell Carcinoma,1.0000,Lung Carcinoma,0.8313,Lung Small Cell Carcinoma,0.8232,Lung Non-Small Cell Carcinoma,0.8186,Lung Adenosquamous Carcinoma,0.8105
LUNG_CANCER,Lung Carcinoma,1,2,Lung Carcinoma,0.8782,Lung Non-Small Cell Carcinoma,0.8175,Lung Adenocarcinoma,0.7520,Lung,0.6994,Lung Squamous Cell Carcinoma,0.6877
LUNG_CARCINOID,Lung Carcinoid Tumor,1,2,Lung Carcinoid Tumor,0.9315,Carcinoid Tumor,0.8730,Lung Atypical Carcinoid Tumor,0.8395,Neuroendocrine Tumor,0.7073,Neuroendocrine Carcinoma,0.7047
LUNG_CARCINOMA,Lung Carcinoma,1,2,Lung Carcinoma,0.9623,Lung Non-Small Cell Carcinoma,0.8742,Lung Adenocarcinoma,0.8464,Lung Squamous Cell Carcinoma,0.7893,Lung Large Cell Carcinoma,0.7312
LUNG_NSC,Lung Non-Small Cell Carcinoma,2,2,Lung,0.7296,Lung Non-Small Cell Carcinoma,0.6283,Lung Carcinoma,0.6194,Lung Adenocarcinoma In Situ,0.5856,fibroblast of lung,0.5768
LUNG_SMALL_CELL,Lung Small Cell Carcinoma,2,2,Small Cell,0.8449,Lung Small Cell Carcinoma,0.8439,"Malignant Tumor, Small Cell Type",0.8198,Lung Non-Small Cell Carcinoma,0.7733,Combined Lung Small Cell Carcinoma,0.7581
LUSC,Lung Squamous Cell Carcinoma,99,2,Fibrolamellar Carcinoma,0.5055,Low-CSD Melanoma,0.5002,"Lung Large Cell Carcinoma, Clear Cell Variant",0.4984,Breast Lobular Carcinoma,0.4976,Lentigo Maligna,0.4925
LYMPH NODE,Lymph Node,1,2,Lymph Node,1.0000,Lymphoid,0.6725,Metastatic Malignant Neoplasm in the Regional Lymph Nodes,0.5951,Esophageal Lymph Node,0.5196,Lymphoma,0.5150
"LYMPHATIC CANCER, NOS",Lymphoma,1,2,Lymphoma,0.6852,Lymphocytic Neoplasm,0.6258,Lymphoid,0.6061,Hematopoietic and Lymphoid Cell Neoplasm,0.6040,Leukemia,0.5682
LYMPHOBLASTIC LYMPHOMA,Lymphoblastic Lymphoma,1,2,Lymphoblastic Lymphoma,1.0000,Chronic Lymphoblastic Lymphoma,0.8925,B Lymphoblastic Leukemia/Lymphoma,0.8709,Acute Lymphoblastic Leukemia,0.8184,B Acute Lymphoblastic Leukemia,0.7713
LYMPHOBLASTIC_LYMPHOMA,Lymphoblastic Lymphoma,1,2,Lymphoblastic Lymphoma,0.9835,B Lymphoblastic Leukemia/Lymphoma,0.8875,Chronic Lymphoblastic Lymphoma,0.8604,Acute Lymphoblastic Leukemia,0.8272,B Acute Lymphoblastic Leukemia,0.7772
LYMPHOEPITHELIOMA-LIKE CARCINOMA OF THE LUNG,Lung Lymphoepithelial Carcinoma,1,2,Lung Lymphoepithelial Carcinoma,0.9542,Lung Mucoepidermoid Carcinoma,0.8081,Lung Non-Small Cell Carcinoma<;>Lung Mucoepidermoid Carcinoma,0.7779,Lung Sarcomatoid Carcinoma,0.7568,Lung Large Cell Carcinoma,0.7549
LYMPHOID,Lymphoid,1,2,Lymphoid,1.0000,Lymphocytic Neoplasm,0.7074,Lymph Node,0.6725,Lymphoma,0.6602,Hematopoietic and Lymphoid Cell Neoplasm,0.6222
LYMPHOID CANCER,Lymphoma,3,2,Lymphocytic Neoplasm,0.8396,Lymphoid,0.7561,Lymphoma,0.7384,B-Cell Neoplasm,0.7245,Hematopoietic and Lymphoid Cell Neoplasm,0.7203
LYMPHOID NEOPLASM,Lymphocytic Neoplasm,1,2,Lymphocytic Neoplasm,0.8601,Lymphoid,0.7862,Hematopoietic and Lymphoid Cell Neoplasm,0.7552,Lymphoma,0.7530,B-Cell Neoplasm,0.7432
LYMPHOMA,Lymphoma,1,2,Lymphoma,1.0000,Non-Hodgkin Lymphoma,0.7743,Lymphocytic Neoplasm,0.7550,Lymphoblastic Lymphoma,0.7223,B-Cell Neoplasm,0.7106
LYMPHOMA_BURKITT,Burkitt Lymphoma,1,2,Burkitt Lymphoma,0.9684,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.9135,B-Cell Non-Hodgkin Lymphoma,0.8023,B-Cell Non-Hodgkin Lymphoma<;>Undifferentiated,0.7652,B Lymphoblastic Leukemia/Lymphoma,0.7619
LYMPHOMA_DLBCL,Diffuse Large B-Cell Lymphoma,1,2,Diffuse Large B-Cell Lymphoma,0.8587,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.8024,Centroblastic Lymphoma,0.7711,B-Cell Non-Hodgkin Lymphoma,0.7604,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.7547
LYMPHOMA_HODGKIN,Hodgkin Lymphoma,1,2,Hodgkin Lymphoma,0.9624,Classic Hodgkin Lymphoma,0.8804,Non-Hodgkin Lymphoma,0.7744,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.6475,B-Cell Non-Hodgkin Lymphoma,0.6222
LYMPHOMA_UNSPECIFIED,Lymphoma,1,2,Lymphoma,0.9731,Non-Hodgkin Lymphoma,0.7803,Lymphocytic Neoplasm,0.7298,B-Cell Neoplasm,0.7014,Lymphoblastic Lymphoma,0.6952
M0,Acute Myeloid Leukemia with Minimal Differentiation,99,2,Nonseminomatous,0.6004,Tumor Free,0.5700,Monoclonal Gammopathy of Undetermined Significance,0.5664,Occult Stage,0.5517,Moderately Differentiated,0.5414
M1AUER,Acute Myeloid Leukemia without Maturation<;>Auer Rods Present,99,2,Myelodysplastic Syndrome with Excess Blasts-1,0.5675,Acute Myeloid Leukemia with Multilineage Dysplasia,0.5580,Acute Myeloid Leukemia with Mutated NPM1,0.5404,Acute Myeloid Leukemia with Minimal Differentiation,0.5399,Chronic Myelomonocytic Leukemia-1,0.5364
M2,Acute Myeloid Leukemia with Maturation,99,2,Chronic Myelomonocytic Leukemia-2,0.5699,Biphasic Mesothelioma,0.5443,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.5215,Moderately Differentiated,0.5171,Alveolar Rhabdomyosarcoma,0.5056
M2AUER,Acute Myeloid Leukemia with Maturation<;>Auer Rods Present,99,2,Myelodysplastic Syndrome with Excess Blasts-2,0.6071,Chronic Myelomonocytic Leukemia-2,0.5868,Myelodysplastic Syndrome with Multilineage Dysplasia,0.5453,Myelodysplastic Syndrome with Excess Blasts-1,0.5427,Myelodysplastic Syndrome with Excess Blasts,0.5306
M3,Acute Promyelocytic Leukemia with PML-RARA,99,2,Moderately Differentiated,0.5349,Mature,0.5164,Thymoma Type B3,0.4928,Chronic Myelomonocytic Leukemia-1,0.4827,"Medulloblastoma, Non-WNT/Non-SHH, Group 3",0.4785
M4,Acute Myelomonocytic Leukemia,99,2,Acute Myeloid Leukemia with Maturation,0.5481,Thymoma Type B3,0.5460,Mature,0.5341,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.5324,Moderately Differentiated,0.5284
M4AUER,Acute Myelomonocytic Leukemia<;>Auer Rods Present,99,2,Myelodysplastic Syndrome with Excess Blasts-1,0.5661,Myelodysplastic Syndrome with Excess Blasts-2,0.5613,Acute Myeloid Leukemia with Multilineage Dysplasia,0.5548,Myelodysplastic Syndrome with Excess Blasts,0.5514,Myelodysplastic Syndrome with Multilineage Dysplasia,0.5488
M5,Acute Monoblastic and Monocytic Leukemia,1,2,Acute Monoblastic and Monocytic Leukemia,0.6235,Acute Myeloid Leukemia with Maturation,0.6157,Acute Myelomonocytic Leukemia,0.6141,Acute Monocytic Leukemia,0.6114,Acute Myeloid Leukemia with Minimal Differentiation,0.5971
M5A,Acute Monoblastic and Monocytic Leukemia,3,2,Acute Myeloid Leukemia with Minimal Differentiation,0.5911,Acute Monocytic Leukemia,0.5862,Acute Monoblastic and Monocytic Leukemia,0.5775,Acute Myelomonocytic Leukemia,0.5770,Acute Myeloid Leukemia with Maturation,0.5753
M6,Acute Erythroid Leukemia,99,2,Arm,0.5128,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.5017,Mature,0.4845,Acute Monocytic Leukemia,0.4826,Alveolar Rhabdomyosarcoma,0.4729
M7,Acute Megakaryoblastic Leukemia,99,2,Chronic Myelomonocytic Leukemia-2,0.4922,Chronic Myelomonocytic Leukemia-1,0.4820,nan,0.4659,Manubrium,0.4653,Mature,0.4491
M7DOWN,Acute Megakaryoblastic Leukemia<;>Down Syndrome,99,2,"Diffuse Midline Glioma, H3 K27M-Mutant",0.5288,Chronic Myelomonocytic Leukemia-2,0.4911,"Myelodysplastic Syndrome, Unclassifiable",0.4908,"Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable",0.4821,Myelodysplastic Syndrome with Multilineage Dysplasia,0.4749
MALIGNANT AMELANOTIC MELANOMA,Amelanotic Melanoma,1,2,Amelanotic Melanoma,0.9662,Acral Lentiginous Melanoma,0.7493,Low-CSD Melanoma,0.7214,Lentigo Maligna Melanoma,0.6974,Desmoplastic Melanoma,0.6955
MALIGNANT FIBROUS HISTIOCYTOMA,Undifferentiated Pleomorphic Sarcoma,3,2,Histiocytic Sarcoma,0.7973,Skin Fibrous Histiocytoma,0.7843,Undifferentiated Pleomorphic Sarcoma,0.7817,Myxoinflammatory Fibroblastic Sarcoma,0.7702,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,0.7582
MALIGNANT FIBROUS HISTIOCYTOMA-PLEOMORPHIC SARCOMA,Undifferentiated Pleomorphic Sarcoma,1,2,Undifferentiated Pleomorphic Sarcoma,0.8554,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,0.8314,Undifferentiated Pleomorphic Sarcoma<;>Undifferentiated Spindle Cell Sarcoma,0.7825,Pleomorphic Rhabdomyosarcoma,0.7609,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,0.7602
MALIGNANT LYMPHOMA,Lymphoma,1,2,Lymphoma,0.9527,Non-Hodgkin Lymphoma,0.7693,Lymphocytic Neoplasm,0.7291,Hematopoietic and Lymphoid Cell Neoplasm,0.6885,Leukemia,0.6828
MALIGNANT MELANOMA,Melanoma,1,2,Melanoma,0.9561,Cutaneous Melanoma,0.8936,Mucosal Melanoma,0.7626,Lentigo Maligna Melanoma,0.7480,Malignant Neoplasm,0.7326
MALIGNANT MELANOTIC MELANOMA,Melanoma,1,2,Melanoma,0.8327,Lentigo Maligna Melanoma,0.8229,Cutaneous Melanoma,0.8092,Amelanotic Melanoma,0.7403,Acral Lentiginous Melanoma,0.7344
MALIGNANT MIXED MULLERIAN TUMOR MMMT,Malignant Mixed Mesodermal (Mullerian) Tumor,1,2,Malignant Mixed Mesodermal (Mullerian) Tumor,0.8965,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.7981,"Uterine Carcinosarcoma, Heterologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.7836,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.7675,Malignant Mixed Mesodermal (Mullerian) Tumor<;>Carcinosarcoma<;>Yolk Sac Tumor,0.7004
MALIGNANT PERIPHERAL NERVE SHEATH TUMOR,Malignant Peripheral Nerve Sheath Tumor,1,2,Malignant Peripheral Nerve Sheath Tumor,1.0000,Nerve Sheath Neoplasm,0.7929,Schwannoma,0.7308,Plexiform Schwannoma,0.7006,Cellular Schwannoma,0.6902
MALIGNANT PERIPHERAL NERVE SHEATH TUMORS MPNST,Malignant Peripheral Nerve Sheath Tumor,1,2,Malignant Peripheral Nerve Sheath Tumor,0.8337,Plexiform Schwannoma,0.7200,Melanotic Schwannoma,0.6886,Spitz Melanoma,0.6535,Cellular Schwannoma,0.6494
MALIGNANT PHYLLODES TUMOR OF THE BREAST,Malignant Breast Phyllodes Tumor,1,2,Malignant Breast Phyllodes Tumor,0.9807,Phyllodes Tumor,0.8669,Benign Breast Phyllodes Tumor,0.8037,Borderline Breast Phyllodes Tumor,0.7992,Malignant PEComa,0.6213
MALIGNANT PT,Malignant Breast Phyllodes Tumor,99,2,Malignant Neoplasm,0.7329,Carcinoma,0.7201,With Tumor,0.6946,Locally Advanced Malignant Neoplasm,0.6945,Adenocarcinoma<;>Invasive,0.6774
MALIGNANT RHABDOID TUMOR,Rhabdoid Tumor,1,2,Rhabdoid Tumor,0.9500,Atypical Teratoid/Rhabdoid Tumor,0.8637,Extrarenal Rhabdoid Tumor,0.8550,Rhabdoid Tumor<;>Extracranial,0.8235,Undifferentiated Round Cell Sarcoma,0.7066
MALIGNANT SACROCOCCYGEAL TERATOMA,Sacrococcygeal Teratoma,1,2,Sacrococcygeal Teratoma,0.9089,Sacral Chordoma,0.5933,Teratoma with Somatic-Type Malignancy,0.5853,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.5655,Seminoma<;>Mature Teratoma,0.5545
MALIGNANT SMALL CELL TUMOR,"Malignant Tumor, Small Cell Type",1,2,"Malignant Tumor, Small Cell Type",0.9814,Small Cell Adenocarcinoma,0.8534,Small Cell Neuroendocrine Carcinoma,0.8449,Lung Small Cell Carcinoma,0.8303,Small Cell,0.8292
MALIGNANT TUMOR,Malignant Neoplasm,1,2,Malignant Neoplasm,0.9884,Carcinoma,0.8520,Neoplasm,0.8045,Primary Neoplasm,0.7714,With Tumor,0.7591
MALIGNANT_FIBROUS_HISTIOCYTOMA,Undifferentiated Pleomorphic Sarcoma,3,2,Histiocytic Sarcoma,0.8214,Skin Fibrous Histiocytoma,0.7758,Undifferentiated Pleomorphic Sarcoma,0.7508,Myxoinflammatory Fibroblastic Sarcoma,0.7300,True Histiocytic Lymphoma,0.7241
MALIGNANT_MELANOMA,Melanoma,1,2,Melanoma,0.9318,Cutaneous Melanoma,0.8562,Lentigo Maligna Melanoma,0.7542,Mucosal Melanoma,0.7408,Malignant Neoplasm,0.7224
MALIGNANT_PAPILLARY_SEROUS_ADENOCARCINOMA,Papillary Serous Cystadenocarcinoma,1,2,Papillary Serous Cystadenocarcinoma,0.8906,Serous Adenocarcinoma,0.8710,Serous Cystadenocarcinoma,0.8529,Serous Adenocarcinoma<;>High Grade,0.8371,Ovarian Serous Adenocarcinoma,0.8188
MALIGNANT_RHABDOID_TUMOR,Rhabdoid Tumor,1,2,Rhabdoid Tumor,0.9281,Atypical Teratoid/Rhabdoid Tumor,0.8501,Extrarenal Rhabdoid Tumor,0.8318,Rhabdoid Tumor<;>Extracranial,0.7991,Undifferentiated Round Cell Sarcoma,0.6961
MAMMARY ANALOGUE SECRETORY CARCINOMA OF SALIVARY GLAND ORIGIN,Salivary Gland Secretory Carcinoma,1,2,Salivary Gland Secretory Carcinoma,0.8479,Salivary Gland Adenocarcinoma,0.7547,Breast Secretory Carcinoma,0.7508,Salivary Gland Basal Cell Adenocarcinoma,0.7195,Salivary Duct Carcinoma,0.7042
MANTLE CELL LYMPHOMA,Mantle Cell Lymphoma,1,2,Mantle Cell Lymphoma,1.0000,B-Cell Non-Hodgkin Lymphoma<;>Mantle Cell Lymphoma,0.8958,Marginal Zone Lymphoma,0.7811,Nodal Marginal Zone Lymphoma,0.7257,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.7119
MANTLE_CELL_LYMPHOMA,Mantle Cell Lymphoma,1,2,Mantle Cell Lymphoma,0.9703,B-Cell Non-Hodgkin Lymphoma<;>Mantle Cell Lymphoma,0.8787,Marginal Zone Lymphoma,0.7713,Nodal Marginal Zone Lymphoma,0.7228,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.7174
MANUBRIUM,Manubrium,1,2,Manubrium,1.0000,Cribriform,0.5214,Pleura,0.5072,Arm,0.4844,Lung,0.4673
MARGINAL ZONE LYMPHOMA,Marginal Zone Lymphoma,1,2,Marginal Zone Lymphoma,1.0000,Nodal Marginal Zone Lymphoma,0.9390,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.8572,Mantle Cell Lymphoma,0.7811,B-Cell Non-Hodgkin Lymphoma<;>Mantle Cell Lymphoma,0.6905
MASKED LOW HYPODIPLOID,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,3,2,Hypodiploidy,0.7492,Masked Near-Haploidy,0.7351,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,0.6846,Cytogenetic Abnormality<;>Low Risk,0.6207,Near-Haploidy,0.6156
MASKED NEAR HAPLOID,Masked Near-Haploidy,1,2,Masked Near-Haploidy,0.8803,Near-Haploidy,0.7257,Diploidy,0.5667,Hypodiploidy,0.5034,Complex Karyotype,0.4720
MASTOCYTOSIS,Mastocytosis,1,2,Mastocytosis,1.0000,Systemic Mastocytosis,0.9138,Histiocytosis,0.6050,Plasmacytoma,0.5885,Langerhans Cell Histiocytosis,0.5728
MATURE,Mature,1,2,Mature,1.0000,Well Differentiated,0.6387,Moderately Differentiated,0.5894,Mature Teratoma,0.5741,Acute Myeloid Leukemia with Maturation,0.5735
MATURE B-CELL LYMPHOMA,Mature B-Cell Non-Hodgkin Lymphoma,1,2,Mature B-Cell Non-Hodgkin Lymphoma,0.9105,Mature B-Cell Neoplasm,0.9074,B-Cell Non-Hodgkin Lymphoma,0.8173,Monoclonal B-Cell Lymphocytosis,0.8070,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.8027
MATURE B-CELL NEOPLASMS,Mature B-Cell Neoplasm,1,2,Mature B-Cell Neoplasm,0.9951,B-Cell Neoplasm,0.8916,Mature B-Cell Non-Hodgkin Lymphoma,0.8820,Monoclonal B-Cell Lymphocytosis,0.8056,B-Cell Non-Hodgkin Lymphoma,0.7843
MATURE T AND NK NEOPLASMS,Mature T-Cell and NK-Cell Neoplasm,1,2,Mature T-Cell and NK-Cell Neoplasm,0.9568,Histiocytic and Dendritic Cell Neoplasm,0.6798,T-Cell Non-Hodgkin Lymphoma,0.6768,Therapy-Related Myeloid Neoplasm,0.6685,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.6460
MATURE TERATOMA,Mature Teratoma,1,2,Mature Teratoma,1.0000,Immature Teratoma,0.9278,Teratoma,0.9044,Nonseminomatous<;>Mature Teratoma,0.8890,Nonseminomatous<;>Immature Teratoma,0.8476
MBL,Medulloblastoma,99,2,Monoclonal B-Cell Lymphocytosis,0.5006,Monoclonal Gammopathy of Undetermined Significance,0.4924,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.4656,B-Cell Non-Hodgkin Lymphoma<;>Mantle Cell Lymphoma,0.4528,Chronic Myelomonocytic Leukemia-1,0.4524
MCRC METASTASIS,Metastatic Colorectal Carcinoma,2,2,Metastatic Colorectal Carcinoma<;>Primary,0.7505,Metastatic Colorectal Carcinoma,0.7221,Metastatic Lesion,0.7038,Metastatic Lesion<;>Recurrent,0.6868,Metastatic,0.6867
MCRC PRIMARY,Metastatic Colorectal Carcinoma<;>Primary,3,2,Hypermutated Colorectal Carcinoma,0.6628,Colon Medullary Carcinoma,0.6418,Metastatic Colorectal Carcinoma<;>Primary,0.6378,Medullary Carcinoma,0.6245,Colorectal Neuroendocrine Carcinoma,0.6199
MDS,Myelodysplastic Syndrome,1,2,Myelodysplastic Syndrome,0.8585,Myelodysplastic Syndrome with Multilineage Dysplasia,0.7956,"Myelodysplastic Syndrome, Unclassifiable",0.7880,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.7656,Myelodysplastic Syndrome with Excess Blasts,0.7570
MDS WITH EXCESS BLASTS,Myelodysplastic Syndrome with Excess Blasts,1,2,Myelodysplastic Syndrome with Excess Blasts,0.9599,Myelodysplastic Syndrome with Excess Blasts-1,0.9089,Myelodysplastic Syndrome with Excess Blasts-2,0.8729,Myelodysplastic Syndrome with Multilineage Dysplasia,0.7913,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.7613
MDS WITH EXCESS BLASTS-1,Myelodysplastic Syndrome with Excess Blasts-1,1,2,Myelodysplastic Syndrome with Excess Blasts-1,0.9560,Myelodysplastic Syndrome with Excess Blasts,0.8747,Myelodysplastic Syndrome with Excess Blasts-2,0.8714,Myelodysplastic Syndrome with Multilineage Dysplasia,0.7290,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.7106
MDS WITH EXCESS BLASTS-2,Myelodysplastic Syndrome with Excess Blasts-2,1,2,Myelodysplastic Syndrome with Excess Blasts-2,0.9642,Myelodysplastic Syndrome with Excess Blasts-1,0.8735,Myelodysplastic Syndrome with Excess Blasts,0.8454,Myelodysplastic Syndrome with Multilineage Dysplasia,0.7303,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.6911
MDS WITH ISOLATED DEL5Q,Myelodysplastic Syndrome with Isolated del(5q),1,2,Myelodysplastic Syndrome with Isolated del(5q),0.9394,Myelodysplastic Syndrome with del(5q),0.8744,Myelodysplastic Syndrome with Multilineage Dysplasia,0.6719,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.6641,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,0.6163
MDS WITH MULTILINEAGE DYSPLASIA,Myelodysplastic Syndrome with Multilineage Dysplasia,1,2,Myelodysplastic Syndrome with Multilineage Dysplasia,0.9470,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.8463,Acute Myeloid Leukemia with Multilineage Dysplasia,0.8268,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.7830,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.7799
MDS WITH RING SIDEROBLASTS,Myelodysplastic Syndrome with Ring Sideroblasts,1,2,Myelodysplastic Syndrome with Ring Sideroblasts,0.9604,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.9100,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.8881,Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis,0.8357,Pure Erythroid Leukemia,0.6693
MDS WITH RING SIDEROBLASTS AND MULTILINEAGE DYSPLASIA,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,1,2,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.9648,Myelodysplastic Syndrome with Ring Sideroblasts,0.9310,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.9262,Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis,0.8701,Myelodysplastic Syndrome with Multilineage Dysplasia,0.7521
MDS WITH RING SIDEROBLASTS AND SINGLE LINEAGE DYSPLASIA,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,1,2,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.9671,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.9264,Myelodysplastic Syndrome with Ring Sideroblasts,0.9131,Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis,0.8286,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.7766
MDS WITH SINGLE LINEAGE DYSPLASIA,Myelodysplastic Syndrome with Single Lineage Dysplasia,1,2,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.9529,Myelodysplastic Syndrome with Multilineage Dysplasia,0.8267,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.8001,"Myelodysplastic Syndrome, Unclassifiable",0.7702,Acute Myeloid Leukemia with Multilineage Dysplasia,0.7392
"MDS, UNCLASSIFIABLE","Myelodysplastic Syndrome, Unclassifiable",1,2,"Myelodysplastic Syndrome, Unclassifiable",0.9174,"Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable",0.8080,Myelodysplastic Syndrome,0.7528,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.7451,Myelodysplastic Syndrome with Multilineage Dysplasia,0.7446
MDS-U,"Myelodysplastic Syndrome, Unclassifiable",1,2,"Myelodysplastic Syndrome, Unclassifiable",0.8310,Myelodysplastic Syndrome with Multilineage Dysplasia,0.7631,Myelodysplastic Syndrome with Excess Blasts-1,0.7479,Myelodysplastic Syndrome with Excess Blasts,0.7463,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.7390
MDS/MPN WITH RING SIDEROBLASTS AND THROMBOCYTOSIS,Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis,1,2,Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis,0.9495,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.8613,Myelodysplastic Syndrome with Ring Sideroblasts,0.8456,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.8184,Myelodysplastic Syndrome with Multilineage Dysplasia,0.6567
"MDS/MPN, UNCLASSIFIABLE","Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable",1,2,"Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable",0.8854,"Myelodysplastic Syndrome, Unclassifiable",0.8306,Myelodysplastic/Myeloproliferative Neoplasm,0.7669,Myelodysplastic Syndrome with Multilineage Dysplasia,0.7212,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.6797
MDSMPN,Myelodysplastic/Myeloproliferative Neoplasm,1,2,Myelodysplastic/Myeloproliferative Neoplasm,0.6503,Myelodysplastic Syndrome with Multilineage Dysplasia,0.6255,"Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable",0.6084,Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.5748,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.5572
MDSMPN DIAGNOSIS AT ACQUISITION,Myelodysplastic/Myeloproliferative Neoplasm,5,2,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,0.5749,Acute Myeloid Leukemia with Multilineage Dysplasia,0.5718,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.5707,Myelodysplastic Syndrome with Multilineage Dysplasia,0.5563,Myelodysplastic/Myeloproliferative Neoplasm,0.5433
MEDULLARY,"Medullary Carcinoma, Not Otherwise Specified",2,2,Medullary Carcinoma,0.6486,"Medullary Carcinoma, Not Otherwise Specified",0.6458,Kidney Medullary Carcinoma,0.5809,Breast Medullary Carcinoma,0.5725,Mature,0.5535
MEDULLARY BREAST CARCINOMA,Breast Medullary Carcinoma,1,2,Breast Medullary Carcinoma,0.9830,Medullary Carcinoma,0.8418,"Medullary Carcinoma, Not Otherwise Specified",0.8362,Thyroid Gland Medullary Carcinoma,0.7985,Kidney Medullary Carcinoma,0.7663
MEDULLARY CARCINOMA,"Medullary Carcinoma, Not Otherwise Specified",2,2,Medullary Carcinoma,1.0000,"Medullary Carcinoma, Not Otherwise Specified",0.9800,Kidney Medullary Carcinoma,0.9178,Thyroid Gland Medullary Carcinoma,0.9085,Breast Medullary Carcinoma,0.8688
MEDULLARY CARCINOMA OF THE COLON,Colon Medullary Carcinoma,1,2,Colon Medullary Carcinoma,0.9725,Medullary Carcinoma,0.7461,"Medullary Carcinoma, Not Otherwise Specified",0.7309,Kidney Medullary Carcinoma,0.7229,Colon Mucinous Adenocarcinoma,0.7227
MEDULLARY THYROID CANCER,Thyroid Gland Medullary Carcinoma,1,2,Thyroid Gland Medullary Carcinoma,0.9640,"Medullary Carcinoma, Not Otherwise Specified",0.8695,Medullary Carcinoma,0.8692,Kidney Medullary Carcinoma,0.8093,Breast Medullary Carcinoma,0.8034
MEDULLARY THYROID CARCINOMA,Thyroid Gland Medullary Carcinoma,1,2,Thyroid Gland Medullary Carcinoma,0.9896,Medullary Carcinoma,0.9133,"Medullary Carcinoma, Not Otherwise Specified",0.9127,Kidney Medullary Carcinoma,0.8432,Breast Medullary Carcinoma,0.8145
MEDULLARY_CARCINOMA,Medullary Carcinoma,1,2,Medullary Carcinoma,0.9852,"Medullary Carcinoma, Not Otherwise Specified",0.9712,Kidney Medullary Carcinoma,0.9076,Thyroid Gland Medullary Carcinoma,0.8884,Breast Medullary Carcinoma,0.8600
MEDULLA_CARCINOMA,Thyroid Gland Medullary Carcinoma,5,2,Medullary Carcinoma,0.8281,"Medullary Carcinoma, Not Otherwise Specified",0.8211,Kidney Medullary Carcinoma,0.7668,Breast Medullary Carcinoma,0.7076,Thyroid Gland Medullary Carcinoma,0.6799
MEDULLOBLASTOMA,Medulloblastoma,1,2,Medulloblastoma,1.0000,Primitive Neuroectodermal Tumor<;>Medulloblastoma,0.9278,"Medulloblastoma, Non-WNT/Non-SHH, Group 3",0.8694,Anaplastic Medulloblastoma,0.8565,Desmoplastic/Nodular Medulloblastoma,0.8458
MED_GROUP_3,"Medulloblastoma, Non-WNT/Non-SHH, Group 3",99,2,Chronic Myelomonocytic Leukemia-2,0.5102,Chronic Myelomonocytic Leukemia-1,0.4937,Mixed,0.4654,Hypermutated Colorectal Carcinoma,0.4625,Chronic Myelomonocytic Leukemia,0.4587
MELANOMA,Melanoma,1,2,Melanoma,1.0000,Cutaneous Melanoma,0.8935,Mucosal Melanoma,0.7657,Skin Carcinoma,0.7337,Malignant Neoplasm,0.7188
MELANOMA CUTANEOUS,Cutaneous Melanoma,1,2,Cutaneous Melanoma,0.9876,Melanoma,0.8919,Skin Carcinoma,0.7977,Malignant Skin Neoplasm,0.7930,Mucosal Melanoma,0.7466
MELANOMA MUCOSAL,Mucosal Melanoma,1,2,Mucosal Melanoma,0.9854,Mucosal Melanoma of the Head and Neck,0.7665,Cutaneous Melanoma,0.7472,Melanoma,0.7400,Mucoepidermoid Carcinoma,0.6577
MELANOMA OF UNKNOWN PRIMARY,Melanoma of Unknown Primary,1,2,Melanoma of Unknown Primary,1.0000,Primary Neoplasm<;>Unpaired,0.6962,Melanoma,0.6958,Spitz Melanoma,0.6565,Uveal Melanoma,0.6498
MELANOMA OTHER,Melanoma,1,2,Melanoma,0.7805,Melanoma of Unknown Primary,0.7123,Cutaneous Melanoma,0.6893,Melanoma Involvement of Regional Cutaneous or Subcutaneous Tissue,0.6495,With Tumor,0.6176
MELANOMA UVEAL,Uveal Melanoma,1,2,Uveal Melanoma,0.9902,Ocular Melanoma,0.8024,Lentigo Maligna Melanoma,0.7132,Melanoma,0.6938,Melanoma of Unknown Primary,0.6487
"MELANOMA, AMELANOTIC",Amelanotic Melanoma,1,2,Amelanotic Melanoma,0.9858,Acral Lentiginous Melanoma,0.7461,Low-CSD Melanoma,0.7272,Spitz Melanoma,0.6906,Melanoma,0.6830
MELANOTIC MELANOMA,Melanoma,1,2,Melanoma,0.8444,Lentigo Maligna Melanoma,0.8140,Cutaneous Melanoma,0.7992,Amelanotic Melanoma,0.7698,Spitz Melanoma,0.7535
MELANOTIC SCHWANNOMA,Melanotic Schwannoma,1,2,Melanotic Schwannoma,1.0000,Plexiform Schwannoma,0.8440,Cellular Schwannoma,0.8355,Schwannoma,0.8261,Neurocutaneous Melanosis,0.7113
MENINGIOMA,Meningioma,1,2,Meningioma,1.0000,Atypical Meningioma,0.7504,Anaplastic (Malignant) Meningioma,0.7362,Meningeal Solitary Fibrous Tumor,0.6202,Glioma,0.6085
MENINGOTHELIAL TUMOR,Meningioma,1,2,Meningioma,0.6971,Glioneuronal Tumor,0.6797,Meningeal Solitary Fibrous Tumor,0.6738,Neuroepithelial Neoplasm,0.6668,Mesenchymal Cell Neoplasm,0.6374
MERKEL CELL CARCINOMA,Merkel Cell Carcinoma,1,2,Merkel Cell Carcinoma,1.0000,Pilomatrical Carcinoma,0.7433,Keratoacanthoma,0.7342,Skin Metatypical Carcinoma,0.7189,Mucoepidermoid Carcinoma,0.7079
MERKEL_CELL_CARCINOMA,Merkel Cell Carcinoma,1,2,Merkel Cell Carcinoma,0.9744,Keratoacanthoma,0.7041,Skin Metatypical Carcinoma,0.7038,Pilomatrical Carcinoma,0.7002,Mucoepidermoid Carcinoma,0.6823
MESENCHYMAL CHONDROSARCOMA,Mesenchymal Chondrosarcoma,1,2,Mesenchymal Chondrosarcoma,1.0000,Chondrosarcoma,0.9258,Dedifferentiated Chondrosarcoma,0.8478,Chondroblastoma,0.8342,Extraskeletal Myxoid Chondrosarcoma,0.8242
MESENCHYMAL NEOPLASM,Mesenchymal Cell Neoplasm,1,2,Mesenchymal Cell Neoplasm,0.9724,Soft Tissue Neoplasm,0.7168,Sarcoma,0.6919,Malignant Soft Tissue Neoplasm,0.6707,Mesenchymal Chondrosarcoma,0.6585
MESO,Mesothelioma,99,2,Sarcoma,0.6433,Carcinosarcoma,0.6425,Malignant Neoplasm,0.6224,Malignant Mixed Mesodermal (Mullerian) Tumor,0.6094,Moderately Differentiated,0.6004
MESONEPHRIC CARCINOMA,Mesonephric Adenocarcinoma,1,2,Mesonephric Adenocarcinoma,0.9697,Collecting Duct Carcinoma,0.7847,Renal Cell Carcinoma,0.7796,Chromophobe Renal Cell Carcinoma,0.7673,Kidney Medullary Carcinoma,0.7626
MESOTHELIOMA,Mesothelioma,1,2,Mesothelioma,1.0000,Sarcomatoid Mesothelioma,0.8447,Pleural Mesothelioma,0.8385,Diffuse Malignant Mesothelioma,0.8069,Epithelioid Mesothelioma,0.8040
MET,Metastatic,99,2,Malignant Mixed Mesodermal (Mullerian) Tumor,0.5494,Chronic Myelomonocytic Leukemia,0.5040,Mature,0.4998,Melanoma,0.4960,Myeloid Sarcoma,0.4949
METAPLASIA,Metaplasia,1,2,Metaplasia,1.0000,Metaplastic,0.8645,Classic Histology,0.6454,Metaplastic Carcinoma,0.6341,Epithelial-to-Mesenchymal Transition,0.6322
METAPLASTIC,Metaplastic,1,2,Metaplastic,1.0000,Metaplasia,0.8645,Metaplastic Carcinoma,0.7897,Poorly Differentiated,0.6605,Well Differentiated,0.6511
METAPLASTIC BREAST CANCER,Breast Metaplastic Carcinoma,1,2,Breast Metaplastic Carcinoma,0.9610,Breast Metaplastic Carcinoma<;>Epithelial,0.8803,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.7949,Metaplastic Carcinoma,0.7660,Breast Carcinoma with Osseous Metaplasia,0.7224
METAPLASTIC CARCINOMA,Metaplastic Carcinoma,1,2,Metaplastic Carcinoma,1.0000,Mixed Carcinoma,0.8085,Metaplastic,0.7897,Undifferentiated Carcinoma,0.7762,Breast Metaplastic Carcinoma,0.7599
METAPLASTIC_BREAST_CARCINOMA,Breast Metaplastic Carcinoma,1,2,Breast Metaplastic Carcinoma,0.9600,Breast Metaplastic Carcinoma<;>Epithelial,0.8859,Metaplastic Carcinoma,0.7986,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.7916,Metaplastic,0.7107
METAPLASTIC_CARCINOMA,Metaplastic Carcinoma,1,2,Metaplastic Carcinoma,0.9757,Metaplastic,0.8157,Mixed Carcinoma,0.7757,Undifferentiated Carcinoma,0.7611,Breast Metaplastic Carcinoma,0.7410
METASTASIS,Metastasis,1,2,Metastasis,1.0000,Metastatic,0.9205,Distant Metastasis,0.8905,Metastatic Lesion,0.8710,Secondary Malignant Neoplasm,0.7985
METASTATIC,Metastatic,1,2,Metastatic,1.0000,Metastasis,0.9205,Metastatic Lesion,0.9075,Distant Metastasis,0.8783,Secondary Malignant Neoplasm,0.8002
METASTATIC CARCINOMA,Carcinoma,99,2,Metastatic,0.8857,Metastatic Lesion,0.8573,Secondary Malignant Neoplasm,0.8352,Metastasis,0.8082,Distant Metastasis,0.7945
METASTATIC CASTRATION-RESISTANT,Castration-Resistant Prostate Carcinoma<;>Metastatic Prostate Carcinoma,1,2,Castration-Resistant Prostate Carcinoma<;>Metastatic Prostate Carcinoma,0.8624,Castration-Resistant Prostate Carcinoma,0.8472,Castration-Resistant Prostate Carcinoma<;>Non-Metastatic Prostate Carcinoma,0.7883,Castration-Sensitive Prostate Carcinoma,0.7858,Castration-Resistant Prostate Carcinoma<;>Prostate Adenocarcinoma,0.7555
METASTATIC DISEASE,Metastatic Lesion,2,2,Metastatic,0.9582,Metastatic Lesion,0.9275,Metastasis,0.8816,Distant Metastasis,0.8769,Secondary Malignant Neoplasm,0.8346
METASTATIC DISEASE CONFIRMED,Metastatic Lesion,1,2,Metastatic Lesion,0.7857,Metastatic,0.7853,Distant Metastasis,0.7338,Secondary Malignant Neoplasm,0.7116,Metastasis,0.6969
METASTATIC HORMONE-SENSITIVE,Castration-Sensitive Prostate Carcinoma,3,2,Metastatic,0.7219,Metastatic Lesion,0.6926,Castration-Sensitive Prostate Carcinoma,0.6717,Castration-Resistant Prostate Carcinoma<;>Metastatic Prostate Carcinoma,0.6713,Castration-Resistant Prostate Carcinoma,0.6527
METASTATIC SITE: BONE,Bone<;>Site of Metastasis,1,2,Bone<;>Site of Metastasis,0.9305,Malignant Bone Neoplasm,0.7255,Metastatic Lesion,0.7253,Metastatic,0.6942,Distant Metastasis,0.6823
METASTATIC SITE: BRAIN,Brain<;>Site of Metastasis,1,2,Brain<;>Site of Metastasis,0.9469,Malignant Brain Neoplasm,0.7164,Metastatic Lesion,0.6437,Malignant Central Nervous System Neoplasm,0.6402,Central Nervous System<;>Brain,0.6255
METASTATIC SITE: PLEURAL EFFUSION,Pleural Effusion<;>Site of Metastasis,1,2,Pleural Effusion<;>Site of Metastasis,0.9486,Breast Ductal Carcinoma<;>Pleural Effusion<;>Site of Metastasis,0.7964,Breast Adenocarcinoma<;>Pleural Effusion<;>Site of Metastasis,0.7538,Malignant Pleural Neoplasm,0.6732,Distant Metastasis<;>Lung,0.6520
"METASTATIC, VARIANT HISTOLOGY",Aggressive Variant Prostate Carcinoma,99,2,Metastatic,0.7567,Metastatic Lesion,0.7364,Metastasis,0.6913,Distant Metastasis,0.6599,Solid<;>High Grade Transformation,0.6491
METASTATIC_OVARIAN_CANCER,Metastatic Ovarian Carcinoma,1,2,Metastatic Ovarian Carcinoma,0.9275,Ovarian Carcinoma,0.6735,Ovarian Carcinosarcoma,0.6523,Metastatic,0.6411,Metastatic Lesion,0.6280
METATYPICAL,Skin Metatypical Carcinoma,99,2,Mature,0.6396,Primary,0.6230,Classic Histology,0.5962,Mixed,0.5833,Metaplastic,0.5618
MGUS,Monoclonal Gammopathy of Undetermined Significance,1,2,Monoclonal Gammopathy of Undetermined Significance,0.6310,Mucinous,0.5711,Malignant Myoepithelioma,0.5234,Monophasic Synovial Sarcoma,0.5130,Moderately Differentiated,0.4911
MICROPAPILLARY,Micropapillary Growth Pattern,1,2,Micropapillary Growth Pattern,0.8284,Ductal<;>Micropapillary Growth Pattern,0.6840,Micropapillary Growth Pattern<;>Solid,0.6821,Lung Micropapillary Adenocarcinoma,0.5479,Papillary,0.5446
MICROPAPILLARY ADENOCARCINOMA 82653,Lung Micropapillary Adenocarcinoma,1,2,Lung Micropapillary Adenocarcinoma,0.6245,Lepidic Adenocarcinoma,0.6034,Mixed Cell Adenocarcinoma,0.5890,Cystadenocarcinoma<;>Poorly Differentiated,0.5801,Lung Colloid Adenocarcinoma,0.5719
MICROPAPILLARY/ SOLID,Micropapillary Growth Pattern<;>Solid,1,2,Micropapillary Growth Pattern<;>Solid,0.8786,Micropapillary Growth Pattern,0.7696,Borderline Ovarian Serous Tumor-Micropapillary Variant,0.6641,Lung Micropapillary Adenocarcinoma,0.6623,Solid,0.6510
"MINIMALLY INVASIVE ADENOCARCINOMA, NON-MUCINOUS 82502",Minimally Invasive Lung Non-Mucinous Adenocarcinoma,1,2,Minimally Invasive Lung Non-Mucinous Adenocarcinoma,0.6080,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.5820,Minimally Invasive Lung Adenocarcinoma,0.5678,Mucinous Adenocarcinoma,0.5405,"Mucinous Adenocarcinoma, Endocervical Type",0.5379
MISCELLANEOUS BRAIN TUMOR,Brain Neoplasm,1,2,Brain Neoplasm,0.8338,Malignant Brain Neoplasm,0.7494,Central Nervous System Neoplasm,0.7022,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.6481,Malignant Central Nervous System Neoplasm,0.6309
MISCELLANEOUS NEUROEPITHELIAL TUMOR,Neuroepithelial Neoplasm,1,2,Neuroepithelial Neoplasm,0.8989,Dysembryoplastic Neuroepithelial Tumor,0.7624,Glioneuronal Tumor,0.7599,Neuroepithelial Neoplasm<;>High Grade,0.7575,Primitive Neuroectodermal Tumor,0.7551
MIT FAMILY TRANSLOCATION RENAL CELL CARCINOMA,MiT Family Translocation-Associated Renal Cell Carcinoma,1,2,MiT Family Translocation-Associated Renal Cell Carcinoma,0.9294,Chromophobe Renal Cell Carcinoma,0.6863,Fumarate Hydratase-Deficient Renal Cell Carcinoma,0.6803,Clear Cell Renal Cell Carcinoma,0.6699,Sarcomatoid Renal Cell Carcinoma,0.6661
MIXED,Mixed,1,2,Mixed,1.0000,Mixed Germ Cell Tumor,0.6694,Mixed Carcinoma,0.6498,Mixed Cell Adenocarcinoma,0.6481,"Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified",0.6326
MIXED 80% ALVEOLAR,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,99,2,Alveolar,0.6594,Gingiva,0.4893,Mixed,0.4845,Alveolar Rhabdomyosarcoma,0.4613,Alveolar Soft Part Sarcoma,0.4564
MIXED ACINAR & DUCTAL,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,4,2,Pancreatic Mixed Acinar-Ductal Carcinoma,0.7644,Acinar Cell,0.6549,Ductal,0.6516,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.6411,Breast Mixed Ductal and Lobular Carcinoma,0.6409
MIXED ACINAR-DUCTAL CARCINOMA,Pancreatic Mixed Acinar-Ductal Carcinoma,1,2,Pancreatic Mixed Acinar-Ductal Carcinoma,0.9141,Mixed Cell Adenocarcinoma,0.8214,Breast Mixed Ductal and Lobular Carcinoma,0.7912,Pancreatic Mixed Acinar-Neuroendocrine Carcinoma,0.7843,Acinar Cell Carcinoma,0.7747
MIXED ACINAR-NEUROENDOCRINE CARCINOMA,Pancreatic Mixed Acinar-Neuroendocrine Carcinoma,1,2,Pancreatic Mixed Acinar-Neuroendocrine Carcinoma,0.9342,Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.8420,Pancreatic Mixed Acinar-Ductal Carcinoma,0.8338,Adenocarcinoma with Neuroendocrine Differentiation,0.8265,Mixed Cell Adenocarcinoma,0.8151
MIXED ADENOCARCINOMA AND NEUROENDOCRINE CARCINOMA,Digestive System Mixed Adenoneuroendocrine Carcinoma,99,2,Adenocarcinoma with Neuroendocrine Differentiation,0.9015,Mixed Cell Adenocarcinoma,0.8396,Pancreatic Mixed Acinar-Neuroendocrine Carcinoma,0.8313,Neuroendocrine Carcinoma,0.8305,Neuroendocrine Carcinoma<;>Poorly Differentiated,0.8144
MIXED CANCER TYPES,Mixed Carcinoma,1,2,Mixed Carcinoma,0.8841,Mixed Cell Adenocarcinoma,0.7927,Mixed Germ Cell Tumor,0.7483,Cervical Carcinoma<;>Mixed,0.7321,Mixed,0.7222
MIXED CARCINOMA,Mixed Carcinoma,1,2,Mixed Carcinoma,1.0000,Mixed Cell Adenocarcinoma,0.9007,Cervical Carcinoma<;>Mixed,0.8133,Metaplastic Carcinoma,0.8085,Undifferentiated Carcinoma,0.7700
MIXED CERVICAL CARCINOMA,Cervical Carcinoma<;>Mixed,1,2,Cervical Carcinoma<;>Mixed,0.9785,Mixed Carcinoma,0.8194,"Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type",0.7490,Endometrial Carcinoma<;>Mixed,0.7294,Mixed Cell Adenocarcinoma,0.7110
MIXED DUCTAL 65% AND ACINAR,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,3,2,Pancreatic Mixed Acinar-Ductal Carcinoma,0.7064,Breast Mixed Ductal and Lobular Carcinoma,0.6558,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.6130,Pancreatic Mixed Acinar-Neuroendocrine Carcinoma,0.6064,Mixed Cell Adenocarcinoma,0.6025
MIXED DUCTAL AND ACINAR,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,99,2,Pancreatic Mixed Acinar-Ductal Carcinoma,0.7668,Breast Mixed Ductal and Lobular Carcinoma,0.6570,Ductal,0.6511,Acinar Cell,0.6500,Pancreatic Mixed Acinar-Neuroendocrine Carcinoma,0.6433
MIXED DUCTAL AND ACINAR TYPE,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,99,2,Pancreatic Mixed Acinar-Ductal Carcinoma,0.7759,Breast Mixed Ductal and Lobular Carcinoma,0.6658,Pancreatic Mixed Acinar-Neuroendocrine Carcinoma,0.6457,Acinar Cell Carcinoma,0.6430,Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.6340
MIXED GERM CELL TUMOR,Mixed Germ Cell Tumor,1,2,Mixed Germ Cell Tumor,1.0000,Nongerminomatous Germ Cell Tumor<;>Mixed Germ Cell Tumor,0.9162,Nongerminomatous Germ Cell Tumor,0.7342,Germ Cell Tumor,0.7330,Extragonadal Germ Cell Tumor,0.7269
MIXED INFILTRATING LOBULAR AND GRADE 1 DUCTAL CARCINOMA,Breast Mixed Ductal and Lobular Carcinoma,1,2,Breast Mixed Ductal and Lobular Carcinoma,0.8595,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.7962,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.7729,Invasive Breast Lobular Carcinoma,0.7145,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.6716
MIXED INVASIVE DUCTAL AND INVASIVE LOBULAR,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,1,2,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.8871,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.8791,Breast Mixed Ductal and Lobular Carcinoma,0.8221,Invasive Breast Lobular Carcinoma,0.7491,Invasive Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.6523
MIXED OVARIAN CARCINOMA,ovary mixed epithelial carcinoma,1,2,ovary mixed epithelial carcinoma,0.9339,Ovarian Carcinosarcoma,0.7563,Endometrial Carcinoma<;>Mixed,0.7553,Endometrial Clear Cell Adenocarcinoma<;>Mixed,0.7438,Ovarian Neuroendocrine Carcinoma<;>High Grade,0.7167
"MIXED PHENOTYPE ACUTE LEUKAEMIA, B/MYELOID, NOS","Mixed Phenotype Acute Leukemia, B/Myeloid",1,2,"Mixed Phenotype Acute Leukemia, B/Myeloid",0.9893,"Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified",0.9820,Acute Biphenotypic Leukemia,0.8335,"Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified",0.7941,Acute Monoblastic and Monocytic Leukemia,0.7702
"MIXED PHENOTYPE ACUTE LEUKAEMIA, T/MYELOID, NOS","Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified",1,2,"Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified",0.9827,"Mixed Phenotype Acute Leukemia, B/Myeloid",0.8205,"Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified",0.8013,Acute Biphenotypic Leukemia,0.7202,Acute Monoblastic and Monocytic Leukemia,0.7029
"MIXED PHENOTYPE ACUTE LEUKEMIA, B/MYELOID, NOS","Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified",2,2,"Mixed Phenotype Acute Leukemia, B/Myeloid",0.9964,"Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified",0.9882,Acute Biphenotypic Leukemia,0.8501,"Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified",0.8155,Acute Monoblastic and Monocytic Leukemia,0.7836
"MIXED PHENOTYPE ACUTE LEUKEMIA, T/MYELOID, NOS","Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified",1,2,"Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified",0.9898,"Mixed Phenotype Acute Leukemia, B/Myeloid",0.8255,"Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified",0.8073,Acute Biphenotypic Leukemia,0.7337,Acute Monoblastic and Monocytic Leukemia,0.7150
MIXED SEROUS AND ENDOMETRIOID,Endometrial Serous Adenocarcinoma,1,2,Endometrial Serous Adenocarcinoma,0.7616,Endometrioid Tumor,0.7410,Endometrial Carcinoma<;>Mixed,0.7297,Endometrioid Stromal Sarcoma,0.7286,Mixed<;>Serous<;>Clear Cells,0.7274
MIXED_ADENOSQUAMOUS_CARCINOMA,Adenosquamous Carcinoma,3,2,Mixed Cell Adenocarcinoma,0.8657,Mixed Carcinoma,0.8441,Adenosquamous Carcinoma,0.8367,"Lung Adenocarcinoma, Mixed Subtype",0.7823,Cervical Adenosquamous Carcinoma,0.7557
MIXED_CARCINOMA,Mixed Carcinoma,1,2,Mixed Carcinoma,0.9814,Mixed Cell Adenocarcinoma,0.8738,Metaplastic Carcinoma,0.8153,Cervical Carcinoma<;>Mixed,0.8098,Undifferentiated Carcinoma,0.7798
MIXED_ENDOMETRIOID_CLEAR_CELL,Endometrial Clear Cell Adenocarcinoma<;>Mixed,1,2,Endometrial Clear Cell Adenocarcinoma<;>Mixed,0.8546,Endometrial Carcinoma<;>Mixed,0.8028,Endometrioid Tumor,0.7423,Mixed<;>Serous<;>Clear Cells,0.7386,Endometrioid Adenocarcinoma,0.7220
MIXED_GERM_CELL,Mixed Germ Cell Tumor,1,2,Mixed Germ Cell Tumor,0.7814,Germ Cell,0.7697,Nongerminomatous Germ Cell Tumor<;>Mixed Germ Cell Tumor,0.7014,Mixed,0.6816,Mixed<;>Serous<;>Clear Cells,0.6047
MIXED_SEROUS_CLEAR_CELL,Mixed<;>Serous<;>Clear Cells,1,2,Mixed<;>Serous<;>Clear Cells,0.9204,Serous Adenocarcinoma<;>High Grade,0.7246,Serous Adenocarcinoma,0.7245,Serous Cystadenocarcinoma,0.7214,Endometrial Clear Cell Adenocarcinoma<;>Mixed,0.7001
"MLL TRANSLOCATION, POOR RISK",MLL Gene Translocation<;>Low Risk,1,2,MLL Gene Translocation<;>Low Risk,0.8147,Acute Myeloid Leukemia with MLL Rearrangement,0.6613,MLL Gene Translocation,0.6609,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.6281,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6281
"MLL TRANSLOCATION, T9:11",MLL Gene Translocation,1,2,MLL Gene Translocation,0.7404,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6595,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.6595,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,0.6090,Acute Myeloid Leukemia with MLL Rearrangement,0.5996
"MLL TRANSLOCATION, T9;11",Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,3,2,MLL Gene Translocation,0.7521,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6855,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.6855,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,0.6242,Acute Myeloid Leukemia with MLL Rearrangement,0.6220
MLL-ALL,Acute Myeloid Leukemia with MLL Rearrangement,1,2,Acute Myeloid Leukemia with MLL Rearrangement,0.7200,MLL Gene Translocation,0.6630,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6249,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL,0.6249,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.6149
MMMT,Malignant Mixed Mesodermal (Mullerian) Tumor,1,2,Malignant Mixed Mesodermal (Mullerian) Tumor,0.5701,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.4936,Malignant Myoepithelioma,0.4831,Monoclonal Gammopathy of Undetermined Significance,0.4784,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.4777
MODERATELY DIFFERENTIATED,Moderately Differentiated,1,2,Moderately Differentiated,1.0000,Poorly Differentiated,0.8615,Well Differentiated,0.8569,Adenocarcinoma<;>Moderately Differentiated,0.8092,Moderately Differentiated Adenocarcinoma Cell,0.8043
MODERATELY DIFFERENTIATED DUCTAL ADENOCARCINOMA 60% + NEUROENDOCRINE 40%,Pancreatic Moderately Differentiated Ductal Adenocarcinoma<;>Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,1,2,Pancreatic Moderately Differentiated Ductal Adenocarcinoma<;>Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.6612,Moderately Differentiated Adenocarcinoma Cell,0.6503,Pancreatic Mixed Acinar-Ductal Carcinoma,0.6281,Adenocarcinoma<;>Moderately Differentiated,0.6189,Tubular Adenocarcinoma<;>Moderately Differentiated,0.6161
MODERATELY DIFFERENTIATED TUBULAR ADENOCARCINOMA,Tubular Adenocarcinoma<;>Moderately Differentiated,1,2,Tubular Adenocarcinoma<;>Moderately Differentiated,0.9817,Tubular Adenocarcinoma<;>Well Differentiated Adenocarcinoma Cell,0.8620,Tubular Adenocarcinoma,0.8454,Adenocarcinoma<;>Moderately Differentiated,0.8325,Moderately Differentiated Adenocarcinoma Cell,0.8298
MONOCLONAL B-CELL LYMPHOCYTOSIS,Monoclonal B-Cell Lymphocytosis,1,2,Monoclonal B-Cell Lymphocytosis,1.0000,Mature B-Cell Neoplasm,0.7983,Mature B-Cell Non-Hodgkin Lymphoma,0.7458,Plasmacytoma,0.7030,Plasma Cell Myeloma,0.7004
MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA,Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma,1,2,Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma,1.0000,Angioimmunoblastic T-Cell Lymphoma,0.7213,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.6643,T-Cell Non-Hodgkin Lymphoma,0.6125,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.6055
MORPHEAN,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,99,2,Classic Histology,0.5082,Metaplasia,0.4690,Metaplastic,0.4611,Desmoplastic,0.4600,Mixed,0.4563
MSI,Microsatellite Instability,1,2,Microsatellite Instability,0.8239,High-Frequency Microsatellite Instability,0.7748,Microsatellite Stable,0.7600,Colon Adenocarcinoma<;>Microsatellite Instability,0.7366,Microsatellite Stable Colorectal Carcinoma,0.7043
MSI HYPER-MUTATED,Microsatellite Instability,4,2,High-Frequency Microsatellite Instability,0.7729,Hypermutated Colorectal Carcinoma,0.7197,Colon Adenocarcinoma<;>Microsatellite Instability,0.7127,Microsatellite Instability,0.7038,Rectal Adenocarcinoma<;>Microsatellite Instability,0.6667
MSI-H,High-Frequency Microsatellite Instability,1,2,High-Frequency Microsatellite Instability,0.7350,Microsatellite Instability,0.6981,Colon Adenocarcinoma<;>Microsatellite Instability,0.6851,Microsatellite Stable Colorectal Carcinoma,0.6498,Microsatellite Stable,0.6419
MSS,Microsatellite Stable,1,2,Microsatellite Stable,0.6605,High-Frequency Microsatellite Instability,0.6021,Microsatellite Stable Colorectal Carcinoma,0.5960,Microsatellite Instability,0.5949,Monophasic Synovial Sarcoma,0.5899
MUCINOUS,Mucinous,1,2,Mucinous,1.0000,Mucinous Adenocarcinoma,0.8261,Mucinous Cystadenocarcinoma,0.7091,Mucinous gastric carcinoma,0.7013,Signet Ring Cell<;>Mucinous,0.6967
MUCINOUS ADENOCARCINOMA LYMPH NODE,Mucinous Adenocarcinoma<;>Lymph Node,1,2,Mucinous Adenocarcinoma<;>Lymph Node,0.9766,Mucinous Adenocarcinoma,0.6917,Mucinous Cystadenocarcinoma,0.6754,Appendix Mucinous Adenocarcinoma,0.6566,Breast Mucinous Carcinoma,0.6237
MUCINOUS ADENOCARCINOMA OF ENDOCERVICAL TYPE,"Mucinous Adenocarcinoma, Endocervical Type",1,2,"Mucinous Adenocarcinoma, Endocervical Type",0.9921,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.7806,Mucinous Adenocarcinoma,0.7283,Cervical Endometrioid Adenocarcinoma,0.7271,Mucinous Cystadenocarcinoma,0.7183
MUCINOUS ADENOCARCINOMA OF THE APPENDIX,Appendix Mucinous Adenocarcinoma,1,2,Appendix Mucinous Adenocarcinoma,0.9789,Appendix Goblet Cell Adenocarcinoma,0.8133,Colon Mucinous Adenocarcinoma,0.8016,Mucinous Adenocarcinoma,0.7949,Gastric Mucinous Adenocarcinoma,0.7747
MUCINOUS ADENOCARCINOMA OF THE COLON AND RECTUM,Rectal Mucinous Adenocarcinoma<;>Colon Mucinous Adenocarcinoma,1,2,Rectal Mucinous Adenocarcinoma<;>Colon Mucinous Adenocarcinoma,0.9278,Colon Mucinous Adenocarcinoma,0.8944,Rectal Mucinous Adenocarcinoma,0.8054,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.7392,Appendix Mucinous Adenocarcinoma,0.7281
MUCINOUS CARCINOMA,Mucinous Adenocarcinoma,1,2,Mucinous Adenocarcinoma,0.9721,Mucinous Cystadenocarcinoma,0.8748,Mucinous,0.8447,Mucinous gastric carcinoma,0.8322,Gastric Mucinous Adenocarcinoma,0.8101
MUCINOUS COLLOID ADENOCARCINOMA,Gastric Mucinous Adenocarcinoma,5,2,Mucinous Adenocarcinoma,0.8953,Mucinous Cystadenocarcinoma,0.8460,Breast Mucinous Carcinoma,0.7731,Lung Colloid Adenocarcinoma,0.7711,Gastric Mucinous Adenocarcinoma,0.7710
MUCINOUS CYSTADENOCARCINOMA,Mucinous Cystadenocarcinoma,1,2,Mucinous Cystadenocarcinoma,1.0000,Mucinous Adenocarcinoma,0.8790,Cystadenocarcinoma,0.8175,Breast Mucinous Carcinoma,0.7498,Cystadenocarcinoma<;>Poorly Differentiated,0.7482
MUCINOUS CYSTIC NEOPLASM,Pancreatic Mucinous-Cystic Neoplasm,1,2,Pancreatic Mucinous-Cystic Neoplasm,0.8425,Mucinous,0.8141,Mucinous Cystadenocarcinoma,0.8088,Mucinous Adenocarcinoma,0.7929,Malignant Ovarian Mucinous Tumor,0.7119
MUCINOUS FEATURES,Mucinous,1,2,Mucinous,0.9414,Mucinous Adenocarcinoma,0.7774,Mucinous Cystadenocarcinoma,0.6601,Mucinous gastric carcinoma,0.6522,Signet Ring Cell<;>Mucinous,0.6436
"MUCINOUS FEATURES, SIGNET RING FEATURES",Signet Ring Cell<;>Mucinous,1,2,Signet Ring Cell<;>Mucinous,0.8952,Signet Ring Adenocarcinoma Cell,0.7378,Mucinous,0.7202,Signet Ring Cell Carcinoma,0.7065,Signet Ring Cell,0.6993
MUCINOUS FEATURES; SIGNET RING FEATURES,Signet Ring Cell<;>Mucinous,1,2,Signet Ring Cell<;>Mucinous,0.8940,Signet Ring Adenocarcinoma Cell,0.7449,Signet Ring Cell Carcinoma,0.7370,Signet Ring Cell,0.6852,Pancreatic Signet Ring Cell Carcinoma,0.6833
MUCINOUS LIPOSARCOMA,Liposarcoma<;>Mucinous,1,2,Liposarcoma<;>Mucinous,0.9735,Myxoid Liposarcoma,0.8240,myxoid/round cell liposarcoma,0.7908,Liposarcoma,0.7902,Well Differentiated Liposarcoma,0.7849
MUCINOUS OVARIAN CANCER,Malignant Ovarian Mucinous Tumor,1,2,Malignant Ovarian Mucinous Tumor,0.9356,Ovarian Seromucinous Carcinoma,0.7843,Mucinous Adenocarcinoma,0.7807,Mucinous Cystadenocarcinoma,0.7739,Breast Mucinous Carcinoma,0.7729
MUCINOUS STOMACH ADENOCARCINOMA,Gastric Mucinous Adenocarcinoma,1,2,Gastric Mucinous Adenocarcinoma,0.9602,Mucinous gastric carcinoma,0.9358,Mucinous Adenocarcinoma,0.7960,Gastric Poorly Cohesive Adenocarcinoma,0.7925,Appendix Mucinous Adenocarcinoma,0.7645
MUCINOUS_CARCINOMA,Mucinous Adenocarcinoma,1,2,Mucinous Adenocarcinoma,0.9481,Mucinous Cystadenocarcinoma,0.8651,Mucinous,0.8565,Mucinous gastric carcinoma,0.8071,Breast Mucinous Carcinoma,0.7961
MUCM,Mucosal Melanoma,99,2,Mucinous,0.6688,Mucosa,0.5898,Mucoepidermoid Carcinoma,0.5653,Signet Ring Cell<;>Mucinous,0.5643,Monoclonal Gammopathy of Undetermined Significance,0.5560
MUCOEPIDERMOID CARCINOMA,Mucoepidermoid Carcinoma,1,2,Mucoepidermoid Carcinoma,1.0000,Lung Mucoepidermoid Carcinoma,0.7805,Lung Non-Small Cell Carcinoma<;>Lung Mucoepidermoid Carcinoma,0.7534,Skin Metatypical Carcinoma,0.7233,Epithelial-Myoepithelial Carcinoma,0.7095
MUCOEPIDERMOID CARCINOMA OF THE LUNG,Lung Mucoepidermoid Carcinoma,1,2,Lung Mucoepidermoid Carcinoma,0.9788,Lung Non-Small Cell Carcinoma<;>Lung Mucoepidermoid Carcinoma,0.9268,Lung Lymphoepithelial Carcinoma,0.7884,Lung Sarcomatoid Carcinoma,0.7806,Mucoepidermoid Carcinoma,0.7451
MUCOEPIDERMOID_CARCINOMA,Mucoepidermoid Carcinoma,1,2,Mucoepidermoid Carcinoma,0.9788,Lung Mucoepidermoid Carcinoma,0.7421,Epithelial-Myoepithelial Carcinoma,0.7421,Skin Metatypical Carcinoma,0.7279,Lung Non-Small Cell Carcinoma<;>Lung Mucoepidermoid Carcinoma,0.7221
MUCOSAL,Mucosa,1,2,Mucosa,0.9456,Buccal Mucosa,0.6587,Epithelial,0.6324,Superficial,0.5865,Mucosal Melanoma,0.5833
MUCOSAL MELANOMA OF THE ESOPHAGUS,Esophageal Melanoma,1,2,Esophageal Melanoma,0.8649,Esophageal Squamous Cell Carcinoma,0.6403,Mucosal Melanoma,0.6327,Esophageal Neuroendocrine Carcinoma<;>Adenocarcinoma,0.6175,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.6160
MUCOSAL MELANOMA OF THE URETHRA,Urethral Melanoma,1,2,Urethral Melanoma,0.8865,Urethral Adenocarcinoma,0.7182,Urethral Urothelial Carcinoma,0.7071,Urethral Squamous Cell Carcinoma,0.7054,Urethral Carcinoma,0.6835
MUCOSAL MELANOMA OF THE VULVA/VAGINA,Vaginal Melanoma,1,2,Vaginal Melanoma,0.7816,Vulvar Carcinoma<;>Vaginal Carcinoma,0.7200,Vulvar Squamous Cell Carcinoma,0.6694,Vulvar Carcinoma,0.6608,Vaginal Squamous Cell Carcinoma,0.6031
MULLERIAN CARCINOMA,Malignant Mixed Mesodermal (Mullerian) Tumor,1,2,Malignant Mixed Mesodermal (Mullerian) Tumor,0.8137,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.7480,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.7337,Uterine Carcinosarcoma,0.7231,"Uterine Carcinosarcoma, Heterologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.7180
MULLERIAN CARCINOSARCOMA AND YOLK SAC TUMOR,Malignant Mixed Mesodermal (Mullerian) Tumor<;>Carcinosarcoma<;>Yolk Sac Tumor,1,2,Malignant Mixed Mesodermal (Mullerian) Tumor<;>Carcinosarcoma<;>Yolk Sac Tumor,0.8968,Malignant Mixed Mesodermal (Mullerian) Tumor,0.8202,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.8149,"Uterine Carcinosarcoma, Heterologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.8028,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.7796
MULLERIAN_CARCINOMA,Malignant Mixed Mesodermal (Mullerian) Tumor,1,2,Malignant Mixed Mesodermal (Mullerian) Tumor,0.8242,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.7441,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.7236,"Uterine Carcinosarcoma, Heterologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.7131,Uterine Carcinosarcoma,0.6971
MULTIPLE MYELOMA,Plasma Cell Myeloma,1,2,Plasma Cell Myeloma,0.8894,Smoldering Plasma Cell Myeloma,0.8174,Plasma Cell Myeloma<;>Plasmacytoma,0.8169,Plasmacytoma,0.7156,Plasma Cell Leukemia,0.6927
"MULTIPLE MYELOMA, PLASMACYTOMA",Plasma Cell Myeloma<;>Plasmacytoma,2,2,Plasma Cell Myeloma,0.9640,Plasma Cell Myeloma<;>Plasmacytoma,0.9630,Plasmacytoma,0.8826,Smoldering Plasma Cell Myeloma,0.8557,Plasma Cell Leukemia,0.8395
MULTIPLE_MYELOMA,Plasma Cell Myeloma,1,2,Plasma Cell Myeloma,0.8498,Smoldering Plasma Cell Myeloma,0.8115,Plasma Cell Myeloma<;>Plasmacytoma,0.7831,Plasmacytoma,0.6808,Plasma Cell Leukemia,0.6618
MUSCLE,Muscle,1,2,Muscle,1.0000,Soft Tissue,0.5852,Rhabdomyosarcoma,0.5467,Tissue,0.5241,Conventional Leiomyosarcoma,0.4880
MUSCLE INVASIVE UROTHELIAL CARCINOMA PT2 OR ABOVE,Infiltrating Urothelial Carcinoma,1,2,Infiltrating Urothelial Carcinoma,0.7202,upper tract urothelial carcinoma,0.6100,Urothelial Carcinoma,0.5885,Bladder Urothelial Carcinoma,0.5674,infiltrating bladder urothelial carcinoma sarcomatoid variant,0.5649
MYCOSIS FUNGOIDES,Mycosis Fungoides,1,2,Mycosis Fungoides,1.0000,Mycosis Fungoides and Sezary Syndrome,0.8342,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.5958,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.5825,Follicular Dendritic Cell Sarcoma,0.5772
MYCOSIS_FUNGOIDES,Mycosis Fungoides,1,2,Mycosis Fungoides,0.9805,Mycosis Fungoides and Sezary Syndrome,0.8182,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.5621,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.5526,Follicular Helper T-Cell Lymphoma,0.5477
MYCOSIS_FUNGOIDES-SEZARY_SYNDROME,Mycosis Fungoides and Sezary Syndrome,1,2,Mycosis Fungoides and Sezary Syndrome,0.9676,Mycosis Fungoides,0.8506,Sezary Syndrome,0.6911,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.5869,Follicular Helper T-Cell Lymphoma,0.5774
MYELODYSPLASTIC SYNDROME ASSOCIATED WITH ISOLATED DEL(5Q),Myelodysplastic Syndrome with del(5q),2,2,Myelodysplastic Syndrome with Isolated del(5q),0.9877,Myelodysplastic Syndrome with del(5q),0.9184,Myelodysplastic Syndrome with Multilineage Dysplasia,0.6388,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.6281,Myeloid Leukemia Associated with Down Syndrome,0.5943
MYELODYSPLASTIC SYNDROME ASSOCIATED WITH ISOLATED DEL5Q,Myelodysplastic Syndrome with Isolated del(5q),1,2,Myelodysplastic Syndrome with Isolated del(5q),0.9755,Myelodysplastic Syndrome with del(5q),0.9223,Myelodysplastic Syndrome with Multilineage Dysplasia,0.6669,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.6382,Myelodysplastic Syndrome with Excess Blasts,0.6224
"MYELODYSPLASTIC SYNDROME, UNCLASSIFIABLE","Myelodysplastic Syndrome, Unclassifiable",1,2,"Myelodysplastic Syndrome, Unclassifiable",1.0000,Myelodysplastic Syndrome,0.8521,"Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable",0.8437,Myelodysplastic Syndrome with Multilineage Dysplasia,0.8131,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.8106
MYELODYSPLASTIC SYNDROMES,Myelodysplastic Syndrome,1,2,Myelodysplastic Syndrome,0.9939,"Myelodysplastic Syndrome, Unclassifiable",0.8447,Therapy-Related Myelodysplastic Syndrome,0.8250,Myelodysplastic Syndrome with Multilineage Dysplasia,0.8244,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.8234
"MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM, UNCLASSIFIABLE","Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable",1,2,"Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable",1.0000,Myelodysplastic/Myeloproliferative Neoplasm,0.8622,"Myelodysplastic Syndrome, Unclassifiable",0.8437,Myelodysplastic Syndrome with Multilineage Dysplasia,0.7376,Myeloproliferative Neoplasm,0.6985
MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS,Myelodysplastic/Myeloproliferative Neoplasm,1,2,Myelodysplastic/Myeloproliferative Neoplasm,0.9938,"Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable",0.8591,Myeloproliferative Neoplasm,0.8312,Myelodysplastic Syndrome with Multilineage Dysplasia,0.8140,Myelodysplastic Syndrome,0.7799
MYELOID ATYPICAL,Atypical Chronic Myeloid Leukemia,1,2,Atypical Chronic Myeloid Leukemia,0.8172,Acute Myeloid Leukemia,0.7230,Acute Myeloid Leukemia with Maturation,0.7219,Acute Myeloid Leukemia Not Otherwise Specified,0.7147,Acute Myeloid Leukemia with Minimal Differentiation,0.7068
MYELOID LEUKAEMIA ASSOCIATED WITH DOWN SYNDROME,Myeloid Leukemia Associated with Down Syndrome,1,2,Myeloid Leukemia Associated with Down Syndrome,0.9843,Acute Megakaryoblastic Leukemia<;>Down Syndrome,0.7185,Myelodysplastic Syndrome with Multilineage Dysplasia,0.6834,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,0.6774,Acute Myeloid Leukemia with Multilineage Dysplasia,0.6650
MYELOID LEUKEMIA ASSOCIATED WITH DOWN SYNDROME,Myeloid Leukemia Associated with Down Syndrome,1,2,Myeloid Leukemia Associated with Down Syndrome,1.0000,Acute Megakaryoblastic Leukemia<;>Down Syndrome,0.7433,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,0.7184,Acute Myeloid Leukemia with Multilineage Dysplasia,0.7029,Myelodysplastic Syndrome with Multilineage Dysplasia,0.7017
MYELOID NEOPLASM,Myeloid Neoplasm,1,2,Myeloid Neoplasm,1.0000,Myeloid Sarcoma,0.7928,Therapy-Related Myeloid Neoplasm,0.7423,Myeloproliferative Neoplasm,0.7283,Hematopoietic and Lymphoid Cell Neoplasm,0.7222
MYELOID SARCOMA,Myeloid Sarcoma,1,2,Myeloid Sarcoma,1.0000,Myeloid Neoplasm,0.7928,Therapy-Related Myeloid Neoplasm,0.6940,Acute Myeloid Leukemia,0.6933,Histiocytic Sarcoma,0.6827
MYELOMA,Plasma Cell Myeloma,1,2,Plasma Cell Myeloma,0.8880,Plasma Cell Myeloma<;>Plasmacytoma,0.8025,Smoldering Plasma Cell Myeloma,0.7890,Plasmacytoma,0.7513,Plasma Cell Leukemia,0.7074
MYELOPROLIFERATIVE NEOPLASMS,Myeloproliferative Neoplasm,1,2,Myeloproliferative Neoplasm,0.9962,Myelodysplastic/Myeloproliferative Neoplasm,0.8267,Myeloid Neoplasm,0.7164,Polycythemia Vera<;>Myelofibrosis,0.7020,"Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable",0.6941
MYOEPITHELIAL CARCINOMA,Malignant Myoepithelioma,2,2,Epithelial-Myoepithelial Carcinoma,0.8886,Malignant Myoepithelioma,0.8844,Mucoepidermoid Carcinoma,0.7061,Metaplastic Carcinoma,0.6850,Breast Secretory Carcinoma,0.6660
MYOFIBROMA,Myofibroma,1,2,Myofibroma,1.0000,Infantile Myofibroma,0.8436,Inflammatory Myofibroblastic Tumor,0.8036,Fibrothecoma,0.7639,Solitary Fibrous Tumor,0.7275
MYXOFIBROSARCOMA,Myxofibrosarcoma,1,2,Myxofibrosarcoma,1.0000,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,0.8681,Myxoid Liposarcoma,0.8398,Myxoinflammatory Fibroblastic Sarcoma,0.8144,Myxoma,0.7552
MYXOID CHONDROSARCOMA,Extraskeletal Myxoid Chondrosarcoma,1,2,Extraskeletal Myxoid Chondrosarcoma,0.8792,Mesenchymal Chondrosarcoma,0.8373,Dedifferentiated Chondrosarcoma,0.8244,Chondrosarcoma,0.7769,Chondroblastic Osteosarcoma,0.7523
MYXOID FIBROSARCOMA,Myxofibrosarcoma,1,2,Myxofibrosarcoma,0.8794,Myxoinflammatory Fibroblastic Sarcoma,0.8274,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,0.8247,Myxoid Liposarcoma,0.7899,Low Grade Fibromyxoid Sarcoma,0.7899
MYXOID LIPOSARCOMA,Myxoid Liposarcoma,1,2,Myxoid Liposarcoma,1.0000,myxoid/round cell liposarcoma,0.9072,Myxofibrosarcoma,0.8398,Pleomorphic Liposarcoma,0.8393,Well Differentiated Liposarcoma,0.8392
MYXOID/ROUND-CELL LIPOSARCOMA,myxoid/round cell liposarcoma,1,2,myxoid/round cell liposarcoma,0.9977,Myxoid Liposarcoma,0.9102,Pleomorphic Liposarcoma,0.8384,Liposarcoma,0.8121,Well Differentiated Liposarcoma,0.8030
MYXOINFLAMMATORY FIBROBLASTIC SARCOMA,Myxoinflammatory Fibroblastic Sarcoma,1,2,Myxoinflammatory Fibroblastic Sarcoma,1.0000,Myxofibrosarcoma,0.8144,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,0.7890,Low Grade Fibromyxoid Sarcoma,0.7814,Sclerosing Epithelioid Fibrosarcoma,0.7215
MYXOMA,Myxoma,1,2,Myxoma,1.0000,Myxofibrosarcoma,0.7552,Teratoma,0.7221,Fibrothecoma,0.7028,Mature Teratoma,0.6993
MYXOPAPILLARY EPENDYMOMA,Myxopapillary Ependymoma,1,2,Myxopapillary Ependymoma,1.0000,Ependymoma,0.8497,Anaplastic Ependymoma,0.8176,Supratentorial Ependymoma<;>Subependymoma,0.7871,Ependymal Tumor,0.7780
NASOPHARYNGEAL CARCINOMA,Nasopharyngeal Carcinoma,1,2,Nasopharyngeal Carcinoma,1.0000,Nasopharyngeal-Type Undifferentiated Carcinoma,0.8409,Sinonasal Adenocarcinoma,0.6834,Sinonasal Undifferentiated Carcinoma,0.6770,Sinonasal Squamous Cell Carcinoma,0.6707
NATURAL KILLER CELL LYMPHOBLASTIC LEUKEMIA/LYMPHOMA,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,1,2,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,1.0000,Lymphoblastic Lymphoma,0.7175,Chronic Lymphoblastic Lymphoma,0.6995,B Lymphoblastic Leukemia/Lymphoma,0.6910,T Lymphoblastic Leukemia/Lymphoma,0.6505
NATURAL KILLER NK CELL LYMPHOBLASTIC LEUKEMIA/LYMPHOMA,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,1,2,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,0.9796,Lymphoblastic Lymphoma,0.6612,Chronic Lymphoblastic Lymphoma,0.6429,Anaplastic Large Cell Lymphoma,0.6402,B Lymphoblastic Leukemia/Lymphoma,0.6300
NBL,Neuroblastoma,1,2,Neuroblastoma,0.6905,B-Cell Non-Hodgkin Lymphoma,0.5776,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.5730,Dysembryoplastic Neuroepithelial Tumor,0.5699,B-Cell Non-Hodgkin Lymphoma<;>Burkitt Lymphoma,0.5573
NBNC,"Non-B, Non-C Hepatitis",99,2,Neuroblastoma,0.6921,Neurocutaneous Melanosis,0.5607,Dysembryoplastic Neuroepithelial Tumor,0.5562,Olfactory Neuroblastoma,0.5465,Central Neurocytoma,0.5463
NEAR HAPLOID,Near-Haploidy,1,2,Near-Haploidy,0.9089,Diploidy,0.7952,Masked Near-Haploidy,0.7466,Hypodiploidy,0.6576,Normal Karyotype,0.6249
NEPHROBLASTOMATOSIS,Nephroblastomatosis,1,2,Nephroblastomatosis,1.0000,Wilms Tumor,0.7210,Dysembryoplastic Neuroepithelial Tumor,0.5888,Kidney Oncocytoma,0.5880,Kidney Angiomyolipoma,0.5660
NERVE SHEATH TUMOR,Nerve Sheath Neoplasm,1,2,Nerve Sheath Neoplasm,0.9831,Schwannoma,0.8714,Malignant Peripheral Nerve Sheath Tumor,0.8087,Cellular Schwannoma,0.7748,Plexiform Schwannoma,0.7297
NESTED STROMAL EPITHELIAL TUMOR OF THE LIVER,Calcifying Nested Stromal-Epithelial Tumor of the Liver,1,2,Calcifying Nested Stromal-Epithelial Tumor of the Liver,0.9210,Hepatoblastoma,0.6477,Pleomorphic Hepatocellular Carcinoma,0.6114,Hepatocellular Adenoma,0.5688,Gallbladder Small Cell Neuroendocrine Carcinoma,0.5665
NEUROBLASTOMA,Neuroblastoma,1,2,Neuroblastoma,1.0000,Olfactory Neuroblastoma,0.7832,Primitive Neuroectodermal Tumor,0.7310,Peripheral Primitive Neuroectodermal Tumor,0.6914,Medulloblastoma,0.6801
NEUROBLASTOMA,Neuroblastoma,1,2,Neuroblastoma,0.9019,Olfactory Neuroblastoma,0.7449,Ganglioneuroblastoma,0.6609,"Ganglioneuroblastoma, Nodular",0.6606,Maturing Ganglioneuroma<;>Ganglioneuroblastoma<;>Well Differentiated,0.6489
NEUROCUTANEOUS MELANOCYTOSIS,Neurocutaneous Melanosis,1,2,Neurocutaneous Melanosis,0.9677,Melanotic Schwannoma,0.6969,Blue Nevus,0.6415,Atypical Spindle Melanocyte<;>Epithelioid Melanocyte,0.6285,Lentigo Maligna,0.6244
NEUROENDOCRINE,Neuroendocrine Neoplasm,1,2,Neuroendocrine Neoplasm,0.8445,Neuroendocrine Tumor,0.8071,Pituitary Neuroendocrine Tumor,0.7458,Neuroendocrine Carcinoma,0.7079,Endocrine,0.6974
NEUROENDOCRINE CARCINOMA,Neuroendocrine Carcinoma,1,2,Neuroendocrine Carcinoma,1.0000,Adenocarcinoma with Neuroendocrine Differentiation,0.8898,Neuroendocrine Carcinoma<;>Poorly Differentiated,0.8789,Large Cell Neuroendocrine Carcinoma,0.8747,Neuroendocrine Tumor,0.8731
NEUROENDOCRINE CARCINOMA NOS,Neuroendocrine Carcinoma,1,2,Neuroendocrine Carcinoma,0.9950,Neuroendocrine Tumor,0.8870,Neuroendocrine Neoplasm,0.8843,Adenocarcinoma with Neuroendocrine Differentiation,0.8779,Neuroendocrine Carcinoma<;>Poorly Differentiated,0.8679
"NEUROENDOCRINE CARCINOMA, NOS",Neuroendocrine Carcinoma,1,2,Neuroendocrine Carcinoma,0.9939,Neuroendocrine Tumor,0.8858,Adenocarcinoma with Neuroendocrine Differentiation,0.8814,Neuroendocrine Neoplasm,0.8811,Neuroendocrine Carcinoma<;>Poorly Differentiated,0.8691
NEUROENDOCRINE TUMOR,Neuroendocrine Tumor,1,2,Neuroendocrine Tumor,1.0000,Neuroendocrine Neoplasm,0.9818,Pituitary Neuroendocrine Tumor,0.8789,Neuroendocrine Carcinoma,0.8731,Pancreatic Neuroendocrine Tumor,0.8554
"NEUROENDOCRINE TUMOR, NOS",Neuroendocrine Tumor,1,2,Neuroendocrine Tumor,0.9937,Neuroendocrine Neoplasm,0.9808,Pituitary Neuroendocrine Tumor,0.8725,Neuroendocrine Carcinoma,0.8651,Pancreatic Neuroendocrine Tumor,0.8421
NEUROEPITHELIAL TUMOR,Neuroepithelial Neoplasm,1,2,Neuroepithelial Neoplasm,0.9736,Primitive Neuroectodermal Tumor,0.8183,Dysembryoplastic Neuroepithelial Tumor,0.7935,Neuroepithelial Neoplasm<;>High Grade,0.7871,Peripheral Primitive Neuroectodermal Tumor,0.7600
NEUROEPITHELIOMA,Primitive Neuroectodermal Tumor,2,2,Neuroepithelial Neoplasm,0.8244,Primitive Neuroectodermal Tumor,0.7641,Dysembryoplastic Neuroepithelial Tumor,0.7408,Central Nervous System Medulloepithelioma,0.7389,Glioneuronal Tumor,0.7388
NEUROFIBROMA,Neurofibroma,1,2,Neurofibroma,1.0000,Plexiform Neurofibroma,0.8273,Schwannoma,0.7744,Nerve Sheath Neoplasm,0.7128,Cellular Schwannoma,0.6873
NEUROTROPIC,Desmoplastic Neurotropic Melanoma,99,2,Peripheral Nervous System,0.6194,Brain,0.6015,Central Nervous System<;>Brain,0.5529,Central Nervous System Disorder,0.5222,Glioma,0.5134
NHL,Non-Hodgkin Lymphoma,1,2,Non-Hodgkin Lymphoma,0.7425,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.6775,B-Cell Non-Hodgkin Lymphoma,0.6724,Neuroblastoma,0.6427,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,0.6421
NKC,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,1,2,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,0.5651,Mature T-Cell and NK-Cell Neoplasm,0.5236,Clear Cell,0.5092,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0.4818,Hilar Cholangiocarcinoma,0.4786
NODAL MARGINAL ZONE LYMPHOMA,Nodal Marginal Zone Lymphoma,1,2,Nodal Marginal Zone Lymphoma,1.0000,Marginal Zone Lymphoma,0.9390,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.8634,Mantle Cell Lymphoma,0.7257,B-Cell Non-Hodgkin Lymphoma<;>Mantle Cell Lymphoma,0.6762
NODAL PERIPHERAL T-CELL LYMPHOMA WITH TFH PHENOTYPE,Follicular Helper T-Cell Lymphoma,1,2,Follicular Helper T-Cell Lymphoma,0.7378,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.6557,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6463,Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma,0.6188,Angioimmunoblastic T-Cell Lymphoma,0.6089
NODULAR,Nodular Neoplasm,1,2,Nodular Neoplasm,0.9099,Cutaneous Nodular Melanoma,0.6176,Neurofibroma,0.6030,"Ganglioneuroblastoma, Nodular",0.5972,Organoid,0.5845
NON AML MDSMPN DIAGNOSIS AT ACQUISITION,Myelodysplastic/Myeloproliferative Neoplasm,99,2,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,0.6972,Acute Myeloid Leukemia with Multilineage Dysplasia,0.6879,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.6405,Acute Myeloid Leukemia without Maturation,0.6252,Acute Myeloid Leukemia with Maturation<;>Auer Rods Present,0.6071
NON SMALL CELL LUNG CANCER,Lung Non-Small Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma,0.9526,Non-Small Cell Carcinoma,0.8423,Lung Carcinoma,0.8299,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.7727,Lung Small Cell Carcinoma,0.7681
NON SMALL CELL LUNG CANCER OTHER,Lung Non-Small Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma,0.7239,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.6330,Lung Carcinoma,0.6196,Lung Adenocarcinoma In Situ<;>Lung Non-Small Cell Carcinoma,0.5988,Lung Non-Mucinous Adenocarcinoma,0.5890
NON-GERMINOMATOUS GERM CELL TUMOR,Nongerminomatous Germ Cell Tumor,1,2,Nongerminomatous Germ Cell Tumor,0.9428,Testicular Non-Seminomatous Germ Cell Tumor,0.8216,Nongerminomatous Germ Cell Tumor<;>Mixed Germ Cell Tumor,0.7970,Germ Cell Tumor,0.7844,Extragonadal Germ Cell Tumor,0.7504
NON-GLABROUS SKIN,Non-Glabrous Skin,1,2,Non-Glabrous Skin,1.0000,Skin,0.6138,Superficial,0.5881,Nonseminomatous,0.5264,Undifferentiated,0.4915
NON-HODGKIN LYMPHOMA,Non-Hodgkin Lymphoma,1,2,Non-Hodgkin Lymphoma,1.0000,B-Cell Non-Hodgkin Lymphoma,0.8129,Lymphoma,0.7743,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.7152,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.6920
NON-HODGKINS LYMPHOMA,Non-Hodgkin Lymphoma,1,2,Non-Hodgkin Lymphoma,0.9940,B-Cell Non-Hodgkin Lymphoma,0.8070,Lymphoma,0.7824,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.7030,"Malignant Lymphoma, Large Cell, Non-Cleaved<;>Diffuse",0.6951
NON-METASTATIC CASTRATION-RESISTANT,Castration-Resistant Prostate Carcinoma<;>Non-Metastatic Prostate Carcinoma,1,2,Castration-Resistant Prostate Carcinoma<;>Non-Metastatic Prostate Carcinoma,0.8490,Castration-Resistant Prostate Carcinoma,0.8313,Castration-Sensitive Prostate Carcinoma,0.7801,Castration-Resistant Prostate Carcinoma<;>Metastatic Prostate Carcinoma,0.7675,Castration-Resistant Prostate Carcinoma<;>Prostate Adenocarcinoma,0.7292
NON-PAPILLARY,Non-Papillary Pattern,2,2,Papillary,0.8025,Non-Papillary Pattern,0.7784,Papillary Carcinoma,0.6283,Papillary Adenocarcinoma,0.6067,Acinar Cell Carcinoma<;>Papillary,0.5521
NON-SEMINOMA,Nongerminomatous Germ Cell Tumor,99,2,Seminoma,0.8305,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.7937,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.7881,Seminoma<;>Mature Teratoma,0.7717,Testicular Non-Seminomatous Germ Cell Tumor,0.7518
NON-SEMINOMA; CHORIOCARCINOMANON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; TERATOMA IMMATURE,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Choriocarcinoma<;>Mature Teratoma,99,2,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.8093,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor<;>Choriocarcinoma,0.7564,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.7358,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,0.7358,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.7290
NON-SEMINOMA; EMBRYONAL CARCINOMA,Embryonal Carcinoma<;>Nonseminomatous,2,2,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.8901,Embryonal Carcinoma<;>Nonseminomatous,0.8862,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8418,Embryonal Carcinoma<;>Seminoma,0.8324,Germ Cell Tumor<;>Embryonal Carcinoma,0.8090
NON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; TERATOMA MATURE,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma,99,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8855,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8248,Nonseminomatous<;>Immature Teratoma<;>Embryonal Carcinoma<;>Mature Teratoma,0.8169,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.8157,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.7655
NON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; CHORIOCARCINOMANON-SEMINOMA; YOLK SAC TUMORSEMINOMA; NOS,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,1,2,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.8348,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.7698,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.7169,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,0.7169,Nonseminomatous<;>Immature Teratoma<;>Embryonal Carcinoma<;>Mature Teratoma,0.7162
NON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; TERATOMA IMMATURENON-SEMINOMA; YOLK SAC TUMOR,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,99,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8445,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7832,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.7535,Nonseminomatous<;>Immature Teratoma<;>Embryonal Carcinoma<;>Mature Teratoma,0.7510,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.7082
NON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; YOLK SAC TUMOR,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,1,2,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,0.8295,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.8129,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,0.8129,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.8102,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Seminoma,0.8102
NON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; CHORIOCARCINOMA,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor<;>Choriocarcinoma,2,2,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.8035,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor<;>Choriocarcinoma,0.7531,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.7343,Choriocarcinoma<;>Nonseminomatous<;>Seminoma,0.7275,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.7230
NON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; TERATOMA IMMATURE,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,99,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8283,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7918,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.7722,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,0.7722,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7518
NON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; TERATOMA MATURE,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,5,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8283,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7918,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.7722,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,0.7722,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7518
NON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; TERATOMA IMMATURESEMINOMA; NOS,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,99,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8283,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7918,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.7722,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,0.7722,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7518
NON-SEMINOMA; EMBRYONAL CARCINOMASEMINOMA; NOS,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,1,2,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.8541,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8394,Embryonal Carcinoma<;>Nonseminomatous,0.8265,Nonseminomatous<;>Immature Teratoma<;>Embryonal Carcinoma<;>Mature Teratoma,0.7683,Choriocarcinoma<;>Nonseminomatous<;>Seminoma,0.7641
NON-SEMINOMA; EMBRYONAL CARCINOMA[NOT AVAILABLE],Embryonal Carcinoma<;>Nonseminomatous,3,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8357,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.8337,Embryonal Carcinoma<;>Nonseminomatous,0.8213,Nonseminomatous<;>Immature Teratoma<;>Embryonal Carcinoma<;>Mature Teratoma,0.7601,Embryonal Carcinoma<;>Seminoma,0.7376
NON-SEMINOMA; EMBRYONAL CARCINOMA[NOT AVAILABLE][NOT AVAILABLE][NOT AVAILABLE],Embryonal Carcinoma<;>Nonseminomatous,3,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8064,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.7929,Embryonal Carcinoma<;>Nonseminomatous,0.7655,Nonseminomatous<;>Immature Teratoma<;>Embryonal Carcinoma<;>Mature Teratoma,0.7332,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.6993
NON-SEMINOMA; TERATOMA IMMATURE,Nonseminomatous<;>Immature Teratoma,1,2,Nonseminomatous<;>Immature Teratoma,0.8649,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8378,Nonseminomatous<;>Mature Teratoma,0.8259,Immature Teratoma,0.8091,Seminoma<;>Mature Teratoma,0.8089
NON-SEMINOMA; TERATOMA IMMATURENON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; YOLK SAC TUMOR,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Immature Teratoma,3,2,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7787,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Mature Teratoma<;>Seminoma,0.7777,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Immature Teratoma,0.7769,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Immature Teratoma<;>Seminoma,0.7769,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.7683
NON-SEMINOMA; TERATOMA IMMATURENON-SEMINOMA; YOLK SAC TUMOR,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor,99,2,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Mature Teratoma<;>Seminoma,0.8563,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Immature Teratoma,0.8562,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Immature Teratoma<;>Seminoma,0.8562,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.8371,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Choriocarcinoma<;>Mature Teratoma,0.8371
NON-SEMINOMA; TERATOMA IMMATURENON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; EMBRYONAL CARCINOMA,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,99,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8027,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7660,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Mature Teratoma<;>Seminoma,0.7590,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.7589,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,0.7589
NON-SEMINOMA; TERATOMA IMMATURENON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; TERATOMA MATURE,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,99,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8027,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7660,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Mature Teratoma<;>Seminoma,0.7590,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.7589,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,0.7589
NON-SEMINOMA; TERATOMA MATURE,Nonseminomatous<;>Mature Teratoma,2,2,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8617,Nonseminomatous<;>Mature Teratoma,0.8420,Seminoma<;>Mature Teratoma,0.8402,Nonseminomatous<;>Immature Teratoma,0.8138,Mature Teratoma,0.7923
NON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; TERATOMA IMMATURENON-SEMINOMA; YOLK SAC TUMOR,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,99,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8337,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7838,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.7582,Nonseminomatous<;>Immature Teratoma<;>Embryonal Carcinoma<;>Mature Teratoma,0.7503,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.7041
NON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; TERATOMA IMMATURENON-SEMINOMA; EMBRYONAL CARCINOMA,Nonseminomatous<;>Immature Teratoma<;>Embryonal Carcinoma<;>Mature Teratoma,4,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8155,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.7634,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7582,Nonseminomatous<;>Immature Teratoma<;>Embryonal Carcinoma<;>Mature Teratoma,0.7368,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.6890
NON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; TERATOMA IMMATURENON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; YOLK SAC TUMOR,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,99,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8155,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.7634,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7582,Nonseminomatous<;>Immature Teratoma<;>Embryonal Carcinoma<;>Mature Teratoma,0.7368,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.6890
NON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; TERATOMA IMMATURENON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; CHORIOCARCINOMA,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Choriocarcinoma<;>Mature Teratoma,99,2,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7854,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Immature Teratoma,0.7776,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Immature Teratoma<;>Seminoma,0.7776,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Mature Teratoma<;>Seminoma,0.7774,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.7729
NON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; TERATOMA IMMATURENON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; EMBRYONAL CARCINOMASEMINOMA; NOS,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,99,2,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7854,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Immature Teratoma,0.7776,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Immature Teratoma<;>Seminoma,0.7776,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Mature Teratoma<;>Seminoma,0.7774,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.7729
NON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; YOLK SAC TUMOR,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor,99,2,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Immature Teratoma,0.8456,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Immature Teratoma<;>Seminoma,0.8456,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Mature Teratoma<;>Seminoma,0.8439,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.8290,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Seminoma,0.8290
NON-SEMINOMA; TERATOMA MATURESEMINOMA; NOSNON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; YOLK SAC TUMOR,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Seminoma,99,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8505,Nonseminomatous<;>Immature Teratoma<;>Embryonal Carcinoma<;>Mature Teratoma,0.8052,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.8042,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.7589,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,0.7589
NON-SEMINOMA; TERATOMA MATURE[NOT AVAILABLE]NON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; YOLK SAC TUMOR,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,4,2,Nonseminomatous<;>Immature Teratoma<;>Embryonal Carcinoma<;>Mature Teratoma,0.8052,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8022,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7417,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.7413,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,0.7413
NON-SEMINOMA; YOLK SAC TUMOR,Nonseminomatous<;>Yolk Sac Tumor,1,2,Nonseminomatous<;>Yolk Sac Tumor,0.9164,Nongerminomatous Germ Cell Tumor<;>Yolk Sac Tumor,0.8824,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,0.8800,Yolk Sac Tumor,0.8622,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor,0.8581
NON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; EMBRYONAL CARCINOMA,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,2,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8389,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,0.8191,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.8132,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,0.8132,Yolk Sac Tumor<;>Seminoma,0.8069
NON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; TERATOMA IMMATURE,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,99,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8079,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.7826,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,0.7826,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7817,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7626
NON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; TERATOMA MATURESEMINOMA; NOS,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,3,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8079,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma,0.7826,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,0.7826,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7817,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7626
NON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; TERATOMA MATURE,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor,99,2,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Immature Teratoma,0.8216,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Immature Teratoma<;>Seminoma,0.8216,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8207,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Mature Teratoma<;>Seminoma,0.8205,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.8131
NON-SEMINOMATOUS GERM CELL TUMO,Nongerminomatous Germ Cell Tumor,2,2,Testicular Non-Seminomatous Germ Cell Tumor,0.8543,Nongerminomatous Germ Cell Tumor,0.8236,Nongerminomatous Germ Cell Tumor<;>Mixed Germ Cell Tumor,0.7711,Extragonadal Germ Cell Tumor,0.7365,Mixed Germ Cell Tumor,0.7301
NON-SEMINOMATOUS GERM CELL TUMOR,Nongerminomatous Germ Cell Tumor,2,2,Testicular Non-Seminomatous Germ Cell Tumor,0.9175,Nongerminomatous Germ Cell Tumor,0.9005,Nongerminomatous Germ Cell Tumor<;>Mixed Germ Cell Tumor,0.7853,Germ Cell Tumor,0.7733,Testicular Germ Cell Tumor,0.7550
"NON-SEMINOMATOUS GERM CELL TUMOR, PREDOMINANTLY YOLK SAC TYPE",Nongerminomatous Germ Cell Tumor<;>Yolk Sac Tumor,1,2,Nongerminomatous Germ Cell Tumor<;>Yolk Sac Tumor,0.9160,Nonseminomatous<;>Yolk Sac Tumor,0.8399,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,0.8189,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7814,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Seminoma,0.7814
NON-SEMINOMATOUS MIXED GERM CELL TUMOR,Nongerminomatous Germ Cell Tumor<;>Mixed Germ Cell Tumor,1,2,Nongerminomatous Germ Cell Tumor<;>Mixed Germ Cell Tumor,0.8995,Mixed Germ Cell Tumor,0.8931,Nongerminomatous Germ Cell Tumor,0.7409,Testicular Non-Seminomatous Germ Cell Tumor,0.7325,Choriocarcinoma<;>Nonseminomatous<;>Seminoma,0.6984
NON-SMALL CELL LUNG,Lung Non-Small Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma,0.8807,Lung Carcinoma,0.7584,Lung,0.7352,Lung Small Cell Carcinoma,0.7074,Non-Small Cell Carcinoma,0.7069
NON-SMALL CELL LUNG CANCER,Lung Non-Small Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma,0.9583,Lung Carcinoma,0.8372,Non-Small Cell Carcinoma,0.8300,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.7823,Lung Small Cell Carcinoma,0.7697
"NON-SMALL CELL LUNG CANCER NSCLC, ADENOCARCINOMA",Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,1,2,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.9250,Lung Adenocarcinoma,0.8595,Lung Non-Mucinous Adenocarcinoma,0.8397,Solid Lung Adenocarcinoma,0.8190,Lung Acinar Adenocarcinoma,0.7587
"NON-SMALL CELL LUNG CANCER NSCLC, ADENOSQUAMOUS CARCINOMA",Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,1,2,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.9370,Lung Adenosquamous Carcinoma,0.8945,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.7640,Adenosquamous Carcinoma,0.7632,Lung Adenoid Cystic Carcinoma,0.7020
"NON-SMALL CELL LUNG CANCER NSCLC, LARGE CELL CARCINOMA",Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.9419,Lung Large Cell Carcinoma,0.9099,"Lung Large Cell Carcinoma, Clear Cell Variant",0.8414,Lung Non-Small Cell Carcinoma,0.7659,Large Cell Carcinoma,0.7464
"NON-SMALL CELL LUNG CANCER NSCLC, MUCOEPIDERMOID CARCINOMA",Lung Non-Small Cell Carcinoma<;>Lung Mucoepidermoid Carcinoma,1,2,Lung Non-Small Cell Carcinoma<;>Lung Mucoepidermoid Carcinoma,0.9447,Lung Mucoepidermoid Carcinoma,0.8974,Lung Lymphoepithelial Carcinoma,0.7729,Lung Sarcomatoid Carcinoma,0.7320,Mucoepidermoid Carcinoma,0.7295
"NON-SMALL CELL LUNG CANCER NSCLC, SQUAMOUS CELL CARCINOMA",Lung Squamous Cell Carcinoma,1,2,Lung Squamous Cell Carcinoma,0.8729,Lung Non-Small Cell Carcinoma,0.7758,Lung Adenosquamous Carcinoma,0.7737,Lung Sarcomatoid Carcinoma,0.7565,Lung Small Cell Carcinoma,0.7502
"NON-SMALL CELL LUNG CANCER NSCLC, UNSPECIFIED",Lung Non-Small Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma,0.8816,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.7845,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.7740,Lung Carcinoma,0.7664,Lung Non-Mucinous Adenocarcinoma,0.7445
NON-SMALL_CELL LUNG_CANCER,Lung Non-Small Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma,0.9177,Non-Small Cell Carcinoma,0.8103,Lung Carcinoma,0.7996,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.7554,Lung Small Cell Carcinoma,0.7254
NON_HODGKIN_LYMPHOMA,Non-Hodgkin Lymphoma,1,2,Non-Hodgkin Lymphoma,0.9768,B-Cell Non-Hodgkin Lymphoma,0.7872,Lymphoma,0.7477,Hodgkin Lymphoma,0.7088,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.7019
NON_SMALL_CELL_CARCINOMA,Non-Small Cell Carcinoma,1,2,Non-Small Cell Carcinoma,0.9700,Lung Non-Small Cell Carcinoma,0.7985,"Malignant Tumor, Small Cell Type",0.7967,Small Cell Adenocarcinoma,0.7752,Sarcomatoid Carcinoma,0.7646
NON_SMALL_CELL_LUNG_CANCER,Lung Non-Small Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma,0.9089,Non-Small Cell Carcinoma,0.8405,Lung Carcinoma,0.7787,Lung Small Cell Carcinoma,0.7649,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.7479
NORMAL KARYOTYPE,Normal Karyotype,1,2,Normal Karyotype,1.0000,Diploidy,0.6599,Near-Haploidy,0.6592,Complex Karyotype,0.6412,Hypodiploidy,0.5936
NORMAL-LIKE,Normal Breast-Like Subtype of Breast Carcinoma,2,2,Normal Karyotype,0.6554,Normal Breast-Like Subtype of Breast Carcinoma,0.5680,nan,0.5540,Benign Neoplasm,0.5451,Not Otherwise Specified,0.5281
NOS,Not Otherwise Specified,1,2,Not Otherwise Specified,0.6359,nan,0.5588,Nonseminomatous,0.5147,Brain,0.5101,Unclassified,0.5038
NOSNON-SEMINOMA,Nonseminomatous,99,2,Seminoma,0.9388,Testicular Seminoma,0.9078,Embryonal Carcinoma<;>Seminoma,0.8828,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.8575,Seminoma<;>Mature Teratoma,0.8554
NOT SPECIFIED,Not Otherwise Specified,1,2,Not Otherwise Specified,0.9401,Unclassified,0.7066,Nonseminomatous,0.6107,nan,0.5523,Undifferentiated,0.5474
NO_FUSION,Ewing Sarcoma,99,2,Not Otherwise Specified,0.6230,Fusion-Negative Rhabdomyosarcoma,0.5864,Tumor Free,0.5718,nan,0.5536,Unilateral,0.5530
NSCLC,Lung Non-Small Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma,0.8256,Lung Carcinoma,0.7889,Lung Adenocarcinoma,0.7621,Non-Small Cell Carcinoma,0.7183,Lung Sarcomatoid Carcinoma,0.7179
"NSCLC, ADENOCARCINOMA",Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,2,2,Lung Adenocarcinoma,0.9055,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.8891,Solid Lung Adenocarcinoma,0.8508,Lung Non-Mucinous Adenocarcinoma,0.8173,Lung Non-Small Cell Carcinoma,0.7861
NSCLC_ADENOCARCINOMA,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,2,2,Lung Adenocarcinoma,0.8872,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.8663,Lung Non-Mucinous Adenocarcinoma,0.8422,Solid Lung Adenocarcinoma,0.8285,Lung Non-Small Cell Carcinoma,0.7850
NSCLC_ADENOSQUAMOUS,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,2,2,Lung Adenosquamous Carcinoma,0.8544,Lung Non-Small Cell Carcinoma<;>Lung Adenosquamous Carcinoma,0.8276,Lung Adenocarcinoma,0.7670,Adenosquamous Carcinoma,0.7611,Lung Non-Small Cell Carcinoma<;>Lung Adenocarcinoma,0.7499
NSCLC_LARGE_CELL,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.8631,Lung Large Cell Carcinoma,0.8479,"Lung Large Cell Carcinoma, Clear Cell Variant",0.8095,Lung Non-Small Cell Carcinoma,0.7899,Lung Sarcomatoid Carcinoma,0.7316
NSCLC_MUCOEPIDERMOID,Lung Non-Small Cell Carcinoma<;>Lung Mucoepidermoid Carcinoma,1,2,Lung Non-Small Cell Carcinoma<;>Lung Mucoepidermoid Carcinoma,0.8262,Lung Mucoepidermoid Carcinoma,0.8243,Lung Lymphoepithelial Carcinoma,0.7582,Mucoepidermoid Carcinoma,0.7325,Lung Sarcomatoid Carcinoma,0.7211
NSCLC_SQUAMOUS,Lung Squamous Cell Carcinoma,1,2,Lung Squamous Cell Carcinoma,0.8011,Lung Non-Small Cell Carcinoma,0.7855,Squamous Cell Carcinoma,0.7445,Lung Adenosquamous Carcinoma,0.7413,Lung Carcinoma,0.7295
NUP98 TRANSLOCATION,NUP98 Gene<;>Chromosomal Translocation,1,2,NUP98 Gene<;>Chromosomal Translocation,0.9221,MLL Gene Translocation,0.6775,Translocation,0.6398,Supratentorial Ependymoma YAP1 Fusion-Positive,0.4940,Metastasis,0.4753
OCCULT,Occult Stage,1,2,Occult Stage,0.8259,Unclassified,0.6302,Extrahepatic,0.5933,Not Otherwise Specified,0.5577,Undifferentiated,0.5468
OCULAR MELANOMA,Ocular Melanoma,1,2,Ocular Melanoma,1.0000,Uveal Melanoma,0.8028,Melanoma,0.6590,Lentigo Maligna Melanoma,0.6523,Cutaneous Melanoma,0.6359
ODONTOGENIC CARCINOMA,Odontogenic Carcinoma,1,2,Odontogenic Carcinoma,1.0000,Clear Cell Odontogenic Carcinoma,0.8533,Gingival Carcinoma,0.6499,Salivary Duct Carcinoma,0.6340,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0.5984
OESOPHAGEAL SQUAMOUS CELL CARCINOMA,Esophageal Squamous Cell Carcinoma,1,2,Esophageal Squamous Cell Carcinoma,0.9633,Esophageal Adenocarcinoma<;>Esophageal Squamous Cell Carcinoma,0.8796,Esophageal Carcinoma,0.8234,Esophageal Adenosquamous Carcinoma,0.7992,Esophageal Adenocarcinoma,0.7780
OLFACTORY NEUROBLASTOMA,Olfactory Neuroblastoma,1,2,Olfactory Neuroblastoma,1.0000,Neuroblastoma,0.7832,"Astroblastoma, MN1-Altered",0.6744,Pineoblastoma,0.6603,Central Neurocytoma,0.6601
OLIGOASTROCYTOMA,Oligoastrocytoma,1,2,Oligoastrocytoma,1.0000,Anaplastic Oligoastrocytoma,0.8752,Oligodendroglioma,0.7148,Astrocytoma,0.6848,Anaplastic Oligodendroglioma,0.6771
OLIGODENDROGLIOMA,Oligodendroglioma,1,2,Oligodendroglioma,1.0000,Anaplastic Oligodendroglioma,0.9014,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.7860,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.7175,Oligoastrocytoma,0.7148
"OLIGODENDROGLIOMA, IDH-MUTANT AND 1P/19Q-CODELETED","Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1,2,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1.0000,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.9449,Anaplastic Oligodendroglioma,0.8172,Oligodendroglioma,0.7860,Anaplastic Oligoastrocytoma,0.6945
OMENTUM,Omentum,1,2,Omentum,1.0000,Peritoneum,0.6070,Pleura,0.5520,Abdominal Wall,0.5422,Appendage of the Uterus,0.5206
ONCOCYTIC,Oncocytic Neoplasm,1,2,Oncocytic Neoplasm,0.9170,Thyroid Gland Oncocytic Adenoma,0.7276,Thyroid Gland Oncocytic Carcinoma,0.6988,Kidney Oncocytoma,0.6862,Clear Cell,0.6239
ONCOCYTIC ADENOMA OF THE THYROID,Thyroid Gland Oncocytic Adenoma,1,2,Thyroid Gland Oncocytic Adenoma,0.9887,Thyroid Gland Oncocytic Carcinoma,0.8412,Oncocytic Neoplasm,0.7763,Kidney Oncocytoma,0.7708,Thyroid Gland Follicular Carcinoma<;>Thyroid Gland Oncocytic Carcinoma,0.7638
ONCOCYTOMA,Oncocytic Neoplasm,1,2,Oncocytic Neoplasm,0.9039,Kidney Oncocytoma,0.8847,Thyroid Gland Oncocytic Adenoma,0.8156,Thyroid Gland Oncocytic Carcinoma,0.7727,Adrenal Cortical Oncocytic Carcinoma,0.7513
OPTIC NERVE GLIOMA,Optic Nerve Glioma,1,2,Optic Nerve Glioma,1.0000,Visual Pathway Glioma,0.7763,Angiocentric Glioma,0.6619,Plexiform Schwannoma,0.6245,Glioma,0.6208
OPTIC PATHWAY GLIOMA,Visual Pathway Glioma,2,2,Optic Nerve Glioma,0.9125,Visual Pathway Glioma,0.8895,Angiocentric Glioma,0.7532,Glioma,0.6439,Diffuse Midline Glioma,0.6393
ORAL,Oral,1,2,Oral,1.0000,Pharynx,0.5737,Gastric,0.5614,Head and Neck,0.5501,Intestinal,0.5494
ORAL CAVITY SQUAMOUS CELL CARCINOMA,Oral Cavity Squamous Cell Carcinoma,1,2,Oral Cavity Squamous Cell Carcinoma,1.0000,upper aerodigestive tract neoplasm<;>Oral Cavity Squamous Cell Carcinoma,0.9177,Buccal Mucosa Squamous Cell Carcinoma,0.8219,Oropharyngeal Squamous Cell Carcinoma,0.7815,Tongue Squamous Cell Carcinoma,0.7689
ORAL DYSPLASIA,Oral Epithelial Dysplasia,1,2,Oral Epithelial Dysplasia,0.8992,Dysplastic Nevus,0.5632,Metaplasia,0.5401,Odontogenic Carcinoma,0.5161,Papilloma,0.4943
ORGANOID,Organoid,1,2,Organoid,1.0000,Lobular,0.5794,Follicle,0.5780,Diploidy,0.5646,Solid,0.5620
OROPHARYNX SQUAMOUS CELL CARCINOMA,Oropharyngeal Squamous Cell Carcinoma,1,2,Oropharyngeal Squamous Cell Carcinoma,0.9444,Pharyngeal Squamous Cell Carcinoma,0.8569,Hypopharyngeal Squamous Cell Carcinoma,0.7753,Oral Cavity Squamous Cell Carcinoma,0.7320,upper aerodigestive tract neoplasm<;>Oral Cavity Squamous Cell Carcinoma,0.7242
OS,Osteosarcoma,2,2,Bone,0.6578,Osteosarcoma,0.6202,Alveolar,0.5863,Osteoblastic Osteosarcoma,0.5811,Ovary,0.5751
OSSIFYING FIBROMYXOID TUMOR,Ossifying Fibromyxoid Tumor,1,2,Ossifying Fibromyxoid Tumor,1.0000,Giant Cell Tumor of Bone,0.7749,Fibroblastic Osteosarcoma,0.6749,Periosteal Osteosarcoma,0.6656,Solitary Fibrous Tumor,0.6644
OSTEOBLASTIC OSTEOSARCOMA,Osteoblastic Osteosarcoma,1,2,Osteoblastic Osteosarcoma,1.0000,Osteosarcoma,0.8925,Fibroblastic Osteosarcoma,0.8370,Parosteal Osteosarcoma,0.8352,Chondroblastic Osteosarcoma,0.8140
OSTEOSARCOMA,Osteosarcoma,1,2,Osteosarcoma,1.0000,Extraskeletal Osteosarcoma,0.8955,Osteoblastic Osteosarcoma,0.8925,Parosteal Osteosarcoma,0.8558,Fibroblastic Osteosarcoma,0.8422
OTHER UTERINE TUMOR,Uterine Neoplasm,1,2,Uterine Neoplasm,0.7744,Uterine Carcinosarcoma,0.5664,With Tumor,0.5405,Uterine Corpus Sarcoma,0.5165,Uterine Corpus PEComa,0.5147
OV,Ovarian Carcinoma,99,2,Ovary,0.6986,Follicle,0.5614,Organoid,0.5138,Oral,0.5106,Ovarian Dysgerminoma,0.5043
OVARIAN ADENOCARCINOMA,Ovarian Adenocarcinoma,1,2,Ovarian Adenocarcinoma,1.0000,Ovarian Carcinoma,0.9183,Ovarian Carcinosarcoma,0.7828,Ovarian Serous Adenocarcinoma,0.7643,Ovarian Clear Cell Tumor,0.7462
OVARIAN CANCER,Ovarian Carcinoma,1,2,Ovarian Carcinoma,0.9609,Ovarian Adenocarcinoma,0.8637,Ovarian Epithelial Tumor,0.7413,Ovarian Carcinosarcoma,0.7372,Ovary,0.7309
"OVARIAN CANCER, OTHER",Ovarian Carcinoma,1,2,Ovarian Carcinoma,0.7287,Ovarian Adenocarcinoma,0.6526,Ovary,0.6477,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0.6221,Ovarian Epithelial Tumor,0.6083
OVARIAN CARCINOMA,Ovarian Carcinoma,1,2,Ovarian Carcinoma,1.0000,Ovarian Adenocarcinoma,0.9183,Ovarian Carcinosarcoma,0.7810,Fallopian Tube Carcinoma<;>Ovarian Carcinoma,0.7441,Ovarian Clear Cell Tumor,0.7430
OVARIAN CARCINOMA OTHER,Ovarian Carcinoma,1,2,Ovarian Carcinoma,0.7169,Ovarian Adenocarcinoma,0.6500,Ovary,0.6298,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0.6214,Ovarian Clear Cell Tumor,0.6118
OVARIAN CARCINOSARCOMA/MALIGNANT MIXED MESODERMAL TUMOR,Ovarian Carcinosarcoma,2,2,ovary mixed epithelial carcinoma,0.8374,Ovarian Carcinosarcoma,0.8028,"Uterine Carcinosarcoma, Heterologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.7935,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.7888,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.7682
OVARIAN CLEAR CELL,Malignant Ovarian Clear Cell Tumor,1,2,Malignant Ovarian Clear Cell Tumor,0.9079,Ovarian Clear Cell Tumor,0.8983,Ovarian Clear Cell Cystadenocarcinoma,0.7991,Borderline Ovarian Clear Cell Tumor,0.7501,Clear Cell,0.7223
OVARIAN EPITHELIAL CARCINOMA OVCA,Ovarian Carcinoma,4,2,Ovarian Adenocarcinoma,0.7755,Ovarian Carcinosarcoma,0.7744,ovary mixed epithelial carcinoma,0.7553,Ovarian Carcinoma,0.7542,Malignant Ovarian Clear Cell Tumor,0.7452
OVARIAN EPITHELIAL TUMOR,Ovarian Epithelial Tumor,1,2,Ovarian Epithelial Tumor,1.0000,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0.7593,Ovarian Carcinoma,0.7323,Ovarian Germ Cell Tumor,0.7108,Ovarian Clear Cell Tumor,0.7042
OVARIAN FIBROTHECOMA,Ovarian Fibrothecoma,1,2,Ovarian Fibrothecoma,1.0000,Ovarian Dysgerminoma,0.6922,Fibrothecoma,0.6903,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0.6372,Ovarian Clear Cell Tumor,0.6362
OVARIAN GERM CELL TUMOR,Ovarian Germ Cell Tumor,1,2,Ovarian Germ Cell Tumor,1.0000,Ovarian Granulosa Cell Tumor,0.7929,Granulosa Cell Tumor,0.7419,Testicular Germ Cell Tumor,0.7276,Ovarian Clear Cell Tumor,0.7255
OVARIAN GRANULOSA CELL TUMOR,Ovarian Granulosa Cell Tumor,1,2,Ovarian Granulosa Cell Tumor,1.0000,Granulosa Cell Tumor,0.9381,Juvenile Granulosa Cell Tumor,0.8019,Ovarian Germ Cell Tumor,0.7929,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0.6802
OVARIAN HIGH-GRADE SEROUS,Ovarian High Grade Serous Adenocarcinoma,1,2,Ovarian High Grade Serous Adenocarcinoma,0.9035,Serous Adenocarcinoma<;>High Grade,0.8312,Ovarian Low Grade Serous Adenocarcinoma,0.8166,Ovarian Serous Adenocarcinoma,0.8095,Borderline Ovarian Serous Tumor,0.8081
OVARIAN LOW-GRADE SEROUS,Ovarian Low Grade Serous Adenocarcinoma,1,2,Ovarian Low Grade Serous Adenocarcinoma,0.8904,Borderline Ovarian Serous Tumor,0.8343,Ovarian High Grade Serous Adenocarcinoma,0.8215,Ovarian Serous Adenocarcinoma,0.7997,Serous Adenocarcinoma,0.7358
OVARIAN SEROMUCINOUS CARCINOMA,Ovarian Seromucinous Carcinoma,1,2,Ovarian Seromucinous Carcinoma,1.0000,Ovarian Serous Adenocarcinoma,0.7605,Ovarian High Grade Serous Adenocarcinoma,0.7489,Malignant Ovarian Mucinous Tumor,0.7400,Ovarian Carcinosarcoma,0.7344
OVARIAN SEROUS CARCINOMA,Ovarian Serous Adenocarcinoma,1,2,Ovarian Serous Adenocarcinoma,0.9597,Ovarian High Grade Serous Adenocarcinoma,0.9107,Ovarian Low Grade Serous Adenocarcinoma,0.8903,Serous Adenocarcinoma,0.8711,Serous Cystadenocarcinoma,0.8425
"OVARIAN/FALLOPIAN TUBE CANCER, NOS",Fallopian Tube Carcinoma<;>Ovarian Carcinoma,1,2,Fallopian Tube Carcinoma<;>Ovarian Carcinoma,0.7521,Ovarian Carcinoma,0.7259,Ovarian Adenocarcinoma,0.6145,Ovarian Epithelial Tumor,0.6042,Ovary,0.5821
OVARIAN_CANCER,Ovarian Carcinoma,1,2,Ovarian Carcinoma,0.8601,Ovary,0.7600,Ovarian Adenocarcinoma,0.7559,Ovarian Carcinosarcoma,0.6996,Ovarian Epithelial Tumor,0.6945
OVARIAN_CARCINOMA,Ovarian Carcinoma,1,2,Ovarian Carcinoma,0.9449,Ovarian Adenocarcinoma,0.8568,Ovarian Carcinosarcoma,0.7568,Ovarian Epithelial Tumor,0.7401,Ovary,0.7245
OVARY,Ovary,1,2,Ovary,1.0000,Ovarian Epithelial Tumor,0.6730,Ovarian Carcinoma,0.6716,Ovarian Adenocarcinoma,0.6009,Follicle,0.5894
OVARY/FALLOPIAN TUBE,Appendage of the Uterus,99,2,Ovary,0.7711,Ovarian Epithelial Tumor,0.5942,Fallopian Tube Carcinoma<;>Ovarian Carcinoma,0.5637,Ovarian Carcinoma,0.5509,Follicle,0.5297
OVARY_ADENOCARCINOMA,Ovarian Adenocarcinoma,1,2,Ovarian Adenocarcinoma,0.9321,Ovarian Carcinoma,0.8400,Ovarian Carcinosarcoma,0.7560,Ovarian Clear Cell Tumor,0.7181,Ovarian Serous Adenocarcinoma,0.7116
OVARY_CARCINOMA,Ovarian Carcinoma,1,2,Ovarian Carcinoma,0.9264,Ovarian Adenocarcinoma,0.8535,Ovarian Carcinosarcoma,0.7582,Ovarian Epithelial Tumor,0.7548,Ovary,0.7328
PAAD,Pancreatic Adenocarcinoma,99,2,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.5339,Adamantinomatous Craniopharyngioma,0.5208,Adamantinoma,0.5192,Bronchiolar Adenoma/Ciliated Muconodular Papillary Tumor,0.5058,Pancreatic Mixed Acinar-Ductal Carcinoma,0.5025
PAGET DISEASE OF THE NIPPLE,Nipple Paget Disease,1,2,Nipple Paget Disease,0.9745,Extramammary Paget Disease,0.7491,Breast Inflammatory Carcinoma,0.5383,Eccrine Carcinoma,0.5007,Pancreatic Intraductal Tubulopapillary Neoplasm,0.4979
PAIRED PRIMARY TUMOR,Primary Neoplasm<;>Paired,1,2,Primary Neoplasm<;>Paired,0.8709,Primary Neoplasm<;>Unpaired,0.7083,With Tumor,0.6607,Primary Neoplasm,0.6461,Peripheral Primitive Neuroectodermal Tumor,0.6011
PANCREAS,Pancreas,1,2,Pancreas,1.0000,Pancreatic Carcinoma,0.7065,Exocrine Gland,0.6679,Pancreatic Adenocarcinoma,0.6449,Pancreatic Undifferentiated Carcinoma,0.6036
PANCREAS-ADENOCARCINOMA DUCTAL TYPE,Pancreatic Ductal Adenocarcinoma,1,2,Pancreatic Ductal Adenocarcinoma,0.9516,Pancreatic Ductal Adenocarcinoma<;>Exocrine Gland,0.8179,Prostate Ductal Adenocarcinoma,0.8084,Pancreatic Adenocarcinoma,0.7937,Pancreatic Adenosquamous Carcinoma<;>Ductal,0.7772
PANCREAS-ADENOCARCINOMA-OTHER SUBTYPE,Pancreatic Adenocarcinoma,1,2,Pancreatic Adenocarcinoma,0.7674,Pancreatic Carcinoma,0.7098,Pancreatic Undifferentiated Carcinoma,0.6982,Pancreatic Acinar Cell Carcinoma,0.6728,Pancreatic Ductal Adenocarcinoma,0.6709
PANCREAS-COLLOID MUCINOUS NON-CYSTIC CARCINOMA,Pancreatic Colloid Carcinoma,1,2,Pancreatic Colloid Carcinoma,0.8395,Pancreatic Mucinous-Cystic Neoplasm,0.8263,Pancreatic Mixed Acinar-Neuroendocrine Carcinoma,0.7416,Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.7292,Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.6995
PANCREAS-UNDIFFERENTIATED CARCINOMA,Pancreatic Undifferentiated Carcinoma,1,2,Pancreatic Undifferentiated Carcinoma,0.9683,Pancreatoblastoma,0.7928,Pancreatic Carcinoma,0.7818,Pancreatic Adenocarcinoma,0.7744,Pancreatic Acinar Cell Carcinoma,0.7407
PANCREATIC ADENOCARCINOMA,Pancreatic Adenocarcinoma,1,2,Pancreatic Adenocarcinoma,1.0000,Pancreatic Carcinoma,0.9140,Pancreatic Acinar Cell Carcinoma,0.8504,Pancreatic Ductal Adenocarcinoma,0.8500,Pancreatic Undifferentiated Carcinoma,0.7914
PANCREATIC CANCER,Pancreatic Carcinoma,1,2,Pancreatic Carcinoma,0.9680,Pancreatic Adenocarcinoma,0.8703,Pancreas,0.7571,Pancreatic Undifferentiated Carcinoma,0.7534,Pancreatobiliary Carcinoma,0.7301
PANCREATIC CANCER OTHER,Pancreatic Carcinoma,1,2,Pancreatic Carcinoma,0.7504,Pancreatic Adenocarcinoma,0.6574,Pancreatic Undifferentiated Carcinoma,0.6470,Pancreas,0.6423,Pancreatic Neuroendocrine Tumor,0.6000
"PANCREATIC CANCER, NOS",Pancreatic Carcinoma,1,2,Pancreatic Carcinoma,0.9660,Pancreatic Adenocarcinoma,0.8665,Pancreatic Undifferentiated Carcinoma,0.7485,Pancreas,0.7439,Pancreatobiliary Carcinoma,0.7296
PANCREATIC DUCTAL ADENOCARCINOMA,Pancreatic Ductal Adenocarcinoma,1,2,Pancreatic Ductal Adenocarcinoma,1.0000,Pancreatic Ductal Adenocarcinoma<;>Exocrine Gland,0.8763,Pancreatic Adenocarcinoma,0.8500,Prostate Ductal Adenocarcinoma,0.8259,Pancreatic Adenosquamous Carcinoma<;>Ductal,0.8073
PANCREATIC NEUROENDOCRINE,Pancreatic Neuroendocrine Tumor,1,2,Pancreatic Neuroendocrine Tumor,0.8587,Neuroendocrine Neoplasm,0.7455,Neuroendocrine Tumor,0.7329,Pituitary Neuroendocrine Tumor,0.7283,Digestive System Neuroendocrine Tumor,0.6925
PANCREATIC NEUROENDOCRINE TUMOR,Pancreatic Neuroendocrine Tumor,1,2,Pancreatic Neuroendocrine Tumor,1.0000,Neuroendocrine Tumor,0.8554,Neuroendocrine Neoplasm,0.8364,Pituitary Neuroendocrine Tumor,0.8083,Digestive System Neuroendocrine Tumor,0.8022
PANCREATIC_CANCER,Pancreatic Carcinoma,1,2,Pancreatic Carcinoma,0.9046,Pancreatic Adenocarcinoma,0.8107,Pancreas,0.7718,Pancreatic Undifferentiated Carcinoma,0.7424,Pancreatobiliary Carcinoma,0.6882
PANCREATOBILIARY,Pancreatobiliary Carcinoma,3,2,Pancreas,0.7772,Biliary Tract,0.7212,Pancreatobiliary Carcinoma,0.7104,Bile Duct,0.6533,Proximal Bile Duct,0.6367
PANCREATOBILIARY AMPULLARY CARCINOMA,Ampulla of Vater Pancreatobiliary Type Adenocarcinoma,1,2,Ampulla of Vater Pancreatobiliary Type Adenocarcinoma,0.8816,Ampulla of Vater Carcinoma,0.8299,Pancreatobiliary Carcinoma,0.8024,Extrahepatic Bile Duct Adenocarcinoma,0.6607,Pancreatic Acinar Cell Carcinoma,0.6384
PANCREATOBLASTOMA,Pancreatoblastoma,1,2,Pancreatoblastoma,1.0000,Pancreatic Undifferentiated Carcinoma,0.8142,Pancreatic Neuroendocrine Tumor,0.7680,Pancreatic Insulinoma<;>Benign,0.7163,Pancreatic Colloid Carcinoma,0.6927
PANET,Pancreatic Neuroendocrine Tumor,99,2,Polymorphous Low Grade Neuroepithelial Tumor of the Young,0.5907,Pancreatic Mixed Acinar-Neuroendocrine Carcinoma,0.5876,Peripheral Primitive Neuroectodermal Tumor,0.5800,"Astroblastoma, MN1-Altered",0.5737,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.5724
PAPILLARY,Papillary,1,2,Papillary,1.0000,Non-Papillary Pattern,0.6834,Papillary Carcinoma,0.6592,Papillary Adenocarcinoma,0.6189,Ductal,0.5824
PAPILLARY ADENOCARCINOMA 82603,Papillary Adenocarcinoma,1,2,Papillary Adenocarcinoma,0.6528,Papillary Serous Cystadenocarcinoma,0.6526,Acinar Cell Carcinoma<;>Papillary,0.6165,Lung Papillary Adenocarcinoma,0.6147,Gastric Papillary Adenocarcinoma,0.6113
PAPILLARY CARCINOMA,Papillary Carcinoma,1,2,Papillary Carcinoma,1.0000,Papillary Adenocarcinoma,0.9332,Thyroid Gland Papillary Carcinoma,0.8831,Classic Thyroid Gland Papillary Carcinoma,0.8552,Acinar Cell Carcinoma<;>Papillary,0.8093
"PAPILLARY CARCINOMA, DIFFUSE SCLEROSING VARIANT",Diffuse Sclerosing Variant Thyroid Gland Papillary Carcinoma,1,2,Diffuse Sclerosing Variant Thyroid Gland Papillary Carcinoma,0.9453,Papillary Adenocarcinoma,0.7565,Papillary Carcinoma,0.7466,Classic Thyroid Gland Papillary Carcinoma,0.7368,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,0.6946
PAPILLARY CARCINOMA: MIXED PAPILLARY AND FOLLICULAR VARIANT,Follicular Variant Thyroid Gland Papillary Carcinoma,1,2,Follicular Variant Thyroid Gland Papillary Carcinoma,0.8836,Thyroid Gland Papillary and Follicular Carcinoma,0.7857,Classic Thyroid Gland Papillary Carcinoma,0.7534,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.7282,Papillary Carcinoma,0.7272
PAPILLARY INFILTRATING DUCTAL CARCINOMA-MAMMARY GLAND,Breast Papillary Ductal Carcinoma with Invasion,1,2,Breast Papillary Ductal Carcinoma with Invasion,0.8880,Breast Solid Papillary Carcinoma,0.7233,Acinar Cell Carcinoma<;>Papillary,0.6633,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,0.6459,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.6332
PAPILLARY INFILTRATING DUCTAL CARCINOMA-MAMMARY GLAND; BREAST,Breast Papillary Ductal Carcinoma with Invasion,1,2,Breast Papillary Ductal Carcinoma with Invasion,0.9077,Breast Solid Papillary Carcinoma,0.7493,Acinar Cell Carcinoma<;>Papillary,0.6418,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.6250,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,0.6224
PAPILLARY KIDNEY RENAL CELL CARCINOMA,Papillary Renal Cell Carcinoma,1,2,Papillary Renal Cell Carcinoma,0.9850,Clear Cell Papillary Renal Neoplasm,0.8864,Chromophobe Renal Cell Carcinoma,0.8389,Renal Cell Carcinoma,0.8332,Clear Cell Renal Cell Carcinoma,0.8186
PAPILLARY RENAL CELL CARCINOMA,Papillary Renal Cell Carcinoma,1,2,Papillary Renal Cell Carcinoma,1.0000,Clear Cell Papillary Renal Neoplasm,0.8751,Renal Cell Carcinoma,0.8342,Chromophobe Renal Cell Carcinoma,0.8335,Clear Cell Renal Cell Carcinoma,0.8147
PAPILLARY STOMACH ADENOCARCINOMA,Gastric Papillary Adenocarcinoma,1,2,Gastric Papillary Adenocarcinoma,0.9522,Papillary Adenocarcinoma,0.7722,Gastric Tubular Adenocarcinoma,0.7510,Gastric Poorly Cohesive Adenocarcinoma,0.7492,Gastric Adenocarcinoma,0.7197
PAPILLARY THROID CARCINOMA,Thyroid Gland Papillary Carcinoma,1,2,Thyroid Gland Papillary Carcinoma,0.8279,Classic Thyroid Gland Papillary Carcinoma,0.8148,Papillary Carcinoma,0.7984,Papillary Transitional Cell Carcinoma,0.7920,Papillary Adenocarcinoma,0.7873
PAPILLARY THYROID CANCER,Thyroid Gland Papillary Carcinoma,1,2,Thyroid Gland Papillary Carcinoma,0.9739,Classic Thyroid Gland Papillary Carcinoma,0.9046,Papillary Carcinoma,0.8573,Thyroid Gland Papillary and Follicular Carcinoma,0.8464,Papillary Adenocarcinoma,0.7935
"PAPILLARY, FOLLICULAR",Thyroid Gland Papillary and Follicular Carcinoma,99,2,Papillary,0.7960,Non-Papillary Pattern,0.5965,Follicle,0.5791,Follicular Variant Thyroid Gland Papillary Carcinoma,0.5616,Papillary Carcinoma,0.5608
"PAPILLARY, TALL CELL VARIANT",Tall Cell Variant Thyroid Gland Papillary Carcinoma,1,2,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.8150,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.6611,Classic Thyroid Gland Papillary Carcinoma,0.6578,Follicular Variant Thyroid Gland Papillary Carcinoma,0.6423,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,0.6422
PAPILLARY_ADENOCARCINOMA,Papillary Adenocarcinoma,1,2,Papillary Adenocarcinoma,0.9796,Papillary Carcinoma,0.9054,Acinar Cell Carcinoma<;>Papillary,0.8748,Lung Papillary Adenocarcinoma,0.7969,Gastric Papillary Adenocarcinoma,0.7903
PAPILLARY_CARCINOMA,Papillary Carcinoma,1,2,Papillary Carcinoma,0.9755,Papillary Adenocarcinoma,0.8994,Thyroid Gland Papillary Carcinoma,0.8433,Classic Thyroid Gland Papillary Carcinoma,0.8138,Papillary Transitional Cell Carcinoma,0.7772
PAPILLARY_TRANSITIONAL_CELL_CARCINOMA,Papillary Transitional Cell Carcinoma,1,2,Papillary Transitional Cell Carcinoma,0.9703,Papillary Carcinoma,0.8189,Transitional Cell Carcinoma,0.7846,Urothelial Papilloma,0.7693,"Kidney Carcinoma, Transitional Cells",0.7563
PAPILLOMA,Papilloma,1,2,Papilloma,1.0000,Urothelial Papilloma,0.6747,Pilomatrical Carcinoma,0.5802,Dysplastic Nevus,0.5799,Papillary Carcinoma,0.5578
PARAGANGLIOMA,Paraganglioma,1,2,Paraganglioma,1.0000,Adrenal Gland Pheochromocytoma<;>Paraganglioma,0.9168,Extra-Adrenal Sympathetic Paraganglioma,0.8862,Adrenal Gland Pheochromocytoma,0.8152,Extra-Adrenal Pheochromocytoma,0.7861
PARAGANGLIOMA; EXTRA-ADRENAL PHEOCHROMOCYTOMA,Extra-Adrenal Sympathetic Paraganglioma,3,2,Adrenal Gland Pheochromocytoma<;>Paraganglioma,0.9387,Extra-Adrenal Pheochromocytoma,0.9348,Extra-Adrenal Sympathetic Paraganglioma,0.8907,Adrenal Gland Pheochromocytoma,0.8888,Paraganglioma,0.8748
PARAOSTEAL OSTEOSARCOMA,Parosteal Osteosarcoma,1,2,Parosteal Osteosarcoma,0.8525,Periosteal Osteosarcoma,0.8301,Osteosarcoma,0.7790,Osteoblastic Osteosarcoma,0.7662,Telangiectatic Osteosarcoma,0.7617
PARASPIL MASS,Neoplasm<;>Paraspinal,1,2,Neoplasm<;>Paraspinal,0.6343,Myxoma,0.5411,Neurofibroma,0.4963,Nipple Paget Disease,0.4917,Plexiform Neurofibroma,0.4907
PAST,Pilocytic Astrocytoma,99,2,Distal,0.5332,Gingiva,0.5129,Primary,0.5071,Distant,0.4907,Recurrent,0.4823
PAX3/FOXO1-FUSION,PAX3/FOXO1 Fusion Gene,1,2,PAX3/FOXO1 Fusion Gene,0.9590,Fusion-Positive Rhabdomyosarcoma,0.6331,Fusion-Negative Rhabdomyosarcoma,0.5483,Supratentorial Ependymoma YAP1 Fusion-Positive,0.5385,FOXA1 Gene,0.5183
PCPG,Adrenal Gland Pheochromocytoma<;>Paraganglioma,99,2,Extra-Adrenal Pheochromocytoma,0.4594,PEComa,0.4467,Castration-Resistant Prostate Carcinoma<;>Prostate Neuroendocrine Neoplasm,0.4289,Castration-Resistant Prostate Carcinoma,0.4257,Gastric,0.4209
PDA -  SIGNET RING,Pancreatic Signet Ring Cell Carcinoma,99,2,Signet Ring Cell,0.6476,Papillary,0.5483,Signet Ring Adenocarcinoma Cell,0.5330,Ductal,0.5262,Ductal<;>Micropapillary Growth Pattern,0.5080
PDA - ADENOSQUAMOUS CARCINOMA,Pancreatic Ductal Adenocarcinoma<;>Pancreatic Adenosquamous Carcinoma,99,2,Adenosquamous Carcinoma,0.9237,Cervical Adenosquamous Carcinoma,0.8087,Lung Adenosquamous Carcinoma,0.8054,Poorly Differentiated Adenocarcinoma,0.7470,Squamous Cell Carcinoma<;>Poorly Differentiated,0.7460
PDA - MIXED DUCTAL ENDOCRINE CARCINOMA,Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,1,2,Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.8123,Pancreatic Mixed Acinar-Ductal Carcinoma,0.7952,Digestive System Mixed Adenoneuroendocrine Carcinoma,0.7820,Pancreatic Mixed Acinar-Neuroendocrine Carcinoma,0.7406,Pancreatic Moderately Differentiated Ductal Adenocarcinoma<;>Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.7081
PDA - MUCINOUS NON-CYSTIC CARCINOMA,Pancreatic Colloid Carcinoma,99,2,Mucinous Adenocarcinoma,0.8218,Mucinous Cystadenocarcinoma,0.7822,Pancreatic Mixed Acinar-Ductal Carcinoma,0.7313,Pancreatic Mucinous-Cystic Neoplasm,0.7300,Mucinous,0.6945
PDA - UNDIFFERENTIATED ANAPLASTIC CARCINOMA,Pancreatic Undifferentiated Carcinoma,99,2,Anaplastic Carcinoma,0.8281,Adenocarcinoma<;>Undifferentiated Carcinoma,0.7954,Undifferentiated Carcinoma,0.7945,Adenocarcinoma<;>Undifferentiated,0.7780,Undifferentiated Pleomorphic Sarcoma,0.7776
PDA - UNDIFFERENTIATED CARCINOMA SOME MULTINUCLEATED BUT NOT OSTEOCLAST,Pancreatic Undifferentiated Carcinoma,99,2,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0.8158,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells<;>Sarcomatoid Carcinoma,0.7630,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,0.7532,Giant Cell Carcinoma,0.6803,Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.6591
PDA - UNDIFFERENTIATED CARCINOMA WITH OSTEOCLAST LIKE GIANT CELLS,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,1,2,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0.8965,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells<;>Sarcomatoid Carcinoma,0.8293,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,0.7998,Giant Cell Carcinoma,0.7989,Undifferentiated Carcinoma,0.6893
PDA - UNDIFFERENTIATED CARCINOMA WITH SPINDLING AND OSTEOCLAST LIKE GIANT CELLS,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells<;>Sarcomatoid Carcinoma,2,2,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0.8229,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells<;>Sarcomatoid Carcinoma,0.8072,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,0.7905,Undifferentiated Pleomorphic Sarcoma,0.7448,Giant Cell Carcinoma,0.7321
PDAC-CLEAR CELL,Clear Cell,1,2,Clear Cell,0.8214,Adenocarcinoma Clear Cell,0.7325,Clear Cell Adenocarcinoma,0.6983,Pancreatic Adenocarcinoma<;>Poorly Differentiated Adenocarcinoma Cell,0.6732,Pancreatic Undifferentiated Carcinoma,0.6544
PEDIATRIC HIGH GRADE GLIOMAS,Malignant Glioma<;>Pediatric,1,2,Malignant Glioma<;>Pediatric,0.8719,Low Grade Glioma<;>Pediatric,0.8623,High Grade Astrocytic Tumor,0.7359,Malignant Glioma,0.7290,Low Grade Glioma,0.7028
PEDIATRIC LOW GRADE GLIOMAS,Low Grade Glioma<;>Pediatric,1,2,Low Grade Glioma<;>Pediatric,0.9742,Malignant Glioma<;>Pediatric,0.8233,Low Grade Glioma,0.8162,Low Grade Glioma<;>Low Grade Astrocytoma,0.7497,Glioneuronal Tumor,0.6654
PENILE CANCER,Penile Carcinoma,1,2,Penile Carcinoma,0.9619,Squamous Cell Carcinoma of the Penis,0.7009,Prostate Carcinoma,0.6680,Urethral Carcinoma,0.6258,Anal Carcinoma,0.6242
PENILE SQUAMOUS CELL CARCINOMA,Squamous Cell Carcinoma of the Penis,1,2,Squamous Cell Carcinoma of the Penis,0.9381,Penile Carcinoma,0.8678,Basaloid Squamous Cell Carcinoma of the Penis,0.7863,Urethral Squamous Cell Carcinoma,0.7508,Prostate Squamous Cell Carcinoma,0.7411
PERIHILAR CHOLANGIOCARCINOMA,Hilar Cholangiocarcinoma,1,2,Hilar Cholangiocarcinoma,0.9106,Cholangiocarcinoma,0.8587,Intrahepatic Cholangiocarcinoma,0.8325,Hepatocellular Carcinoma<;>Intrahepatic Cholangiocarcinoma,0.8009,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.7698
PERIOSTEAL OSTEOSARCOMA,Periosteal Osteosarcoma,1,2,Periosteal Osteosarcoma,1.0000,Parosteal Osteosarcoma,0.8648,Telangiectatic Osteosarcoma,0.8045,Osteosarcoma,0.8013,Fibroblastic Osteosarcoma,0.7951
PERIPHERAL MEDULLOEPITHELIOMA,Central Nervous System Medulloepithelioma,1,2,Central Nervous System Medulloepithelioma,0.8986,Peripheral Primitive Neuroectodermal Tumor,0.7798,Pineoblastoma,0.7044,Primitive Neuroectodermal Tumor<;>Medulloblastoma,0.7021,Ganglioneuroblastoma,0.6929
PERIPHERAL NERVOUS SYSTEM,Peripheral Nervous System,1,2,Peripheral Nervous System,1.0000,Central Nervous System<;>Brain,0.6307,Brain,0.6073,Malignant Peripheral Nerve Sheath Tumor,0.5702,Central Nervous System Disorder,0.5479
PERIPHERAL NEUROECTODERMAL TUMOR,Peripheral Primitive Neuroectodermal Tumor,1,2,Peripheral Primitive Neuroectodermal Tumor,0.9737,Primitive Neuroectodermal Tumor,0.9307,Neuroepithelial Neoplasm,0.7501,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7195,Dysembryoplastic Neuroepithelial Tumor,0.7184
"PERIPHERAL T-CELL LYMPHOMA, NOS","Peripheral T-Cell Lymphoma, Not Otherwise Specified",1,2,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.9678,T-Cell Non-Hodgkin Lymphoma,0.8013,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.7669,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.7017,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.6997
PERIPHERAL_T_CELL_LYMPHOMA_UNSPECIFIED,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",1,2,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.9569,T-Cell Non-Hodgkin Lymphoma,0.8197,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.8012,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.7256,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.7101
"PERITONEAL CANCER, NOS",Malignant Peritoneal Neoplasm,1,2,Malignant Peritoneal Neoplasm,0.9428,Peritoneal Mesothelioma,0.8052,Peritoneum,0.6830,Ovarian Carcinoma,0.6518,Malignant Pleural Neoplasm,0.6396
PERITONEAL MESOTHELIOMA,Peritoneal Mesothelioma,1,2,Peritoneal Mesothelioma,1.0000,Pleural Mesothelioma,0.8289,Malignant Peritoneal Neoplasm,0.8182,Mesothelioma,0.7879,Sarcomatoid Mesothelioma,0.7476
PERITONEAL SEROUS CARCINOMA,Malignant Peritoneal Neoplasm,99,2,Ovarian Serous Adenocarcinoma,0.7883,Serous Cystadenocarcinoma,0.7808,Ovarian High Grade Serous Adenocarcinoma,0.7582,Serous Adenocarcinoma,0.7581,Ovarian Seromucinous Carcinoma,0.7431
PERITONEUM,Peritoneum,1,2,Peritoneum,1.0000,Malignant Peritoneal Neoplasm,0.7047,Abdominal Wall,0.6958,Peritoneal Mesothelioma,0.6143,Omentum,0.6070
PERIVASCULAR EPITHELIOID CELL TUMOR,PEComa,2,2,Epithelioid Hemangioendothelioma,0.7769,PEComa,0.7619,Epithelioid Cell<;>Spindle Cell Neoplasm,0.7380,Epithelioid Mesothelioma,0.7156,Epithelioid Trophoblastic Tumor,0.7137
PFA,"Posterior Fossa Ependymoma, Group A (PFA)",1,2,"Posterior Fossa Ependymoma, Group A (PFA)",0.5807,nan,0.4874,Primary,0.4770,Solitary Fibrous Tumor,0.4565,Primary Effusion Lymphoma,0.4532
PFB,"Posterior Fossa Ependymoma, Group B (PFB)",1,2,"Posterior Fossa Ependymoma, Group B (PFB)",0.5795,"Posterior Fossa Ependymoma, Group A (PFA)",0.5109,B-Cell Non-Hodgkin Lymphoma<;>Primary Effusion Lymphoma,0.4891,B-Cell Non-Hodgkin Lymphoma<;>Follicular Lymphoma,0.4807,Congenital Peribronchial Myofibroblastic Tumor,0.4628
PH+-ALL,B Acute Lymphoblastic Leukemia with t(9<;>22)(q34.1<;>q11.2)<;> BCR-ABL1,99,2,Acute Lymphoblastic Leukemia,0.6676,Philadelphia Chromosome Positive,0.6501,Acute Biphenotypic Leukemia,0.6454,B Acute Lymphoblastic Leukemia,0.6344,Lymphoblastic Lymphoma,0.6261
PH-LIKEALL,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,99,2,Philadelphia Chromosome Positive,0.4916,Lobular,0.4887,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,0.4759,B-Cell Prolymphocytic Leukemia,0.4691,nan,0.4660
PHARYNX,Pharynx,1,2,Pharynx,1.0000,Head and Neck,0.6194,Stomach,0.5874,Oral,0.5737,Gastric,0.5613
PHEOCHROMOCYTOMA,Adrenal Gland Pheochromocytoma,1,2,Adrenal Gland Pheochromocytoma,0.9774,Adrenal Gland Pheochromocytoma<;>Paraganglioma,0.9421,Extra-Adrenal Pheochromocytoma,0.9178,Paraganglioma,0.8692,Extra-Adrenal Sympathetic Paraganglioma,0.8102
PHYLLODES,Phyllodes Tumor,1,2,Phyllodes Tumor,0.7138,Malignant Breast Phyllodes Tumor,0.6583,Benign Breast Phyllodes Tumor,0.6543,Borderline Breast Phyllodes Tumor,0.5939,Chordoma,0.4959
PH_POSITIVE,Philadelphia Chromosome Positive,1,2,Philadelphia Chromosome Positive,0.7217,Estrogen Receptor Positive,0.5170,Hypertension,0.5079,Hyperdiploidy,0.5040,HER2/Neu Positive,0.4769
PILOCYTIC ASTROCYTOMA,Pilocytic Astrocytoma,1,2,Pilocytic Astrocytoma,1.0000,Pilomyxoid Astrocytoma,0.8840,Astrocytoma,0.8370,Diffuse Astrocytoma,0.8045,Anaplastic Astrocytoma,0.7537
PILOMATRIX CARCINOMA,Pilomatrical Carcinoma,1,2,Pilomatrical Carcinoma,0.9623,Keratoacanthoma,0.7490,Merkel Cell Carcinoma,0.7465,Skin Metatypical Carcinoma,0.7255,Spitz Melanoma,0.6924
PILOMYXOID ASTROCYTOMA,Pilomyxoid Astrocytoma,1,2,Pilomyxoid Astrocytoma,1.0000,Pilocytic Astrocytoma,0.8840,Astrocytoma,0.7395,Diffuse Astrocytoma,0.7049,Anaplastic Astrocytoma,0.7000
PINEAL GERM CELL TUMOR,Pineal Region Germ Cell Tumor,1,2,Pineal Region Germ Cell Tumor,0.9780,Pineoblastoma,0.7333,Pineal Parenchymal Tumor of Intermediate Differentiation,0.6805,Extragonadal Germ Cell Tumor,0.6725,Central Nervous System Germinoma,0.6699
PINEAL PARENCHYMAL TUMOR OF INTERMEDIATE DIFFERENTIATION,Pineal Parenchymal Tumor of Intermediate Differentiation,1,2,Pineal Parenchymal Tumor of Intermediate Differentiation,1.0000,Pineoblastoma,0.6839,Pineal Region Neoplasm,0.6702,Pineal Region Germ Cell Tumor,0.6449,Polymorphous Low Grade Neuroepithelial Tumor of the Young,0.6233
PINEAL TUMOR,Pineal Region Neoplasm,1,2,Pineal Region Neoplasm,0.9597,Pineal Parenchymal Tumor of Intermediate Differentiation,0.7185,Pineal Region Germ Cell Tumor,0.7074,Pineoblastoma,0.6659,Pituitary Neuroendocrine Tumor,0.6585
PINEOBLASTOMA,Pineoblastoma,1,2,Pineoblastoma,1.0000,Pineal Region Germ Cell Tumor,0.7009,Plexiform Schwannoma,0.6925,Pineal Parenchymal Tumor of Intermediate Differentiation,0.6839,Extra-Adrenal Sympathetic Paraganglioma,0.6781
PITUICYTOMA,Pituicytoma,1,2,Pituicytoma,1.0000,Pituitary Neuroendocrine Tumor,0.7098,Pineoblastoma,0.6538,Central Neurocytoma,0.6424,Ganglioglioma,0.6169
PITUITARY ADENOMA,Pituitary Neuroendocrine Tumor,3,2,Pituicytoma,0.6703,Sellar Region Neoplasm,0.6551,Pituitary Neuroendocrine Tumor,0.6510,Adrenal Cortical Adenoma,0.6285,Craniopharyngioma,0.5846
PLASMA CELL MYELOMA,Plasma Cell Myeloma,1,2,Plasma Cell Myeloma,1.0000,Plasma Cell Myeloma<;>Plasmacytoma,0.9668,Plasmacytoma,0.8859,Plasma Cell Leukemia,0.8586,Smoldering Plasma Cell Myeloma,0.8480
PLASMACYTOID/SIGNET RING CELL BLADDER CARCINOMA,plasmacytoid variant infiltrating bladder urothelial carcinoma,1,2,plasmacytoid variant infiltrating bladder urothelial carcinoma,0.8042,Bladder Small Cell Neuroendocrine Carcinoma,0.7854,Signet Ring Cell Carcinoma,0.7010,infiltrating bladder urothelial carcinoma sarcomatoid variant,0.6855,Papillary Transitional Cell Carcinoma,0.6560
PLASMACYTOID/SIGNET RING CELL BLADDER CARCINOMA,plasmacytoid variant infiltrating bladder urothelial carcinoma,1,2,plasmacytoid variant infiltrating bladder urothelial carcinoma,0.7519,Bladder Small Cell Neuroendocrine Carcinoma,0.7061,Signet Ring Cell Carcinoma,0.6593,infiltrating bladder urothelial carcinoma sarcomatoid variant,0.6475,Signet Ring Adenocarcinoma Cell,0.6304
PLASMACYTOMA,Plasmacytoma,1,2,Plasmacytoma,1.0000,Plasma Cell Myeloma<;>Plasmacytoma,0.9227,Plasma Cell Leukemia,0.9153,Plasma Cell Myeloma,0.8859,Smoldering Plasma Cell Myeloma,0.7348
PLASMA_CELL_LEUKEMIA,Plasma Cell Leukemia,1,2,Plasma Cell Leukemia,0.9615,Plasmacytoma,0.8554,Plasma Cell Myeloma<;>Plasmacytoma,0.8133,Plasma Cell Myeloma,0.8044,B-Cell Prolymphocytic Leukemia,0.7168
PLASMA_CELL_MYELOMA,Plasma Cell Myeloma,1,2,Plasma Cell Myeloma,0.9753,Plasma Cell Myeloma<;>Plasmacytoma,0.9417,Smoldering Plasma Cell Myeloma,0.8689,Plasmacytoma,0.8548,Plasma Cell Leukemia,0.8316
PLEOMORPHIC 'MFH' / UNDIFFERENTIATED PLEOMORPHIC SARCOMA,Undifferentiated Pleomorphic Sarcoma,1,2,Undifferentiated Pleomorphic Sarcoma,0.8401,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,0.8260,Undifferentiated Pleomorphic Sarcoma<;>Undifferentiated Spindle Cell Sarcoma,0.7859,Pleomorphic Rhabdomyosarcoma,0.7757,Pleomorphic Liposarcoma,0.7334
PLEOMORPHIC CARCINOMA OF THE LUNG,Lung Pleomorphic Carcinoma,1,2,Lung Pleomorphic Carcinoma,0.9812,Lung Spindle Cell Carcinoma,0.8043,Lung Sarcomatoid Carcinoma,0.7927,"Lung Large Cell Carcinoma, Clear Cell Variant",0.7407,Lung Non-Small Cell Carcinoma<;>Poorly Differentiated,0.7403
PLEOMORPHIC HEPATOCELLULAR CARCINOMA,Pleomorphic Hepatocellular Carcinoma,1,2,Pleomorphic Hepatocellular Carcinoma,1.0000,Hepatocellular Carcinoma,0.7412,Hepatocellular Adenoma<;>Hepatocellular Carcinoma,0.7262,Lung Pleomorphic Carcinoma,0.7098,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.7058
PLEOMORPHIC LIPOSARCOMA,Pleomorphic Liposarcoma,1,2,Pleomorphic Liposarcoma,1.0000,Dedifferentiated Liposarcoma,0.8634,Well Differentiated Liposarcoma,0.8598,myxoid/round cell liposarcoma,0.8446,Myxoid Liposarcoma,0.8393
PLEOMORPHIC RHABDOMYOSARCOMA,Pleomorphic Rhabdomyosarcoma,1,2,Pleomorphic Rhabdomyosarcoma,1.0000,Undifferentiated Pleomorphic Sarcoma,0.8744,Spindle Cell Rhabdomyosarcoma,0.8335,Pleomorphic Liposarcoma,0.8302,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.8179
PLEOMORPHIC SARCOMA,Undifferentiated Pleomorphic Sarcoma,1,2,Undifferentiated Pleomorphic Sarcoma,0.9553,Pleomorphic Rhabdomyosarcoma,0.8796,Undifferentiated Pleomorphic Sarcoma<;>Undifferentiated Spindle Cell Sarcoma,0.8660,undifferentiated sarcoma,0.8078,Pleomorphic Liposarcoma,0.8076
PLEOMORPHIC XANTHOASTROCYTOMA,Pleomorphic Xanthoastrocytoma,1,2,Pleomorphic Xanthoastrocytoma,1.0000,Anaplastic Pleomorphic Xanthoastrocytoma,0.9298,Disseminated Juvenile Xanthogranuloma,0.7085,Skin Fibrous Histiocytoma,0.6948,Pleomorphic Liposarcoma,0.6871
PLEOMORPHIC_SARCOMA,Undifferentiated Pleomorphic Sarcoma,1,2,Undifferentiated Pleomorphic Sarcoma,0.9264,Pleomorphic Rhabdomyosarcoma,0.8595,Undifferentiated Pleomorphic Sarcoma<;>Undifferentiated Spindle Cell Sarcoma,0.8418,undifferentiated sarcoma,0.8256,Spindle Cell Sarcoma,0.7704
PLEURA,Pleura,1,2,Pleura,1.0000,Malignant Pleural Neoplasm,0.6705,Pleural Fluid,0.6452,Peritoneum,0.5857,Pleural Mesothelioma,0.5590
"PLEURAL CANCER, NOS",Malignant Pleural Neoplasm,1,2,Malignant Pleural Neoplasm,0.9249,Pleural Mesothelioma,0.7654,Pleura,0.6709,Pleural Effusion<;>Site of Metastasis,0.6699,Malignant Peritoneal Neoplasm,0.6517
PLEURAL FLUID,Pleural Fluid,1,2,Pleural Fluid,1.0000,Malignant Pleural Neoplasm,0.6647,Pleura,0.6452,Pleural Effusion<;>Site of Metastasis,0.6069,Pleural Mesothelioma,0.5766
PLEURAL MESOTHELIOMA,Pleural Mesothelioma,1,2,Pleural Mesothelioma,1.0000,Pleural Sarcomatoid Mesothelioma,0.8490,Mesothelioma,0.8385,Peritoneal Mesothelioma,0.8289,Pleural Epithelioid Mesothelioma,0.8075
"PLEURAL MESOTHELIOMA, BIPHASIC TYPE",Pleural Biphasic Mesothelioma,1,2,Pleural Biphasic Mesothelioma,0.9801,Biphasic Mesothelioma,0.9039,Pleural Sarcomatoid Mesothelioma,0.7882,Pleural Epithelioid Mesothelioma,0.7829,Pleural Mesothelioma,0.7438
"PLEURAL MESOTHELIOMA, EPITHELIOID TYPE",Pleural Epithelioid Mesothelioma,1,2,Pleural Epithelioid Mesothelioma,0.9726,Epithelioid Mesothelioma,0.8830,Pleural Sarcomatoid Mesothelioma,0.8012,Pleural Biphasic Mesothelioma,0.7919,Pleural Mesothelioma,0.7776
"PLEURAL MESOTHELIOMA, SARCOMATOID TYPE",Pleural Sarcomatoid Mesothelioma,1,2,Pleural Sarcomatoid Mesothelioma,0.9791,Sarcomatoid Mesothelioma,0.8875,Pleural Mesothelioma,0.8333,Pleural Epithelioid Mesothelioma,0.8329,Pleural Biphasic Mesothelioma,0.7942
PLEUROPULMONARY BLASTOMA,Pleuropulmonary Blastoma,1,2,Pleuropulmonary Blastoma,1.0000,Blastic Plasmacytoid Dendritic Cell Neoplasm,0.7014,Lung Pleomorphic Carcinoma,0.6188,Myeloproliferative Neoplasm,0.6024,Lung Inflammatory Myofibroblastic Tumor,0.6013
PLEUROPULMONARY BLASTOMA PPB,Pleuropulmonary Blastoma,1,2,Pleuropulmonary Blastoma,0.9054,Blastic Plasmacytoid Dendritic Cell Neoplasm,0.6516,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.5932,B-Cell Non-Hodgkin Lymphoma<;>Primary Effusion Lymphoma,0.5853,Pleural Biphasic Mesothelioma,0.5814
PLEUROPULMORY BLASTOMA PPB,Pleuropulmonary Blastoma,1,2,Pleuropulmonary Blastoma,0.8874,Blastic Plasmacytoid Dendritic Cell Neoplasm,0.6821,B-Cell Non-Hodgkin Lymphoma<;>Primary Effusion Lymphoma,0.6198,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.6112,B-Cell Prolymphocytic Leukemia,0.6038
PLEXIFORM FIBROHISTIOCYTIC TUMOR,Plexiform Fibrohistiocytic Tumor,1,2,Plexiform Fibrohistiocytic Tumor,1.0000,Plexiform Neurofibroma,0.8289,Plexiform Schwannoma,0.7838,Skin Fibrous Histiocytoma,0.7265,Dermatofibrosarcoma Protuberans,0.7062
PLEXIFORM NEUROFIBROMA,Plexiform Neurofibroma,1,2,Plexiform Neurofibroma,1.0000,Plexiform Schwannoma,0.8728,Plexiform Fibrohistiocytic Tumor,0.8289,Neurofibroma,0.8273,Melanotic Schwannoma,0.7111
PLEXIFORM SCHWANNOMA,Plexiform Schwannoma,1,2,Plexiform Schwannoma,1.0000,Plexiform Neurofibroma,0.8728,Melanotic Schwannoma,0.8440,Schwannoma,0.8083,Cellular Schwannoma,0.7960
PLMESO,Pleural Mesothelioma,99,2,B-Cell Non-Hodgkin Lymphoma<;>Primary Effusion Lymphoma,0.4913,Primary Effusion Lymphoma,0.4771,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.4619,Manubrium,0.4608,Fusion-Positive Rhabdomyosarcoma,0.4607
PML-RARA,PML-RARA Fusion Protein Expression,2,2,Acute Promyelocytic Leukemia with PML-RARA,0.8148,PML-RARA Fusion Protein Expression,0.7379,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA,0.6082,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.5884,Chronic Myelomonocytic Leukemia-1,0.5850
PNET,Primitive Neuroectodermal Tumor,2,2,Peripheral Primitive Neuroectodermal Tumor,0.8389,Primitive Neuroectodermal Tumor,0.7937,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7419,Polymorphous Low Grade Neuroepithelial Tumor of the Young,0.7245,Neuroblastoma,0.7205
POLE ULTRA-MUTATED,POLE-Ultramutated Endometrial Endometrioid Adenocarcinoma,99,2,Endometrial Carcinoma<;>POLE Gene Mutation,0.6329,Rectal Adenocarcinoma<;>POLE Gene Mutation,0.6322,Colon Adenocarcinoma<;>POLE Gene Mutation,0.6261,Esophageal Adenocarcinoma<;>POLE Gene Mutation,0.6249,Gastric Adenocarcinoma<;>POLE Gene Mutation,0.6174
POLYCYTHAEMIA VERA MYELOFIBROSIS,Polycythemia Vera<;>Myelofibrosis,1,2,Polycythemia Vera<;>Myelofibrosis,0.9870,Primary Myelofibrosis,0.8438,Essential Thrombocythemia<;>Myelofibrosis,0.8059,Polycythemia Vera,0.8042,Overt Primary Myelofibrosis,0.7952
POLYCYTHEMIA VERA,Polycythemia Vera,1,2,Polycythemia Vera,1.0000,Polycythemia Vera<;>Myelofibrosis,0.8254,Erythroleukemia,0.6899,Essential Thrombocythemia,0.6591,Pure Erythroid Leukemia,0.6413
POOR RISK CYTOGENETIC ABNORMALITY,Cytogenetic Abnormality<;>Low Risk,1,2,Cytogenetic Abnormality<;>Low Risk,0.8459,Cytogenetic Abnormality<;>Intermediate Risk,0.7917,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.6302,Hypodiploidy,0.6218,Atypical Chronic Myeloid Leukemia,0.6163
POORLY DIFFERENTIATED,Poorly Differentiated,1,2,Poorly Differentiated,1.0000,Well Differentiated,0.8929,Moderately Differentiated,0.8615,Carcinoma<;>Poorly Differentiated,0.8265,Undifferentiated,0.7697
POORLY DIFFERENTIATED ADENOCARCINOMA,Poorly Differentiated Adenocarcinoma,1,2,Poorly Differentiated Adenocarcinoma,1.0000,Adenocarcinoma<;>Poorly Differentiated,0.9811,Carcinoma<;>Poorly Differentiated,0.9156,Adenocarcinoma<;>Well Differentiated,0.8886,Adenocarcinoma<;>Undifferentiated Carcinoma,0.8608
POORLY DIFFERENTIATED CARCINOMA,Carcinoma<;>Poorly Differentiated,1,2,Carcinoma<;>Poorly Differentiated,0.9820,Poorly Differentiated Adenocarcinoma,0.9347,Adenocarcinoma<;>Poorly Differentiated,0.9174,Poorly Differentiated,0.8351,Squamous Cell Carcinoma<;>Poorly Differentiated,0.8317
POORLY DIFFERENTIATED CARCINOMA OF THE STOMACH,Gastric Carcinoma<;>Poorly Differentiated,1,2,Gastric Carcinoma<;>Poorly Differentiated,0.9465,Gastric Poorly Cohesive Adenocarcinoma,0.8429,Gastric Undifferentiated Carcinoma,0.7923,Gastric Adenosquamous Carcinoma,0.7463,Gastric Adenocarcinoma,0.7368
"POORLY DIFFERENTIATED CARCINOMA, NOS",Carcinoma<;>Poorly Differentiated,1,2,Carcinoma<;>Poorly Differentiated,0.9828,Poorly Differentiated Adenocarcinoma,0.9213,Adenocarcinoma<;>Poorly Differentiated,0.9115,Squamous Cell Carcinoma<;>Poorly Differentiated,0.8324,Poorly Differentiated,0.8308
POORLY DIFFERENTIATED NEC,Neuroendocrine Carcinoma<;>Poorly Differentiated,1,2,Neuroendocrine Carcinoma<;>Poorly Differentiated,0.8500,Adenocarcinoma with Neuroendocrine Differentiation,0.7729,Neuroendocrine Carcinoma,0.7586,Small Cell Neuroendocrine Carcinoma,0.7582,Undifferentiated Carcinoma,0.7548
POORLY DIFFERENTIATED NON-SMALL CELL LUNG CANCER,Lung Non-Small Cell Carcinoma<;>Poorly Differentiated,1,2,Lung Non-Small Cell Carcinoma<;>Poorly Differentiated,0.9380,Lung Non-Small Cell Carcinoma,0.7926,Lung Pleomorphic Carcinoma,0.7717,Lung Non-Mucinous Adenocarcinoma,0.7350,Lung Non-Small Cell Carcinoma<;>Large Cell Carcinoma,0.7293
POORLY DIFFERENTIATED ONCOCYTIC CARCINOMA,Oncocytic Variant Thyroid Gland Papillary Carcinoma,2,2,Thyroid Gland Oncocytic Carcinoma,0.8368,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.7795,Poorly Differentiated Thyroid Gland Carcinoma,0.7682,Poorly Differentiated Adenocarcinoma,0.7657,Oncocytic Neoplasm,0.7524
POORLY DIFFERENTIATED OR PLEOMORPHIC OR EPITHELIOID LEIOMYOSARCOMA,Leiomyosarcoma,3,2,Well Differentiated Leiomyosarcoma,0.8844,Conventional Leiomyosarcoma,0.8541,Leiomyosarcoma,0.8280,Uterine Corpus Myxoid Leiomyosarcoma,0.7780,Uterine Corpus Epithelioid Leiomyosarcoma,0.7740
POORLY DIFFERENTIATED PANCREATIC ADENOCARCINOMA,Pancreatic Adenocarcinoma<;>Poorly Differentiated Adenocarcinoma Cell,1,2,Pancreatic Adenocarcinoma<;>Poorly Differentiated Adenocarcinoma Cell,0.9506,Pancreatic Undifferentiated Carcinoma,0.8467,Pancreatic Adenocarcinoma,0.8400,Pancreatic Adenosquamous Carcinoma,0.8134,Pancreatic Acinar Cell Carcinoma,0.8081
POORLY DIFFERENTIATED THYROID CANCER,Poorly Differentiated Thyroid Gland Carcinoma,1,2,Poorly Differentiated Thyroid Gland Carcinoma,0.9710,Differentiated Thyroid Gland Carcinoma,0.8504,Thyroid Gland Anaplastic Carcinoma,0.7896,Carcinoma<;>Poorly Differentiated,0.7474,Poorly Differentiated Adenocarcinoma,0.7435
POORLY DIFFERENTIATED THYROID CARCINOMA,Poorly Differentiated Thyroid Gland Carcinoma,1,2,Poorly Differentiated Thyroid Gland Carcinoma,0.9945,Differentiated Thyroid Gland Carcinoma,0.8596,Thyroid Gland Anaplastic Carcinoma,0.8141,Thyroid Gland Papillary Carcinoma,0.7855,Poorly Differentiated Adenocarcinoma,0.7826
POORLY_COHESIVE,Gastric Poorly Cohesive Adenocarcinoma,99,2,Poorly Differentiated,0.5547,Mixed,0.5175,Undifferentiated,0.5042,Anaplastic,0.5016,Well Differentiated,0.4894
POORLY_DIFFERENTIATED_GASTRIC CARCINOMA,Gastric Carcinoma<;>Poorly Differentiated,1,2,Gastric Carcinoma<;>Poorly Differentiated,0.9636,Gastric Undifferentiated Carcinoma,0.8641,Gastric Poorly Cohesive Adenocarcinoma,0.8526,Gastric Carcinoma,0.7872,Gastric Adenocarcinoma,0.7826
POROCARCINOMA/SPIROADENOCARCINOMA,Porocarcinoma,1,2,Porocarcinoma,0.7656,Papillary Serous Cystadenocarcinoma,0.6784,Serous Cystadenocarcinoma,0.6461,Cystadenocarcinoma,0.6425,Cystadenocarcinoma<;>High Grade<;>Serous,0.6207
POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS,Post-Transplant Lymphoproliferative Disorder,1,2,Post-Transplant Lymphoproliferative Disorder,0.9656,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,0.7863,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.6362,Therapy-Related Myelodysplastic Syndrome,0.6164,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.5746
PRAD,Prostate Adenocarcinoma,99,2,Rosai-Dorfman Disease,0.4563,Retinoblastoma,0.4486,Arm,0.4454,Basal,0.4406,Bronchiolar Adenoma/Ciliated Muconodular Papillary Tumor,0.4403
PRE-T,T Lymphoblastic Leukemia/Lymphoma,99,2,Mature,0.5843,Primary,0.5740,Transitional Cells,0.5712,Blastic Phase,0.5590,Occult Stage,0.5095
PRIMARY,Primary,1,2,Primary,1.0000,Primary Neoplasm,0.6801,Limited Stage<;>Primary,0.6480,First Relapse,0.5560,Unilateral,0.5521
PRIMARY CNS MELANOMA,Central Nervous System Melanoma,1,2,Central Nervous System Melanoma,0.8708,Malignant Central Nervous System Neoplasm,0.6884,Central Nervous System Germinoma,0.6683,Central Nervous System Medulloepithelioma,0.6565,Malignant Brain Neoplasm,0.6348
PRIMARY CUTANEOUS CD30 POSITIVE T-CELL LYMPHOPROLIFERATIVE DISORDERS,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,1,2,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.9860,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.7767,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6858,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.6848,Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma,0.6601
PRIMARY CUTANEOUS CD8 POSITIVE AGGRESSIVE EPIDERMOTROPIC CYTOTOXIC T-CELL LYMPHOMA,Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma,1,2,Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma,0.9961,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.7200,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.6864,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6548,Angioimmunoblastic T-Cell Lymphoma,0.6458
PRIMARY DLBCL OF THE CNS,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,1,2,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.8567,Diffuse Intrinsic Pontine Glioma,0.6411,Brain<;>Site of Metastasis<;>Metastatic Prostate Carcinoma<;>Lymphoid Leukemia,0.6252,Diffuse Large B-Cell Lymphoma,0.6100,Central Nervous System Germinoma,0.5926
PRIMARY EFFUSION LYMPHOMA,Primary Effusion Lymphoma,1,2,Primary Effusion Lymphoma,1.0000,B-Cell Non-Hodgkin Lymphoma<;>Primary Effusion Lymphoma,0.8659,Plasma Cell Leukemia,0.6656,Plasmacytoma,0.6501,Plasma Cell Myeloma,0.6452
PRIMARY ESOPHAGUS,Gastroesophageal Cancer<;>Primary Neoplasm,3,2,Esophagus,0.7408,Esophageal Carcinoma,0.6363,Gastroesophageal Cancer<;>Primary Neoplasm,0.6274,Esophageal Adenocarcinoma,0.5887,Esophageal Neuroendocrine Tumor,0.5688
PRIMARY MEDIASTINAL THYMIC DLBCL,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,1,2,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.8911,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.8008,Thymoma Type B3,0.6872,Thymoma Type B1,0.6758,Thymoma Type B2,0.6574
PRIMARY MEDIASTINAL THYMIC LARGE B-CELL LYMPHOMA,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,1,2,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.9900,B-Cell Non-Hodgkin Lymphoma<;>Mediastinal Non-Hodgkin Lymphoma<;>Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.8096,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.7095,Thymoma Type B1,0.6963,Thymoma Type B2,0.6855
PRIMARY MYELOFIBROSIS,Primary Myelofibrosis,1,2,Primary Myelofibrosis,1.0000,Secondary Myelofibrosis,0.9000,Overt Primary Myelofibrosis,0.8886,Polycythemia Vera<;>Myelofibrosis,0.8475,Essential Thrombocythemia<;>Myelofibrosis,0.8314
"PRIMARY MYELOFIBROSIS,OVERT FIBROTIC STAGE",Overt Primary Myelofibrosis,1,2,Overt Primary Myelofibrosis,0.9307,Primary Myelofibrosis,0.8267,Secondary Myelofibrosis,0.8216,Essential Thrombocythemia<;>Myelofibrosis,0.7601,Polycythemia Vera<;>Myelofibrosis,0.7195
PRIMARY NEUROEPITHELIAL TUMOR,Neuroepithelial Neoplasm,1,2,Neuroepithelial Neoplasm,0.8684,Primitive Neuroectodermal Tumor,0.8483,Peripheral Primitive Neuroectodermal Tumor,0.8131,Neuroepithelial Neoplasm<;>High Grade,0.7847,Dysembryoplastic Neuroepithelial Tumor,0.7772
PRIMARY RESIDUAL,Primary Neoplasm,99,2,Residual Nodal Disease,0.7520,Relapse,0.6589,Recurrent,0.6515,First Relapse,0.6492,Recurrence,0.6393
PRIMARY TUMOR UNPAIRED,Primary Neoplasm<;>Unpaired,1,2,Primary Neoplasm<;>Unpaired,0.9119,Primary Neoplasm<;>Paired,0.7814,Melanoma of Unknown Primary,0.6609,Primary Neoplasm,0.6260,With Tumor,0.6219
PRIMARY TUMOUR,Primary Neoplasm,1,2,Primary Neoplasm,0.9632,With Tumor,0.7731,Neoplasm,0.7709,Malignant Neoplasm,0.7534,Primary Neoplasm<;>Paired,0.7329
PRIMITIVE NEUROECTODERMAL TUMOR,Primitive Neuroectodermal Tumor,1,2,Primitive Neuroectodermal Tumor,1.0000,Peripheral Primitive Neuroectodermal Tumor,0.9420,Dysembryoplastic Neuroepithelial Tumor,0.7733,Primitive Neuroectodermal Tumor<;>Medulloblastoma,0.7714,Neuroepithelial Neoplasm,0.7423
PRIMITIVE NEUROECTODERMAL TUMOR PNET,Primitive Neuroectodermal Tumor,2,2,Peripheral Primitive Neuroectodermal Tumor,0.9122,Primitive Neuroectodermal Tumor,0.8649,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7690,Primitive Neuroectodermal Tumor<;>Medulloblastoma,0.7349,Polymorphous Low Grade Neuroepithelial Tumor of the Young,0.7291
PRIMITIVE NEUROECTODERMAL TUMOUR-MEDULLOBLASTOMA,Primitive Neuroectodermal Tumor<;>Medulloblastoma,1,2,Primitive Neuroectodermal Tumor<;>Medulloblastoma,0.9878,Medulloblastoma,0.9269,"Medulloblastoma, Non-WNT/Non-SHH, Group 3",0.8523,Anaplastic Medulloblastoma,0.8349,Desmoplastic/Nodular Medulloblastoma,0.8303
PRO MYELOCYTIC LEUKEMIA,Acute Promyelocytic Leukemia with PML-RARA,99,2,Acute Myeloid Leukemia,0.7928,Chronic Myelogenous Leukemia,0.7847,Myeloproliferative Neoplasm,0.7586,Acute Myeloid Leukemia with Maturation,0.7534,Acute Myeloid Leukemia Not Otherwise Specified,0.7413
PROGRESSIVE FIRST HGG RECORD,Malignant Glioma<;>Progressive,3,2,Primary,0.5266,First Relapse,0.5222,Malignant Glioma<;>Progressive,0.4943,Philadelphia Chromosome Positive,0.4784,Blastic Phase,0.4658
PROSTATE,Prostate Gland,1,2,Prostate Gland,0.9159,Prostate Carcinoma,0.8176,Prostate Adenocarcinoma,0.7255,Prostate Carcinoma<;>Incidental Finding,0.6624,Prostate Ductal Adenocarcinoma,0.6336
PROSTATE ADENOCARCINOMA,Prostate Adenocarcinoma,1,2,Prostate Adenocarcinoma,1.0000,Prostate Carcinoma,0.9161,Prostate Ductal Adenocarcinoma,0.8706,Prostate Acinar Adenocarcinoma,0.8254,Prostate Squamous Cell Carcinoma,0.7858
PROSTATE ADENOCARCINOMA ACINAR TYPE,Prostate Acinar Adenocarcinoma,1,2,Prostate Acinar Adenocarcinoma,0.9828,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.9245,Acinar Cell Carcinoma,0.8555,Lung Acinar Adenocarcinoma,0.8450,Acinar Cell Carcinoma<;>Papillary,0.8443
"PROSTATE ADENOCARCINOMA, NOT OTHERWISED SPECIFIED, WITH DUCTAL FEATUES",Prostate Ductal Adenocarcinoma,1,2,Prostate Ductal Adenocarcinoma,0.8508,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.8244,Prostate Acinar Adenocarcinoma,0.7803,Prostate Adenocarcinoma,0.7483,Pancreatic Mixed Acinar-Ductal Carcinoma,0.6893
"PROSTATE ADENOCARCINOMA, OTHER SUBTYPE",Prostate Adenocarcinoma,1,2,Prostate Adenocarcinoma,0.7844,Prostate Carcinoma,0.7338,Prostate Carcinoma<;>Incidental Finding,0.7232,Prostate Ductal Adenocarcinoma,0.7083,Prostate Acinar Adenocarcinoma,0.7061
PROSTATE CANCER,Prostate Carcinoma,1,2,Prostate Carcinoma,0.9715,Prostate Adenocarcinoma,0.8804,Prostate Squamous Cell Carcinoma,0.7700,Prostate Gland,0.7681,Prostate Ductal Adenocarcinoma,0.7304
"PROSTATE CANCER, NOS",Prostate Carcinoma,1,2,Prostate Carcinoma,0.9681,Prostate Adenocarcinoma,0.8749,Prostate Gland,0.7701,Prostate Squamous Cell Carcinoma,0.7683,Prostate Ductal Adenocarcinoma,0.7259
PROSTATE HYPERPLASIA,Benign Prostatic Hyperplasia,1,2,Benign Prostatic Hyperplasia,0.8979,Prostate Gland,0.6873,Prostate Carcinoma,0.5843,Prostate Carcinoma<;>Incidental Finding,0.5591,Prostate Adenocarcinoma,0.5380
PROSTATE NEUROENDOCRINE CARCINOMA,Prostate Neuroendocrine Carcinoma,1,2,Prostate Neuroendocrine Carcinoma,1.0000,Prostate Small Cell Neuroendocrine Carcinoma,0.8868,Castration-Resistant Prostate Carcinoma<;>Prostate Neuroendocrine Neoplasm,0.8614,Neuroendocrine Carcinoma<;>Poorly Differentiated,0.7941,Neuroendocrine Carcinoma,0.7862
PROSTATE SMALL CELL CARCINOMA,Prostate Small Cell Neuroendocrine Carcinoma,1,2,Prostate Small Cell Neuroendocrine Carcinoma,0.9184,Prostate Squamous Cell Carcinoma,0.7964,Prostate Neuroendocrine Carcinoma,0.7552,Small Cell Adenocarcinoma,0.7448,Lung Small Cell Carcinoma,0.7251
PROSTATE SQUAMOUS CELL CARCINOMA,Prostate Squamous Cell Carcinoma,1,2,Prostate Squamous Cell Carcinoma,1.0000,Prostate Carcinoma,0.8105,Prostate Adenocarcinoma,0.7858,Squamous Cell Carcinoma of the Penis,0.7220,Squamous Cell Carcinoma,0.6984
PROSTATE; METASTATIC SITE: BRAIN; CARCINOMA PATIENT WITH METASTATIC CARCINOMA OF THE PROSTATE AND A 3 YEAR HISTORY OF LYMPHOCYTIC LEUKEMIA.,Brain<;>Site of Metastasis<;>Metastatic Prostate Carcinoma<;>Lymphoid Leukemia,1,2,Brain<;>Site of Metastasis<;>Metastatic Prostate Carcinoma<;>Lymphoid Leukemia,0.7739,Metastatic Prostate Carcinoma<;>Lymphoid Leukemia,0.6435,Bone<;>Site of Metastasis<;>Prostate Adenocarcinoma,0.5002,Castration-Resistant Prostate Carcinoma<;>Metastatic Prostate Carcinoma,0.4947,"Glioblastoma, IDH-Wildtype<;>Glioblastoma with Primitive Neuronal Component",0.4934
PROSTATE_ADENOCARCINOMA,Prostate Adenocarcinoma,1,2,Prostate Adenocarcinoma,0.9558,Prostate Carcinoma,0.8787,Prostate Ductal Adenocarcinoma,0.8556,Prostate Acinar Adenocarcinoma,0.8055,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.7547
PROSTATE_CANCER,Prostate Carcinoma,1,2,Prostate Carcinoma,0.8933,Prostate Adenocarcinoma,0.8126,Prostate Gland,0.7890,Prostate Carcinoma<;>Incidental Finding,0.7407,Prostate Squamous Cell Carcinoma,0.7048
PROSTATE_HYPERPLASIA,Benign Prostatic Hyperplasia,1,2,Benign Prostatic Hyperplasia,0.8869,Prostate Gland,0.6736,Prostate Carcinoma,0.5701,Prostate Carcinoma<;>Incidental Finding,0.5654,Urothelial Papilloma,0.5367
PROSTATE_SMALL_CELL,Prostate Small Cell Neuroendocrine Carcinoma,1,2,Prostate Small Cell Neuroendocrine Carcinoma,0.8415,Prostate Neuroendocrine Carcinoma,0.7691,Prostate Squamous Cell Carcinoma,0.7303,Prostate Carcinoma,0.7277,Prostate Adenocarcinoma,0.7185
PROSTATIC ADENOCARCINOMA ACINAR TYPE MIXED WITH PROSTATIC DUCT ADENOCARCINOMA,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,1,2,Prostate Acinar Adenocarcinoma<;>Prostate Ductal Adenocarcinoma,0.8503,Prostate Acinar Adenocarcinoma,0.8295,Pancreatic Mixed Acinar-Ductal Carcinoma,0.7894,Acinar Cell Carcinoma<;>Papillary,0.7297,Pancreatic Mixed Acinar-Neuroendocrine Carcinoma,0.7194
PROXIMAL-TYPE EPITHELIOID SARCOMA,Proximal-Type Epithelioid Sarcoma,1,2,Proximal-Type Epithelioid Sarcoma,1.0000,Epithelioid Sarcoma,0.8340,Epithelioid Mesothelioma,0.7109,Sclerosing Epithelioid Fibrosarcoma,0.6986,Malignant PEComa,0.6847
PROXIMAL-TYPE EPITHELIOID SARCOMA PTES,Proximal-Type Epithelioid Sarcoma,1,2,Proximal-Type Epithelioid Sarcoma,0.8926,Epithelioid Sarcoma,0.6964,Malignant PEComa,0.6752,Sclerosing Epithelioid Fibrosarcoma,0.6508,Pleural Epithelioid Mesothelioma,0.6146
PSEUDOMYOGENIC HEMANGIOENDOTHELIOMA,Pseudomyogenic Hemangioendothelioma,1,2,Pseudomyogenic Hemangioendothelioma,1.0000,Epithelioid Hemangioendothelioma,0.7835,Hemangioblastoma,0.7251,Plexiform Fibrohistiocytic Tumor,0.6753,Inflammatory Myofibroblastic Tumor,0.6743
PURE ERYTHROID LEUKEMIA,Pure Erythroid Leukemia,1,2,Pure Erythroid Leukemia,1.0000,Acute Erythroid Leukemia,0.9015,Erythroleukemia,0.8568,Acute Myeloid Leukemia,0.6929,Acute Undifferentiated Leukemia,0.6589
RA,Refractory Anemia,99,2,Arm,0.5296,Primary,0.5156,Retinoblastoma,0.4833,Synovial Sarcoma,0.4829,Not Otherwise Specified,0.4783
RAEB,Myelodysplastic Syndrome with Excess Blasts,3,2,Myelodysplastic Syndrome with Excess Blasts-1,0.7258,Acute Erythroid Leukemia,0.7247,Myelodysplastic Syndrome with Excess Blasts,0.7226,Pure Erythroid Leukemia,0.6988,Myelodysplastic Syndrome with Excess Blasts-2,0.6907
RAEB1,Myelodysplastic Syndrome with Excess Blasts-1,1,2,Myelodysplastic Syndrome with Excess Blasts-1,0.7235,Myelodysplastic Syndrome with Excess Blasts-2,0.6636,Myelodysplastic Syndrome with Excess Blasts,0.6478,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA,0.6440,Acute Erythroid Leukemia,0.6435
RARS,Myelodysplastic Syndrome with Ring Sideroblasts,1,2,Myelodysplastic Syndrome with Ring Sideroblasts,0.4869,Acute Promyelocytic Leukemia with PML-RARA,0.4779,PML-RARA Fusion Protein Expression,0.4775,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.4755,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.4708
RARS-T,Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis,99,2,Acute Promyelocytic Leukemia with PML-RARA,0.5207,PML-RARA Fusion Protein Expression,0.5154,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.4741,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.4698,Myelodysplastic Syndrome with Ring Sideroblasts,0.4619
RBL,Retinoblastoma,1,2,Retinoblastoma,0.7399,Trilateral Retinoblastoma,0.6199,EBV-Related Lymphoma,0.5117,Lymphoma,0.5016,Rhabdoid Tumor,0.4981
RCMD,Myelodysplastic Syndrome with Multilineage Dysplasia,99,2,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.5785,Myelodysplastic Syndrome with Ring Sideroblasts,0.5286,Chronic Myelomonocytic Leukemia,0.5219,Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis,0.5206,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.5195
RCMD-RS,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,1,2,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.6480,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.6025,Myelodysplastic Syndrome with Ring Sideroblasts,0.5991,Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis,0.5872,Myelodysplastic Syndrome with Multilineage Dysplasia,0.5543
READ,Rectal Adenocarcinoma,99,2,Cell Line,0.4825,Oral,0.4770,Mature,0.4730,Translocation,0.4719,Resection,0.4711
READ_CIN,Rectal Adenocarcinoma<;>Chromosomal Instability,99,2,nan,0.4936,Not Otherwise Specified,0.4919,Unclassified,0.4640,Neuroblastoma,0.4617,Therapy-Related Myeloid Neoplasm,0.4574
READ_GS,Rectal Adenocarcinoma,99,2,Solid,0.4949,Rhabdomyosarcoma,0.4804,Cell Line,0.4669,Embryonal Rhabdomyosarcoma,0.4620,Genomic Stability,0.4525
READ_MSI,Rectal Adenocarcinoma<;>Microsatellite Instability,4,2,Microsatellite Instability,0.6335,Microsatellite Stable,0.6241,High-Frequency Microsatellite Instability,0.5797,Rectal Adenocarcinoma<;>Microsatellite Instability,0.5423,Microsatellite Stable Colorectal Carcinoma,0.5415
READ_POLE,Rectal Adenocarcinoma<;>POLE Gene Mutation,1,2,Rectal Adenocarcinoma<;>POLE Gene Mutation,0.5074,Endometrial Carcinoma<;>POLE Gene Mutation,0.4825,Esophageal Adenocarcinoma<;>POLE Gene Mutation,0.4752,POLE-Ultramutated Endometrial Endometrioid Adenocarcinoma,0.4744,Gastric Adenocarcinoma<;>POLE Gene Mutation,0.4656
RECTAL ADENOCARCINOMA,Rectal Adenocarcinoma,1,2,Rectal Adenocarcinoma,1.0000,Adenocarcinoma<;>Well Differentiated<;>Rectum,0.8352,Colorectal Adenocarcinoma,0.7889,Rectal Mucinous Adenocarcinoma,0.7850,Anal Carcinoma,0.7013
RECTAL MUCINOUS ADENOCARCINOMA,Rectal Mucinous Adenocarcinoma,1,2,Rectal Mucinous Adenocarcinoma,1.0000,Rectal Mucinous Adenocarcinoma<;>Colon Mucinous Adenocarcinoma,0.9012,Rectal Adenocarcinoma,0.7850,Adenocarcinoma<;>Well Differentiated<;>Rectum,0.7550,Colon Mucinous Adenocarcinoma,0.7325
RECTOSIGMOID JUNCTION,Rectosigmoid Region,1,2,Rectosigmoid Region,0.8766,Rectum,0.6540,Sigmoid Colon,0.6236,Colorectal,0.5969,Hepatic Flexure,0.5870
RECTUM,Rectum,1,2,Rectum,1.0000,Rectosigmoid Region,0.7741,Colorectal,0.7458,Colon,0.6545,Rectal Adenocarcinoma,0.6366
RECTUM; ADENOCARCINOMA; WELL DIFFERENTIATED,Adenocarcinoma<;>Well Differentiated<;>Rectum,1,2,Adenocarcinoma<;>Well Differentiated<;>Rectum,0.9610,Rectal Adenocarcinoma,0.8065,Rectal Neuroendocrine Tumor<;>Well Differentiated,0.7496,Rectal Mucinous Adenocarcinoma,0.7294,Colorectal Adenocarcinoma,0.7022
RECURRENCE,Recurrence,1,2,Recurrence,1.0000,Recurrent,0.9505,Relapse,0.8841,Regional<;>Recurrence,0.8282,"Neoplasm Recurrence, Local",0.7877
RECURRENCE FIRST HGG RECORD,Recurrent Malignant Glioma,4,2,First Relapse,0.6825,Recurrence,0.5361,Recurrent,0.5307,Recurrent Malignant Glioma,0.4910,Locally Recurrent Malignant Neoplasm,0.4890
RECURRENCE/PERSISTENT METASTASIC TUMOR TO LYMPH NODE,Metastatic Malignant Neoplasm in the Lymph Nodes<;>Recurrent,1,2,Metastatic Malignant Neoplasm in the Lymph Nodes<;>Recurrent,0.8647,Metastatic Malignant Neoplasm in the Regional Lymph Nodes,0.7847,Regional<;>Recurrence,0.7365,Metastatic Lesion<;>Recurrent,0.7292,Residual Nodal Disease,0.6944
RECURRENT,Recurrent,1,2,Recurrent,1.0000,Recurrence,0.9505,Relapse,0.8868,Regional<;>Recurrence,0.7825,Metastatic Lesion<;>Recurrent,0.7504
RECURRENT METASTATIC DISEASE,Metastatic Lesion<;>Recurrent,1,2,Metastatic Lesion<;>Recurrent,0.9362,Regional<;>Recurrence,0.8414,Recurrence,0.8076,Metastatic Malignant Neoplasm in the Lymph Nodes<;>Recurrent,0.8069,Metastatic,0.7984
RECURRENT_ENDOMETRIAL_CARCINOMA,Recurrent Endometrial Carcinoma,1,2,Recurrent Endometrial Carcinoma,0.9707,Endometrial Dedifferentiated Carcinoma,0.6368,Endometrial Carcinoma,0.6312,Recurrent,0.6220,Endometrial Carcinoma<;>Microsatellite Instability,0.6186
REFRACTORY ANAEMIA WITH EXCESS BLASTS,Myelodysplastic Syndrome with Excess Blasts,1,2,Myelodysplastic Syndrome with Excess Blasts,0.8378,Myelodysplastic Syndrome with Excess Blasts-1,0.7959,Myelodysplastic Syndrome with Excess Blasts-2,0.7847,Refractory Anemia,0.7558,Acute Erythroid Leukemia,0.7196
REFRACTORY ANEMIA,Refractory Anemia,1,2,Refractory Anemia,1.0000,Therapy-Related Myelodysplastic Syndrome,0.6258,Myelodysplastic Syndrome with Ring Sideroblasts,0.6242,Myelodysplastic Syndrome,0.6131,Acute Erythroid Leukemia,0.5953
REFRACTORY ANEMIA WITH EXCESS BLASTS-1,Myelodysplastic Syndrome with Excess Blasts-1,1,2,Myelodysplastic Syndrome with Excess Blasts-1,0.8557,Myelodysplastic Syndrome with Excess Blasts-2,0.7905,Myelodysplastic Syndrome with Excess Blasts,0.7666,Acute Erythroid Leukemia,0.6767,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.6698
REFRACTORY ANEMIA WITH EXCESS BLASTS-2,Myelodysplastic Syndrome with Excess Blasts-2,1,2,Myelodysplastic Syndrome with Excess Blasts-2,0.8897,Myelodysplastic Syndrome with Excess Blasts-1,0.7906,Myelodysplastic Syndrome with Excess Blasts,0.7551,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.6420,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA,0.6338
REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA,Myelodysplastic Syndrome with Multilineage Dysplasia,2,2,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.8180,Myelodysplastic Syndrome with Multilineage Dysplasia,0.8078,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.7609,Myelodysplastic Syndrome with Ring Sideroblasts,0.7535,Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis,0.7513
REGIONAL CUTANEOUS OR SUBCUTANEOUS METASTASIS,Melanoma Involvement of Regional Cutaneous or Subcutaneous Tissue,1,2,Melanoma Involvement of Regional Cutaneous or Subcutaneous Tissue,0.8497,Metastatic Lesion,0.7238,Distant Metastasis,0.6834,Metastatic,0.6752,Secondary Malignant Neoplasm,0.6728
REGIONAL LYMPH NODE METASTASIS,Metastatic Malignant Neoplasm in the Regional Lymph Nodes,1,2,Metastatic Malignant Neoplasm in the Regional Lymph Nodes,0.8947,Residual Nodal Disease,0.7513,Metastatic Malignant Neoplasm in the Lymph Nodes<;>Recurrent,0.7385,Distant Metastasis,0.7226,Regional<;>Recurrence,0.7037
REGIONAL NODES,Metastatic Malignant Neoplasm in the Regional Lymph Nodes,2,2,Lymph Node,0.8014,Metastatic Malignant Neoplasm in the Regional Lymph Nodes,0.7800,Residual Nodal Disease,0.6826,Regional<;>Recurrence,0.6335,Local-Regional,0.6189
REGIONAL RECURRENCE,Regional<;>Recurrence,1,2,Regional<;>Recurrence,0.9681,Recurrence,0.8152,Locally Recurrent Malignant Neoplasm,0.8021,"Neoplasm Recurrence, Local",0.7899,Relapse,0.7713
REL CELL CARCINOMA,Renal Cell Carcinoma,99,2,Large Cell Carcinoma,0.7627,Undifferentiated Carcinoma,0.7275,Signet Ring Cell Carcinoma,0.7153,Mixed Carcinoma,0.7133,Anaplastic Carcinoma,0.7125
"REL ONCOCYTIC NEOPLASM, FAVOR CHROMOPHOBE, EOSINOPHILIC",Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,1,2,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0.7564,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.6769,Kidney Oncocytoma,0.6693,Thyroid Gland Follicular Carcinoma<;>Thyroid Gland Oncocytic Carcinoma,0.6555,Thyroid Gland Oncocytic Carcinoma,0.6544
"REL ONCOCYTIC NEOPLASM, FAVOR ONCOCYTOMA",Kidney Oncocytoma,3,2,Oncocytic Neoplasm,0.8140,Thyroid Gland Oncocytic Adenoma,0.7739,Kidney Oncocytoma,0.7718,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.7694,Thyroid Gland Oncocytic Carcinoma,0.7392
RELA-FUSION,"Supratentorial Ependymoma, ZFTA-RELA Fusion-Positive",5,2,Ewing Sarcoma<;>EWSR1/FLI1 Fusion Protein,0.5073,Fusion-Positive Rhabdomyosarcoma,0.4896,PAX3/FOXO1 Fusion Gene,0.4876,CBFB-MYH11 Fusion Protein Expression,0.4755,"Supratentorial Ependymoma, ZFTA-RELA Fusion-Positive",0.4745
RELAPSE,Relapse,1,2,Relapse,1.0000,Recurrent,0.8868,Recurrence,0.8841,First Relapse,0.8146,Regional<;>Recurrence,0.7803
RELAPSED_AML,Recurrent Acute Myeloid Leukemia,1,2,Recurrent Acute Myeloid Leukemia,0.8990,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.7422,Acute Lymphoblastic Leukemia<;>Recurrent Disease,0.6823,First Relapse,0.6645,Relapse,0.6543
RENAL ANGIOMYOLIPOMA,Kidney Angiomyolipoma,1,2,Kidney Angiomyolipoma,0.9793,Kidney Oncocytoma,0.6397,Chromophobe Renal Cell Carcinoma,0.6363,Mesonephric Adenocarcinoma,0.6186,Classic Variant of Chromophobe Renal Cell Carcinoma,0.5959
RENAL CANCER,Kidney Carcinoma,1,2,Kidney Carcinoma,0.9404,Renal Cell Carcinoma,0.9095,Clear Cell Renal Cell Carcinoma,0.7746,Kidney Medullary Carcinoma,0.7540,Papillary Renal Cell Carcinoma,0.7384
"RENAL CARCINOMA, CLEAR CELL",Clear Cell Renal Cell Carcinoma,1,2,Clear Cell Renal Cell Carcinoma,0.9890,Renal Cell Carcinoma,0.9070,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.8910,Chromophobe Renal Cell Carcinoma,0.8844,Clear Cell Adenocarcinoma,0.8590
"RENAL CARCINOMA, TRANSITIONAL CELL","Kidney Carcinoma, Transitional Cells",1,2,"Kidney Carcinoma, Transitional Cells",0.9697,Transitional Cell Carcinoma,0.8737,Urothelial Carcinoma,0.8312,Renal Cell Carcinoma,0.8056,Clear Cell Renal Cell Carcinoma,0.7999
RENAL CELL CARCINOMA,Renal Cell Carcinoma,1,2,Renal Cell Carcinoma,1.0000,Kidney Carcinoma,0.9162,Clear Cell Renal Cell Carcinoma,0.9119,Sarcomatoid Renal Cell Carcinoma,0.8418,Papillary Renal Cell Carcinoma,0.8342
RENAL CELL CARCINOMA-P/MD,Renal Cell Carcinoma<;>Poorly Differentiated<;>Moderately Differentiated,4,2,Papillary Renal Cell Carcinoma,0.8241,Renal Cell Carcinoma,0.8134,Renal Cell Carcinoma<;>Poorly Differentiated,0.7996,Renal Cell Carcinoma<;>Poorly Differentiated<;>Moderately Differentiated,0.7860,Clear Cell Renal Cell Carcinoma,0.7827
RENAL CELL CARCINOMA-PD,Renal Cell Carcinoma<;>Poorly Differentiated,2,2,Papillary Renal Cell Carcinoma,0.8492,Renal Cell Carcinoma<;>Poorly Differentiated,0.8254,Renal Cell Carcinoma,0.8113,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.7942,Clear Cell Renal Cell Carcinoma,0.7873
RENAL CELL CARCINOMA-VPD,Renal Cell Carcinoma<;>Poorly Differentiated,5,2,Clear Cell Renal Cell Carcinoma,0.6890,Fumarate Hydratase-Deficient Renal Cell Carcinoma,0.6824,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.6759,Papillary Renal Cell Carcinoma,0.6659,Renal Cell Carcinoma<;>Poorly Differentiated,0.6601
RENAL CLEAR CELL,Clear Cell Renal Cell Carcinoma,2,2,Clear Cell,0.8520,Clear Cell Renal Cell Carcinoma,0.8114,Clear Cell Papillary Renal Neoplasm,0.7477,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.7451,Renal Cell Carcinoma,0.7326
RENAL CLEAR CELL CARCINOMA,Clear Cell Renal Cell Carcinoma,1,2,Clear Cell Renal Cell Carcinoma,0.9926,Renal Cell Carcinoma,0.9208,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.9115,Chromophobe Renal Cell Carcinoma,0.8933,Clear Cell Adenocarcinoma,0.8566
RENAL CLEAR CELL CARCINOMA WITH SARCOMATOID FEATURES,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,1,2,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.9665,Sarcomatoid Renal Cell Carcinoma,0.9504,Clear Cell Renal Cell Carcinoma,0.8632,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.8434,Chromophobe Renal Cell Carcinoma,0.8084
RENAL LEIOMYOBLASTOMA,Bizarre Leiomyoma<;>Kidney Leiomyoma,1,2,Bizarre Leiomyoma<;>Kidney Leiomyoma,0.7865,Leiomyosarcoma,0.7377,Kidney Angiomyolipoma,0.7007,Conventional Leiomyosarcoma,0.6922,Uterine Corpus Leiomyosarcoma,0.6752
RENAL MEDULLARY CARCINOMA,Kidney Medullary Carcinoma,1,2,Kidney Medullary Carcinoma,0.9877,Medullary Carcinoma,0.9163,"Medullary Carcinoma, Not Otherwise Specified",0.8846,Renal Cell Carcinoma,0.8519,Thyroid Gland Medullary Carcinoma,0.8368
RENAL MUCINOUS TUBULAR SPINDLE CELL CARCINOMA,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,1,2,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,0.9092,Sarcomatoid Renal Cell Carcinoma,0.8411,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.8242,Chromophobe Renal Cell Carcinoma,0.7482,Mesonephric Adenocarcinoma,0.7383
RENAL NON-CLEAR CELL CARCINOMA,Renal Cell Carcinoma,1,2,Renal Cell Carcinoma,0.9074,Clear Cell Renal Cell Carcinoma,0.9009,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.8569,Renal Cell Carcinoma<;>Poorly Differentiated,0.8536,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.8495
RENAL ONCOCYTOMA,Kidney Oncocytoma,1,2,Kidney Oncocytoma,0.9801,Adrenal Cortical Oncocytic Carcinoma,0.8079,Clear Cell Papillary Renal Neoplasm,0.7639,Oncocytic Neoplasm,0.7479,Papillary Renal Cell Carcinoma,0.7477
RENAL SPINDLE CELL CARCINOMA,Sarcomatoid Carcinoma,99,2,Sarcomatoid Renal Cell Carcinoma,0.9035,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.8810,Clear Cell Renal Cell Carcinoma,0.8135,Renal Cell Carcinoma,0.7952,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,0.7911
RENAL_CELL_CARCINOMA,Renal Cell Carcinoma,1,2,Renal Cell Carcinoma,0.9763,Kidney Carcinoma,0.9174,Clear Cell Renal Cell Carcinoma,0.8938,Sarcomatoid Renal Cell Carcinoma,0.8331,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.8253
RENAL_LEIOMYOBLASTOMA,Bizarre Leiomyoma<;>Kidney Leiomyoma,1,2,Bizarre Leiomyoma<;>Kidney Leiomyoma,0.7963,Leiomyosarcoma,0.7826,Conventional Leiomyosarcoma,0.7347,Well Differentiated Leiomyosarcoma,0.7128,Uterine Corpus Leiomyosarcoma,0.7122
RESECTION,Resection,1,2,Resection,1.0000,Surgical Procedure,0.6387,Invasive,0.6273,Cystectomy,0.6252,Biopsy Specimen,0.5755
RESIDUAL NODAL DISEASE,Residual Nodal Disease,1,2,Residual Nodal Disease,1.0000,Regional<;>Recurrence,0.6639,Metastatic Malignant Neoplasm in the Regional Lymph Nodes,0.6592,Metastatic Malignant Neoplasm in the Lymph Nodes<;>Recurrent,0.6364,Recurrent,0.5958
RETINOBLASTOMA,Retinoblastoma,1,2,Retinoblastoma,1.0000,Trilateral Retinoblastoma,0.8745,Neuroblastoma,0.6509,Rhabdoid Tumor,0.6372,Medulloblastoma,0.6338
RHABDOID CANCER,Rhabdoid Tumor,1,2,Rhabdoid Tumor,0.9445,Extrarenal Rhabdoid Tumor,0.8728,Atypical Teratoid/Rhabdoid Tumor,0.8455,Rhabdoid Tumor<;>Extracranial,0.8346,Undifferentiated Round Cell Sarcoma,0.7163
RHABDOID TUMOR,Rhabdoid Tumor,1,2,Rhabdoid Tumor,1.0000,Extrarenal Rhabdoid Tumor,0.8970,Atypical Teratoid/Rhabdoid Tumor,0.8687,Rhabdoid Tumor<;>Extracranial,0.8257,Desmoplastic Small Round Cell Tumor,0.6839
RHABDOID TUMOUR,Rhabdoid Tumor,1,2,Rhabdoid Tumor,0.9948,Extrarenal Rhabdoid Tumor,0.8947,Atypical Teratoid/Rhabdoid Tumor,0.8648,Rhabdoid Tumor<;>Extracranial,0.8379,Desmoplastic Small Round Cell Tumor,0.6888
RHABDOID_TUMOUR,Rhabdoid Tumor,1,2,Rhabdoid Tumor,0.9840,Extrarenal Rhabdoid Tumor,0.8804,Atypical Teratoid/Rhabdoid Tumor,0.8659,Rhabdoid Tumor<;>Extracranial,0.8325,Desmoplastic Small Round Cell Tumor,0.6918
RHABDOMYOSARCOMA,Rhabdomyosarcoma,1,2,Rhabdomyosarcoma,1.0000,Embryonal Rhabdomyosarcoma,0.8649,Sclerosing Rhabdomyosarcoma,0.8329,Spindle Cell Rhabdomyosarcoma,0.8185,Fusion-Negative Rhabdomyosarcoma,0.7990
"RHABDOMYOSARCOMA, ALVEOLAR",Alveolar Rhabdomyosarcoma,1,2,Alveolar Rhabdomyosarcoma,0.9897,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.8503,Rhabdomyosarcoma,0.8074,Sclerosing Rhabdomyosarcoma,0.8012,Pleomorphic Rhabdomyosarcoma,0.7620
"RHABDOMYOSARCOMA, ALVEOLAR SUBTYPE",Alveolar Rhabdomyosarcoma,1,2,Alveolar Rhabdomyosarcoma,0.9827,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.8591,Rhabdomyosarcoma,0.7962,Sclerosing Rhabdomyosarcoma,0.7791,Pleomorphic Rhabdomyosarcoma,0.7636
"RHABDOMYOSARCOMA, EMBRYONAL",Embryonal Rhabdomyosarcoma,1,2,Embryonal Rhabdomyosarcoma,0.9919,Rhabdomyosarcoma,0.8705,Embryonal Carcinoma,0.8047,Embryonal Carcinoma<;>Nonseminomatous,0.7736,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.7672
RMS,Rhabdomyosarcoma,1,2,Rhabdomyosarcoma,0.8181,Embryonal Rhabdomyosarcoma,0.7524,Alveolar Rhabdomyosarcoma,0.7405,Sclerosing Rhabdomyosarcoma,0.7386,Fusion-Negative Rhabdomyosarcoma,0.7339
ROSAI-DORFMAN DISEASE,Rosai-Dorfman Disease,1,2,Rosai-Dorfman Disease,1.0000,Histiocytosis,0.5942,Langerhans Cell Histiocytosis,0.5904,Disseminated Juvenile Xanthogranuloma,0.5815,Follicular Dendritic Cell Sarcoma,0.5376
ROSETTE-FORMING GLIONEURONAL TUMOR OF THE FOURTH VENTRICLE,Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle,1,2,Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle,1.0000,Extraventricular Neurocytoma,0.6707,Anaplastic Ependymoma,0.6490,"Supratentorial Ependymoma, ZFTA-RELA Fusion-Positive",0.6477,Angiocentric Glioma,0.6367
"ROUND CELL SARCOMA, NOS",Undifferentiated Round Cell Sarcoma,2,2,Round Cell Sarcoma,0.9953,Undifferentiated Round Cell Sarcoma,0.9270,Sarcomatoid Carcinoma,0.8191,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.7853,undifferentiated sarcoma,0.7627
"ROUND CELL SARCOMA, OTHER",Round Cell Sarcoma,1,2,Round Cell Sarcoma,0.8543,Undifferentiated Round Cell Sarcoma,0.8229,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.8083,Desmoplastic Small Round Cell Tumor,0.7136,Sarcoma,0.6934
RT,Rhabdoid Tumor,4,2,Residual Nodal Disease,0.5671,Atypical Teratoid/Rhabdoid Tumor,0.5481,Local-Regional,0.5473,Rhabdoid Tumor,0.5453,Therapy-Related Myeloid Neoplasm,0.5345
RUNX1-RUNX1T1,AML1-ETO Fusion Protein Expression,99,2,Acute Myeloid Leukemia with Mutated RUNX1,0.7536,Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.7105,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.6901,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.6013,Acute Myeloid Leukemia with Mutated CEBPA,0.5927
SALIVARY ADENOCARCINOMA,Salivary Gland Adenocarcinoma,1,2,Salivary Gland Adenocarcinoma,0.9870,Salivary Gland Carcinoma,0.9077,Salivary Gland Squamous Cell Carcinoma,0.8569,Salivary Duct Carcinoma,0.8544,Salivary Gland Secretory Carcinoma,0.8443
SALIVARY ADENOCARCINOMA NOS,Salivary Gland Adenocarcinoma,1,2,Salivary Gland Adenocarcinoma,0.9803,Salivary Gland Carcinoma,0.9098,Salivary Gland Squamous Cell Carcinoma,0.8616,Salivary Duct Carcinoma,0.8480,Salivary Gland Secretory Carcinoma,0.8383
SALIVARY CANCER,Salivary Gland Carcinoma,1,2,Salivary Gland Carcinoma,0.9261,Salivary Gland Adenocarcinoma,0.8162,Salivary Duct Carcinoma,0.7896,Salivary Gland Squamous Cell Carcinoma,0.7847,Salivary Gland Secretory Carcinoma,0.7277
SALIVARY CARCINOMA,Salivary Gland Carcinoma,1,2,Salivary Gland Carcinoma,0.9851,Salivary Gland Adenocarcinoma,0.8974,Salivary Gland Squamous Cell Carcinoma,0.8796,Salivary Duct Carcinoma,0.8780,Salivary Gland Secretory Carcinoma,0.8260
"SALIVARY CARCINOMA, OTHER",Salivary Gland Carcinoma,1,2,Salivary Gland Carcinoma,0.7707,Salivary Duct Carcinoma,0.6998,Salivary Gland Adenocarcinoma,0.6848,Salivary Gland Secretory Carcinoma,0.6703,Salivary Gland Squamous Cell Carcinoma,0.6600
SALIVARY DUCT CARCINOMA,Salivary Duct Carcinoma,1,2,Salivary Duct Carcinoma,1.0000,Salivary Gland Carcinoma,0.8736,Salivary Gland Adenocarcinoma,0.8445,Salivary Gland Secretory Carcinoma,0.8023,Salivary Gland Squamous Cell Carcinoma,0.7989
SALIVARY GLAND CANCER,Salivary Gland Carcinoma,1,2,Salivary Gland Carcinoma,0.9367,Salivary Gland Adenocarcinoma,0.8214,Salivary Gland Squamous Cell Carcinoma,0.7952,Salivary Duct Carcinoma,0.7703,Salivary Gland,0.7348
SALIVARY GLAND-TYPE TUMOR OF THE LUNG,Malignant Mixed Tumor of the Salivary Gland<;>Lung Neoplasm,1,2,Malignant Mixed Tumor of the Salivary Gland<;>Lung Neoplasm,0.7687,Lung Sarcomatoid Carcinoma,0.6693,Lung Inflammatory Myofibroblastic Tumor,0.6403,Lung Mucoepidermoid Carcinoma,0.6385,Lung Spindle Cell Carcinoma,0.6329
SALIVARY_GLAND,Salivary Gland,1,2,Salivary Gland,0.9684,Exocrine Gland,0.7305,Salivary Gland Carcinoma,0.6457,Salivary Gland Adenocarcinoma,0.6034,Salivary Gland Secretory Carcinoma,0.5735
SARC,Sarcoma,4,2,Classic Histology,0.5438,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.5366,Microsatellite Stable,0.5163,Sarcoma,0.5044,Sclerosing Rhabdomyosarcoma,0.5007
SARC LMS,Uterine Corpus Leiomyosarcoma,99,2,Conventional Leiomyosarcoma,0.6125,Leiomyosarcoma,0.5827,Well Differentiated Leiomyosarcoma,0.5691,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.5020,Uterine Corpus Myxoid Leiomyosarcoma,0.5015
SARC LS,Liposarcoma,99,2,Conventional Leiomyosarcoma,0.5407,Microsatellite Stable Colorectal Carcinoma,0.5105,Leiomyosarcoma,0.5054,Microsatellite Stable,0.5052,Well Differentiated Leiomyosarcoma,0.5042
SARC UPSMFS,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,99,2,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.5109,Monoclonal Gammopathy of Undetermined Significance,0.5082,Myxoinflammatory Fibroblastic Sarcoma,0.5042,Undifferentiated Pleomorphic Sarcoma<;>Undifferentiated Spindle Cell Sarcoma,0.4830,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.4823
SARCOMA,Sarcoma,1,2,Sarcoma,1.0000,Bone Sarcoma,0.8243,undifferentiated sarcoma,0.8243,Soft Tissue Sarcoma,0.7995,Sarcomatoid Carcinoma,0.7951
SARCOMA LEIOMYO,Uterine Corpus Leiomyosarcoma,2,2,Leiomyosarcoma,0.9253,Uterine Corpus Leiomyosarcoma,0.8572,Well Differentiated Leiomyosarcoma,0.8426,Conventional Leiomyosarcoma,0.8411,Uterine Corpus Myxoid Leiomyosarcoma,0.7728
SARCOMA LIPO,Liposarcoma,1,2,Liposarcoma,0.8806,Well Differentiated Liposarcoma,0.7709,Myxoid Liposarcoma,0.7657,Liposarcoma<;>Mucinous,0.7480,Pleomorphic Liposarcoma,0.7450
SARCOMA UPS/MXF,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,99,2,Myxoinflammatory Fibroblastic Sarcoma,0.6870,Sarcoma,0.6785,undifferentiated sarcoma,0.6656,Soft Tissue Sarcoma,0.6491,Undifferentiated Soft Tissue Sarcoma,0.6465
"SARCOMA, NOS",Sarcoma,1,2,Sarcoma,0.9872,undifferentiated sarcoma,0.8328,Bone Sarcoma,0.8113,Sarcomatoid Carcinoma,0.8064,Soft Tissue Sarcoma,0.7826
SARCOMA; SYNOVIAL; POORLY DIFFERENTIATED,Synovial Sarcoma<;>Poorly Differentiated,1,2,Synovial Sarcoma<;>Poorly Differentiated,0.9868,Biphasic Synovial Sarcoma,0.8545,Synovial Sarcoma,0.8314,Monophasic Synovial Sarcoma,0.8287,Undifferentiated Pleomorphic Sarcoma,0.7332
SARCOMATOID,Sarcomatoid Carcinoma,1,2,Sarcomatoid Carcinoma,0.9410,undifferentiated sarcoma,0.8712,Sarcoma,0.8299,Round Cell Sarcoma,0.8191,Carcinosarcoma,0.8178
SARCOMATOID CARCINOMA OF THE LUNG,Lung Sarcomatoid Carcinoma,1,2,Lung Sarcomatoid Carcinoma,0.9715,Lung Spindle Cell Carcinoma,0.8546,Lung Pleomorphic Carcinoma,0.8067,Lung Mucoepidermoid Carcinoma,0.7939,Lung Small Cell Carcinoma,0.7669
SARCOMATOID CARCINOMA OF THE URINARY BLADDER,infiltrating bladder urothelial carcinoma sarcomatoid variant,1,2,infiltrating bladder urothelial carcinoma sarcomatoid variant,0.8182,Bladder Squamous Cell Carcinoma,0.7654,Bladder Urachal Carcinoma,0.7318,Bladder Urachal Adenocarcinoma,0.7281,Bladder Small Cell Neuroendocrine Carcinoma,0.7234
SARCOMATOID MESOTHELIOMA,Sarcomatoid Mesothelioma,1,2,Sarcomatoid Mesothelioma,1.0000,Pleural Sarcomatoid Mesothelioma,0.8659,Epithelioid Mesothelioma,0.8562,Mesothelioma,0.8447,Diffuse Malignant Mesothelioma,0.8436
SARCOMATOID RENAL CELL CARCINOMA,Sarcomatoid Renal Cell Carcinoma,1,2,Sarcomatoid Renal Cell Carcinoma,1.0000,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.9486,Clear Cell Renal Cell Carcinoma,0.8440,Renal Cell Carcinoma,0.8418,Chromophobe Renal Cell Carcinoma,0.8091
SARC_DDLPS,Dedifferentiated Liposarcoma,99,2,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.5021,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.4805,Microsatellite Stable,0.4645,Alveolar Soft Part Sarcoma,0.4627,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.4574
SARC_LMS,Leiomyosarcoma,3,2,Conventional Leiomyosarcoma,0.5813,Microsatellite Stable,0.5616,Leiomyosarcoma,0.5569,Well Differentiated Leiomyosarcoma,0.5299,Microsatellite Stable Colorectal Carcinoma,0.5220
SARC_MFS/UPS,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,99,2,Myxoinflammatory Fibroblastic Sarcoma,0.5509,Microsatellite Stable,0.5176,Solitary Fibrous Tumor,0.5151,High-Frequency Microsatellite Instability,0.5100,Fusion-Positive Rhabdomyosarcoma,0.4990
SARC_OTHER,Sarcoma,99,2,Not Otherwise Specified,0.5735,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.5182,Nonseminomatous,0.5171,Unclassified,0.4897,Extrahepatic,0.4857
SBS,Small Intestinal Carcinoma,99,2,Hereditary Spherocytosis,0.5268,Basal,0.5003,Down Syndrome,0.4785,Myelodysplastic Syndrome with Excess Blasts,0.4637,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.4617
SCC HEAD AND NECK,Head and Neck Squamous Cell Carcinoma,1,2,Head and Neck Squamous Cell Carcinoma,0.9163,Head and Neck Carcinoma,0.9007,Squamous Cell Carcinoma,0.7914,Malignant Head and Neck Neoplasm,0.7851,Skin Squamous Cell Carcinoma,0.7313
SCCOHT,"Ovarian Small Cell Carcinoma, Hypercalcemic Type",4,2,Cytology Specimen Type,0.4876,Head and Neck Squamous Cell Carcinoma<;>Spindle Cell Squamous Cell Carcinoma,0.4873,SPOP Gene,0.4783,"Ovarian Small Cell Carcinoma, Hypercalcemic Type",0.4703,Adrenal Cortical Oncocytic Carcinoma,0.4701
SCHMINKE TUMOR/LYMPHOEPITHELIAL CARCINOMA,Nasopharyngeal-Type Undifferentiated Carcinoma,99,2,Lung Lymphoepithelial Carcinoma,0.6848,Mucoepidermoid Carcinoma,0.6746,Sebaceous Carcinoma,0.6506,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells<;>Sarcomatoid Carcinoma,0.6322,Sweat Gland Carcinoma,0.6276
SCHWANNOMA,Schwannoma,1,2,Schwannoma,1.0000,Cellular Schwannoma,0.9192,Nerve Sheath Neoplasm,0.8513,Melanotic Schwannoma,0.8261,Plexiform Schwannoma,0.8083
SCLC,Lung Small Cell Carcinoma,1,2,Lung Small Cell Carcinoma,0.7802,Combined Lung Small Cell Carcinoma,0.7637,Small Cell Adenocarcinoma,0.7637,Small Cell Neuroendocrine Carcinoma,0.7499,Non-Small Cell Carcinoma,0.7487
SCLEROSING EPITHELIOID FIBROSARCOMA,Sclerosing Epithelioid Fibrosarcoma,1,2,Sclerosing Epithelioid Fibrosarcoma,1.0000,Myxoinflammatory Fibroblastic Sarcoma,0.7215,Epithelioid Sarcoma,0.7105,Dermatofibrosarcoma Protuberans,0.6999,Proximal-Type Epithelioid Sarcoma,0.6986
SCLEROSING RHABDOMYOSARCOMA,Sclerosing Rhabdomyosarcoma,1,2,Sclerosing Rhabdomyosarcoma,1.0000,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.9073,Spindle Cell Rhabdomyosarcoma,0.8786,Rhabdomyosarcoma,0.8329,Alveolar Rhabdomyosarcoma,0.8045
SEBACEOUS CARCINOMA,Sebaceous Carcinoma,1,2,Sebaceous Carcinoma,1.0000,Sweat Gland Carcinoma,0.8103,Eccrine Carcinoma,0.7557,Pilomatrical Carcinoma,0.7074,Adenocarcinoma<;>Dermoid Cyst,0.6723
SECOND MALIGNANCY,Secondary Malignant Neoplasm,1,2,Secondary Malignant Neoplasm,0.9253,Metastatic Lesion,0.7757,Metastatic Lesion<;>Recurrent,0.7345,Metastatic,0.7235,Metastasis,0.7193
SECOND MALIGNANCY FIRST HGG RECORD,Malignant Glioma<;>Secondary Malignant Neoplasm,99,2,First Relapse,0.5415,Mediastinal Germ Cell Tumor with Somatic-Type Malignancy,0.5035,Solid<;>High Grade Transformation,0.4723,Estrogen Receptor Positive<;>HER2/Neu Positive<;>HER2-Positive Breast Carcinoma,0.4569,Secondary Malignant Neoplasm,0.4479
SECOND RECURRENCE,Recurrence,1,2,Recurrence,0.8694,Recurrent,0.8257,Metastatic Lesion<;>Recurrent,0.8244,Regional<;>Recurrence,0.8059,Relapse,0.7928
SECONDARY MYELOFIBROSIS,Secondary Myelofibrosis,1,2,Secondary Myelofibrosis,1.0000,Primary Myelofibrosis,0.9000,Overt Primary Myelofibrosis,0.8673,Essential Thrombocythemia<;>Myelofibrosis,0.7977,Polycythemia Vera<;>Myelofibrosis,0.7932
SECONDARY OSTEOSARCOMA,Secondary Osteosarcoma,1,2,Secondary Osteosarcoma,1.0000,Osteosarcoma,0.8084,Extraskeletal Osteosarcoma,0.7785,Parosteal Osteosarcoma,0.7509,Osteoblastic Osteosarcoma,0.7342
SELLAR TUMOR,Sellar Region Neoplasm,1,2,Sellar Region Neoplasm,0.9257,Pituicytoma,0.6834,Craniopharyngioma,0.6707,Pineal Region Neoplasm,0.6492,Pituitary Neuroendocrine Tumor,0.6221
SEMINAL VESICLE CARCINOMA,Malignant Seminal Vesicle Neoplasm,1,2,Malignant Seminal Vesicle Neoplasm,0.8689,Prostate Small Cell Neuroendocrine Carcinoma,0.6102,Prostate Squamous Cell Carcinoma,0.5976,Prostate Neuroendocrine Carcinoma,0.5962,Urethral Melanoma,0.5603
SEMINOMA,Seminoma,1,2,Seminoma,1.0000,Testicular Seminoma,0.9382,Embryonal Carcinoma<;>Seminoma,0.8977,Seminoma<;>Mature Teratoma,0.8609,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.8497
SEMINOMA; NOS,Seminoma,1,2,Seminoma,0.9902,Testicular Seminoma,0.9348,Embryonal Carcinoma<;>Seminoma,0.8967,Seminoma<;>Mature Teratoma,0.8585,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.8431
SEMINOMA; NOSNON-SEMINOMA; CHORIOCARCINOMA,Choriocarcinoma<;>Nonseminomatous<;>Seminoma,1,2,Choriocarcinoma<;>Nonseminomatous<;>Seminoma,0.8903,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.8507,Embryonal Carcinoma<;>Seminoma,0.8150,Yolk Sac Tumor<;>Seminoma,0.8057,Seminoma,0.7974
SEMINOMA; NOSNON-SEMINOMA; EMBRYONAL CARCINOMA,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,2,2,Embryonal Carcinoma<;>Seminoma,0.9236,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.8924,Testicular Seminoma,0.8740,Seminoma,0.8621,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8619
SEMINOMA; NOSNON-SEMINOMA; TERATOMA MATURE,Nonseminomatous<;>Mature Teratoma<;>Seminoma,2,2,Seminoma<;>Mature Teratoma,0.9169,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8835,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8609,Seminoma,0.8289,Testicular Seminoma,0.8262
SEMINOMA; NOSNON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; EMBRYONAL CARCINOMA,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,1,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8742,Embryonal Carcinoma<;>Seminoma,0.7722,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.7714,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.7679,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7658
SEMINOMA; NOSNON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; YOLK SAC TUMOR,Nonseminomatous<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Mature Teratoma<;>Seminoma,99,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8131,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.7297,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7246,Seminoma<;>Mature Teratoma,0.7198,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.7057
SEMINOMA; NOSNON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; TERATOMA IMMATURENON-SEMINOMA; YOLK SAC TUMOR,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Mature Teratoma<;>Seminoma,99,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.7884,Seminoma<;>Mature Teratoma,0.7531,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.7510,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7258,Testicular Seminoma,0.7122
SEMINOMA; NOSNON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; EMBRYONAL CARCINOMANON-SEMINOMA; TERATOMA IMMATURE,Nonseminomatous<;>Immature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma<;>Seminoma,99,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.7831,Yolk Sac Tumor<;>Seminoma,0.7606,Embryonal Carcinoma<;>Seminoma,0.7502,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.7333,Testicular Seminoma,0.7197
SEMINOMA; NOSNON-SEMINOMA; YOLK SAC TUMORNON-SEMINOMA; TERATOMA MATURENON-SEMINOMA; TERATOMA IMMATURE,Nonseminomatous<;>Mature Teratoma<;>Yolk Sac Tumor<;>Immature Teratoma<;>Seminoma,99,2,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.7900,Yolk Sac Tumor<;>Seminoma,0.7471,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7385,Seminoma<;>Mature Teratoma,0.7329,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.7236
SEROUS,Serous,1,2,Serous,1.0000,Serous Adenocarcinoma,0.7468,Serous Cystadenocarcinoma,0.6960,Serous Adenocarcinoma<;>High Grade,0.6938,Mixed<;>Serous<;>Clear Cells,0.6736
SEROUS BORDERLINE OVARIAN TUMOR,Borderline Ovarian Serous Tumor,1,2,Borderline Ovarian Serous Tumor,0.9784,Ovarian Low Grade Serous Adenocarcinoma,0.7830,Ovarian High Grade Serous Adenocarcinoma,0.7598,Borderline Ovarian Serous Tumor-Micropapillary Variant,0.7596,Ovarian Serous Adenocarcinoma,0.7468
"SEROUS BORDERLINE OVARIAN TUMOR, MICROPAPILLARY",Borderline Ovarian Serous Tumor-Micropapillary Variant,1,2,Borderline Ovarian Serous Tumor-Micropapillary Variant,0.9536,Borderline Ovarian Serous Tumor,0.8238,Ovarian Low Grade Serous Adenocarcinoma,0.6916,Papillary Serous Cystadenocarcinoma,0.6612,Borderline Ovarian Clear Cell Tumor,0.6594
SEROUS CYSTADENOCARCINOMA,Serous Cystadenocarcinoma,1,2,Serous Cystadenocarcinoma,1.0000,Cystadenocarcinoma<;>High Grade<;>Serous,0.9083,Serous Adenocarcinoma,0.9045,Papillary Serous Cystadenocarcinoma,0.9036,Serous Adenocarcinoma<;>High Grade,0.8831
SEROUS CYSTADENOMA OF THE PANCREAS,Pancreatic Serous Cystadenoma,1,2,Pancreatic Serous Cystadenoma,0.9807,Serous Cystadenocarcinoma,0.7894,Papillary Serous Cystadenocarcinoma,0.7610,Cystadenocarcinoma<;>High Grade<;>Serous,0.7106,Solid Pseudopapillary Neoplasm of the Pancreas,0.6931
SEROUS ENDOMETRIAL ADENOCARCINOMA,Endometrial Serous Adenocarcinoma,1,2,Endometrial Serous Adenocarcinoma,0.9929,Serous Adenocarcinoma,0.8715,Ovarian Serous Adenocarcinoma,0.8707,Ovarian High Grade Serous Adenocarcinoma,0.8195,Serous Adenocarcinoma<;>High Grade,0.8149
SEROUS OVARIAN CANCER,Ovarian Serous Adenocarcinoma,1,2,Ovarian Serous Adenocarcinoma,0.9334,Ovarian High Grade Serous Adenocarcinoma,0.8976,Serous Adenocarcinoma,0.8742,Ovarian Low Grade Serous Adenocarcinoma,0.8740,Serous Adenocarcinoma<;>High Grade,0.8385
SEROUS_CARCINOMA,Ovarian Serous Adenocarcinoma,3,2,Serous Adenocarcinoma,0.9446,Serous Adenocarcinoma<;>High Grade,0.9007,Ovarian Serous Adenocarcinoma,0.8825,Serous Cystadenocarcinoma,0.8760,Ovarian High Grade Serous Adenocarcinoma,0.8425
SERTOLI-LEYDIG CELL TUMOR,Ovarian Sertoli-Leydig Cell Tumor,1,2,Ovarian Sertoli-Leydig Cell Tumor,0.9607,Sex Cord-Stromal Tumor,0.7354,Testicular mesothelioma,0.7026,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0.7019,Seminoma,0.6719
SEX CORD STROMAL TUMOR,Sex Cord-Stromal Tumor,1,2,Sex Cord-Stromal Tumor,0.9944,Ovarian Sertoli-Leydig Cell Tumor,0.6632,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0.6335,Gastrointestinal Stromal Tumor,0.6331,Seminoma,0.6212
SEX CORD-STROMAL TUMOUR,Sex Cord-Stromal Tumor,1,2,Sex Cord-Stromal Tumor,0.9942,Ovarian Sertoli-Leydig Cell Tumor,0.6680,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0.6485,Gastrointestinal Stromal Tumor,0.6336,Seminoma,0.6297
SEZARY SYNDROME,Sezary Syndrome,1,2,Sezary Syndrome,1.0000,Mycosis Fungoides and Sezary Syndrome,0.6806,Extranodal Disease,0.4937,Rosai-Dorfman Disease,0.4847,Ewing Sarcoma,0.4656
SEZARY_SYNDROME,Sezary Syndrome,1,2,Sezary Syndrome,0.9795,Mycosis Fungoides and Sezary Syndrome,0.6967,Extranodal Disease,0.5011,Rosai-Dorfman Disease,0.4813,Mycosis Fungoides,0.4712
SIGMOID COLON,Sigmoid Colon,1,2,Sigmoid Colon,1.0000,Ascending Colon,0.8027,Transverse Colon,0.7786,Descending Colon,0.7686,Rectosigmoid Region,0.6990
SIGNET RING,Signet Ring Cell,1,2,Signet Ring Cell,0.7263,Signet Ring Adenocarcinoma Cell,0.5937,Signet Ring Cell<;>Mucinous,0.5895,Papillary,0.5754,Signet Ring Cell Carcinoma,0.5601
SIGNET RING CELL,Signet Ring Cell,1,2,Signet Ring Cell,1.0000,Signet Ring Adenocarcinoma Cell,0.8198,Signet Ring Cell<;>Mucinous,0.7528,Signet Ring Cell Carcinoma,0.7170,Pancreatic Signet Ring Cell Carcinoma,0.6553
SIGNET RING CELL ADENOCARCINOMA OF THE COLON AND RECTUM,Rectal Signet Ring Cell Adenocarcinoma<;>Colon Signet Ring Cell Adenocarcinoma,1,2,Rectal Signet Ring Cell Adenocarcinoma<;>Colon Signet Ring Cell Adenocarcinoma,0.9398,Appendix Signet Ring Cell Carcinoma,0.8230,Signet Ring Cell Carcinoma,0.8095,Signet Ring Adenocarcinoma Cell,0.8038,Pancreatic Signet Ring Cell Carcinoma,0.7747
SIGNET RING CELL CARCINOMA OF THE STOMACH,Gastric Signet Ring Cell Adenocarcinoma,1,2,Gastric Signet Ring Cell Adenocarcinoma,0.9423,Signet Ring Cell Carcinoma,0.8413,Appendix Signet Ring Cell Carcinoma,0.8057,Signet Ring Adenocarcinoma Cell,0.7987,Rectal Signet Ring Cell Adenocarcinoma<;>Colon Signet Ring Cell Adenocarcinoma,0.7930
SIGNET RING CELL TYPE OF THE APPENDIX,Appendix Signet Ring Cell Carcinoma,1,2,Appendix Signet Ring Cell Carcinoma,0.8951,Signet Ring Cell<;>Mucinous,0.7870,Signet Ring Adenocarcinoma Cell,0.7764,Signet Ring Cell,0.7375,Rectal Signet Ring Cell Adenocarcinoma<;>Colon Signet Ring Cell Adenocarcinoma,0.7293
"SIGNET RING, MUCINOUS FEATURES",Signet Ring Cell<;>Mucinous,1,2,Signet Ring Cell<;>Mucinous,0.9302,Signet Ring Adenocarcinoma Cell,0.8098,Signet Ring Cell Carcinoma,0.7820,Signet Ring Cell,0.7661,Pancreatic Signet Ring Cell Carcinoma,0.7281
SIGNET_RING_ADENOCARCINOMA,Signet Ring Adenocarcinoma Cell,2,2,Signet Ring Cell Carcinoma,0.9334,Signet Ring Adenocarcinoma Cell,0.9277,Gastric Signet Ring Cell Adenocarcinoma,0.8371,Pancreatic Signet Ring Cell Carcinoma,0.8351,Signet Ring Cell<;>Mucinous,0.8249
SIGNET_RING_CELL,Signet Ring Cell,1,2,Signet Ring Cell,0.9305,Signet Ring Adenocarcinoma Cell,0.7282,Signet Ring Cell<;>Mucinous,0.7039,Signet Ring Cell Carcinoma,0.6488,Pancreatic Signet Ring Cell Carcinoma,0.5865
SINONASAL ADENOCARCINOMA,Sinonasal Adenocarcinoma,1,2,Sinonasal Adenocarcinoma,1.0000,Sinonasal Undifferentiated Carcinoma,0.8621,Sinonasal Squamous Cell Carcinoma,0.8480,Adenoid Cystic Carcinoma,0.6932,Nasopharyngeal Carcinoma,0.6834
SINONASAL SQUAMOUS CELL CARCINOMA,Sinonasal Squamous Cell Carcinoma,1,2,Sinonasal Squamous Cell Carcinoma,1.0000,Sinonasal Undifferentiated Carcinoma,0.8667,Sinonasal Adenocarcinoma,0.8480,Squamous Cell Carcinoma,0.7176,Sarcomatoid Carcinoma,0.6844
SINONASAL UNDIFFERENTIATED CARCINOMA,Sinonasal Undifferentiated Carcinoma,1,2,Sinonasal Undifferentiated Carcinoma,1.0000,Sinonasal Squamous Cell Carcinoma,0.8667,Sinonasal Adenocarcinoma,0.8621,Nasopharyngeal-Type Undifferentiated Carcinoma,0.7926,Undifferentiated Carcinoma,0.7675
SKCM,Cutaneous Melanoma,99,2,Extraskeletal Myxoid Chondrosarcoma,0.5844,Pseudomyogenic Hemangioendothelioma,0.5760,Mesenchymal Chondrosarcoma,0.5649,PEComa,0.5499,Epithelial-Myoepithelial Carcinoma,0.5470
SKIN,Skin,1,2,Skin,1.0000,Malignant Skin Neoplasm,0.6758,Superficial,0.6548,Skin Carcinoma,0.6498,Tissue,0.6139
SKIN ADNEXAL CARCINOMA,skin appendage carcinoma,1,2,skin appendage carcinoma,0.8195,Eccrine Carcinoma,0.7226,Sebaceous Carcinoma,0.7169,Skin Acantholytic Squamous Cell Carcinoma,0.7049,Skin Metatypical Carcinoma,0.7004
SKIN CANCER,Malignant Skin Neoplasm,2,2,Skin Carcinoma,0.9442,Malignant Skin Neoplasm,0.9238,Cutaneous Melanoma,0.7495,Skin Squamous Cell Carcinoma,0.7428,Skin,0.7103
"SKIN CANCER, NON-MELANOMA",Skin Carcinoma,1,2,Skin Carcinoma,0.8267,Malignant Skin Neoplasm,0.8199,Cutaneous Melanoma,0.7164,Melanoma,0.6874,Skin Squamous Cell Carcinoma,0.6682
SKIN_CANCER,Malignant Skin Neoplasm,2,2,Skin Carcinoma,0.9090,Malignant Skin Neoplasm,0.8930,Skin,0.7312,Cutaneous Melanoma,0.7227,Skin Squamous Cell Carcinoma,0.7223
SKIN_SQUAMOUS,Skin Squamous Cell Carcinoma,1,2,Skin Squamous Cell Carcinoma,0.7198,Squamous Cell Carcinoma,0.7173,Skin,0.6752,Cervical Squamous Neoplasm,0.6453,Skin Carcinoma,0.6359
SMALL BOWEL ADENOCARCINOMA,Small Intestinal Adenocarcinoma,1,2,Small Intestinal Adenocarcinoma,0.9577,Small Intestinal Carcinoma,0.8639,Small Cell Adenocarcinoma,0.6997,Cecum Adenocarcinoma,0.6549,Colorectal Adenocarcinoma,0.6538
SMALL BOWEL CANCER,Small Intestinal Carcinoma,1,2,Small Intestinal Carcinoma,0.9220,Small Intestinal Adenocarcinoma,0.7981,Colorectal Carcinoma,0.6847,Small Intestinal Neuroendocrine Neoplasm,0.6680,Malignant Intestinal Neoplasm,0.6656
SMALL BOWEL CARCINOMA,Small Intestinal Carcinoma,1,2,Small Intestinal Carcinoma,0.9545,Small Intestinal Adenocarcinoma,0.8616,Colorectal Carcinoma,0.6643,Small Intestinal Neuroendocrine Neoplasm,0.6448,Colorectal Adenocarcinoma,0.6415
SMALL BOWEL NEUROENDOCRINE TUMOR,Small Intestinal Neuroendocrine Neoplasm,1,2,Small Intestinal Neuroendocrine Neoplasm,0.9571,Small Intestinal Neuroendocrine Neoplasm<;>Well Differentiated,0.8092,Colorectal Neuroendocrine Tumor,0.8024,Digestive System Neuroendocrine Tumor,0.7492,Somatostatin-Producing Neuroendocrine Tumor,0.7261
SMALL BOWEL WELL-DIFFERENTIATED NEUROENDOCRINE TUMOR,Small Intestinal Neuroendocrine Neoplasm<;>Well Differentiated,1,2,Small Intestinal Neuroendocrine Neoplasm<;>Well Differentiated,0.9156,Small Intestinal Neuroendocrine Neoplasm,0.9007,Colorectal Neuroendocrine Tumor,0.7584,Rectal Neuroendocrine Tumor<;>Well Differentiated,0.7431,Digestive System Neuroendocrine Tumor,0.7113
SMALL CELL,Small Cell,1,2,Small Cell,1.0000,"Malignant Tumor, Small Cell Type",0.8745,Small Cell Adenocarcinoma,0.8084,Small Cell Neuroendocrine Carcinoma,0.7661,Non-Small Cell Carcinoma,0.7208
SMALL CELL BLADDER CANCER,Bladder Small Cell Neuroendocrine Carcinoma,1,2,Bladder Small Cell Neuroendocrine Carcinoma,0.8941,Bladder Squamous Cell Carcinoma,0.7656,Bladder Urothelial Carcinoma,0.7385,Bladder Adenocarcinoma,0.7243,Bladder Urachal Carcinoma,0.7134
SMALL CELL BRONCHIOALVEOLAR CARCINOMA,Lung Small Cell Carcinoma,1,2,Lung Small Cell Carcinoma,0.7687,Combined Lung Small Cell Carcinoma,0.7624,Lung Spindle Cell Carcinoma,0.7309,Small Cell Adenocarcinoma,0.7309,Lung Adenosquamous Carcinoma,0.7070
SMALL CELL CARCINOMA,Small Cell Neuroendocrine Carcinoma,4,2,Small Cell Adenocarcinoma,0.9309,"Malignant Tumor, Small Cell Type",0.9284,Lung Small Cell Carcinoma,0.8873,Small Cell Neuroendocrine Carcinoma,0.8545,Small Cell,0.8477
SMALL CELL CARCINOMA OF  GALLBLADDER,Gallbladder Small Cell Neuroendocrine Carcinoma,1,2,Gallbladder Small Cell Neuroendocrine Carcinoma,0.9130,Gallbladder Squamous Cell Carcinoma,0.8117,Gallbladder Adenosquamous Carcinoma,0.7805,Gallbladder Large Cell Neuroendocrine Carcinoma,0.7804,Gallbladder Adenocarcinoma,0.7490
SMALL CELL CARCINOMA OF THE CERVIX,Cervical Small Cell Neuroendocrine Carcinoma,1,2,Cervical Small Cell Neuroendocrine Carcinoma,0.8701,Cervical Squamous Cell Carcinoma,0.7375,Lung Small Cell Carcinoma,0.7031,Small Cell Adenocarcinoma,0.6936,Ovarian Small Cell Carcinoma,0.6721
SMALL CELL CARCINOMA OF THE OVARY,Ovarian Small Cell Carcinoma,1,2,Ovarian Small Cell Carcinoma,0.9605,"Ovarian Small Cell Carcinoma, Hypercalcemic Type",0.8643,Ovarian Small Cell Carcinoma<;>Dermoid Cyst,0.7826,Ovarian Carcinosarcoma,0.7700,Ovarian Adenocarcinoma,0.6875
SMALL CELL CARCINOMA OF THE OVARY HYPERCALCEMIC TYPE SCCOHT,"Ovarian Small Cell Carcinoma, Hypercalcemic Type",1,2,"Ovarian Small Cell Carcinoma, Hypercalcemic Type",0.8912,Ovarian Small Cell Carcinoma,0.7320,Ovarian Carcinosarcoma,0.6419,ovary mixed epithelial carcinoma,0.6351,Ovarian Small Cell Carcinoma<;>Dermoid Cyst,0.6336
SMALL CELL CARCINOMA OF THE STOMACH,Gastric Small Cell Neuroendocrine Carcinoma,1,2,Gastric Small Cell Neuroendocrine Carcinoma,0.8710,Small Cell Adenocarcinoma,0.7332,Gastric Adenosquamous Carcinoma,0.7216,Lung Small Cell Carcinoma,0.7151,Small Cell Neuroendocrine Carcinoma,0.7148
SMALL CELL CARCINOMA OF UNKNOWN PRIMARY,Small Cell Neuroendocrine Carcinoma,2,2,Melanoma of Unknown Primary,0.7158,Small Cell Neuroendocrine Carcinoma,0.7128,High Grade<;>Small Cell Neuroendocrine Carcinoma<;>Small Cell Adenocarcinoma,0.6927,Small Cell Adenocarcinoma,0.6850,"Malignant Tumor, Small Cell Type",0.6664
SMALL CELL LUNG CANCER,Lung Small Cell Carcinoma,1,2,Lung Small Cell Carcinoma,0.9603,Combined Lung Small Cell Carcinoma,0.8498,"Malignant Tumor, Small Cell Type",0.8193,Small Cell Adenocarcinoma,0.8189,Lung Non-Small Cell Carcinoma,0.8129
SMALL CELL LUNG CANCER SCLC,Lung Small Cell Carcinoma,1,2,Lung Small Cell Carcinoma,0.8839,Combined Lung Small Cell Carcinoma,0.8197,Small Cell Adenocarcinoma,0.7682,Small Cell Neuroendocrine Carcinoma,0.7451,"Malignant Tumor, Small Cell Type",0.7451
SMALL CELL NEUROENDOCRINE CARCINOMA OF GALLBLADDER,Gallbladder Small Cell Neuroendocrine Carcinoma,1,2,Gallbladder Small Cell Neuroendocrine Carcinoma,0.9879,Gallbladder Large Cell Neuroendocrine Carcinoma,0.8783,Gallbladder Neuroendocrine Tumor,0.8139,Gallbladder Squamous Cell Carcinoma,0.7738,Gallbladder Adenosquamous Carcinoma,0.7554
SMALL CELL OSTEOSARCOMA,Small Cell Osteosarcoma,1,2,Small Cell Osteosarcoma,1.0000,Osteosarcoma,0.8416,Fibroblastic Osteosarcoma,0.8126,Chondroblastic Osteosarcoma,0.8083,Osteoblastic Osteosarcoma,0.8033
SMALL INTESTINAL CARCINOMA,Small Intestinal Carcinoma,1,2,Small Intestinal Carcinoma,1.0000,Small Intestinal Adenocarcinoma,0.9117,Small Intestinal Neuroendocrine Neoplasm,0.6935,Colorectal Carcinoma,0.6478,Small Cell Adenocarcinoma,0.6394
SMALL ROUND BLUE CELL TUMOR,Desmoplastic Small Round Cell Tumor,1,2,Desmoplastic Small Round Cell Tumor,0.7660,Round Cell Sarcoma,0.7375,Undifferentiated Round Cell Sarcoma,0.7280,Small Cell Neuroendocrine Carcinoma,0.7086,"Malignant Tumor, Small Cell Type",0.6850
SMALL ROUND BLUE CELL TUMOR/ EWING SARCOMA,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,1,2,Desmoplastic Small Round Cell Tumor<;>Ewing Sarcoma,0.8601,Ewing Sarcoma,0.8586,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.8200,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.8005,Fusion-Positive Rhabdomyosarcoma,0.6714
SMALL_CELL_ADENOCARCINOMA,Small Cell Adenocarcinoma,1,2,Small Cell Adenocarcinoma,0.9641,"Malignant Tumor, Small Cell Type",0.8272,Small Cell,0.8111,High Grade<;>Small Cell Neuroendocrine Carcinoma<;>Small Cell Adenocarcinoma,0.8017,Lung Small Cell Carcinoma,0.7754
SMALL_CELL_CARCINOMA,Small Cell Neuroendocrine Carcinoma,5,2,"Malignant Tumor, Small Cell Type",0.9217,Small Cell Adenocarcinoma,0.9009,Lung Small Cell Carcinoma,0.8621,Small Cell,0.8545,Small Cell Neuroendocrine Carcinoma,0.8364
SMOLDERING MYELOMA,Smoldering Plasma Cell Myeloma,1,2,Smoldering Plasma Cell Myeloma,0.9293,Plasma Cell Myeloma,0.7719,Plasma Cell Myeloma<;>Plasmacytoma,0.7125,Plasmacytoma,0.6507,Plasma Cell Leukemia,0.6460
SOFT TISSUE,Soft Tissue,1,2,Soft Tissue,1.0000,Soft Tissue Neoplasm,0.7306,Tissue,0.6979,Malignant Soft Tissue Neoplasm,0.6952,Soft Tissue Sarcoma,0.6576
"SOFT TISSUE CANCER, NOS",Malignant Soft Tissue Neoplasm,1,2,Malignant Soft Tissue Neoplasm,0.9276,Soft Tissue Sarcoma,0.8725,Soft Tissue Neoplasm,0.8598,Soft Tissue,0.7289,Undifferentiated Soft Tissue Sarcoma,0.7202
SOFT TISSUE MYOEPITHELIAL CARCINOMA,Malignant Myoepithelioma,4,2,Undifferentiated Soft Tissue Sarcoma,0.7975,Clear Cell Sarcoma of Soft Tissue,0.7649,Epithelial-Myoepithelial Carcinoma,0.7558,Malignant Myoepithelioma,0.7473,Soft Tissue Sarcoma,0.7421
SOFT TISSUE SARCOMA,Soft Tissue Sarcoma,1,2,Soft Tissue Sarcoma,1.0000,Malignant Soft Tissue Neoplasm,0.9191,Undifferentiated Soft Tissue Sarcoma,0.8706,Soft Tissue Neoplasm,0.8026,Sarcoma,0.7995
SOFT TISSUE SARCOMA OTHER,Soft Tissue Sarcoma,1,2,Soft Tissue Sarcoma,0.8405,Malignant Soft Tissue Neoplasm,0.7905,Undifferentiated Soft Tissue Sarcoma,0.7465,Soft Tissue Neoplasm,0.7195,Sarcoma,0.6781
SOFT TISSUE TUMOR,Soft Tissue Neoplasm,1,2,Soft Tissue Neoplasm,0.9832,Malignant Soft Tissue Neoplasm,0.8474,Soft Tissue Sarcoma,0.8319,Soft Tissue,0.7311,Mesenchymal Cell Neoplasm,0.7227
SOFT_TISSUE,Soft Tissue,1,2,Soft Tissue,0.9778,Soft Tissue Neoplasm,0.7274,Malignant Soft Tissue Neoplasm,0.7016,Tissue,0.6951,Soft Tissue Sarcoma,0.6658
SOLID,Solid,1,2,Solid,1.0000,Solid<;>Carcinoma Exhibiting Undifferentiated or Dedifferentiated Features,0.6318,Micropapillary Growth Pattern<;>Solid,0.6066,Cribriform<;>Solid,0.5779,Serous,0.5728
SOLID >30%,Solid,1,2,Solid,0.6206,Solid<;>High Grade Transformation,0.5430,With Tumor,0.4950,Solid<;>Carcinoma Exhibiting Undifferentiated or Dedifferentiated Features,0.4919,Locally Advanced Malignant Neoplasm,0.4901
SOLID >50%,Solid,1,2,Solid,0.6253,Solid<;>High Grade Transformation,0.5796,With Tumor,0.5230,Solid<;>Carcinoma Exhibiting Undifferentiated or Dedifferentiated Features,0.5227,Carcinoma,0.5187
SOLID ADENOCARCINOMA 82303,Solid Lung Adenocarcinoma,5,2,Serous Adenocarcinoma<;>High Grade,0.6394,Serous Adenocarcinoma,0.6344,Serous Cystadenocarcinoma,0.6142,Ovarian High Grade Serous Adenocarcinoma,0.6090,Solid Lung Adenocarcinoma,0.6014
SOLID PAPILLARY CARCINOMA OF THE BREAST,Breast Solid Papillary Carcinoma,1,2,Breast Solid Papillary Carcinoma,0.9843,Breast Papillary Ductal Carcinoma with Invasion,0.7200,Papillary Carcinoma,0.7022,Papillary Adenocarcinoma,0.6866,Acinar Cell Carcinoma<;>Papillary,0.6730
SOLID PSEUDOPAPILLARY NEOPLASM OF THE PANCREAS,Solid Pseudopapillary Neoplasm of the Pancreas,1,2,Solid Pseudopapillary Neoplasm of the Pancreas,1.0000,Pancreatic Serous Cystadenoma,0.7205,Pancreatic Mucinous-Cystic Neoplasm,0.7008,Pancreatic Colloid Carcinoma,0.6914,Pancreatic Intraductal Tubulopapillary Neoplasm,0.6684
SOLID/DEDIFFERENTIATED,Solid<;>Carcinoma Exhibiting Undifferentiated or Dedifferentiated Features,1,2,Solid<;>Carcinoma Exhibiting Undifferentiated or Dedifferentiated Features,0.8754,Poorly Differentiated,0.7326,Anaplastic Lesion<;>Diffuse,0.7121,Solid<;>High Grade Transformation,0.7064,Undifferentiated,0.6979
SOLID/HIGH-GRADE TRANSFORMATION,Solid<;>High Grade Transformation,1,2,Solid<;>High Grade Transformation,0.9525,Solid<;>Carcinoma Exhibiting Undifferentiated or Dedifferentiated Features,0.7026,Well Differentiated Lesion<;>Invasive,0.6751,Anaplastic,0.6674,Anaplastic Carcinoma,0.6526
SOLITARY FIBROUS TUMOR,Solitary Fibrous Tumor,1,2,Solitary Fibrous Tumor,1.0000,Central Nervous System Solitary Fibrous Tumor,0.8469,Meningeal Solitary Fibrous Tumor,0.7980,Skin Fibrous Histiocytoma,0.7734,Infantile Myofibroma,0.7285
SOLITARY FIBROUS TUMOR OF THE CENTRAL NERVOUS SYSTEM,Central Nervous System Solitary Fibrous Tumor,1,2,Central Nervous System Solitary Fibrous Tumor,0.9865,Meningeal Solitary Fibrous Tumor,0.8562,Solitary Fibrous Tumor,0.8094,Central Neurocytoma,0.6922,NTRK-Rearranged Spindle Cell Neoplasm,0.6227
SOLITARY FIBROUS TUMOR/HEMANGIOPERICYTOMA,Solitary Fibrous Tumor,1,2,Solitary Fibrous Tumor,0.8704,Central Nervous System Solitary Fibrous Tumor,0.7383,Skin Fibrous Histiocytoma,0.7192,Meningeal Solitary Fibrous Tumor,0.7184,Pseudomyogenic Hemangioendothelioma,0.6919
SOMATOSTATINOMA,Somatostatin-Producing Neuroendocrine Tumor,1,2,Somatostatin-Producing Neuroendocrine Tumor,0.9286,Pituitary Neuroendocrine Tumor,0.6653,Digestive System Neuroendocrine Tumor,0.6507,Neuroendocrine Tumor,0.6480,Pancreatic Neuroendocrine Tumor,0.6443
SPECIFIC DX AT ACQUISITION MDSMPN,Myelodysplastic/Myeloproliferative Neoplasm,99,2,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,0.4432,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.4315,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.4240,Acute Myeloid Leukemia with Multilineage Dysplasia,0.4212,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.4187
SPECIFIC_DX_AT_ACQUISITION_MDSMPN,Myelodysplastic/Myeloproliferative Neoplasm,99,2,Acute Myeloid Leukemia with Myelodysplasia-Related Changes,0.4799,Distant,0.4633,Acute Myeloid Leukemia<;>Myelodysplastic Syndrome,0.4546,Acute Myeloid Leukemia with Multilineage Dysplasia,0.4428,Myeloid Leukemia Associated with Down Syndrome,0.4321
SPINDLE CELL,Spindle Cell Neoplasm,1,2,Spindle Cell Neoplasm,0.8568,Epithelioid Cell<;>Spindle Cell Neoplasm,0.7375,Spindle Cell Sarcoma,0.7244,Undifferentiated Pleomorphic Sarcoma<;>Undifferentiated Spindle Cell Sarcoma,0.6505,Head and Neck Squamous Cell Carcinoma<;>Spindle Cell Squamous Cell Carcinoma,0.6437
SPINDLE CELL CARCINOMA OF THE LUNG,Lung Spindle Cell Carcinoma,1,2,Lung Spindle Cell Carcinoma,0.9787,Lung Sarcomatoid Carcinoma,0.8377,Lung Pleomorphic Carcinoma,0.8209,Spindle Cell Sarcoma,0.7316,Lung Adenosquamous Carcinoma,0.7199
SPINDLE CELL RHABDOMYOSARCOMA,Spindle Cell Rhabdomyosarcoma,1,2,Spindle Cell Rhabdomyosarcoma,1.0000,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.9503,Sclerosing Rhabdomyosarcoma,0.8786,Pleomorphic Rhabdomyosarcoma,0.8335,Rhabdomyosarcoma,0.8185
SPINDLE CELL SARCOMA,Spindle Cell Sarcoma,1,2,Spindle Cell Sarcoma,1.0000,Spindle Cell Neoplasm,0.8649,Undifferentiated Pleomorphic Sarcoma<;>Undifferentiated Spindle Cell Sarcoma,0.8562,Spindle Cell Rhabdomyosarcoma,0.8086,Sarcomatoid Carcinoma,0.7799
SPINDLE CELL/SCLEROSING RHABDOMYOSARCOMA,Spindle Cell/Sclerosing Rhabdomyosarcoma,1,2,Spindle Cell/Sclerosing Rhabdomyosarcoma,1.0000,Spindle Cell Rhabdomyosarcoma,0.9503,Sclerosing Rhabdomyosarcoma,0.9073,Anaplastic Lesion<;>Spindle Cell/Sclerosing Rhabdomyosarcoma<;>Diffuse,0.8360,Pleomorphic Rhabdomyosarcoma,0.8179
SPINDLE CELLEPITHELIOID CELL,Epithelioid Cell<;>Spindle Cell Neoplasm,1,2,Epithelioid Cell<;>Spindle Cell Neoplasm,0.7609,Spindle Cell Neoplasm,0.7493,Epithelioid Cell,0.6853,Basaloid Cell,0.6694,Spindle Cell Sarcoma,0.6389
SPINDLED/SCLEROSING/DIFFUSE ANAPLASIA,Anaplastic Lesion<;>Spindle Cell/Sclerosing Rhabdomyosarcoma<;>Diffuse,1,2,Anaplastic Lesion<;>Spindle Cell/Sclerosing Rhabdomyosarcoma<;>Diffuse,0.7208,Spindle Cell Sarcoma,0.6906,Sclerosing Epithelioid Fibrosarcoma,0.6844,Undifferentiated Pleomorphic Sarcoma<;>Undifferentiated Spindle Cell Sarcoma,0.6730,Biphasic Synovial Sarcoma,0.6503
SPINE,Vertebral Column,1,2,Vertebral Column,0.8643,Bone,0.5733,Central Nervous System<;>Brain,0.5554,Brain,0.5406,Head and Neck,0.5037
SPITZOID MELANOMA,Spitz Melanoma,1,2,Spitz Melanoma,0.9532,Desmoplastic Melanoma,0.7258,Skin Metatypical Carcinoma,0.7218,Low-CSD Melanoma,0.7081,Desmoplastic Neurotropic Melanoma,0.7059
SPLENIC FLEXURE,Splenic Flexure,1,2,Splenic Flexure,1.0000,Hepatic Flexure,0.8875,Ascending Colon,0.6379,Transverse Colon,0.6137,Descending Colon,0.5940
SQUAMOUS CELL CARCINOMA,Squamous Cell Carcinoma,1,2,Squamous Cell Carcinoma,1.0000,Skin Squamous Cell Carcinoma,0.9180,Squamous Cell Carcinoma<;>Poorly Differentiated,0.8235,Cervical Squamous Cell Carcinoma,0.8203,Head and Neck Squamous Cell Carcinoma,0.8033
SQUAMOUS CELL CARCINOMA ARISING IN A MATURE CYSTIC TERATOMA OF THE OVARY,Ovarian Small Cell Carcinoma<;>Dermoid Cyst,1,2,Ovarian Small Cell Carcinoma<;>Dermoid Cyst,0.7372,ovary mixed epithelial carcinoma,0.6453,Ovarian Seromucinous Carcinoma,0.6370,Ovarian Clear Cell Cystadenocarcinoma,0.6351,Ovarian Carcinosarcoma,0.6147
SQUAMOUS CELL CARCINOMA OF GALLBLADDER,Gallbladder Squamous Cell Carcinoma,1,2,Gallbladder Squamous Cell Carcinoma,0.9858,Gallbladder Adenosquamous Carcinoma,0.8846,Gallbladder Carcinoma,0.7839,Gallbladder Adenocarcinoma,0.7744,Gallbladder Small Cell Neuroendocrine Carcinoma,0.7491
SQUAMOUS CELL CARCINOMA OF THE VULVA/VAGINA,Vaginal Squamous Cell Carcinoma,2,2,Vulvar Squamous Cell Carcinoma,0.8653,Vaginal Squamous Cell Carcinoma,0.8064,Vulvar Carcinoma<;>Vaginal Carcinoma,0.8056,Vulvar Carcinoma,0.7634,Vaginal Carcinoma,0.6837
"SQUAMOUS CELL CARCINOMA, BASALOID",Squamous Cell Carcinoma<;>Basaloid Cell,1,2,Squamous Cell Carcinoma<;>Basaloid Cell,0.9822,Basal Cell Carcinoma,0.8721,Head and Neck Basaloid Carcinoma,0.8633,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.7423,Squamous Cell Carcinoma,0.7402
"SQUAMOUS CELL CARCINOMA, BUCCAL MUCOSA",Buccal Mucosa Squamous Cell Carcinoma,1,2,Buccal Mucosa Squamous Cell Carcinoma,0.9894,Oral Cavity Squamous Cell Carcinoma,0.7992,upper aerodigestive tract neoplasm<;>Oral Cavity Squamous Cell Carcinoma,0.7675,Tongue Squamous Cell Carcinoma,0.6756,Oropharyngeal Squamous Cell Carcinoma,0.6692
"SQUAMOUS CELL CARCINOMA, HYPOPHARYNGEAL",Hypopharyngeal Squamous Cell Carcinoma,1,2,Hypopharyngeal Squamous Cell Carcinoma,0.9882,Pharyngeal Squamous Cell Carcinoma,0.7675,Head and Neck Squamous Cell Carcinoma,0.7436,Oropharyngeal Squamous Cell Carcinoma,0.7389,upper aerodigestive tract neoplasm<;>Oral Cavity Squamous Cell Carcinoma,0.6955
"SQUAMOUS CELL CARCINOMA, LARYNGEAL",Laryngeal Squamous Cell Carcinoma,1,2,Laryngeal Squamous Cell Carcinoma,0.9914,Tongue Squamous Cell Carcinoma,0.7098,Pharyngeal Squamous Cell Carcinoma,0.6867,Lung Squamous Cell Carcinoma,0.6788,Cervical Squamous Cell Carcinoma,0.6769
"SQUAMOUS CELL CARCINOMA, NOS",Squamous Cell Carcinoma,1,2,Squamous Cell Carcinoma,0.9941,Skin Squamous Cell Carcinoma,0.9221,Squamous Cell Carcinoma<;>Poorly Differentiated,0.8241,Cervical Squamous Cell Carcinoma,0.8138,Head and Neck Squamous Cell Carcinoma,0.7954
"SQUAMOUS CELL CARCINOMA, ORAL",Oral Cavity Squamous Cell Carcinoma,1,2,Oral Cavity Squamous Cell Carcinoma,0.9574,upper aerodigestive tract neoplasm<;>Oral Cavity Squamous Cell Carcinoma,0.8615,Buccal Mucosa Squamous Cell Carcinoma,0.8011,Oropharyngeal Squamous Cell Carcinoma,0.7908,Head and Neck Squamous Cell Carcinoma,0.7822
"SQUAMOUS CELL CARCINOMA, PHARYNX",Pharyngeal Squamous Cell Carcinoma,1,2,Pharyngeal Squamous Cell Carcinoma,0.8840,Hypopharyngeal Squamous Cell Carcinoma,0.8254,Oropharyngeal Squamous Cell Carcinoma,0.7484,Head and Neck Squamous Cell Carcinoma,0.7183,Laryngeal Squamous Cell Carcinoma,0.6798
"SQUAMOUS CELL CARCINOMA, SALIVARY GLAND",Salivary Gland Squamous Cell Carcinoma,1,2,Salivary Gland Squamous Cell Carcinoma,0.9892,Salivary Gland Carcinoma,0.8826,Salivary Gland Adenocarcinoma,0.8596,Salivary Duct Carcinoma,0.7838,Salivary Gland Secretory Carcinoma,0.7805
"SQUAMOUS CELL CARCINOMA, TONGUE",Tongue Squamous Cell Carcinoma,1,2,Tongue Squamous Cell Carcinoma,0.9890,Oral Cavity Squamous Cell Carcinoma,0.7613,upper aerodigestive tract neoplasm<;>Oral Cavity Squamous Cell Carcinoma,0.7171,Laryngeal Squamous Cell Carcinoma,0.7005,Cervical Squamous Cell Carcinoma,0.6861
"SQUAMOUS CELL CARCINOMA, VULVAR",Vulvar Squamous Cell Carcinoma,1,2,Vulvar Squamous Cell Carcinoma,0.9847,Vulvar Carcinoma,0.8885,Vulvar Carcinoma<;>Vaginal Carcinoma,0.7992,Vaginal Squamous Cell Carcinoma,0.7452,Cervical Squamous Cell Carcinoma,0.6406
SQUAMOUS CELL CARCINOMA-VPD,Squamous Cell Carcinoma<;>Poorly Differentiated,5,2,Vaginal Squamous Cell Carcinoma,0.6592,Prostate Squamous Cell Carcinoma,0.6295,Oropharyngeal Squamous Cell Carcinoma,0.6159,Cervical Adenosquamous Carcinoma,0.6121,Squamous Cell Carcinoma<;>Poorly Differentiated,0.6116
SQUAMOUS_CELL_CARCINOMA,Squamous Cell Carcinoma,1,2,Squamous Cell Carcinoma,0.9745,Skin Squamous Cell Carcinoma,0.8944,Squamous Cell Carcinoma<;>Poorly Differentiated,0.8087,Cervical Squamous Cell Carcinoma,0.7820,Head and Neck Squamous Cell Carcinoma,0.7588
ST-RELPOS,"Supratentorial Ependymoma, ZFTA-RELA Fusion-Positive",99,2,Relapse,0.5493,First Relapse,0.5311,Recurrent,0.5224,Local-Regional,0.5186,Microsatellite Stable Colorectal Carcinoma,0.5185
ST-SE,Supratentorial Ependymoma<;>Subependymoma,5,2,Calcifying Nested Stromal-Epithelial Tumor of the Liver,0.5009,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.4990,Embryonal Carcinoma<;>Seminoma,0.4973,Infantile Sarcoma,0.4968,Supratentorial Ependymoma<;>Subependymoma,0.4937
ST-YAP,Supratentorial Ependymoma YAP1 Fusion-Positive,2,2,SPOP Gene,0.5438,Supratentorial Ependymoma YAP1 Fusion-Positive,0.4845,nan,0.4633,MiT Family Translocation-Associated Renal Cell Carcinoma,0.4520,Primary,0.4427
STAD,Gastric Adenocarcinoma,99,2,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.4979,Therapy-Related Myelodysplastic Syndrome,0.4750,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.4601,Down Syndrome,0.4576,Adamantinoma,0.4501
STAD_CIN,Gastric Adenocarcinoma<;>Chromosomal Instability,99,2,Cervical Adenocarcinoma In Situ,0.4611,Esophageal Adenocarcinoma<;>Microsatellite Instability,0.4604,Not Otherwise Specified,0.4572,Therapy-Related Myelodysplastic Syndrome,0.4567,Microsatellite Stable,0.4526
STAD_EBV,Gastric Adenocarcinoma<;>Epstein-Barr Virus,99,2,Epstein-Barr Virus,0.5699,EBV-Related Lymphoma,0.5462,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.4875,Bilateral,0.4665,Hepatitis B Virus Surface Antigen Positive,0.4609
STAD_GS,Gastric Adenocarcinoma,99,2,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.4727,Therapy-Related Myelodysplastic Syndrome,0.4393,Biphasic Synovial Sarcoma,0.4245,Microsatellite Stable,0.4244,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.4225
STAD_MSI,Gastric Adenocarcinoma<;>Microsatellite Instability,99,2,Microsatellite Stable,0.6309,Microsatellite Instability,0.6191,High-Frequency Microsatellite Instability,0.5597,Esophageal Adenocarcinoma<;>Microsatellite Instability,0.5541,Rectal Adenocarcinoma<;>Microsatellite Instability,0.5390
STAD_POLE,Gastric Adenocarcinoma<;>POLE Gene Mutation,5,2,SPOP Gene,0.4916,POLE-Ultramutated Endometrial Endometrioid Adenocarcinoma,0.4871,Esophageal Adenocarcinoma<;>POLE Gene Mutation,0.4805,Rectal Adenocarcinoma<;>POLE Gene Mutation,0.4705,Gastric Adenocarcinoma<;>POLE Gene Mutation,0.4594
"STEROID CELL TUMOR, NOS","Ovarian Steroid Cell Tumor, Not Otherwise Specified",1,2,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0.8159,Adrenal Gland Neoplasm,0.6752,Adrenal Cortical Adenoma,0.6480,Carcinoid Tumor,0.6210,Sex Cord-Stromal Tumor,0.6191
STOMACH,Stomach,1,2,Stomach,1.0000,Gastric,0.9274,Gastric Carcinoma,0.6476,Esophagus,0.6113,Pharynx,0.5874
STOMACH ADENOCARCINOMA,Gastric Adenocarcinoma,1,2,Gastric Adenocarcinoma,0.9619,Gastric Carcinoma,0.8522,Gastric Diffuse Adenocarcinoma,0.8043,Gastric Tubular Adenocarcinoma,0.7852,Gastric Intestinal-Type Adenocarcinoma,0.7628
"STOMACH ADENOCARCINOMA, SIGNET RING TYPE",Gastric Signet Ring Cell Adenocarcinoma,1,2,Gastric Signet Ring Cell Adenocarcinoma,0.9428,Signet Ring Adenocarcinoma Cell,0.8411,Signet Ring Cell Carcinoma,0.8084,Appendix Signet Ring Cell Carcinoma,0.7803,Rectal Signet Ring Cell Adenocarcinoma<;>Colon Signet Ring Cell Adenocarcinoma,0.7782
STOMACH ADENOCARINOMA,Gastric Adenocarcinoma,5,2,Adenoid Cystic Carcinoma,0.6979,Gastric Signet Ring Cell Adenocarcinoma,0.6872,Breast Adenoid Cystic Carcinoma,0.6658,Gastric Papillary Adenocarcinoma,0.6615,Gastric Adenocarcinoma,0.6532
STOMACH CANCER,Gastric Carcinoma,1,2,Gastric Carcinoma,0.9056,Gastric Adenocarcinoma,0.7657,Stomach,0.7568,Gastroesophageal Cancer,0.7568,Gastric,0.7305
"STOMACH, ADENOCARCINOMA, DIFFUSE TYPE",Gastric Diffuse Adenocarcinoma,1,2,Gastric Diffuse Adenocarcinoma,0.9627,Gastric Adenocarcinoma,0.8137,Gastric Intestinal-Type Adenocarcinoma,0.7703,Gastric Poorly Cohesive Adenocarcinoma,0.7587,Gastric Tubular Adenocarcinoma,0.7540
"STOMACH, ADENOCARCINOMA, NOT OTHERWISE SPECIFIED NOS",Gastric Adenocarcinoma,1,2,Gastric Adenocarcinoma,0.9292,Gastric Carcinoma,0.8214,Gastric Diffuse Adenocarcinoma,0.8025,Gastric Intestinal-Type Adenocarcinoma,0.7416,Gastric Tubular Adenocarcinoma,0.7391
"STOMACH, INTESTINAL ADENOCARCINOMA, MUCINOUS TYPE",Gastric Mucinous Adenocarcinoma,1,2,Gastric Mucinous Adenocarcinoma,0.8803,Mucinous gastric carcinoma,0.8672,Gastric Intestinal-Type Adenocarcinoma,0.8322,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.8290,Appendix Mucinous Adenocarcinoma,0.7810
"STOMACH, INTESTINAL ADENOCARCINOMA, NOT OTHERWISE SPECIFIED NOS",Gastric Intestinal-Type Adenocarcinoma,1,2,Gastric Intestinal-Type Adenocarcinoma,0.9378,Gastric Adenocarcinoma,0.7545,Gastric Diffuse Adenocarcinoma,0.7135,Gastric Tubular Adenocarcinoma,0.6810,Gastric Mucinous Adenocarcinoma,0.6771
"STOMACH, INTESTINAL ADENOCARCINOMA, PAPILLARY TYPE",Gastric Papillary Adenocarcinoma,1,2,Gastric Papillary Adenocarcinoma,0.8573,Gastric Intestinal-Type Adenocarcinoma,0.8087,Papillary Adenocarcinoma,0.7138,Acinar Cell Carcinoma<;>Papillary,0.6692,Gastric Poorly Cohesive Adenocarcinoma,0.6678
"STOMACH, INTESTINAL ADENOCARCINOMA, TUBULAR TYPE",Gastric Tubular Adenocarcinoma,1,2,Gastric Tubular Adenocarcinoma,0.8626,Gastric Intestinal-Type Adenocarcinoma,0.8546,Tubular Adenocarcinoma,0.7414,Tubular Adenocarcinoma<;>Well Differentiated Adenocarcinoma Cell,0.7052,Gastric Papillary Adenocarcinoma,0.6719
SUN-EXPOSED,Sun-exposed Site,1,2,Sun-exposed Site,0.8877,Superficial,0.5270,Skin,0.4566,Basal,0.4528,Extrahepatic,0.4515
SUPERFICIAL,Superficial,1,2,Superficial,1.0000,Skin,0.6548,Localized,0.6270,Tissue,0.6106,Non-Glabrous Skin,0.5881
SUPERFICIAL SPREADING,Low-CSD Melanoma,99,2,Superficial,0.7251,Diffuse,0.6748,Localized,0.5592,Sun-exposed Site,0.5447,Translocation,0.5203
SUPERFICIAL SPREADING MELANOMA,Low-CSD Melanoma,4,2,Cutaneous Melanoma,0.7435,Cutaneous Nodular Melanoma,0.7307,Spitz Melanoma,0.7190,Low-CSD Melanoma,0.7180,Melanoma,0.7173
SURGERY,Surgical Procedure,1,2,Surgical Procedure,0.9202,Resection,0.7009,Invasive,0.5380,Sarcoma,0.5041,Metaplasia,0.5004
SWEAT GLAND ADENOCARCINOMA,Eccrine Carcinoma,2,2,Sweat Gland Carcinoma,0.9574,Eccrine Carcinoma,0.8139,Sebaceous Carcinoma,0.7909,Pilomatrical Carcinoma,0.6896,Digital Papillary Adenocarcinoma,0.6830
SWEAT GLAND CARCINOMA/APOCRINE ECCRINE CARCINOMA,Sweat Gland Carcinoma,1,2,Sweat Gland Carcinoma,0.8413,Eccrine Carcinoma,0.8261,Sebaceous Carcinoma,0.7602,Pilomatrical Carcinoma,0.6418,Skin Acantholytic Squamous Cell Carcinoma,0.6403
SYNOVIAL,Synovial Neoplasm,1,2,Synovial Neoplasm,0.6907,Synovial Sarcoma,0.6776,Monophasic Synovial Sarcoma,0.5948,Serous,0.5823,Synovial Sarcoma<;>Poorly Differentiated,0.5619
SYNOVIAL SARCOMA,Synovial Sarcoma,1,2,Synovial Sarcoma,1.0000,Monophasic Synovial Sarcoma,0.8503,Synovial Sarcoma<;>Poorly Differentiated,0.8441,Biphasic Synovial Sarcoma,0.7783,Synovial Neoplasm,0.7602
SYNOVIAL SARCOMA - BIPHASIC,Biphasic Synovial Sarcoma,1,2,Biphasic Synovial Sarcoma,0.9751,Synovial Sarcoma<;>Poorly Differentiated,0.8894,Monophasic Synovial Sarcoma,0.8485,Synovial Sarcoma,0.8038,Undifferentiated Pleomorphic Sarcoma,0.7463
SYNOVIAL SARCOMA - MONOPHASIC,Monophasic Synovial Sarcoma,1,2,Monophasic Synovial Sarcoma,0.9772,Synovial Sarcoma<;>Poorly Differentiated,0.8588,Synovial Sarcoma,0.8498,Biphasic Synovial Sarcoma,0.8374,Undifferentiated Pleomorphic Sarcoma,0.6748
SYNOVIAL_SARCOMA,Synovial Sarcoma,1,2,Synovial Sarcoma,0.9717,Monophasic Synovial Sarcoma,0.8367,Synovial Sarcoma<;>Poorly Differentiated,0.8170,Synovial Neoplasm,0.7620,Biphasic Synovial Sarcoma,0.7481
SYSTEMIC MASTOCYTOSIS,Systemic Mastocytosis,1,2,Systemic Mastocytosis,1.0000,Mastocytosis,0.9138,Hereditary Spherocytosis,0.5817,Castleman Disease,0.5788,Monoclonal B-Cell Lymphocytosis,0.5748
S_T_MDS,Myelodysplastic Syndrome,3,2,Therapy-Related Myelodysplastic Syndrome,0.6987,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.6788,Myelodysplastic Syndrome,0.6781,"Myelodysplastic Syndrome, Unclassifiable",0.6750,Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis,0.6641
T-ALL,T Acute Lymphoblastic Leukemia,1,2,T Acute Lymphoblastic Leukemia,0.8194,T Lymphoblastic Leukemia/Lymphoma,0.8154,Lymphoblastic Lymphoma,0.7635,Acute Lymphoblastic Leukemia,0.7471,Early T Acute Lymphoblastic Leukemia,0.7316
T-CELL,T-Lymphocyte,1,2,T-Lymphocyte,0.9578,Transitional Cells,0.5736,Lymphoid,0.5712,T-Cell Non-Hodgkin Lymphoma,0.5638,Fibroblast<;>Lymphocyte,0.5572
T-CELL ACUTE LYMPHOID LEUKEMIA,T Acute Lymphoblastic Leukemia,1,2,T Acute Lymphoblastic Leukemia,0.8883,T Lymphoblastic Leukemia/Lymphoma,0.8327,Early T Acute Lymphoblastic Leukemia,0.7836,Adult T-Cell Leukemia/Lymphoma,0.7810,T-Cell Large Granular Lymphocyte Leukemia,0.7693
T-CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA,T-Cell Large Granular Lymphocyte Leukemia,1,2,T-Cell Large Granular Lymphocyte Leukemia,0.9774,T Lymphoblastic Leukemia/Lymphoma,0.7507,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.7282,T Acute Lymphoblastic Leukemia,0.7030,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,0.6705
"T-CELL, NON-HODGKINS, ANAPLASTIC LARGE CELL ALCL",Anaplastic Large Cell Lymphoma,1,2,Anaplastic Large Cell Lymphoma,0.7090,"Anaplastic Large Cell Lymphoma, ALK-Negative",0.6710,Angioimmunoblastic T-Cell Lymphoma,0.6644,T-Cell Non-Hodgkin Lymphoma,0.6564,"Anaplastic Large Cell Lymphoma, ALK-Positive",0.6439
"T-CELL, NON-HODGKINS, CUTANEOUS",Cutaneous T-Cell Non-Hodgkin Lymphoma,1,2,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.9341,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.8770,T-Cell Non-Hodgkin Lymphoma,0.8172,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.6713,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.6494
"T-CELL, NON-HODGKINS, CUTANEOUS, SEZARY SYNDROME",Sezary Syndrome,1,2,Sezary Syndrome,0.8151,Mycosis Fungoides and Sezary Syndrome,0.7585,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6446,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6142,T-Cell Non-Hodgkin Lymphoma,0.5763
T-CELL_ALL,T Acute Lymphoblastic Leukemia,2,2,T Lymphoblastic Leukemia/Lymphoma,0.7944,T Acute Lymphoblastic Leukemia,0.7801,T-Cell Non-Hodgkin Lymphoma,0.7561,Adult T-Cell Leukemia/Lymphoma,0.7004,Lymphoblastic Lymphoma,0.6861
T-CELL_LYMPHOMA_OTHER,T-Cell Non-Hodgkin Lymphoma,1,2,T-Cell Non-Hodgkin Lymphoma,0.8605,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.7816,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.7600,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.7356,T Lymphoblastic Leukemia/Lymphoma,0.7230
T-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA,T Lymphoblastic Leukemia/Lymphoma,1,2,T Lymphoblastic Leukemia/Lymphoma,0.9926,T Acute Lymphoblastic Leukemia,0.8879,T-Cell Non-Hodgkin Lymphoma,0.7774,Early T Acute Lymphoblastic Leukemia,0.7622,Adult T-Cell Leukemia/Lymphoma,0.7615
TALL,T Acute Lymphoblastic Leukemia,99,2,Hypertension,0.5006,Hyperdiploidy,0.4936,T Lymphoblastic Leukemia/Lymphoma,0.4843,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.4732,With Tumor,0.4692
TALL CELL,Tall Cell Variant Thyroid Gland Papillary Carcinoma,3,2,T-Lymphocyte,0.5905,Transitional Cells,0.5485,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.5454,Fibroblast<;>Lymphocyte,0.5437,Follicular Helper T-Cell Lymphoma,0.5359
TALL CELL VARIANT,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1,2,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.6196,Follicular Helper T-Cell Lymphoma,0.5600,Anaplastic Large Cell Lymphoma,0.5418,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.5375,Lymphocytic Neoplasm,0.5333
TALL CELL VARIANT  PHENOTYPE CHANGED AFTER CONSENSUS UPSTAGED T,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1,2,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.5478,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,0.5225,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.4945,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.4846,Post-Transplant Lymphoproliferative Disorder,0.4748
TC: UNDIFERENTIATED,Thymic Carcinoma<;>Undifferentiated,99,2,Occult Stage,0.5424,Unclassified,0.5198,Not Otherwise Specified,0.4641,Estrogen Receptor Negative<;>HER2/Neu Negative,0.4562,Estrogen Receptor Negative<;>HER2/Neu Positive,0.4501
TC: UNDIFFERENTIATED,Thymic Carcinoma<;>Undifferentiated,99,2,Undifferentiated Malignant Neoplasm,0.8179,Undifferentiated Carcinoma,0.8146,Undifferentiated,0.7942,Carcinoma<;>Undifferentiated,0.7935,undifferentiated sarcoma,0.7552
TC: UNDIFFERENZIATED,Thymic Carcinoma<;>Undifferentiated,99,2,Unclassified,0.5491,Occult Stage,0.5310,Undifferentiated,0.5152,Unilateral,0.5002,Not Otherwise Specified,0.4970
TC:NEC,Thymic Neuroendocrine Carcinoma,5,2,Neuroendocrine Carcinoma,0.5525,With Tumor,0.5444,Nonseminomatous<;>Immature Teratoma<;>Embryonal Carcinoma<;>Mature Teratoma,0.5429,Neuroendocrine Tumor,0.5348,Thymic Neuroendocrine Carcinoma,0.5211
TC:SCC,Thymic Squamous Cell Carcinoma,99,2,Squamous Cell Carcinoma,0.6848,Carcinoma,0.6610,Skin Metatypical Carcinoma,0.6311,Non-Small Cell Carcinoma,0.6246,Undifferentiated Carcinoma,0.6245
TC:UNDIFFERENTIATED,Thymic Carcinoma<;>Undifferentiated,99,2,Undifferentiated Malignant Neoplasm,0.8179,Undifferentiated Carcinoma,0.8146,Undifferentiated,0.7942,Carcinoma<;>Undifferentiated,0.7935,undifferentiated sarcoma,0.7552
TELANGIECTATIC OSTEOSARCOMA,Telangiectatic Osteosarcoma,1,2,Telangiectatic Osteosarcoma,1.0000,Periosteal Osteosarcoma,0.8045,Fibroblastic Osteosarcoma,0.7880,Parosteal Osteosarcoma,0.7829,Osteosarcoma,0.7818
TERATOMA,Teratoma,1,2,Teratoma,1.0000,Mature Teratoma,0.9044,Immature Teratoma,0.8632,Nonseminomatous<;>Mature Teratoma,0.8287,Nonseminomatous<;>Immature Teratoma,0.7963
TERATOMA IMMATURE,Immature Teratoma,1,2,Immature Teratoma,0.9920,Mature Teratoma,0.9292,Nonseminomatous<;>Immature Teratoma,0.9021,Teratoma,0.8736,Nonseminomatous<;>Mature Teratoma,0.8661
TERATOMA IMMATURENON-SEMINOMA,Nonseminomatous<;>Immature Teratoma,99,2,Seminoma<;>Mature Teratoma,0.9050,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8868,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8247,Seminoma,0.7591,Yolk Sac Tumor<;>Seminoma,0.7522
TERATOMA IMMATURESEMINOMA,Nonseminomatous<;>Immature Teratoma,2,2,Immature Teratoma,0.8591,Nonseminomatous<;>Immature Teratoma,0.8123,Mature Teratoma,0.8038,Nonseminomatous<;>Mature Teratoma,0.7796,Teratoma,0.7493
TERATOMA MATURE,Mature Teratoma,1,2,Mature Teratoma,0.9887,Immature Teratoma,0.9006,Teratoma,0.8989,Nonseminomatous<;>Mature Teratoma,0.8784,Nonseminomatous<;>Immature Teratoma,0.8281
TERATOMA MATURENON-SEMINOMA,Nonseminomatous<;>Mature Teratoma,99,2,Seminoma<;>Mature Teratoma,0.9455,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.9126,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.8354,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.7842,Seminoma,0.7838
TERATOMA MATURESEMINOMA,Seminoma<;>Mature Teratoma,99,2,Mature Teratoma,0.8473,Nonseminomatous<;>Mature Teratoma,0.7907,Immature Teratoma,0.7580,Teratoma with Somatic-Type Malignancy,0.7576,Teratoma,0.7553
TERATOMA MATURE[NOT AVAILABLE]NON-SEMINOMA,Nonseminomatous<;>Mature Teratoma,1,2,Nonseminomatous<;>Mature Teratoma,0.8416,Nonseminomatous<;>Immature Teratoma,0.8148,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.7966,Mature Teratoma,0.7639,Seminoma<;>Mature Teratoma,0.7492
TERATOMA WITH MALIGNANT TRANSFORMATION,Teratoma with Somatic-Type Malignancy,1,2,Teratoma with Somatic-Type Malignancy,0.8582,Mature Teratoma,0.7765,Teratoma,0.7712,Immature Teratoma,0.7304,Nonseminomatous<;>Mature Teratoma,0.7097
TESTICULAR CARCINOMA,Testicular Carcinoma,1,2,Testicular Carcinoma,1.0000,Testicular Germ Cell Tumor,0.7630,Testicular mesothelioma,0.7236,Testicular Seminoma,0.7028,Seminoma,0.6452
TESTICULAR MESOTHELIOMA,Testicular mesothelioma,1,2,Testicular mesothelioma,1.0000,Testicular Carcinoma,0.7236,Ovarian Sertoli-Leydig Cell Tumor,0.6855,Testicular Germ Cell Tumor,0.6647,Sarcomatoid Mesothelioma,0.6518
TESTICULAR NON-SEMINOMA,Testicular Non-Seminomatous Germ Cell Tumor,1,2,Testicular Non-Seminomatous Germ Cell Tumor,0.8930,Testicular Seminoma,0.7450,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.7411,Seminoma,0.7351,Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.7337
TESTICULAR SEMINOMA,Testicular Seminoma,1,2,Testicular Seminoma,1.0000,Seminoma,0.9382,Embryonal Carcinoma<;>Seminoma,0.8991,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.8396,Yolk Sac Tumor<;>Seminoma,0.8305
TGCT,Testicular Germ Cell Tumor,1,2,Testicular Germ Cell Tumor,0.7194,Germ Cell Tumor<;>Embryonal Carcinoma,0.6518,Germ Cell Tumor,0.6517,Testicular mesothelioma,0.6498,Testicular Carcinoma,0.6449
TGCT NON-SEM,Testicular Non-Seminomatous Germ Cell Tumor,1,2,Testicular Non-Seminomatous Germ Cell Tumor,0.7059,Nongerminomatous Germ Cell Tumor,0.6774,Nongerminomatous Germ Cell Tumor<;>Mixed Germ Cell Tumor,0.6715,Mediastinal Germ Cell Tumor with Somatic-Type Malignancy,0.6241,Nongerminomatous Germ Cell Tumor<;>Yolk Sac Tumor,0.6232
TGCT SEM,Testicular Seminoma,99,2,Mediastinal Germ Cell Tumor with Somatic-Type Malignancy,0.6358,Embryonal Carcinoma<;>Nonseminomatous<;>Mature Teratoma<;>Seminoma,0.5385,Choriocarcinoma<;>Nonseminomatous<;>Seminoma<;>Mature Teratoma<;>Yolk Sac Tumor<;>Embryonal Carcinoma,0.5274,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.5154,Nongerminomatous Germ Cell Tumor<;>Mixed Germ Cell Tumor,0.5083
TGCT_NON-SEMINOMA,Testicular Non-Seminomatous Germ Cell Tumor,1,2,Testicular Non-Seminomatous Germ Cell Tumor,0.8389,Nongerminomatous Germ Cell Tumor,0.7373,Testicular Germ Cell Tumor,0.7261,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.7105,Nongerminomatous Germ Cell Tumor<;>Mixed Germ Cell Tumor,0.6972
TGCT_SEMINOMA,Testicular Seminoma,2,2,Seminoma,0.9155,Testicular Seminoma,0.9059,Embryonal Carcinoma<;>Seminoma,0.8722,Embryonal Carcinoma<;>Nonseminomatous<;>Seminoma,0.8347,Yolk Sac Tumor<;>Seminoma,0.8202
THCA,Thyroid Gland Carcinoma,99,2,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.4489,"Non-B, Non-C Hepatitis",0.4423,Cholangiocarcinoma,0.4376,Hepatitis C Virus,0.4335,fatty liver disease,0.4164
THERAPY-RELATED MYELODYSPLASTIC SYNDROME,Therapy-Related Myelodysplastic Syndrome,1,2,Therapy-Related Myelodysplastic Syndrome,1.0000,Myelodysplastic Syndrome,0.8340,Myelodysplastic Syndrome with Multilineage Dysplasia,0.7980,Myelodysplastic Syndrome with Excess Blasts,0.7564,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.7409
THERAPY-RELATED MYELOID NEOPLASMS,Therapy-Related Myeloid Neoplasm,1,2,Therapy-Related Myeloid Neoplasm,0.9903,Acute Myeloid Leukemia Not Otherwise Specified<;>Therapy-Related Myeloid Neoplasm,0.8719,Myeloid Neoplasm,0.7249,Therapy-Related Myelodysplastic Syndrome,0.7207,Myeloid Sarcoma,0.6708
THIGH,Thigh,1,2,Thigh,1.0000,Abdomen,0.5658,Arm,0.5333,Distal,0.5186,Breast,0.5145
THIRD RECURRENCE,Recurrence,1,2,Recurrence,0.8077,Recurrent,0.7716,Regional<;>Recurrence,0.7665,Locally Recurrent Malignant Neoplasm,0.7567,Metastatic Lesion<;>Recurrent,0.7447
THPA,Thyroid Gland Papillary Carcinoma,99,2,Benign Prostatic Hyperplasia,0.4810,Thymoma Type AB,0.4116,Therapy-Related Myelodysplastic Syndrome,0.4064,Thymoma Type A,0.4044,Thymoma Type A<;>Thymoma Type AB,0.4030
THPD,Poorly Differentiated Thyroid Gland Carcinoma,99,2,Therapy-Related Myelodysplastic Syndrome,0.5049,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,0.4933,Hereditary Spherocytosis,0.4909,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.4823,Rosai-Dorfman Disease,0.4656
THRBCL,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1,2,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.6029,T-Cell Non-Hodgkin Lymphoma,0.4660,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.4592,Breast,0.4547,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.4538
THYM,Thymoma,1,2,Thymoma,0.7284,Thymoma Type A,0.7052,Thymoma Type B1,0.6932,Thymoma Type B3,0.6839,Thymoma Type B2,0.6634
THYMIC CARCINOMA,Thymic Carcinoma,1,2,Thymic Carcinoma,1.0000,Thymic Squamous Cell Carcinoma,0.8677,Thymic Carcinoma<;>Undifferentiated,0.8608,Thymic Neuroendocrine Carcinoma,0.8508,Thymic Epithelial Neoplasm,0.7837
THYMIC EPITHELIAL TUMOR,Thymic Epithelial Neoplasm,1,2,Thymic Epithelial Neoplasm,0.9857,thymic neuroendocrine tumor,0.8352,Thymoma,0.8185,Thymic Carcinoma,0.8019,Thymus Neoplasm,0.7841
THYMIC NEUROENDOCRINE TUMOR,thymic neuroendocrine tumor,1,2,thymic neuroendocrine tumor,1.0000,Thymic Neuroendocrine Carcinoma,0.9028,Thymic Epithelial Neoplasm,0.8137,Thymoma,0.7717,Thymoma Type B1,0.7451
THYMIC TUMOR,Thymus Neoplasm,1,2,Thymus Neoplasm,0.9295,Thymic Epithelial Neoplasm,0.8892,Thymoma,0.8096,thymic neuroendocrine tumor,0.7856,Thymic Carcinoma,0.7718
THYMOMA,Thymoma,1,2,Thymoma,1.0000,Thymoma Type A,0.8904,Thymoma Type B1<;>Thymoma Type B2,0.8397,Thymoma Type B1,0.8386,Thymoma Type B3,0.8149
THYMOMA; TYPE A,Thymoma Type A,1,2,Thymoma Type A,0.9910,Thymoma,0.8870,Thymoma Type B1,0.8688,Thymoma Type A<;>Thymoma Type AB,0.8572,Thymoma Type B1<;>Thymoma Type B2,0.8498
THYMOMA; TYPE AB,Thymoma Type AB,1,2,Thymoma Type AB,0.9668,Thymoma Type A<;>Thymoma Type AB,0.9488,Thymoma Type B1<;>Thymoma Type B2,0.8726,Thymoma Type B2,0.8689,Thymoma Type B2<;>Thymoma Type B3,0.8689
THYMOMA; TYPE ATHYMOMA; TYPE AB,Thymoma Type A<;>Thymoma Type AB,1,2,Thymoma Type A<;>Thymoma Type AB,0.9383,Thymoma Type AB,0.9130,Thymoma Type B1<;>Thymoma Type B2,0.8682,Thymoma Type B2<;>Thymoma Type B3,0.8609,Thymoma Type B2,0.8580
THYMOMA; TYPE B1,Thymoma Type B1,1,2,Thymoma Type B1,0.9839,Thymoma Type B1<;>Thymoma Type B2,0.9539,Thymoma Type B2,0.8983,Thymoma Type B3,0.8812,Thymoma Type B2<;>Thymoma Type B3,0.8774
THYMOMA; TYPE B1THYMOMA; TYPE B2,Thymoma Type B1<;>Thymoma Type B2,1,2,Thymoma Type B1<;>Thymoma Type B2,0.9437,Thymoma Type B2,0.9223,Thymoma Type B2<;>Thymoma Type B3,0.9187,Thymoma Type B1,0.9117,Thymoma Type B3,0.8703
THYMOMA; TYPE B2,Thymoma Type B2,1,2,Thymoma Type B2,0.9883,Thymoma Type B2<;>Thymoma Type B3,0.9370,Thymoma Type B1<;>Thymoma Type B2,0.9338,Thymoma Type B1,0.8986,Thymoma Type B3,0.8857
THYMOMA; TYPE B2THYMOMA; TYPE B3,Thymoma Type B2<;>Thymoma Type B3,1,2,Thymoma Type B2<;>Thymoma Type B3,0.9462,Thymoma Type B3,0.9270,Thymoma Type B1<;>Thymoma Type B2,0.8933,Thymoma Type B2,0.8908,Thymoma Type B1,0.8537
THYMOMA; TYPE B3,Thymoma Type B3,1,2,Thymoma Type B3,0.9883,Thymoma Type B2<;>Thymoma Type B3,0.9423,Thymoma Type B1<;>Thymoma Type B2,0.8796,Thymoma Type B2,0.8769,Thymoma Type B1,0.8746
THYMOMA; TYPE C,Thymic Carcinoma,99,2,Thymoma Type B3,0.8871,Thymoma Type A,0.8740,Thymoma Type B1,0.8526,Thymoma Type B2<;>Thymoma Type B3,0.8476,Thymoma Type B1<;>Thymoma Type B2,0.8441
THYROID,Thyroid Gland,1,2,Thyroid Gland,0.9502,Thyroid Gland Carcinoma,0.6184,Thyroid Gland Sarcoma,0.5955,Breast,0.5558,Pharynx,0.5344
THYROID CANCER,Thyroid Gland Carcinoma,1,2,Thyroid Gland Carcinoma,0.9343,Thyroid Gland Sarcoma,0.7790,Thyroid Gland,0.7348,thyroid gland squamous cell carcinoma,0.7001,Differentiated Thyroid Gland Carcinoma,0.6980
"THYROID CANCER, NOS",Thyroid Gland Carcinoma,1,2,Thyroid Gland Carcinoma,0.9381,Thyroid Gland Sarcoma,0.7748,Thyroid Gland,0.7420,Differentiated Thyroid Gland Carcinoma,0.7104,thyroid gland squamous cell carcinoma,0.7099
THYROID CARCINOMA,Thyroid Gland Carcinoma,1,2,Thyroid Gland Carcinoma,0.9877,Differentiated Thyroid Gland Carcinoma,0.8007,Thyroid Gland Papillary Carcinoma,0.7848,thyroid gland squamous cell carcinoma,0.7661,Poorly Differentiated Thyroid Gland Carcinoma,0.7463
THYROID CARCINOMA OTHER,Thyroid Gland Carcinoma,1,2,Thyroid Gland Carcinoma,0.7498,Thyroid Gland Papillary and Follicular Carcinoma,0.6224,Thyroid Gland Sarcoma,0.6163,Differentiated Thyroid Gland Carcinoma,0.6158,Thyroid Gland Papillary Carcinoma,0.5895
THYROID PAPILLARY,Thyroid Gland Papillary Carcinoma,1,2,Thyroid Gland Papillary Carcinoma,0.7713,Papillary,0.7699,Papillary Carcinoma,0.7054,Classic Thyroid Gland Papillary Carcinoma,0.7017,Papillary Adenocarcinoma,0.6584
THYROID PAPILLARY CARCINOMA - CLASSICAL/USUAL,Classic Thyroid Gland Papillary Carcinoma,1,2,Classic Thyroid Gland Papillary Carcinoma,0.9005,Thyroid Gland Papillary Carcinoma,0.8026,Thyroid Gland Papillary and Follicular Carcinoma,0.7926,Papillary Carcinoma,0.7760,Follicular Variant Thyroid Gland Papillary Carcinoma,0.7660
THYROID PAPILLARY CARCINOMA - FOLLICULAR >= 99% FOLLICULAR PATTERNED,Follicular Variant Thyroid Gland Papillary Carcinoma,1,2,Follicular Variant Thyroid Gland Papillary Carcinoma,0.8007,Thyroid Gland Papillary and Follicular Carcinoma,0.7437,Classic Thyroid Gland Papillary Carcinoma,0.7094,Diffuse Sclerosing Variant Thyroid Gland Papillary Carcinoma,0.6722,Thyroid Gland Papillary Carcinoma,0.6617
THYROID PAPILLARY CARCINOMA - TALL CELL >= 50% TALL CELL FEATURES,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1,2,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.8303,Classic Thyroid Gland Papillary Carcinoma,0.6675,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.6621,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,0.6400,Thyroid Gland Anaplastic Carcinoma,0.6390
THYROID POORLY DIFFERENTIATED,Poorly Differentiated Thyroid Gland Carcinoma,1,2,Poorly Differentiated Thyroid Gland Carcinoma,0.8320,Differentiated Thyroid Gland Carcinoma,0.8231,Poorly Differentiated,0.7493,Thyroid Gland Anaplastic Carcinoma,0.7054,Carcinoma<;>Poorly Differentiated,0.6608
THYROID SARCOMA,Thyroid Gland Sarcoma,1,2,Thyroid Gland Sarcoma,0.9873,thyroid gland squamous cell carcinoma,0.7891,Thyroid Gland Carcinoma,0.7294,Thyroid Gland Anaplastic Carcinoma,0.6791,Differentiated Thyroid Gland Carcinoma,0.6424
THYROID_CARCINOMA,Thyroid Gland Carcinoma,1,2,Thyroid Gland Carcinoma,0.9529,Differentiated Thyroid Gland Carcinoma,0.8147,Thyroid Gland Papillary Carcinoma,0.7501,Poorly Differentiated Thyroid Gland Carcinoma,0.7385,thyroid gland squamous cell carcinoma,0.7318
THYROID_SARCOMA,Thyroid Gland Sarcoma,1,2,Thyroid Gland Sarcoma,0.9530,thyroid gland squamous cell carcinoma,0.7328,Thyroid Gland Carcinoma,0.6847,Thyroid Gland Anaplastic Carcinoma,0.6387,Differentiated Thyroid Gland Carcinoma,0.6280
THYROID_SQUAMOUS,thyroid gland squamous cell carcinoma,2,2,Thyroid Gland,0.7033,thyroid gland squamous cell carcinoma,0.6900,Thyroid Gland Sarcoma,0.6549,Thyroid Gland Carcinoma,0.6284,Differentiated Thyroid Gland Carcinoma,0.6147
THYROID_SQUAMOUS_CELL_CARCINOMA,thyroid gland squamous cell carcinoma,1,2,thyroid gland squamous cell carcinoma,0.9455,Thyroid Gland Carcinoma,0.7905,Differentiated Thyroid Gland Carcinoma,0.7759,Thyroid Gland Sarcoma,0.7571,Poorly Differentiated Thyroid Gland Carcinoma,0.7365
TISSUE NOS,Tissue,1,2,Tissue,0.9865,Soft Tissue,0.7075,Skin,0.6082,Superficial,0.5981,Mucosa,0.5947
TLL,T Lymphoblastic Leukemia/Lymphoma,1,2,T Lymphoblastic Leukemia/Lymphoma,0.5835,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.5501,T-Cell Large Granular Lymphocyte Leukemia,0.5065,T Acute Lymphoblastic Leukemia,0.4769,Hemophagocytic Lymphohistiocytosis,0.4763
TN,Triple-Negative Breast Cancer Finding,99,2,nan,0.5588,Not Otherwise Specified,0.5079,Translocation,0.4823,Essential Thrombocythemia,0.4768,Gastric,0.4704
TONGUE,Tongue,1,2,Tongue,1.0000,Tongue Squamous Cell Carcinoma,0.5847,Laryngeal,0.5756,Gastric,0.5452,Gingiva,0.5389
TRANSITIONAL CELL CARCINOMA,Transitional Cell Carcinoma,1,2,Transitional Cell Carcinoma,1.0000,"Kidney Carcinoma, Transitional Cells",0.8742,Urothelial Carcinoma,0.8360,Papillary Transitional Cell Carcinoma,0.8118,Bladder Urothelial Carcinoma,0.7769
TRANSITIONAL_CELL,Transitional Cells,1,2,Transitional Cells,0.9668,Columnar Cell,0.6831,immortal epithelial cell line cell,0.6261,Basaloid Cell,0.6150,Clear Cell,0.5990
TRANSITIONAL_CELL_CARCINOMA,Transitional Cell Carcinoma,1,2,Transitional Cell Carcinoma,0.9694,"Kidney Carcinoma, Transitional Cells",0.8606,Urothelial Carcinoma,0.8067,Papillary Transitional Cell Carcinoma,0.7888,Bladder Urothelial Carcinoma,0.7477
TRANSLOCATION,Translocation,1,2,Translocation,1.0000,MLL Gene Translocation,0.6374,Metastasis,0.6246,Resection,0.5629,Distant,0.5588
TRANSLOCATION-ASSOCIATED RENAL CELL CARCINOMA,MiT Family Translocation-Associated Renal Cell Carcinoma,1,2,MiT Family Translocation-Associated Renal Cell Carcinoma,0.8787,Clear Cell Renal Cell Carcinoma,0.7060,Sarcomatoid Renal Cell Carcinoma,0.6978,Renal Cell Carcinoma,0.6976,Fumarate Hydratase-Deficient Renal Cell Carcinoma,0.6945
TRANSVERSE COLON,Transverse Colon,1,2,Transverse Colon,1.0000,Descending Colon,0.8402,Ascending Colon,0.8127,Sigmoid Colon,0.7786,Colon,0.6959
TREATED PRIMARY GBM,Glioblastoma,2,2,Glioblastoma<;>De Novo,0.6855,Glioblastoma,0.6440,Malignant Glioma<;>Progressive,0.6433,"Glioblastoma, IDH-Wildtype<;>Glioblastoma with Primitive Neuronal Component",0.6405,Recurrent Malignant Glioma,0.6089
TRILATERAL,Trilateral Retinoblastoma,1,2,Trilateral Retinoblastoma,0.4499,Unilateral,0.4341,Translocation,0.4283,Diploidy,0.4262,Bilateral,0.4193
TUBULAR,Tubular,1,2,Tubular,1.0000,Duct,0.6579,Ductal,0.6549,Tubular Adenocarcinoma,0.6531,Lobular,0.6109
TUBULAR STOMACH ADENOCARCINOMA,Gastric Tubular Adenocarcinoma,1,2,Gastric Tubular Adenocarcinoma,0.9686,Gastric Adenocarcinoma,0.7961,Tubular Adenocarcinoma,0.7877,Gastric Intestinal-Type Adenocarcinoma,0.7567,Gastric Papillary Adenocarcinoma,0.7549
TUBULAR/ CRIBRIFORM,Breast Tubular Carcinoma<;>Cribriform Pattern,4,2,Cribriform<;>Solid<;>Tubular,0.8110,Cribriform,0.7409,Breast Tubular Carcinoma<;>Cribriform,0.7080,Breast Tubular Carcinoma<;>Cribriform Pattern,0.6887,Tubular,0.6778
TUBULAR_ADENOCARCINOMA,Tubular Adenocarcinoma,1,2,Tubular Adenocarcinoma,0.9780,Tubular Adenocarcinoma<;>Well Differentiated Adenocarcinoma Cell,0.8662,Tubular Adenocarcinoma<;>Moderately Differentiated,0.7906,Breast Tubular Carcinoma,0.7693,Gastric Tubular Adenocarcinoma,0.7692
TUMOR FREE,Tumor Free,1,2,Tumor Free,1.0000,With Tumor,0.5851,Microsatellite Stable,0.5836,Nonseminomatous,0.5741,Undifferentiated,0.5435
TUMOR PRIMARY,Primary Neoplasm,1,2,Primary Neoplasm,0.9385,With Tumor,0.7723,Neoplasm,0.7328,Malignant Neoplasm,0.7253,Primary,0.7253
TUMOR_FREE,Tumor Free,1,2,Tumor Free,0.9683,With Tumor,0.5862,Nonseminomatous,0.5655,Microsatellite Stable,0.5565,Undifferentiated,0.5477
TURBT,Transurethral Resection of Bladder Tumor,1,2,Transurethral Resection of Bladder Tumor,0.5971,Tubular,0.5367,With Tumor,0.4913,Atypical Teratoid/Rhabdoid Tumor,0.4814,Liquid Tumor,0.4806
TYPE A,Thymoma Type A,99,2,Luminal A Breast Carcinoma,0.5376,Acute Leukemia of Ambiguous Lineage,0.5365,Primary,0.5139,Arm,0.5110,Classic Histology,0.5098
TYPE AB,Thymoma Type AB,99,2,Bilateral,0.5077,Activated B-Cell Positive,0.4987,"Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified",0.4816,Acute Leukemia of Ambiguous Lineage,0.4738,"Mixed Phenotype Acute Leukemia, B/Myeloid",0.4608
TYPE ATHYMOMA,Thymoma Type A,99,2,Adamantinoma,0.5999,Oligoastrocytoma,0.5793,Ganglioneuroblastoma,0.5704,Juvenile Granulosa Cell Tumor,0.5626,"Ganglioneuroblastoma, Intermixed",0.5584
TYPE B1,Thymoma Type B1,1,2,Thymoma Type B1,0.5879,Luminal B Breast Carcinoma,0.5823,Thymoma Type B1<;>Thymoma Type B2,0.5315,Basal,0.5307,Luminal A Breast Carcinoma,0.5300
TYPE B1THYMOMA,Thymoma Type B1,1,2,Thymoma Type B1,0.7039,Thymoma Type B1<;>Thymoma Type B2,0.6598,Thymoma Type B2,0.6130,Thymoma Type B3,0.6025,Thymoma Type A,0.5958
TYPE B2,Thymoma Type B2,1,2,Thymoma Type B2,0.5906,Luminal B Breast Carcinoma,0.5804,Bilateral,0.5368,Myelodysplastic Syndrome with Excess Blasts-2,0.5247,Invasive Breast Lobular Carcinoma<;>Hormone Receptor-Positive Breast Carcinoma<;>HER2/Neu Negative,0.5178
TYPE B2THYMOMA,Thymoma Type B2,1,2,Thymoma Type B2,0.7033,Thymoma Type B2<;>Thymoma Type B3,0.6617,Thymoma Type B1<;>Thymoma Type B2,0.6518,Thymoma Type B1,0.6413,Thymoma Type B3,0.6255
TYPE B3,Thymoma Type B3,1,2,Thymoma Type B3,0.5894,Thymoma Type B2<;>Thymoma Type B3,0.5371,Luminal B Breast Carcinoma,0.5362,Basal-Like Breast Carcinoma,0.5250,Invasive Breast Lobular Carcinoma,0.5030
TYPE C,Thymic Carcinoma,99,2,Hepatitis C Virus,0.5492,Cytology Specimen Type,0.5101,"Non-B, Non-C Hepatitis",0.4961,Mixed,0.4744,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.4593
T_CELL,T-Lymphocyte,1,2,T-Lymphocyte,0.9261,Transitional Cells,0.5903,T-Cell Non-Hodgkin Lymphoma,0.5768,Lymphoid,0.5711,Fibroblast<;>Lymphocyte,0.5389
T_CELL_ALCL,Anaplastic Large Cell Lymphoma,99,2,T-Cell Non-Hodgkin Lymphoma,0.6555,Angioimmunoblastic T-Cell Lymphoma,0.6309,T Lymphoblastic Leukemia/Lymphoma,0.6248,Adult T-Cell Leukemia/Lymphoma,0.6195,T-Cell Large Granular Lymphocyte Leukemia,0.6151
T_CELL_CUTANEOUS,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,3,2,T-Lymphocyte,0.7455,Cutaneous T-Cell Non-Hodgkin Lymphoma,0.7428,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6922,T-Cell Non-Hodgkin Lymphoma,0.6417,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.5813
T_CELL_LARGE_GRANULAR_LYMPHOCYTIC_LEUKAEMIA,T-Cell Large Granular Lymphocyte Leukemia,1,2,T-Cell Large Granular Lymphocyte Leukemia,0.9574,T Lymphoblastic Leukemia/Lymphoma,0.7574,T Acute Lymphoblastic Leukemia,0.7090,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.6912,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,0.6690
UCEC,Endometrial Carcinoma<;>Uterine Corpus Cancer,99,2,Epithelial-Myoepithelial Carcinoma,0.6574,Undifferentiated Carcinoma,0.6471,Urothelial Carcinoma,0.6424,upper tract urothelial carcinoma,0.6397,Metaplastic Carcinoma,0.6206
UCEC CSRC,uterine corpus endometrial carcinoma<;>Uterine Carcinosarcoma,99,2,uterine corpus endometrial carcinoma<;>Copy Number<;>Low,0.5140,uterine corpus endometrial carcinoma<;>Copy Number<;>High,0.5094,Cytology Specimen Type,0.5056,Colorectal Neuroendocrine Carcinoma,0.5015,Microsatellite Stable Colorectal Carcinoma,0.4938
UCEC ENDO,Endometrial Endometrioid Adenocarcinoma,99,2,Digestive System Mixed Adenoneuroendocrine Carcinoma,0.5910,Epithelial-Myoepithelial Carcinoma,0.5845,Endometrial Neuroendocrine Carcinoma,0.5678,Colorectal Neuroendocrine Carcinoma,0.5632,POLE-Ultramutated Endometrial Endometrioid Adenocarcinoma,0.5568
UCEC HM,Endometrial Carcinoma<;>Microsatellite Instability,99,2,Hypermutated Colorectal Carcinoma,0.6127,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.5773,"Uterine Carcinosarcoma, Heterologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.5678,Metaplastic Carcinoma,0.5620,Digestive System Mixed Adenoneuroendocrine Carcinoma,0.5604
UCEC SEROUS,Endometrial Serous Adenocarcinoma,99,2,Serous Cystadenocarcinoma,0.7556,Serous Adenocarcinoma,0.7354,Cystadenocarcinoma<;>High Grade<;>Serous,0.7279,Serous Adenocarcinoma<;>High Grade,0.7228,Ovarian Seromucinous Carcinoma,0.7209
UCEC_CN_HIGH,uterine corpus endometrial carcinoma<;>Copy Number<;>High,1,2,uterine corpus endometrial carcinoma<;>Copy Number<;>High,0.6502,Hypermutated Colorectal Carcinoma,0.6271,uterine corpus endometrial carcinoma<;>Copy Number<;>Low,0.5365,Neuroepithelial Neoplasm<;>High Grade,0.5162,Microsatellite Stable Colorectal Carcinoma,0.5150
UCEC_CN_LOW,uterine corpus endometrial carcinoma<;>Copy Number<;>Low,1,2,uterine corpus endometrial carcinoma<;>Copy Number<;>Low,0.6453,Claudin-Low,0.5478,Microsatellite Stable Colorectal Carcinoma,0.5322,Cytogenetic Abnormality<;>Low Risk,0.5310,Unclassified,0.5283
UCEC_MSI,Endometrial Carcinoma<;>Microsatellite Instability,5,2,Microsatellite Stable Colorectal Carcinoma,0.6970,Colon Adenocarcinoma<;>Microsatellite Instability,0.6680,Hypermutated Colorectal Carcinoma,0.6636,Microsatellite Stable,0.6585,Endometrial Carcinoma<;>Microsatellite Instability,0.6567
UCEC_POLE,Endometrial Carcinoma<;>POLE Gene Mutation,2,2,POLE-Ultramutated Endometrial Endometrioid Adenocarcinoma,0.6140,Endometrial Carcinoma<;>POLE Gene Mutation,0.5442,Colon Adenocarcinoma<;>POLE Gene Mutation,0.5133,Esophageal Adenocarcinoma<;>POLE Gene Mutation,0.5086,Unclassified,0.5082
UCS,Uterine Carcinosarcoma,99,2,undifferentiated sarcoma,0.5439,Undifferentiated Carcinoma,0.5326,Undifferentiated Malignant Neoplasm,0.5113,Undifferentiated,0.5033,Sinonasal Undifferentiated Carcinoma,0.4998
UM,Uveal Melanoma,99,2,Melanoma of Unknown Primary,0.5167,Distant,0.5053,Monoclonal Gammopathy of Undetermined Significance,0.5002,Melanoma,0.4987,Not Otherwise Specified,0.4975
UNCLASSIFIED,Unclassified,1,2,Unclassified,1.0000,Not Otherwise Specified,0.6667,Undifferentiated,0.5880,Occult Stage,0.5599,Unclassified Renal Cell Carcinoma,0.5526
UNCLASSIFIED KIDNEY RENAL CELL CARCINOMA,Renal Cell Carcinoma,3,2,Unclassified Renal Cell Carcinoma,0.9791,Clear Cell Renal Cell Carcinoma,0.7772,Renal Cell Carcinoma,0.7735,Kidney Carcinoma,0.7591,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.7451
UNCLASSIFIED RENAL CELL CARCINOMA,Unclassified Renal Cell Carcinoma,1,2,Unclassified Renal Cell Carcinoma,1.0000,Clear Cell Renal Cell Carcinoma,0.7831,Renal Cell Carcinoma,0.7822,Sarcomatoid Renal Cell Carcinoma<;>Clear Cell Renal Cell Carcinoma,0.7552,Clear Cell Renal Cell Carcinoma<;>Poorly Differentiated,0.7515
UNCLASSIFIED SARCOMA,Sarcoma,2,2,undifferentiated sarcoma,0.8430,Sarcoma,0.8150,Undifferentiated Soft Tissue Sarcoma,0.7715,Undifferentiated Malignant Neoplasm,0.7372,Undifferentiated Round Cell Sarcoma,0.7359
UNDIFFERENTIATED,Undifferentiated,1,2,Undifferentiated,1.0000,Undifferentiated Malignant Neoplasm,0.8279,Well Differentiated,0.7984,Carcinoma<;>Undifferentiated,0.7881,Undifferentiated Carcinoma,0.7829
UNDIFFERENTIATED B LYMPHOMA,B-Cell Non-Hodgkin Lymphoma<;>Undifferentiated,1,2,B-Cell Non-Hodgkin Lymphoma<;>Undifferentiated,0.9103,Burkitt Lymphoma,0.8283,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.8074,B-Cell Non-Hodgkin Lymphoma,0.8004,Centroblastic Lymphoma,0.7813
UNDIFFERENTIATED CARCINOMA,Undifferentiated Carcinoma,1,2,Undifferentiated Carcinoma,1.0000,Carcinoma<;>Undifferentiated,0.9749,Undifferentiated Malignant Neoplasm,0.9296,Adenocarcinoma<;>Undifferentiated Carcinoma,0.9186,Adenocarcinoma<;>Undifferentiated,0.8947
UNDIFFERENTIATED CARCINOMA OF THE PANCREAS,Pancreatic Undifferentiated Carcinoma,1,2,Pancreatic Undifferentiated Carcinoma,0.9664,Pancreatoblastoma,0.7810,Pancreatic Colloid Carcinoma,0.7538,Pancreatic Adenosquamous Carcinoma,0.7513,Pancreatic Mixed Ductal-Neuroendocrine Carcinoma,0.7510
UNDIFFERENTIATED MALIGNANT NEOPLASM,Undifferentiated Malignant Neoplasm,1,2,Undifferentiated Malignant Neoplasm,1.0000,Undifferentiated Carcinoma,0.9296,Carcinoma<;>Undifferentiated,0.9293,undifferentiated sarcoma,0.8884,Undifferentiated,0.8279
UNDIFFERENTIATED PLEOMORPHIC SARCOMA MALIGNANT FIBROUS HISTIOCYTOMA,Undifferentiated Pleomorphic Sarcoma,1,2,Undifferentiated Pleomorphic Sarcoma,0.8612,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,0.8567,Undifferentiated Pleomorphic Sarcoma<;>Undifferentiated Spindle Cell Sarcoma,0.8073,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,0.7685,Anaplastic Pleomorphic Xanthoastrocytoma,0.7473
UNDIFFERENTIATED PLEOMORPHIC SARCOMA UPS,Undifferentiated Pleomorphic Sarcoma,1,2,Undifferentiated Pleomorphic Sarcoma,0.7216,Undifferentiated Pleomorphic Sarcoma<;>Undifferentiated Spindle Cell Sarcoma,0.6983,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,0.6874,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,0.6300,undifferentiated sarcoma,0.6126
UNDIFFERENTIATED PLEOMORPHIC SARCOMA/MALIGANT FIBROUS HISTIOCYTOMA/HIGH-GRADE SPINDLE CELL SARCOMA,Undifferentiated Pleomorphic Sarcoma,1,2,Undifferentiated Pleomorphic Sarcoma,0.7902,Undifferentiated Pleomorphic Sarcoma<;>Undifferentiated Spindle Cell Sarcoma,0.7838,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,0.7493,Pleomorphic Rhabdomyosarcoma,0.7030,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,0.7010
UNDIFFERENTIATED PLEOMORPHIC SARCOMA/MALIGNANT FIBROUS HISTIOCYTOMA/HIGH-GRADE SPINDLE CELL SARCOMA,Undifferentiated Pleomorphic Sarcoma<;>Undifferentiated Spindle Cell Sarcoma,2,2,Undifferentiated Pleomorphic Sarcoma,0.8137,Undifferentiated Pleomorphic Sarcoma<;>Undifferentiated Spindle Cell Sarcoma,0.8049,Undifferentiated Pleomorphic Sarcoma<;>Myxofibrosarcoma,0.7813,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,0.7210,Pleomorphic Rhabdomyosarcoma,0.6828
UNDIFFERENTIATED SARCOMA,Undifferentiated Soft Tissue Sarcoma,3,2,undifferentiated sarcoma,1.0000,Undifferentiated Malignant Neoplasm,0.8884,Undifferentiated Soft Tissue Sarcoma,0.8793,Sarcomatoid Carcinoma,0.8542,Undifferentiated Round Cell Sarcoma,0.8529
UNDIFFERENTIATED STOMACH ADENOCARCINOMA,Gastric Undifferentiated Carcinoma,1,2,Gastric Undifferentiated Carcinoma,0.8990,Gastric Adenocarcinoma,0.8323,Gastric Diffuse Adenocarcinoma,0.8240,Gastric Poorly Cohesive Adenocarcinoma,0.8232,Gastric Adenosquamous Carcinoma,0.7916
UNDIFFERENTIATED UTERINE SARCOMA,Uterine Corpus Undifferentiated Sarcoma,1,2,Uterine Corpus Undifferentiated Sarcoma,0.9319,Uterine Carcinosarcoma,0.8341,undifferentiated carcinoma of the corpus uteri,0.7962,Uterine Corpus Sarcoma<;>Mesenchymal,0.7885,Uterine Corpus Sarcoma,0.7752
UNDIFFERENTIATED_ADENOCARCINOMA,Adenocarcinoma<;>Undifferentiated Carcinoma,2,2,Adenocarcinoma<;>Undifferentiated,0.9621,Adenocarcinoma<;>Undifferentiated Carcinoma,0.9424,Undifferentiated Carcinoma,0.8762,Carcinoma<;>Undifferentiated,0.8755,Poorly Differentiated Adenocarcinoma,0.8383
UNDIFFERENTIATED_CARCINOMA,Undifferentiated Carcinoma,1,2,Undifferentiated Carcinoma,0.9832,Carcinoma<;>Undifferentiated,0.9749,Undifferentiated Malignant Neoplasm,0.9303,Adenocarcinoma<;>Undifferentiated Carcinoma,0.9051,Adenocarcinoma<;>Undifferentiated,0.8923
UNDIFFERENTIATED_SARCOMA,undifferentiated sarcoma,1,2,undifferentiated sarcoma,0.9845,Undifferentiated Soft Tissue Sarcoma,0.8863,Undifferentiated Malignant Neoplasm,0.8673,Undifferentiated Round Cell Sarcoma,0.8379,Sarcoma,0.8286
UNILATERAL,Unilateral,1,2,Unilateral,1.0000,Bilateral,0.6835,Diploidy,0.5698,Primary,0.5521,Undifferentiated,0.5316
UNKNOWN TUMOR,Neoplasm,99,2,Melanoma of Unknown Primary,0.7793,Primary Neoplasm<;>Unpaired,0.7443,Undifferentiated Malignant Neoplasm,0.6914,With Tumor,0.6745,Unclassified,0.6594
UNTREATED PRIMARY DE NOVO GBM,Glioblastoma<;>De Novo,1,2,Glioblastoma<;>De Novo,0.6435,"Glioblastoma, IDH-Wildtype<;>Glioblastoma with Primitive Neuronal Component",0.5822,"Glioblastoma, IDH-Wildtype",0.5608,Malignant Glioma<;>Progressive,0.5459,Glioblastoma<;>IDH Family Wildtype,0.5359
UPPER AERODIGESTIVE,upper aerodigestive tract neoplasm,1,2,upper aerodigestive tract neoplasm,0.6849,Fibroblast<;>upper aerodigestive tract,0.6286,Pharynx,0.5535,Lung,0.5271,Laryngeal,0.5182
UPPER TRACT UROTHELIAL,upper tract urothelial carcinoma,2,2,Bladder Urothelial Cell,0.8271,upper tract urothelial carcinoma,0.8219,Urothelial Carcinoma,0.7778,Bladder Urothelial Carcinoma,0.7642,Urothelial Papilloma,0.7593
UPPER TRACT UROTHELIAL CARCINOMA,upper tract urothelial carcinoma,1,2,upper tract urothelial carcinoma,1.0000,Urothelial Carcinoma,0.9220,Bladder Urothelial Carcinoma,0.9056,Urethral Urothelial Carcinoma,0.8551,Bladder Urachal Carcinoma,0.8120
UPPER_AERODIGESTIVE,upper aerodigestive tract neoplasm,1,2,upper aerodigestive tract neoplasm,0.6695,Fibroblast<;>upper aerodigestive tract,0.6211,Pharynx,0.5436,Lung,0.5379,Laryngeal,0.5259
UPPER_AERODIGESTIVE_CARCINOMA,upper aerodigestive tract neoplasm,1,2,upper aerodigestive tract neoplasm,0.7201,upper tract urothelial carcinoma,0.6936,Carcinoma,0.6556,Transitional Cell Carcinoma,0.6531,Urothelial Carcinoma,0.6472
UPPER_AERODIGESTIVE_SQUAMOUS,upper aerodigestive tract neoplasm<;>Oral Cavity Squamous Cell Carcinoma,99,2,Cervical Squamous Neoplasm,0.6692,Squamous Cell Carcinoma,0.6682,Fibroblast<;>upper aerodigestive tract,0.6567,upper aerodigestive tract neoplasm,0.6419,Adenosquamous Carcinoma,0.6232
URACHAL ADENOCARCINOMA,Bladder Urachal Adenocarcinoma,1,2,Bladder Urachal Adenocarcinoma,0.8841,Bladder Urachal Carcinoma,0.8265,Clear Cell Adenocarcinoma,0.7200,Urothelial Carcinoma,0.7045,Urethral Urothelial Carcinoma,0.7005
URACHAL CARCINOMA,Bladder Urachal Carcinoma,1,2,Bladder Urachal Carcinoma,0.9098,Bladder Urachal Adenocarcinoma,0.8839,Urothelial Carcinoma,0.7723,Urethral Urothelial Carcinoma,0.7553,upper tract urothelial carcinoma,0.7539
URETHRAL ADENOCARCINOMA,Urethral Adenocarcinoma,1,2,Urethral Adenocarcinoma,1.0000,Urethral Carcinoma,0.9262,Urethral Squamous Cell Carcinoma,0.8465,Urethral Melanoma,0.8298,Urethral Urothelial Carcinoma,0.8220
URETHRAL CANCER,Urethral Carcinoma,1,2,Urethral Carcinoma,0.9535,Urethral Adenocarcinoma,0.8581,Urethral Urothelial Carcinoma,0.7825,Urethral Melanoma,0.7774,Urethral Squamous Cell Carcinoma,0.7756
URETHRAL SQUAMOUS CELL CARCINOMA,Urethral Squamous Cell Carcinoma,1,2,Urethral Squamous Cell Carcinoma,1.0000,Urethral Carcinoma,0.8579,Urethral Adenocarcinoma,0.8465,Urethral Urothelial Carcinoma,0.8032,Urethral Melanoma,0.7916
URETHRAL UROTHELIAL CARCINOMA,Urethral Urothelial Carcinoma,1,2,Urethral Urothelial Carcinoma,1.0000,upper tract urothelial carcinoma,0.8551,Urethral Carcinoma,0.8542,Urothelial Carcinoma,0.8317,Bladder Urothelial Carcinoma,0.8272
URINARY_TRACT,Urinary System,1,2,Urinary System,0.8975,Bladder,0.7346,Malignant Urinary System Neoplasm,0.7053,Uveal Tract,0.6095,Intestinal,0.6009
UROTHELIAL CARCINOMA,Urothelial Carcinoma,1,2,Urothelial Carcinoma,1.0000,Bladder Urothelial Carcinoma,0.9431,upper tract urothelial carcinoma,0.9220,Transitional Cell Carcinoma,0.8360,Urethral Urothelial Carcinoma,0.8317
UROTHELIAL CARCINOMA OTHER,Urothelial Carcinoma,2,2,upper tract urothelial carcinoma,0.7636,Urothelial Carcinoma,0.7601,Bladder Urothelial Carcinoma,0.6944,Infiltrating Urothelial Carcinoma,0.6867,Urethral Urothelial Carcinoma,0.6490
UROTHELIAL PAPILLOMA,Urothelial Papilloma,1,2,Urothelial Papilloma,1.0000,Urothelial Carcinoma,0.7684,Papillary Transitional Cell Carcinoma,0.7579,Bladder Urothelial Carcinoma,0.7385,upper tract urothelial carcinoma,0.7309
UTERINE ADENOSARCOMA,Uterine Corpus Adenosarcoma,1,2,Uterine Corpus Adenosarcoma,0.9287,Uterine Carcinosarcoma,0.8036,Uterine Corpus Undifferentiated Sarcoma,0.7567,Adenosarcoma,0.7539,Endometrial Adenosquamous Carcinoma,0.7375
UTERINE CARCINOSARCOMA,Uterine Carcinosarcoma,1,2,Uterine Carcinosarcoma,1.0000,uterine corpus endometrial carcinoma<;>Uterine Carcinosarcoma,0.8903,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.8396,Uterine Corpus Undifferentiated Sarcoma,0.8131,Uterine Corpus Sarcoma,0.8006
UTERINE CARCINOSARCOMA/ MALIGNANT MIXED MULLERIAN TUMOR MMMT: NOS,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,1,2,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.8886,"Uterine Carcinosarcoma, Heterologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.8837,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.8753,Malignant Mixed Mesodermal (Mullerian) Tumor,0.8162,Uterine Carcinosarcoma,0.7317
UTERINE CARCINOSARCOMA/ MMMT: HETEROLOGOUS TYPE,"Uterine Carcinosarcoma, Heterologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",1,2,"Uterine Carcinosarcoma, Heterologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.9082,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.8698,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.8332,Uterine Carcinosarcoma,0.7160,Malignant Mixed Mesodermal (Mullerian) Tumor,0.6992
UTERINE CARCINOSARCOMA/MMMT: HOMOLOGOUS TYPE,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",1,2,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.8927,"Uterine Carcinosarcoma, Heterologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.8546,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.7964,Uterine Carcinosarcoma,0.7101,Malignant Mixed Mesodermal (Mullerian) Tumor,0.6940
UTERINE CARCINOSARCOMA/UTERINE MALIGNANT MIXED MULLERIAN TUMOR,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,1,2,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.9460,"Uterine Carcinosarcoma, Heterologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.9157,"Uterine Carcinosarcoma, Homologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.9004,Uterine Carcinosarcoma,0.8116,Malignant Mixed Mesodermal (Mullerian) Tumor,0.7848
UTERINE CLEAR CELL CARCINOMA,Endometrial Clear Cell Adenocarcinoma,1,2,Endometrial Clear Cell Adenocarcinoma,0.8845,Malignant Ovarian Clear Cell Tumor,0.7804,Clear Cell Adenocarcinoma,0.7741,Adenocarcinoma Clear Cell,0.7632,Endometrial Clear Cell Adenocarcinoma<;>Mixed,0.7512
UTERINE CORPUS ENDOMETRIAL CARCINOMA,uterine corpus endometrial carcinoma,1,2,uterine corpus endometrial carcinoma,1.0000,Endometrial Carcinoma<;>Uterine Corpus Cancer,0.9744,Endometrial Carcinoma,0.8854,uterine corpus endometrial carcinoma<;>Uterine Carcinosarcoma,0.8469,Endometrial Adenocarcinoma,0.8288
UTERINE CORPUS ENDOMETRIAL CARCINOMA OTHER,uterine corpus endometrial carcinoma,1,2,uterine corpus endometrial carcinoma,0.6927,Endometrial Carcinoma<;>Uterine Corpus Cancer,0.6841,uterine corpus endometrial carcinoma<;>Uterine Carcinosarcoma,0.6487,undifferentiated carcinoma of the corpus uteri,0.6188,Endometrial Carcinoma,0.6176
UTERINE DEDIFFERENTIATED CARCINOMA,Endometrial Dedifferentiated Carcinoma,1,2,Endometrial Dedifferentiated Carcinoma,0.8985,Uterine Carcinosarcoma,0.7593,undifferentiated carcinoma of the corpus uteri,0.7564,Uterine Corpus Undifferentiated Sarcoma,0.7386,Endometrial Adenocarcinoma<;>Well Differentiated,0.7139
UTERINE ENDOMETRIOID,Endometrial Endometrioid Adenocarcinoma,3,2,Endometrioid Tumor,0.9312,Endometrioid Adenocarcinoma,0.8881,Endometrial Endometrioid Adenocarcinoma,0.8881,Ovarian Endometrioid Adenocarcinoma,0.8045,Cervical Endometrioid Adenocarcinoma,0.8013
UTERINE ENDOMETRIOID CARCINOMA,Endometrial Endometrioid Adenocarcinoma,1,2,Endometrial Endometrioid Adenocarcinoma,0.9439,Endometrioid Adenocarcinoma,0.9339,Cervical Endometrioid Adenocarcinoma,0.9079,Endometrioid Tumor,0.8994,Ovarian Endometrioid Adenocarcinoma,0.8889
UTERINE EPITHELIOID LEIOMYOSARCOMA,Uterine Corpus Epithelioid Leiomyosarcoma,1,2,Uterine Corpus Epithelioid Leiomyosarcoma,0.9706,Uterine Corpus Leiomyosarcoma,0.8508,Uterine Corpus Myxoid Leiomyosarcoma,0.8431,Well Differentiated Leiomyosarcoma,0.8087,Conventional Leiomyosarcoma,0.7769
UTERINE HYPERMUTATED,Endometrial Carcinoma<;>Microsatellite Instability,99,2,Uterine Carcinosarcoma,0.4765,uterine corpus endometrial carcinoma<;>Copy Number<;>High,0.4751,Hyperdiploidy,0.4741,POLE-Ultramutated Endometrial Endometrioid Adenocarcinoma,0.4723,Uterine Corpus PEComa,0.4708
UTERINE LEIOMYOSARCOMA,Uterine Corpus Leiomyosarcoma,1,2,Uterine Corpus Leiomyosarcoma,0.9574,Leiomyosarcoma,0.9328,Well Differentiated Leiomyosarcoma,0.8654,Conventional Leiomyosarcoma,0.8635,Uterine Corpus Myxoid Leiomyosarcoma,0.8520
UTERINE MIXED ENDOMETRIAL CARCINOMA,Endometrial Carcinoma<;>Mixed,1,2,Endometrial Carcinoma<;>Mixed,0.9313,Endometrial Clear Cell Adenocarcinoma<;>Mixed,0.8613,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.8112,"Uterine Carcinosarcoma, Heterologous Type<;>Malignant Mixed Mesodermal (Mullerian) Tumor",0.7819,Endometrial Adenosquamous Carcinoma,0.7779
UTERINE MYXOID LEIOMYOSARCOMA,Uterine Corpus Myxoid Leiomyosarcoma,1,2,Uterine Corpus Myxoid Leiomyosarcoma,0.9613,Uterine Corpus Leiomyosarcoma,0.8579,Well Differentiated Leiomyosarcoma,0.8378,Leiomyosarcoma,0.8279,Conventional Leiomyosarcoma,0.8225
UTERINE NEUROENDOCRINE CARCINOMA,Endometrial Neuroendocrine Carcinoma,1,2,Endometrial Neuroendocrine Carcinoma,0.9062,Uterine Carcinosarcoma,0.8239,uterine corpus endometrial carcinoma<;>Uterine Carcinosarcoma,0.7613,Cervical Neuroendocrine Tumor,0.7261,Cervical Small Cell Neuroendocrine Carcinoma,0.7098
UTERINE PERIVASCULAR EPITHELIOID CELL TUMOR,Uterine Corpus PEComa,1,2,Uterine Corpus PEComa,0.7753,Uterine Corpus Epithelioid Leiomyosarcoma,0.7243,Epithelioid Trophoblastic Tumor,0.7123,Endometrioid Tumor,0.6936,Endometrial Neuroendocrine Carcinoma,0.6807
UTERINE SARCOMA,Uterine Corpus Sarcoma,1,2,Uterine Corpus Sarcoma,0.8879,Uterine Carcinosarcoma,0.8482,Uterine Corpus Sarcoma<;>Mesenchymal,0.8034,Uterine Corpus Undifferentiated Sarcoma,0.7990,Uterine Corpus Adenosarcoma,0.7418
"UTERINE SARCOMA, OTHER",Uterine Corpus Sarcoma,1,2,Uterine Corpus Sarcoma,0.7148,Uterine Carcinosarcoma,0.6954,Uterine Corpus Undifferentiated Sarcoma,0.6856,Uterine Corpus Sarcoma<;>Mesenchymal,0.6373,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.6085
UTERINE SARCOMA/MESENCHYMAL,Uterine Corpus Sarcoma<;>Mesenchymal,1,2,Uterine Corpus Sarcoma<;>Mesenchymal,0.8639,Uterine Corpus Undifferentiated Sarcoma,0.7619,Uterine Carcinosarcoma,0.7574,Uterine Corpus Sarcoma,0.7569,Uterine Carcinosarcoma<;>Malignant Mixed Mesodermal (Mullerian) Tumor,0.7542
UTERINE SEROUS,Endometrial Serous Adenocarcinoma,2,2,Serous,0.8039,Endometrial Serous Adenocarcinoma,0.7437,Ovarian Serous Adenocarcinoma,0.6563,Serous Adenocarcinoma,0.6562,Serous Cystadenocarcinoma,0.6358
UTERINE SEROUS CARCINOMA,Endometrial Serous Adenocarcinoma,1,2,Endometrial Serous Adenocarcinoma,0.9106,Ovarian Serous Adenocarcinoma,0.8418,Serous Adenocarcinoma,0.8087,Ovarian High Grade Serous Adenocarcinoma,0.7945,Ovarian Low Grade Serous Adenocarcinoma,0.7850
UTERINE SEROUS CARCINOMA/UTERINE PAPILLARY SEROUS CARCINOMA,Endometrial Serous Adenocarcinoma,1,2,Endometrial Serous Adenocarcinoma,0.7571,Ovarian Serous Adenocarcinoma,0.6756,Serous Adenocarcinoma,0.6666,Serous Cystadenocarcinoma,0.6603,Serous Adenocarcinoma<;>High Grade,0.6475
UTERINE SMOOTH MUSCLE TUMOR OF UNCERTAIN MALIGNANT POTENTIAL,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential,1,2,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential,0.9759,Conventional Leiomyosarcoma,0.6786,Leiomyosarcoma,0.6597,Uterine Corpus Leiomyosarcoma,0.6489,Well Differentiated Leiomyosarcoma,0.6314
UTERINE UNDIFFERENTIATED CARCINOMA,undifferentiated carcinoma of the corpus uteri,1,2,undifferentiated carcinoma of the corpus uteri,0.9005,Uterine Corpus Undifferentiated Sarcoma,0.8810,Uterine Carcinosarcoma,0.8423,Uterine Corpus Adenosarcoma,0.7771,uterine corpus endometrial carcinoma<;>Uterine Carcinosarcoma,0.7663
UTERINE_SARCOMA,Uterine Corpus Sarcoma,1,2,Uterine Corpus Sarcoma,0.8572,Uterine Carcinosarcoma,0.8279,Uterine Corpus Undifferentiated Sarcoma,0.8032,Uterine Corpus Sarcoma<;>Mesenchymal,0.8030,uterine corpus endometrial carcinoma<;>Uterine Carcinosarcoma,0.7238
UTUC,upper tract urothelial carcinoma,1,2,upper tract urothelial carcinoma,0.6691,Urothelial Carcinoma,0.6560,Bladder Urothelial Carcinoma,0.6159,Undifferentiated Carcinoma,0.6054,Infiltrating Urothelial Carcinoma,0.6046
UVEAL,Uveal Tract,1,2,Uveal Tract,0.8957,Uveal Melanoma,0.6337,Ocular Melanoma,0.5277,Extrahepatic,0.5103,Thyroid Gland,0.5098
UVEAL MELANOMA,Uveal Melanoma,1,2,Uveal Melanoma,1.0000,Ocular Melanoma,0.8028,Lentigo Maligna Melanoma,0.7038,Melanoma,0.6809,Melanoma of Unknown Primary,0.6498
UVEAL_MELANOMA,Uveal Melanoma,1,2,Uveal Melanoma,0.9638,Ocular Melanoma,0.7724,Lentigo Maligna Melanoma,0.7071,Melanoma,0.7043,Melanoma of Unknown Primary,0.6642
UVM,Uveal Melanoma,99,2,Lentigo Maligna Melanoma,0.5481,Mucosal Melanoma,0.5401,Lentigo Maligna,0.5224,Neurocutaneous Melanosis,0.5118,Melanoma of Unknown Primary,0.5016
VAGINAL ADENOCARCINOMA,Vaginal Adenocarcinoma,1,2,Vaginal Adenocarcinoma,1.0000,Vaginal Carcinoma,0.9233,Vaginal Squamous Cell Carcinoma,0.8419,Vaginal Melanoma,0.8351,Vulvar Carcinoma<;>Vaginal Carcinoma,0.7718
VAGINAL CANCER,Vaginal Carcinoma,1,2,Vaginal Carcinoma,0.9405,Vaginal Adenocarcinoma,0.8378,Vulvar Carcinoma<;>Vaginal Carcinoma,0.8148,Vaginal Melanoma,0.7928,Vaginal Squamous Cell Carcinoma,0.7753
VULVA/VAGINA,Vulvar Carcinoma<;>Vaginal Carcinoma,1,2,Vulvar Carcinoma<;>Vaginal Carcinoma,0.6458,Vulvar Carcinoma,0.5959,Vaginal Carcinoma,0.5386,Ovary,0.5218,Bladder,0.5011
"VULVAR/VAGINAL CANCER, NOS",Vulvar Carcinoma<;>Vaginal Carcinoma,1,2,Vulvar Carcinoma<;>Vaginal Carcinoma,0.8470,Vulvar Carcinoma,0.7960,Vaginal Carcinoma,0.6967,Vulvar Squamous Cell Carcinoma,0.6703,Vaginal Melanoma,0.6183
WALDENSTROM MACROGLOBULINEMIA,Waldenstrom Macroglobulinemia,1,2,Waldenstrom Macroglobulinemia,1.0000,Monoclonal B-Cell Lymphocytosis,0.6895,Marginal Zone Lymphoma,0.6269,Nodal Marginal Zone Lymphoma,0.6230,Primary Mediastinal (Thymic) Large B-Cell Lymphoma,0.6191
WDLPS,Well Differentiated Liposarcoma,99,2,Post-Transplant Lymphoproliferative Disorder,0.5004,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,0.4948,Myelodysplastic Syndrome with Single Lineage Dysplasia,0.4725,"Myelodysplastic Syndrome, Unclassifiable",0.4626,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.4482
WELL DIFFERENTIATED,Well Differentiated,1,2,Well Differentiated,1.0000,Poorly Differentiated,0.8929,Moderately Differentiated,0.8569,Undifferentiated,0.7984,Well Differentiated Lesion<;>Invasive,0.7726
WELL DIFFERENTIATED ENDOMETRIAL ADENOCARCINOMA,Endometrial Adenocarcinoma<;>Well Differentiated,1,2,Endometrial Adenocarcinoma<;>Well Differentiated,0.9797,Endometrial Adenocarcinoma,0.8901,Endometrial Clear Cell Adenocarcinoma,0.8664,Endometrial Endometrioid Adenocarcinoma,0.8653,Endometrioid Adenocarcinoma,0.8636
WELL DIFFERENTIATED INVASIVE EOSPHAGEAL SQUAMOUS CELL CARCINOMA,Esophageal Well Differentiated Squamous Cell Carcinoma<;>Invasive,2,2,Esophageal Adenosquamous Carcinoma,0.6927,Esophageal Well Differentiated Squamous Cell Carcinoma<;>Invasive,0.6854,Cervical Adenosquamous Carcinoma,0.6480,Adenosquamous Carcinoma,0.6450,Head and Neck Basaloid Carcinoma,0.6408
WELL DIFFERENTIATED LIPOSARCOMA,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,5,2,Well Differentiated Liposarcoma,1.0000,Dedifferentiated Liposarcoma,0.8834,Liposarcoma,0.8825,Pleomorphic Liposarcoma,0.8598,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,0.8446
WELL DIFFERENTIATED TUBULAR ADENOCARCINOMA,Tubular Adenocarcinoma<;>Well Differentiated Adenocarcinoma Cell,1,2,Tubular Adenocarcinoma<;>Well Differentiated Adenocarcinoma Cell,0.9538,Tubular Adenocarcinoma,0.9333,Tubular Adenocarcinoma<;>Moderately Differentiated,0.8413,Adenocarcinoma<;>Well Differentiated,0.7868,Gastric Tubular Adenocarcinoma,0.7704
WELL-DIFFERENTIATED LEIOMYOSARCOMA RESEMBLING LEIOMYOMA,Well Differentiated Leiomyosarcoma,1,2,Well Differentiated Leiomyosarcoma,0.9617,Conventional Leiomyosarcoma,0.9078,Leiomyosarcoma,0.8882,Uterine Corpus Leiomyosarcoma,0.8180,Uterine Corpus Myxoid Leiomyosarcoma,0.7979
WELL-DIFFERENTIATED LIPOSARCOMA,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,5,2,Well Differentiated Liposarcoma,0.9960,Dedifferentiated Liposarcoma,0.8870,Liposarcoma,0.8781,Pleomorphic Liposarcoma,0.8592,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,0.8484
WELL-DIFFERENTIATED NEUROENDOCRINE TUMOR OF THE APPENDIX,Appendix Neuroendocrine Tumor,1,2,Appendix Neuroendocrine Tumor,0.8747,Appendix Goblet Cell Adenocarcinoma,0.7005,Appendix Signet Ring Cell Carcinoma,0.6805,Appendix Mucinous Adenocarcinoma,0.6491,Small Intestinal Neuroendocrine Neoplasm<;>Well Differentiated,0.6322
WELL-DIFFERENTIATED NEUROENDOCRINE TUMOR OF THE RECTUM,Rectal Neuroendocrine Tumor<;>Well Differentiated,1,2,Rectal Neuroendocrine Tumor<;>Well Differentiated,0.9662,Colorectal Neuroendocrine Tumor,0.8016,Colorectal Neuroendocrine Carcinoma,0.7735,Adenocarcinoma<;>Well Differentiated<;>Rectum,0.7245,Small Intestinal Neuroendocrine Neoplasm<;>Well Differentiated,0.6975
WELL-DIFFERENTIATED NEUROENDOCRINE TUMORS OF THE STOMACH,Gastric Neuroendocrine Tumor,1,2,Gastric Neuroendocrine Tumor,0.8778,Digestive System Neuroendocrine Tumor,0.7512,Gastric Small Cell Neuroendocrine Carcinoma,0.7425,Small Intestinal Neuroendocrine Neoplasm<;>Well Differentiated,0.7002,Somatostatin-Producing Neuroendocrine Tumor,0.6647
WELL-DIFFERENTIATED THYROID CANCER,Differentiated Thyroid Gland Carcinoma,1,2,Differentiated Thyroid Gland Carcinoma,0.8919,Poorly Differentiated Thyroid Gland Carcinoma,0.8195,Thyroid Gland Anaplastic Carcinoma,0.7441,Adenocarcinoma<;>Well Differentiated,0.7063,Classic Thyroid Gland Papillary Carcinoma,0.6864
WILMS,Wilms Tumor,1,2,Wilms Tumor,0.9487,Nephroblastomatosis,0.6655,Infantile Sarcoma,0.5567,Medulloblastoma,0.5469,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.5462
WILMS TUMOR,Wilms Tumor,1,2,Wilms Tumor,1.0000,Nephroblastomatosis,0.7210,Primitive Neuroectodermal Tumor,0.5765,Dysembryoplastic Neuroepithelial Tumor,0.5716,Kidney Medullary Carcinoma,0.5714
WILMS' TUMOR,Wilms Tumor,1,2,Wilms Tumor,0.9950,Nephroblastomatosis,0.7314,Kidney Medullary Carcinoma,0.5866,Clear Cell Papillary Renal Neoplasm,0.5803,Mesonephric Adenocarcinoma,0.5795
WILMS' TUMORS,Wilms Tumor,1,2,Wilms Tumor,0.9866,Nephroblastomatosis,0.7315,Kidney Medullary Carcinoma,0.5879,Kidney Oncocytoma,0.5872,Clear Cell Papillary Renal Neoplasm,0.5812
WITH DUCTAL AND LOBULAR PHENOTYPES,Breast Mixed Ductal and Lobular Carcinoma,2,2,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.7337,Breast Mixed Ductal and Lobular Carcinoma,0.7208,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.7082,Lobular,0.6311,Ductal,0.6230
WITH TUMOR,With Tumor,1,2,With Tumor,1.0000,Neoplasm,0.7836,Primary Neoplasm,0.7406,Malignant Neoplasm,0.7305,Carcinoma,0.7178
WITH_TUMOR,With Tumor,1,2,With Tumor,0.9265,Neoplasm,0.6792,Primary Neoplasm,0.6612,Carcinoma,0.6435,Malignant Neoplasm,0.6403
WT,Wilms Tumor,1,2,Wilms Tumor,0.5824,Tumor Free,0.5817,Classic Histology,0.5350,Well Differentiated,0.5125,Genomic Stability,0.5085
YOLK SAC TUMOR,Yolk Sac Tumor,1,2,Yolk Sac Tumor,1.0000,Nonseminomatous<;>Yolk Sac Tumor,0.8736,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,0.8460,Ovarian Dysgerminoma<;>Yolk Sac Tumor,0.8383,Nongerminomatous Germ Cell Tumor<;>Yolk Sac Tumor,0.7978
YOLK SAC TUMORNON-SEMINOMA,Nonseminomatous<;>Yolk Sac Tumor,99,2,Yolk Sac Tumor<;>Seminoma,0.9678,Embryonal Carcinoma<;>Seminoma,0.8577,Seminoma,0.8369,Testicular Seminoma,0.8225,Seminoma<;>Mature Teratoma,0.8125
YOLK SAC TUMORSEMINOMA,Yolk Sac Tumor<;>Seminoma,99,2,Yolk Sac Tumor,0.9310,Nonseminomatous<;>Yolk Sac Tumor,0.8602,Embryonal Carcinoma<;>Nonseminomatous<;>Yolk Sac Tumor,0.8409,Ovarian Dysgerminoma<;>Yolk Sac Tumor,0.8328,Nongerminomatous Germ Cell Tumor<;>Yolk Sac Tumor,0.7973
